 
# GREAT version 3.0.0	Species assembly: hg19	Association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included
# Ontology summary statistics are provided in the footer.
#
# Ontology	ID	Desc	BinomRank	BinomP	BinomBonfP	BinomFdrQ	RegionFoldEnrich	ExpRegions	ObsRegions	GenomeFrac	SetCov	HyperRank	HyperP	HyperBonfP	HyperFdrQ	GeneFoldEnrich	ExpGenes	ObsGenes	TotalGenes	GeneSetCov	TermCov	Regions	Genes
GO Molecular Function	GO:0000406	double-strand/single-strand DNA junction binding	1	7.192132e-5	2.652458e-1	2.652458e-1	1.390408e+4	7.192132e-5	1	7.192132e-5	1.000000e+0	1	2.217111e-4	8.176705e-1	8.176705e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	MSH2
GO Molecular Function	GO:0032181	dinucleotide repeat insertion binding	1	7.192132e-5	2.652458e-1	2.652458e-1	1.390408e+4	7.192132e-5	1	7.192132e-5	1.000000e+0	1	2.217111e-4	8.176705e-1	8.176705e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	MSH2
GO Molecular Function	GO:0032139	dinucleotide insertion or deletion binding	3	7.665300e-5	2.826963e-1	9.423209e-2	1.304580e+4	7.665300e-5	1	7.665300e-5	1.000000e+0	5	3.325574e-4	1.000000e+0	2.452943e-1	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	MSH2
GO Molecular Function	GO:0000404	loop DNA binding	4	1.487354e-4	5.485362e-1	1.371340e-1	6.723348e+3	1.487354e-4	1	1.487354e-4	1.000000e+0	5	3.325574e-4	1.000000e+0	2.452943e-1	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	MSH2
GO Molecular Function	GO:0019237	centromeric DNA binding	5	1.500166e-4	5.532612e-1	1.106522e-1	6.665927e+3	1.500166e-4	1	1.500166e-4	1.000000e+0	13	6.650594e-4	1.000000e+0	1.886722e-1	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	MSH2
GO Molecular Function	GO:0032357	oxidized purine DNA binding	6	1.847541e-4	6.813731e-1	1.135622e-1	5.412600e+3	1.847541e-4	1	1.847541e-4	1.000000e+0	1	2.217111e-4	8.176705e-1	8.176705e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	MSH2
GO Molecular Function	GO:0032143	single thymine insertion binding	6	1.847541e-4	6.813731e-1	1.135622e-1	5.412600e+3	1.847541e-4	1	1.847541e-4	1.000000e+0	1	2.217111e-4	8.176705e-1	8.176705e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	MSH2
GO Molecular Function	GO:0032142	single guanine insertion binding	8	1.868510e-4	6.891065e-1	8.613831e-2	5.351857e+3	1.868510e-4	1	1.868510e-4	1.000000e+0	5	3.325574e-4	1.000000e+0	2.452943e-1	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	MSH2
GO Molecular Function	GO:0032138	single base insertion or deletion binding	9	2.268294e-4	8.365468e-1	9.294965e-2	4.408600e+3	2.268294e-4	1	2.268294e-4	1.000000e+0	9	4.433975e-4	1.000000e+0	1.816944e-1	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	MSH2
GO Molecular Function	GO:0000400	four-way junction DNA binding	10	2.461580e-4	9.078307e-1	9.078307e-2	4.062431e+3	2.461580e-4	1	2.461580e-4	1.000000e+0	9	4.433975e-4	1.000000e+0	1.816944e-1	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	MSH2
GO Molecular Function	GO:0032137	guanine/thymine mispair binding	11	2.501180e-4	9.224352e-1	8.385774e-2	3.998113e+3	2.501180e-4	1	2.501180e-4	1.000000e+0	5	3.325574e-4	1.000000e+0	2.452943e-1	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	MSH2
GO Molecular Function	GO:0032405	MutLalpha complex binding	12	2.653420e-4	9.785813e-1	8.154844e-2	3.768722e+3	2.653420e-4	1	2.653420e-4	1.000000e+0	11	5.542315e-4	1.000000e+0	1.858187e-1	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	MSH2
GO Molecular Function	GO:0032135	DNA insertion or deletion binding	13	3.083752e-4	1.000000e+0	8.748367e-2	3.242803e+3	3.083752e-4	1	3.083752e-4	1.000000e+0	13	6.650594e-4	1.000000e+0	1.886722e-1	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	MSH2
GO Molecular Function	GO:0032404	mismatch repair complex binding	14	5.427240e-4	1.000000e+0	1.429690e-1	1.842557e+3	5.427240e-4	1	5.427240e-4	1.000000e+0	15	1.108309e-3	1.000000e+0	2.724962e-1	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	MSH2
GO Molecular Function	GO:0030983	mismatched DNA binding	15	5.887873e-4	1.000000e+0	1.447632e-1	1.698406e+3	5.887873e-4	1	5.887873e-4	1.000000e+0	16	1.440682e-3	1.000000e+0	3.320772e-1	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	MSH2
GO Molecular Function	GO:0000403	Y-form DNA binding	16	6.010731e-4	1.000000e+0	1.385473e-1	1.663691e+3	6.010731e-4	1	6.010731e-4	1.000000e+0	11	5.542315e-4	1.000000e+0	1.858187e-1	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	MSH2
GO Molecular Function	GO:0000217	DNA secondary structure binding	17	1.746516e-3	1.000000e+0	3.788912e-1	5.725684e+2	1.746516e-3	1	1.746516e-3	1.000000e+0	16	1.440682e-3	1.000000e+0	3.320772e-1	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	MSH2
GO Molecular Function	GO:0043531	ADP binding	18	3.353980e-3	1.000000e+0	6.871932e-1	2.981532e+2	3.353980e-3	1	3.353980e-3	1.000000e+0	18	2.769621e-3	1.000000e+0	5.674646e-1	3.608200e+2	2.771465e-3	1	25	5.000000e-1	4.000000e-2	unnamed	MSH2
GO Molecular Function	GO:0003684	damaged DNA binding	19	3.594888e-3	1.000000e+0	6.977867e-1	2.781728e+2	3.594888e-3	1	3.594888e-3	1.000000e+0	19	5.535402e-3	1.000000e+0	1.000000e+0	1.804100e+2	5.542930e-3	1	50	5.000000e-1	2.000000e-2	unnamed	MSH2
GO Molecular Function	GO:0003697	single-stranded DNA binding	20	4.825422e-3	1.000000e+0	8.898078e-1	2.072358e+2	4.825422e-3	1	4.825422e-3	1.000000e+0	20	7.193027e-3	1.000000e+0	1.000000e+0	1.387769e+2	7.205809e-3	1	65	5.000000e-1	1.538462e-2	unnamed	MSH2
GO Molecular Function	GO:0008094	DNA-dependent ATPase activity	21	6.777082e-3	1.000000e+0	1.000000e+0	1.475561e+2	6.777082e-3	1	6.777082e-3	1.000000e+0	21	7.966112e-3	1.000000e+0	1.000000e+0	1.252847e+2	7.981819e-3	1	72	5.000000e-1	1.388889e-2	unnamed	MSH2
GO Molecular Function	GO:0003690	double-stranded DNA binding	22	1.394514e-2	1.000000e+0	1.000000e+0	7.170956e+1	1.394514e-2	1	1.394514e-2	1.000000e+0	23	1.369960e-2	1.000000e+0	1.000000e+0	7.274597e+1	1.374647e-2	1	124	5.000000e-1	8.064516e-3	unnamed	MSH2
GO Molecular Function	GO:0008022	protein C-terminus binding	23	1.641438e-2	1.000000e+0	1.000000e+0	6.092218e+1	1.641438e-2	1	1.641438e-2	1.000000e+0	25	1.754933e-2	1.000000e+0	1.000000e+0	5.673270e+1	1.762652e-2	1	159	5.000000e-1	6.289308e-3	unnamed	MSH2
GO Molecular Function	GO:0000287	magnesium ion binding	24	1.834502e-2	1.000000e+0	1.000000e+0	5.451069e+1	1.834502e-2	1	1.834502e-2	1.000000e+0	27	2.062369e-2	1.000000e+0	1.000000e+0	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	MSH2
GO Molecular Function	GO:0005267	potassium channel activity	25	1.837215e-2	1.000000e+0	1.000000e+0	5.443020e+1	1.837215e-2	1	1.837215e-2	1.000000e+0	22	1.292876e-2	1.000000e+0	1.000000e+0	7.709829e+1	1.297046e-2	1	117	5.000000e-1	8.547009e-3	unnamed	KCNK12
GO Molecular Function	GO:0015079	potassium ion transmembrane transporter activity	26	1.978212e-2	1.000000e+0	1.000000e+0	5.055069e+1	1.978212e-2	1	1.978212e-2	1.000000e+0	24	1.469025e-2	1.000000e+0	1.000000e+0	6.782331e+1	1.474419e-2	1	133	5.000000e-1	7.518797e-3	unnamed	KCNK12
GO Molecular Function	GO:0043566	structure-specific DNA binding	27	2.331952e-2	1.000000e+0	1.000000e+0	4.288253e+1	2.331952e-2	1	2.331952e-2	1.000000e+0	28	2.303588e-2	1.000000e+0	1.000000e+0	4.316029e+1	2.316945e-2	1	209	5.000000e-1	4.784689e-3	unnamed	MSH2
GO Molecular Function	GO:0042623	ATPase activity, coupled	28	2.500268e-2	1.000000e+0	1.000000e+0	3.999572e+1	2.500268e-2	1	2.500268e-2	1.000000e+0	30	3.145511e-2	1.000000e+0	1.000000e+0	3.154021e+1	3.170556e-2	1	286	5.000000e-1	3.496503e-3	unnamed	MSH2
GO Molecular Function	GO:0005244	voltage-gated ion channel activity	29	2.526162e-2	1.000000e+0	1.000000e+0	3.958574e+1	2.526162e-2	1	2.526162e-2	1.000000e+0	26	2.007505e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	KCNK12
GO Molecular Function	GO:0016887	ATPase activity	30	3.096702e-2	1.000000e+0	1.000000e+0	3.229242e+1	3.096702e-2	1	3.096702e-2	1.000000e+0	33	3.918602e-2	1.000000e+0	1.000000e+0	2.526751e+1	3.957652e-2	1	357	5.000000e-1	2.801120e-3	unnamed	MSH2
GO Molecular Function	GO:0015077	monovalent inorganic cation transmembrane transporter activity	31	3.573375e-2	1.000000e+0	1.000000e+0	2.798475e+1	3.573375e-2	1	3.573375e-2	1.000000e+0	32	3.624975e-2	1.000000e+0	1.000000e+0	2.733485e+1	3.658334e-2	1	330	5.000000e-1	3.030303e-3	unnamed	KCNK12
GO Molecular Function	GO:0005261	cation channel activity	32	3.661835e-2	1.000000e+0	1.000000e+0	2.730871e+1	3.661835e-2	1	3.661835e-2	1.000000e+0	29	3.003624e-2	1.000000e+0	1.000000e+0	3.304212e+1	3.026440e-2	1	273	5.000000e-1	3.663004e-3	unnamed	KCNK12
GO Molecular Function	GO:0019901	protein kinase binding	33	3.996582e-2	1.000000e+0	1.000000e+0	2.502138e+1	3.996582e-2	1	3.996582e-2	1.000000e+0	36	4.157523e-2	1.000000e+0	1.000000e+0	2.380079e+1	4.201541e-2	1	379	5.000000e-1	2.638522e-3	unnamed	MSH2
GO Molecular Function	GO:0022839	ion gated channel activity	34	4.227146e-2	1.000000e+0	1.000000e+0	2.365662e+1	4.227146e-2	1	4.227146e-2	1.000000e+0	31	3.298197e-2	1.000000e+0	1.000000e+0	3.006833e+1	3.325758e-2	1	300	5.000000e-1	3.333333e-3	unnamed	KCNK12
GO Molecular Function	GO:0019900	kinase binding	35	4.338612e-2	1.000000e+0	1.000000e+0	2.304885e+1	4.338612e-2	1	4.338612e-2	1.000000e+0	39	4.612818e-2	1.000000e+0	1.000000e+0	2.142637e+1	4.667147e-2	1	421	5.000000e-1	2.375297e-3	unnamed	MSH2
GO Molecular Function	GO:0046873	metal ion transmembrane transporter activity	36	4.714781e-2	1.000000e+0	1.000000e+0	2.120989e+1	4.714781e-2	1	4.714781e-2	1.000000e+0	37	4.233480e-2	1.000000e+0	1.000000e+0	2.336917e+1	4.279142e-2	1	386	5.000000e-1	2.590674e-3	unnamed	KCNK12
GO Molecular Function	GO:0005216	ion channel activity	37	4.814144e-2	1.000000e+0	1.000000e+0	2.077212e+1	4.814144e-2	1	4.814144e-2	1.000000e+0	34	4.059818e-2	1.000000e+0	1.000000e+0	2.437973e+1	4.101768e-2	1	370	5.000000e-1	2.702703e-3	unnamed	KCNK12
GO Molecular Function	GO:0022838	substrate-specific channel activity	38	4.861448e-2	1.000000e+0	1.000000e+0	2.057000e+1	4.861448e-2	1	4.861448e-2	1.000000e+0	35	4.146669e-2	1.000000e+0	1.000000e+0	2.386376e+1	4.190455e-2	1	378	5.000000e-1	2.645503e-3	unnamed	KCNK12
GO Molecular Function	GO:0015267	channel activity	39	5.039650e-2	1.000000e+0	1.000000e+0	1.984265e+1	5.039650e-2	1	5.039650e-2	1.000000e+0	38	4.385306e-2	1.000000e+0	1.000000e+0	2.255125e+1	4.434344e-2	1	400	5.000000e-1	2.500000e-3	unnamed	KCNK12
GO Molecular Function	GO:0022890	inorganic cation transmembrane transporter activity	40	5.424017e-2	1.000000e+0	1.000000e+0	1.843652e+1	5.424017e-2	1	5.424017e-2	1.000000e+0	40	5.228984e-2	1.000000e+0	1.000000e+0	1.887134e+1	5.299041e-2	1	478	5.000000e-1	2.092050e-3	unnamed	KCNK12
GO Molecular Function	GO:0032403	protein complex binding	41	5.694276e-2	1.000000e+0	1.000000e+0	1.756149e+1	5.694276e-2	1	5.694276e-2	1.000000e+0	41	6.272959e-2	1.000000e+0	1.000000e+0	1.568783e+1	6.374369e-2	1	575	5.000000e-1	1.739130e-3	unnamed	MSH2
GO Molecular Function	GO:0042803	protein homodimerization activity	42	6.175957e-2	1.000000e+0	1.000000e+0	1.619182e+1	6.175957e-2	1	6.175957e-2	1.000000e+0	42	6.294423e-2	1.000000e+0	1.000000e+0	1.563345e+1	6.396541e-2	1	577	5.000000e-1	1.733102e-3	unnamed	MSH2
GO Molecular Function	GO:0017111	nucleoside-triphosphatase activity	43	6.384690e-2	1.000000e+0	1.000000e+0	1.566247e+1	6.384690e-2	1	6.384690e-2	1.000000e+0	45	8.258634e-2	1.000000e+0	1.000000e+0	1.185348e+1	8.436339e-2	1	761	5.000000e-1	1.314060e-3	unnamed	MSH2
GO Molecular Function	GO:0008324	cation transmembrane transporter activity	44	6.410546e-2	1.000000e+0	1.000000e+0	1.559929e+1	6.410546e-2	1	6.410546e-2	1.000000e+0	43	6.433882e-2	1.000000e+0	1.000000e+0	1.528898e+1	6.540657e-2	1	590	5.000000e-1	1.694915e-3	unnamed	KCNK12
GO Molecular Function	GO:0016462	pyrophosphatase activity	45	6.707668e-2	1.000000e+0	1.000000e+0	1.490831e+1	6.707668e-2	1	6.707668e-2	1.000000e+0	47	8.661694e-2	1.000000e+0	1.000000e+0	1.128974e+1	8.857602e-2	1	799	5.000000e-1	1.251564e-3	unnamed	MSH2
GO Molecular Function	GO:0016818	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	46	6.729645e-2	1.000000e+0	1.000000e+0	1.485962e+1	6.729645e-2	1	6.729645e-2	1.000000e+0	48	8.693477e-2	1.000000e+0	1.000000e+0	1.124751e+1	8.890860e-2	1	802	5.000000e-1	1.246883e-3	unnamed	MSH2
GO Molecular Function	GO:0016817	hydrolase activity, acting on acid anhydrides	47	6.743909e-2	1.000000e+0	1.000000e+0	1.482820e+1	6.743909e-2	1	6.743909e-2	1.000000e+0	49	8.746436e-2	1.000000e+0	1.000000e+0	1.117782e+1	8.946289e-2	1	807	5.000000e-1	1.239157e-3	unnamed	MSH2
GO Molecular Function	GO:0015075	ion transmembrane transporter activity	48	8.122600e-2	1.000000e+0	1.000000e+0	1.231133e+1	8.122600e-2	1	8.122600e-2	1.000000e+0	46	8.301103e-2	1.000000e+0	1.000000e+0	1.179150e+1	8.480683e-2	1	765	5.000000e-1	1.307190e-3	unnamed	KCNK12
GO Molecular Function	GO:0022891	substrate-specific transmembrane transporter activity	49	8.482288e-2	1.000000e+0	1.000000e+0	1.178927e+1	8.482288e-2	1	8.482288e-2	1.000000e+0	50	8.926381e-2	1.000000e+0	1.000000e+0	1.094721e+1	9.134749e-2	1	824	5.000000e-1	1.213592e-3	unnamed	KCNK12
GO Molecular Function	GO:0022857	transmembrane transporter activity	50	9.170810e-2	1.000000e+0	1.000000e+0	1.090416e+1	9.170810e-2	1	9.170810e-2	1.000000e+0	51	9.802388e-2	1.000000e+0	1.000000e+0	9.945424e+0	1.005488e-1	1	907	5.000000e-1	1.102536e-3	unnamed	KCNK12
GO Molecular Function	GO:0022892	substrate-specific transporter activity	51	9.245642e-2	1.000000e+0	1.000000e+0	1.081591e+1	9.245642e-2	1	9.245642e-2	1.000000e+0	52	1.030706e-1	1.000000e+0	1.000000e+0	9.445550e+0	1.058700e-1	1	955	5.000000e-1	1.047120e-3	unnamed	KCNK12
GO Molecular Function	GO:0043565	sequence-specific DNA binding	52	9.345854e-2	1.000000e+0	1.000000e+0	1.069993e+1	9.345854e-2	1	9.345854e-2	1.000000e+0	44	7.577790e-2	1.000000e+0	1.000000e+0	1.294189e+1	7.726844e-2	1	697	5.000000e-1	1.434720e-3	unnamed	MSH2
GO Molecular Function	GO:0042802	identical protein binding	53	9.800114e-2	1.000000e+0	1.000000e+0	1.020396e+1	9.800114e-2	1	9.800114e-2	1.000000e+0	53	1.043301e-1	1.000000e+0	1.000000e+0	9.328335e+0	1.072003e-1	1	967	5.000000e-1	1.034126e-3	unnamed	MSH2
GO Molecular Function	GO:0046983	protein dimerization activity	54	1.038803e-1	1.000000e+0	1.000000e+0	9.626466e+0	1.038803e-1	1	1.038803e-1	1.000000e+0	54	1.064273e-1	1.000000e+0	1.000000e+0	9.139311e+0	1.094174e-1	1	987	5.000000e-1	1.013171e-3	unnamed	MSH2
GO Molecular Function	GO:0005215	transporter activity	55	1.089898e-1	1.000000e+0	1.000000e+0	9.175171e+0	1.089898e-1	1	1.089898e-1	1.000000e+0	56	1.269529e-1	1.000000e+0	1.000000e+0	7.618666e+0	1.312566e-1	1	1184	5.000000e-1	8.445946e-4	unnamed	KCNK12
GO Molecular Function	GO:0019899	enzyme binding	56	1.157271e-1	1.000000e+0	1.000000e+0	8.641016e+0	1.157271e-1	1	1.157271e-1	1.000000e+0	55	1.255021e-1	1.000000e+0	1.000000e+0	7.709829e+0	1.297046e-1	1	1170	5.000000e-1	8.547009e-4	unnamed	MSH2
GO Molecular Function	GO:0005524	ATP binding	57	1.376192e-1	1.000000e+0	1.000000e+0	7.266427e+0	1.376192e-1	1	1.376192e-1	1.000000e+0	57	1.563271e-1	1.000000e+0	1.000000e+0	6.136395e+0	1.629621e-1	1	1470	5.000000e-1	6.802721e-4	unnamed	MSH2
GO Molecular Function	GO:0032559	adenyl ribonucleotide binding	58	1.426806e-1	1.000000e+0	1.000000e+0	7.008664e+0	1.426806e-1	1	1.426806e-1	1.000000e+0	58	1.595825e-1	1.000000e+0	1.000000e+0	6.005659e+0	1.665096e-1	1	1502	5.000000e-1	6.657790e-4	unnamed	MSH2
GO Molecular Function	GO:0030554	adenyl nucleotide binding	59	1.431520e-1	1.000000e+0	1.000000e+0	6.985581e+0	1.431520e-1	1	1.431520e-1	1.000000e+0	59	1.611063e-1	1.000000e+0	1.000000e+0	5.946276e+0	1.681725e-1	1	1517	5.000000e-1	6.591958e-4	unnamed	MSH2
GO Molecular Function	GO:0035639	purine ribonucleoside triphosphate binding	60	1.642264e-1	1.000000e+0	1.000000e+0	6.089156e+0	1.642264e-1	1	1.642264e-1	1.000000e+0	60	1.902943e-1	1.000000e+0	1.000000e+0	4.991976e+0	2.003215e-1	1	1807	5.000000e-1	5.534034e-4	unnamed	MSH2
GO Molecular Function	GO:0032550	purine ribonucleoside binding	61	1.650919e-1	1.000000e+0	1.000000e+0	6.057234e+0	1.650919e-1	1	1.650919e-1	1.000000e+0	61	1.911919e-1	1.000000e+0	1.000000e+0	4.967236e+0	2.013192e-1	1	1816	5.000000e-1	5.506608e-4	unnamed	MSH2
GO Molecular Function	GO:0001883	purine nucleoside binding	62	1.651911e-1	1.000000e+0	1.000000e+0	6.053594e+0	1.651911e-1	1	1.651911e-1	1.000000e+0	62	1.914910e-1	1.000000e+0	1.000000e+0	4.959043e+0	2.016518e-1	1	1819	5.000000e-1	5.497526e-4	unnamed	MSH2
GO Molecular Function	GO:0032549	ribonucleoside binding	63	1.652867e-1	1.000000e+0	1.000000e+0	6.050092e+0	1.652867e-1	1	1.652867e-1	1.000000e+0	63	1.915906e-1	1.000000e+0	1.000000e+0	4.956319e+0	2.017627e-1	1	1820	5.000000e-1	5.494505e-4	unnamed	MSH2
GO Molecular Function	GO:0001882	nucleoside binding	64	1.658155e-1	1.000000e+0	1.000000e+0	6.030800e+0	1.658155e-1	1	1.658155e-1	1.000000e+0	64	1.925871e-1	1.000000e+0	1.000000e+0	4.929235e+0	2.028712e-1	1	1830	5.000000e-1	5.464481e-4	unnamed	MSH2
GO Molecular Function	GO:0032555	purine ribonucleotide binding	65	1.693981e-1	1.000000e+0	1.000000e+0	5.903255e+0	1.693981e-1	1	1.693981e-1	1.000000e+0	65	1.940807e-1	1.000000e+0	1.000000e+0	4.889160e+0	2.045341e-1	1	1845	5.000000e-1	5.420054e-4	unnamed	MSH2
GO Molecular Function	GO:0017076	purine nucleotide binding	66	1.701196e-1	1.000000e+0	1.000000e+0	5.878217e+0	1.701196e-1	1	1.701196e-1	1.000000e+0	67	1.957717e-1	1.000000e+0	1.000000e+0	4.844522e+0	2.064187e-1	1	1862	5.000000e-1	5.370569e-4	unnamed	MSH2
GO Molecular Function	GO:0032553	ribonucleotide binding	67	1.708664e-1	1.000000e+0	1.000000e+0	5.852525e+0	1.708664e-1	1	1.708664e-1	1.000000e+0	66	1.954734e-1	1.000000e+0	1.000000e+0	4.852340e+0	2.060861e-1	1	1859	5.000000e-1	5.379236e-4	unnamed	MSH2
GO Molecular Function	GO:0016787	hydrolase activity	68	1.965374e-1	1.000000e+0	1.000000e+0	5.088091e+0	1.965374e-1	1	1.965374e-1	1.000000e+0	72	2.486583e-1	1.000000e+0	1.000000e+0	3.753849e+0	2.663932e-1	1	2403	5.000000e-1	4.161465e-4	unnamed	MSH2
GO Molecular Function	GO:0097367	carbohydrate derivative binding	69	1.996235e-1	1.000000e+0	1.000000e+0	5.009431e+0	1.996235e-1	1	1.996235e-1	1.000000e+0	68	2.230751e-1	1.000000e+0	1.000000e+0	4.217158e+0	2.371265e-1	1	2139	5.000000e-1	4.675082e-4	unnamed	MSH2
GO Molecular Function	GO:0000166	nucleotide binding	70	2.080686e-1	1.000000e+0	1.000000e+0	4.806107e+0	2.080686e-1	1	2.080686e-1	1.000000e+0	69	2.401781e-1	1.000000e+0	1.000000e+0	3.896544e+0	2.566377e-1	1	2315	5.000000e-1	4.319654e-4	unnamed	MSH2
GO Molecular Function	GO:1901265	nucleoside phosphate binding	71	2.081652e-1	1.000000e+0	1.000000e+0	4.803877e+0	2.081652e-1	1	2.081652e-1	1.000000e+0	70	2.402748e-1	1.000000e+0	1.000000e+0	3.894862e+0	2.567485e-1	1	2316	5.000000e-1	4.317789e-4	unnamed	MSH2
GO Molecular Function	GO:0003677	DNA binding	72	2.170876e-1	1.000000e+0	1.000000e+0	4.606435e+0	2.170876e-1	1	2.170876e-1	1.000000e+0	71	2.465427e-1	1.000000e+0	1.000000e+0	3.788534e+0	2.639543e-1	1	2381	5.000000e-1	4.199916e-4	unnamed	MSH2
GO Molecular Function	GO:0036094	small molecule binding	73	2.286651e-1	1.000000e+0	1.000000e+0	4.373209e+0	2.286651e-1	1	2.286651e-1	1.000000e+0	73	2.643352e-1	1.000000e+0	1.000000e+0	3.514024e+0	2.845740e-1	1	2567	5.000000e-1	3.895598e-4	unnamed	MSH2
GO Molecular Function	GO:0043168	anion binding	74	2.579088e-1	1.000000e+0	1.000000e+0	3.877340e+0	2.579088e-1	1	2.579088e-1	1.000000e+0	74	2.792822e-1	1.000000e+0	1.000000e+0	3.310275e+0	3.020897e-1	1	2725	5.000000e-1	3.669725e-4	unnamed	MSH2
GO Molecular Function	GO:0003676	nucleic acid binding	75	2.841930e-1	1.000000e+0	1.000000e+0	3.518736e+0	2.841930e-1	1	2.841930e-1	1.000000e+0	75	3.411408e-1	1.000000e+0	1.000000e+0	2.655431e+0	3.765867e-1	1	3397	5.000000e-1	2.943774e-4	unnamed	MSH2
GO Molecular Function	GO:0046872	metal ion binding	76	3.527991e-1	1.000000e+0	1.000000e+0	2.834474e+0	3.527991e-1	1	3.527991e-1	1.000000e+0	76	3.911753e-1	1.000000e+0	1.000000e+0	2.275605e+0	4.394435e-1	1	3964	5.000000e-1	2.522704e-4	unnamed	MSH2
GO Molecular Function	GO:0043169	cation binding	77	3.606111e-1	1.000000e+0	1.000000e+0	2.773071e+0	3.606111e-1	1	3.606111e-1	1.000000e+0	77	3.968711e-1	1.000000e+0	1.000000e+0	2.238337e+0	4.467602e-1	1	4030	5.000000e-1	2.481390e-4	unnamed	MSH2
GO Molecular Function	GO:1901363	heterocyclic compound binding	78	4.273925e-1	1.000000e+0	1.000000e+0	2.339769e+0	4.273925e-1	1	4.273925e-1	1.000000e+0	78	5.012582e-1	1.000000e+0	1.000000e+0	1.701981e+0	5.875506e-1	1	5300	5.000000e-1	1.886792e-4	unnamed	MSH2
GO Molecular Function	GO:0097159	organic cyclic compound binding	79	4.323803e-1	1.000000e+0	1.000000e+0	2.312779e+0	4.323803e-1	1	4.323803e-1	1.000000e+0	79	5.069571e-1	1.000000e+0	1.000000e+0	1.678857e+0	5.956433e-1	1	5373	5.000000e-1	1.861158e-4	unnamed	MSH2
GO Molecular Function	GO:0003824	catalytic activity	80	4.361959e-1	1.000000e+0	1.000000e+0	2.292548e+0	4.361959e-1	1	4.361959e-1	1.000000e+0	80	5.163312e-1	1.000000e+0	1.000000e+0	1.641882e+0	6.090571e-1	1	5494	5.000000e-1	1.820167e-4	unnamed	MSH2
GO Molecular Function	GO:0043167	ion binding	81	5.095070e-1	1.000000e+0	1.000000e+0	1.962682e+0	5.095070e-1	1	5.095070e-1	1.000000e+0	81	5.570694e-1	1.000000e+0	1.000000e+0	1.494945e+0	6.689208e-1	1	6034	5.000000e-1	1.657275e-4	unnamed	MSH2
GO Molecular Function	GO:0005515	protein binding	82	6.181781e-1	1.000000e+0	1.000000e+0	1.617657e+0	6.181781e-1	1	6.181781e-1	1.000000e+0	82	6.900633e-1	1.000000e+0	1.000000e+0	1.127985e+0	8.865362e-1	1	7997	5.000000e-1	1.250469e-4	unnamed	MSH2
GO Molecular Function	GO:0005488	binding	83	8.171102e-1	1.000000e+0	1.000000e+0	1.223825e+0	8.171102e-1	1	8.171102e-1	1.000000e+0	83	8.942547e-1	1.000000e+0	1.000000e+0	7.409644e-1	1.349593e+0	1	12174	5.000000e-1	8.214227e-5	unnamed	MSH2
GO Biological Process	GO:0045128	negative regulation of reciprocal meiotic recombination	1	6.982440e-5	7.289667e-1	7.289667e-1	1.432164e+4	6.982440e-5	1	6.982440e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	MSH2
GO Biological Process	GO:0031573	intra-S DNA damage checkpoint	2	3.926745e-4	1.000000e+0	1.000000e+0	2.546638e+3	3.926745e-4	1	3.926745e-4	1.000000e+0	7	7.758812e-4	1.000000e+0	1.000000e+0	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	MSH2
GO Biological Process	GO:0016446	somatic hypermutation of immunoglobulin genes	3	5.538052e-4	1.000000e+0	1.000000e+0	1.805689e+3	5.538052e-4	1	5.538052e-4	1.000000e+0	9	9.975062e-4	1.000000e+0	1.000000e+0	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	MSH2
GO Biological Process	GO:0000710	meiotic mismatch repair	4	5.902030e-4	1.000000e+0	1.000000e+0	1.694332e+3	5.902030e-4	1	5.902030e-4	1.000000e+0	3	4.433975e-4	1.000000e+0	1.000000e+0	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	MSH2
GO Biological Process	GO:0051096	positive regulation of helicase activity	5	6.115101e-4	1.000000e+0	1.000000e+0	1.635296e+3	6.115101e-4	1	6.115101e-4	1.000000e+0	6	6.650594e-4	1.000000e+0	1.000000e+0	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	MSH2
GO Biological Process	GO:0010520	regulation of reciprocal meiotic recombination	6	7.002683e-4	1.000000e+0	1.000000e+0	1.428024e+3	7.002683e-4	1	7.002683e-4	1.000000e+0	2	3.325574e-4	1.000000e+0	1.000000e+0	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	MSH2
GO Biological Process	GO:0045835	negative regulation of meiosis	7	7.131409e-4	1.000000e+0	1.000000e+0	1.402248e+3	7.131409e-4	1	7.131409e-4	1.000000e+0	11	1.108309e-3	1.000000e+0	1.000000e+0	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	MSH2
GO Biological Process	GO:0051095	regulation of helicase activity	8	7.573525e-4	1.000000e+0	9.883450e-1	1.320389e+3	7.573525e-4	1	7.573525e-4	1.000000e+0	9	9.975062e-4	1.000000e+0	1.000000e+0	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	MSH2
GO Biological Process	GO:0043570	maintenance of DNA repeat elements	9	8.227937e-4	1.000000e+0	9.544407e-1	1.215372e+3	8.227937e-4	1	8.227937e-4	1.000000e+0	3	4.433975e-4	1.000000e+0	1.000000e+0	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	MSH2
GO Biological Process	GO:0006311	meiotic gene conversion	10	8.715493e-4	1.000000e+0	9.098975e-1	1.147382e+3	8.715493e-4	1	8.715493e-4	1.000000e+0	3	4.433975e-4	1.000000e+0	1.000000e+0	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	MSH2
GO Biological Process	GO:0060631	regulation of meiosis I	11	1.000185e-3	1.000000e+0	9.492665e-1	9.998152e+2	1.000185e-3	1	1.000185e-3	1.000000e+0	7	7.758812e-4	1.000000e+0	1.000000e+0	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	MSH2
GO Biological Process	GO:0045910	negative regulation of DNA recombination	12	1.205328e-3	1.000000e+0	1.000000e+0	8.296495e+2	1.205328e-3	1	1.205328e-3	1.000000e+0	13	1.551461e-3	1.000000e+0	1.000000e+0	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	MSH2
GO Biological Process	GO:0008340	determination of adult lifespan	13	1.285924e-3	1.000000e+0	1.000000e+0	7.776511e+2	1.285924e-3	1	1.285924e-3	1.000000e+0	12	1.329898e-3	1.000000e+0	1.000000e+0	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	MSH2
GO Biological Process	GO:0006301	postreplication repair	14	1.322133e-3	1.000000e+0	9.859335e-1	7.563538e+2	1.322133e-3	1	1.322133e-3	1.000000e+0	15	1.883760e-3	1.000000e+0	1.000000e+0	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	MSH2
GO Biological Process	GO:0010224	response to UV-B	15	1.339062e-3	1.000000e+0	9.319872e-1	7.467916e+2	1.339062e-3	1	1.339062e-3	1.000000e+0	14	1.773000e-3	1.000000e+0	1.000000e+0	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	MSH2
GO Biological Process	GO:0045190	isotype switching	16	1.396641e-3	1.000000e+0	9.113083e-1	7.160035e+2	1.396641e-3	1	1.396641e-3	1.000000e+0	16	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	MSH2
GO Biological Process	GO:0006298	mismatch repair	17	1.404574e-3	1.000000e+0	8.625737e-1	7.119598e+2	1.404574e-3	1	1.404574e-3	1.000000e+0	17	2.216004e-3	1.000000e+0	1.000000e+0	4.510250e+2	2.217172e-3	1	20	5.000000e-1	5.000000e-2	unnamed	MSH2
GO Biological Process	GO:0002381	immunoglobulin production involved in immunoglobulin mediated immune response	18	1.596204e-3	1.000000e+0	9.257983e-1	6.264863e+2	1.596204e-3	1	1.596204e-3	1.000000e+0	18	2.437470e-3	1.000000e+0	1.000000e+0	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	MSH2
GO Biological Process	GO:0042771	intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	19	1.804697e-3	1.000000e+0	9.916335e-1	5.541098e+2	1.804697e-3	1	1.804697e-3	1.000000e+0	20	2.769621e-3	1.000000e+0	1.000000e+0	3.608200e+2	2.771465e-3	1	25	5.000000e-1	4.000000e-2	unnamed	MSH2
GO Biological Process	GO:0016447	somatic recombination of immunoglobulin gene segments	20	2.138386e-3	1.000000e+0	1.000000e+0	4.676423e+2	2.138386e-3	1	2.138386e-3	1.000000e+0	20	2.769621e-3	1.000000e+0	1.000000e+0	3.608200e+2	2.771465e-3	1	25	5.000000e-1	4.000000e-2	unnamed	MSH2
GO Biological Process	GO:0016445	somatic diversification of immunoglobulins	21	2.719009e-3	1.000000e+0	1.000000e+0	3.677810e+2	2.719009e-3	1	2.719009e-3	1.000000e+0	24	3.212404e-3	1.000000e+0	1.000000e+0	3.110517e+2	3.214899e-3	1	29	5.000000e-1	3.448276e-2	unnamed	MSH2
GO Biological Process	GO:0010165	response to X-ray	22	2.893547e-3	1.000000e+0	1.000000e+0	3.455967e+2	2.893547e-3	1	2.893547e-3	1.000000e+0	19	2.548193e-3	1.000000e+0	1.000000e+0	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	MSH2
GO Biological Process	GO:0002312	B cell activation involved in immune response	23	2.973792e-3	1.000000e+0	1.000000e+0	3.362710e+2	2.973792e-3	1	2.973792e-3	1.000000e+0	23	3.101718e-3	1.000000e+0	1.000000e+0	3.221607e+2	3.104041e-3	1	28	5.000000e-1	3.571429e-2	unnamed	MSH2
GO Biological Process	GO:0006119	oxidative phosphorylation	24	3.050287e-3	1.000000e+0	1.000000e+0	3.278380e+2	3.050287e-3	1	3.050287e-3	1.000000e+0	39	7.855690e-3	1.000000e+0	1.000000e+0	1.270493e+2	7.870961e-3	1	71	5.000000e-1	1.408451e-2	unnamed	MSH2
GO Biological Process	GO:0010259	multicellular organismal aging	25	3.257234e-3	1.000000e+0	1.000000e+0	3.070090e+2	3.257234e-3	1	3.257234e-3	1.000000e+0	24	3.212404e-3	1.000000e+0	1.000000e+0	3.110517e+2	3.214899e-3	1	29	5.000000e-1	3.448276e-2	unnamed	MSH2
GO Biological Process	GO:0040020	regulation of meiosis	26	3.388088e-3	1.000000e+0	1.000000e+0	2.951517e+2	3.388088e-3	1	3.388088e-3	1.000000e+0	22	2.880326e-3	1.000000e+0	1.000000e+0	3.469423e+2	2.882324e-3	1	26	5.000000e-1	3.846154e-2	unnamed	MSH2
GO Biological Process	GO:0002562	somatic diversification of immune receptors via germline recombination within a single locus	27	3.415576e-3	1.000000e+0	1.000000e+0	2.927763e+2	3.415576e-3	1	3.415576e-3	1.000000e+0	27	3.655089e-3	1.000000e+0	1.000000e+0	2.733485e+2	3.658334e-3	1	33	5.000000e-1	3.030303e-2	unnamed	MSH2
GO Biological Process	GO:0072332	intrinsic apoptotic signaling pathway by p53 class mediator	28	3.493815e-3	1.000000e+0	1.000000e+0	2.862201e+2	3.493815e-3	1	3.493815e-3	1.000000e+0	29	4.097676e-3	1.000000e+0	1.000000e+0	2.437973e+2	4.101768e-3	1	37	5.000000e-1	2.702703e-2	unnamed	MSH2
GO Biological Process	GO:0002200	somatic diversification of immune receptors	29	3.636505e-3	1.000000e+0	1.000000e+0	2.749893e+2	3.636505e-3	1	3.636505e-3	1.000000e+0	28	3.987038e-3	1.000000e+0	1.000000e+0	2.505694e+2	3.990910e-3	1	36	5.000000e-1	2.777778e-2	unnamed	MSH2
GO Biological Process	GO:0008630	intrinsic apoptotic signaling pathway in response to DNA damage	30	3.654312e-3	1.000000e+0	1.000000e+0	2.736493e+2	3.654312e-3	1	3.654312e-3	1.000000e+0	32	5.645954e-3	1.000000e+0	1.000000e+0	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	MSH2
GO Biological Process	GO:0051445	regulation of meiotic cell cycle	31	3.735738e-3	1.000000e+0	1.000000e+0	2.676847e+2	3.735738e-3	1	3.735738e-3	1.000000e+0	26	3.433759e-3	1.000000e+0	1.000000e+0	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	MSH2
GO Biological Process	GO:0016064	immunoglobulin mediated immune response	32	3.909104e-3	1.000000e+0	1.000000e+0	2.558131e+2	3.909104e-3	1	3.909104e-3	1.000000e+0	35	7.303486e-3	1.000000e+0	1.000000e+0	1.366742e+2	7.316668e-3	1	66	5.000000e-1	1.515152e-2	unnamed	MSH2
GO Biological Process	GO:0002377	immunoglobulin production	33	4.032525e-3	1.000000e+0	1.000000e+0	2.479836e+2	4.032525e-3	1	4.032525e-3	1.000000e+0	30	4.429551e-3	1.000000e+0	1.000000e+0	2.255125e+2	4.434344e-3	1	40	5.000000e-1	2.500000e-2	unnamed	MSH2
GO Biological Process	GO:0019724	B cell mediated immunity	34	4.060937e-3	1.000000e+0	1.000000e+0	2.462486e+2	4.060937e-3	1	4.060937e-3	1.000000e+0	37	7.634827e-3	1.000000e+0	1.000000e+0	1.307319e+2	7.649243e-3	1	69	5.000000e-1	1.449275e-2	unnamed	MSH2
GO Biological Process	GO:0002440	production of molecular mediator of immune response	35	4.922324e-3	1.000000e+0	1.000000e+0	2.031561e+2	4.922324e-3	1	4.922324e-3	1.000000e+0	31	5.203711e-3	1.000000e+0	1.000000e+0	1.919255e+2	5.210354e-3	1	47	5.000000e-1	2.127660e-2	unnamed	MSH2
GO Biological Process	GO:0000018	regulation of DNA recombination	36	5.026024e-3	1.000000e+0	1.000000e+0	1.989644e+2	5.026024e-3	1	5.026024e-3	1.000000e+0	32	5.645954e-3	1.000000e+0	1.000000e+0	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	MSH2
GO Biological Process	GO:0007127	meiosis I	37	5.621554e-3	1.000000e+0	1.000000e+0	1.778868e+2	5.621554e-3	1	5.621554e-3	1.000000e+0	40	8.407740e-3	1.000000e+0	1.000000e+0	1.186908e+2	8.425254e-3	1	76	5.000000e-1	1.315789e-2	unnamed	MSH2
GO Biological Process	GO:0002449	lymphocyte mediated immunity	38	5.745465e-3	1.000000e+0	1.000000e+0	1.740503e+2	5.745465e-3	1	5.745465e-3	1.000000e+0	43	1.105544e-2	1.000000e+0	1.000000e+0	9.020500e+1	1.108586e-2	1	100	5.000000e-1	1.000000e-2	unnamed	MSH2
GO Biological Process	GO:0002285	lymphocyte activation involved in immune response	39	5.796329e-3	1.000000e+0	1.000000e+0	1.725230e+2	5.796329e-3	1	5.796329e-3	1.000000e+0	34	6.309133e-3	1.000000e+0	1.000000e+0	1.582544e+2	6.318940e-3	1	57	5.000000e-1	1.754386e-2	unnamed	MSH2
GO Biological Process	GO:0051053	negative regulation of DNA metabolic process	40	6.116346e-3	1.000000e+0	1.000000e+0	1.634963e+2	6.116346e-3	1	6.116346e-3	1.000000e+0	36	7.413939e-3	1.000000e+0	1.000000e+0	1.346343e+2	7.427526e-3	1	67	5.000000e-1	1.492537e-2	unnamed	MSH2
GO Biological Process	GO:0002460	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	41	8.424293e-3	1.000000e+0	1.000000e+0	1.187043e+2	8.424293e-3	1	8.424293e-3	1.000000e+0	49	1.226779e-2	1.000000e+0	1.000000e+0	8.126577e+1	1.230530e-2	1	111	5.000000e-1	9.009009e-3	unnamed	MSH2
GO Biological Process	GO:0002443	leukocyte mediated immunity	42	8.643079e-3	1.000000e+0	1.000000e+0	1.156995e+2	8.643079e-3	1	8.643079e-3	1.000000e+0	53	1.402987e-2	1.000000e+0	1.000000e+0	7.102756e+1	1.407904e-2	1	127	5.000000e-1	7.874016e-3	unnamed	MSH2
GO Biological Process	GO:0072331	signal transduction by p53 class mediator	43	8.850259e-3	1.000000e+0	1.000000e+0	1.129910e+2	8.850259e-3	1	8.850259e-3	1.000000e+0	52	1.325916e-2	1.000000e+0	1.000000e+0	7.517083e+1	1.330303e-2	1	120	5.000000e-1	8.333333e-3	unnamed	MSH2
GO Biological Process	GO:0006302	double-strand break repair	44	8.931580e-3	1.000000e+0	1.000000e+0	1.119623e+2	8.931580e-3	1	8.931580e-3	1.000000e+0	45	1.160660e-2	1.000000e+0	1.000000e+0	8.590952e+1	1.164015e-2	1	105	5.000000e-1	9.523810e-3	unnamed	MSH2
GO Biological Process	GO:0002366	leukocyte activation involved in immune response	45	8.959278e-3	1.000000e+0	1.000000e+0	1.116161e+2	8.959278e-3	1	8.959278e-3	1.000000e+0	41	9.732033e-3	1.000000e+0	1.000000e+0	1.025057e+2	9.755557e-3	1	88	5.000000e-1	1.136364e-2	unnamed	MSH2
GO Biological Process	GO:0030183	B cell differentiation	46	9.220034e-3	1.000000e+0	1.000000e+0	1.084595e+2	9.220034e-3	1	9.220034e-3	1.000000e+0	37	7.634827e-3	1.000000e+0	1.000000e+0	1.307319e+2	7.649243e-3	1	69	5.000000e-1	1.449275e-2	unnamed	MSH2
GO Biological Process	GO:0000077	DNA damage checkpoint	47	9.331232e-3	1.000000e+0	1.000000e+0	1.071670e+2	9.331232e-3	1	9.331232e-3	1.000000e+0	59	1.513038e-2	1.000000e+0	1.000000e+0	6.584307e+1	1.518763e-2	1	137	5.000000e-1	7.299270e-3	unnamed	MSH2
GO Biological Process	GO:0031570	DNA integrity checkpoint	48	9.607175e-3	1.000000e+0	1.000000e+0	1.040889e+2	9.607175e-3	1	9.607175e-3	1.000000e+0	61	1.590037e-2	1.000000e+0	1.000000e+0	6.264236e+1	1.596364e-2	1	144	5.000000e-1	6.944444e-3	unnamed	MSH2
GO Biological Process	GO:0009411	response to UV	49	9.876412e-3	1.000000e+0	1.000000e+0	1.012513e+2	9.876412e-3	1	9.876412e-3	1.000000e+0	47	1.193722e-2	1.000000e+0	1.000000e+0	8.352315e+1	1.197273e-2	1	108	5.000000e-1	9.259259e-3	unnamed	MSH2
GO Biological Process	GO:0002250	adaptive immune response	50	1.044836e-2	1.000000e+0	1.000000e+0	9.570883e+1	1.044836e-2	1	1.044836e-2	1.000000e+0	53	1.402987e-2	1.000000e+0	1.000000e+0	7.102756e+1	1.407904e-2	1	127	5.000000e-1	7.874016e-3	unnamed	MSH2
GO Biological Process	GO:0097193	intrinsic apoptotic signaling pathway	51	1.120250e-2	1.000000e+0	1.000000e+0	8.926576e+1	1.120250e-2	1	1.120250e-2	1.000000e+0	56	1.491033e-2	1.000000e+0	1.000000e+0	6.681852e+1	1.496591e-2	1	135	5.000000e-1	7.407407e-3	unnamed	MSH2
GO Biological Process	GO:0007126	meiosis	52	1.161777e-2	1.000000e+0	1.000000e+0	8.607507e+1	1.161777e-2	1	1.161777e-2	1.000000e+0	63	1.623027e-2	1.000000e+0	1.000000e+0	6.136395e+1	1.629621e-2	1	147	5.000000e-1	6.802721e-3	unnamed	MSH2
GO Biological Process	GO:0010212	response to ionizing radiation	53	1.181953e-2	1.000000e+0	1.000000e+0	8.460574e+1	1.181953e-2	1	1.181953e-2	1.000000e+0	51	1.314903e-2	1.000000e+0	1.000000e+0	7.580252e+1	1.319217e-2	1	119	5.000000e-1	8.403361e-3	unnamed	MSH2
GO Biological Process	GO:0043524	negative regulation of neuron apoptotic process	54	1.203392e-2	1.000000e+0	1.000000e+0	8.309845e+1	1.203392e-2	1	1.203392e-2	1.000000e+0	44	1.116569e-2	1.000000e+0	1.000000e+0	8.931188e+1	1.119672e-2	1	101	5.000000e-1	9.900990e-3	unnamed	MSH2
GO Biological Process	GO:0006200	ATP catabolic process	55	1.222124e-2	1.000000e+0	1.000000e+0	8.182474e+1	1.222124e-2	1	1.222124e-2	1.000000e+0	64	1.677999e-2	1.000000e+0	1.000000e+0	5.934539e+1	1.685051e-2	1	152	5.000000e-1	6.578947e-3	unnamed	MSH2
GO Biological Process	GO:0051321	meiotic cell cycle	56	1.229757e-2	1.000000e+0	1.000000e+0	8.131686e+1	1.229757e-2	1	1.229757e-2	1.000000e+0	64	1.677999e-2	1.000000e+0	1.000000e+0	5.934539e+1	1.685051e-2	1	152	5.000000e-1	6.578947e-3	unnamed	MSH2
GO Biological Process	GO:1901215	negative regulation of neuron death	57	1.271045e-2	1.000000e+0	1.000000e+0	7.867544e+1	1.271045e-2	1	1.271045e-2	1.000000e+0	46	1.182702e-2	1.000000e+0	1.000000e+0	8.430374e+1	1.186187e-2	1	107	5.000000e-1	9.345794e-3	unnamed	MSH2
GO Biological Process	GO:0009169	purine ribonucleoside monophosphate catabolic process	58	1.272477e-2	1.000000e+0	1.000000e+0	7.858690e+1	1.272477e-2	1	1.272477e-2	1.000000e+0	67	1.721965e-2	1.000000e+0	1.000000e+0	5.782372e+1	1.729394e-2	1	156	5.000000e-1	6.410256e-3	unnamed	MSH2
GO Biological Process	GO:0009128	purine nucleoside monophosphate catabolic process	59	1.274075e-2	1.000000e+0	1.000000e+0	7.848829e+1	1.274075e-2	1	1.274075e-2	1.000000e+0	68	1.732955e-2	1.000000e+0	1.000000e+0	5.745541e+1	1.740480e-2	1	157	5.000000e-1	6.369427e-3	unnamed	MSH2
GO Biological Process	GO:0009125	nucleoside monophosphate catabolic process	60	1.282505e-2	1.000000e+0	1.000000e+0	7.797241e+1	1.282505e-2	1	1.282505e-2	1.000000e+0	69	1.754933e-2	1.000000e+0	1.000000e+0	5.673270e+1	1.762652e-2	1	159	5.000000e-1	6.289308e-3	unnamed	MSH2
GO Biological Process	GO:0042113	B cell activation	61	1.396950e-2	1.000000e+0	1.000000e+0	7.158450e+1	1.396950e-2	1	1.396950e-2	1.000000e+0	50	1.270846e-2	1.000000e+0	1.000000e+0	7.843913e+1	1.274874e-2	1	115	5.000000e-1	8.695652e-3	unnamed	MSH2
GO Biological Process	GO:0046034	ATP metabolic process	62	1.473510e-2	1.000000e+0	1.000000e+0	6.786516e+1	1.473510e-2	1	1.473510e-2	1.000000e+0	75	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	MSH2
GO Biological Process	GO:0007281	germ cell development	63	1.493390e-2	1.000000e+0	1.000000e+0	6.696173e+1	1.493390e-2	1	1.493390e-2	1.000000e+0	60	1.568040e-2	1.000000e+0	1.000000e+0	6.352465e+1	1.574192e-2	1	142	5.000000e-1	7.042254e-3	unnamed	MSH2
GO Biological Process	GO:0071805	potassium ion transmembrane transport	64	1.522793e-2	1.000000e+0	1.000000e+0	6.566879e+1	1.522793e-2	1	1.522793e-2	1.000000e+0	42	1.072467e-2	1.000000e+0	1.000000e+0	9.299485e+1	1.075328e-2	1	97	5.000000e-1	1.030928e-2	unnamed	KCNK12
GO Biological Process	GO:0007050	cell cycle arrest	65	1.528140e-2	1.000000e+0	1.000000e+0	6.543905e+1	1.528140e-2	1	1.528140e-2	1.000000e+0	56	1.491033e-2	1.000000e+0	1.000000e+0	6.681852e+1	1.496591e-2	1	135	5.000000e-1	7.407407e-3	unnamed	MSH2
GO Biological Process	GO:0000075	cell cycle checkpoint	66	1.587902e-2	1.000000e+0	1.000000e+0	6.297617e+1	1.587902e-2	1	1.587902e-2	1.000000e+0	77	2.336458e-2	1.000000e+0	1.000000e+0	4.254953e+1	2.350202e-2	1	212	5.000000e-1	4.716981e-3	unnamed	MSH2
GO Biological Process	GO:0006310	DNA recombination	67	1.603875e-2	1.000000e+0	1.000000e+0	6.234901e+1	1.603875e-2	1	1.603875e-2	1.000000e+0	74	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	MSH2
GO Biological Process	GO:0009167	purine ribonucleoside monophosphate metabolic process	68	1.657477e-2	1.000000e+0	1.000000e+0	6.033265e+1	1.657477e-2	1	1.657477e-2	1.000000e+0	79	2.391230e-2	1.000000e+0	1.000000e+0	4.156912e+1	2.405632e-2	1	217	5.000000e-1	4.608295e-3	unnamed	MSH2
GO Biological Process	GO:0009126	purine nucleoside monophosphate metabolic process	69	1.659076e-2	1.000000e+0	1.000000e+0	6.027451e+1	1.659076e-2	1	1.659076e-2	1.000000e+0	80	2.402182e-2	1.000000e+0	1.000000e+0	4.137844e+1	2.416717e-2	1	218	5.000000e-1	4.587156e-3	unnamed	MSH2
GO Biological Process	GO:0008584	male gonad development	70	1.665469e-2	1.000000e+0	1.000000e+0	6.004315e+1	1.665469e-2	1	1.665469e-2	1.000000e+0	48	1.204742e-2	1.000000e+0	1.000000e+0	8.275688e+1	1.208359e-2	1	109	5.000000e-1	9.174312e-3	unnamed	MSH2
GO Biological Process	GO:0009161	ribonucleoside monophosphate metabolic process	71	1.887845e-2	1.000000e+0	1.000000e+0	5.297046e+1	1.887845e-2	1	1.887845e-2	1.000000e+0	83	2.555453e-2	1.000000e+0	1.000000e+0	3.888147e+1	2.571920e-2	1	232	5.000000e-1	4.310345e-3	unnamed	MSH2
GO Biological Process	GO:0009123	nucleoside monophosphate metabolic process	72	1.920092e-2	1.000000e+0	1.000000e+0	5.208085e+1	1.920092e-2	1	1.920092e-2	1.000000e+0	84	2.632043e-2	1.000000e+0	1.000000e+0	3.774268e+1	2.649521e-2	1	239	5.000000e-1	4.184100e-3	unnamed	MSH2
GO Biological Process	GO:0010948	negative regulation of cell cycle process	73	1.920177e-2	1.000000e+0	1.000000e+0	5.207854e+1	1.920177e-2	1	1.920177e-2	1.000000e+0	78	2.380277e-2	1.000000e+0	1.000000e+0	4.176157e+1	2.394546e-2	1	216	5.000000e-1	4.629630e-3	unnamed	MSH2
GO Biological Process	GO:0043523	regulation of neuron apoptotic process	74	1.964683e-2	1.000000e+0	1.000000e+0	5.089881e+1	1.964683e-2	1	1.964683e-2	1.000000e+0	66	1.710974e-2	1.000000e+0	1.000000e+0	5.819677e+1	1.718308e-2	1	155	5.000000e-1	6.451613e-3	unnamed	MSH2
GO Biological Process	GO:0046546	development of primary male sexual characteristics	75	2.033334e-2	1.000000e+0	1.000000e+0	4.918031e+1	2.033334e-2	1	2.033334e-2	1.000000e+0	53	1.402987e-2	1.000000e+0	1.000000e+0	7.102756e+1	1.407904e-2	1	127	5.000000e-1	7.874016e-3	unnamed	MSH2
GO Biological Process	GO:1901214	regulation of neuron death	76	2.049695e-2	1.000000e+0	1.000000e+0	4.878776e+1	2.049695e-2	1	2.049695e-2	1.000000e+0	70	1.820853e-2	1.000000e+0	1.000000e+0	5.466970e+1	1.829167e-2	1	165	5.000000e-1	6.060606e-3	unnamed	MSH2
GO Biological Process	GO:0046661	male sex differentiation	77	2.097294e-2	1.000000e+0	1.000000e+0	4.768048e+1	2.097294e-2	1	2.097294e-2	1.000000e+0	56	1.491033e-2	1.000000e+0	1.000000e+0	6.681852e+1	1.496591e-2	1	135	5.000000e-1	7.407407e-3	unnamed	MSH2
GO Biological Process	GO:0006813	potassium ion transport	78	2.098711e-2	1.000000e+0	1.000000e+0	4.764830e+1	2.098711e-2	1	2.098711e-2	1.000000e+0	62	1.612031e-2	1.000000e+0	1.000000e+0	6.178425e+1	1.618536e-2	1	146	5.000000e-1	6.849315e-3	unnamed	KCNK12
GO Biological Process	GO:0022412	cellular process involved in reproduction in multicellular organism	79	2.143467e-2	1.000000e+0	1.000000e+0	4.665338e+1	2.143467e-2	1	2.143467e-2	1.000000e+0	72	2.018479e-2	1.000000e+0	1.000000e+0	4.929235e+1	2.028712e-2	1	183	5.000000e-1	5.464481e-3	unnamed	MSH2
GO Biological Process	GO:0007568	aging	80	2.160529e-2	1.000000e+0	1.000000e+0	4.628496e+1	2.160529e-2	1	2.160529e-2	1.000000e+0	73	2.062369e-2	1.000000e+0	1.000000e+0	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	MSH2
GO Biological Process	GO:0030098	lymphocyte differentiation	81	2.247216e-2	1.000000e+0	1.000000e+0	4.449951e+1	2.247216e-2	1	2.247216e-2	1.000000e+0	71	1.864787e-2	1.000000e+0	1.000000e+0	5.337574e+1	1.873510e-2	1	169	5.000000e-1	5.917160e-3	unnamed	MSH2
GO Biological Process	GO:0097190	apoptotic signaling pathway	82	2.329449e-2	1.000000e+0	1.000000e+0	4.292861e+1	2.329449e-2	1	2.329449e-2	1.000000e+0	92	3.112777e-2	1.000000e+0	1.000000e+0	3.187456e+1	3.137298e-2	1	283	5.000000e-1	3.533569e-3	unnamed	MSH2
GO Biological Process	GO:0051052	regulation of DNA metabolic process	83	2.344366e-2	1.000000e+0	1.000000e+0	4.265546e+1	2.344366e-2	1	2.344366e-2	1.000000e+0	82	2.533565e-2	1.000000e+0	1.000000e+0	3.921957e+1	2.549748e-2	1	230	5.000000e-1	4.347826e-3	unnamed	MSH2
GO Biological Process	GO:0009416	response to light stimulus	84	2.717639e-2	1.000000e+0	1.000000e+0	3.679665e+1	2.717639e-2	1	2.717639e-2	1.000000e+0	94	3.254585e-2	1.000000e+0	1.000000e+0	3.047466e+1	3.281415e-2	1	296	5.000000e-1	3.378378e-3	unnamed	MSH2
GO Biological Process	GO:0002252	immune effector process	85	2.795289e-2	1.000000e+0	1.000000e+0	3.577448e+1	2.795289e-2	1	2.795289e-2	1.000000e+0	100	4.255177e-2	1.000000e+0	1.000000e+0	2.324871e+1	4.301314e-2	1	388	5.000000e-1	2.577320e-3	unnamed	MSH2
GO Biological Process	GO:0045786	negative regulation of cell cycle	86	2.832384e-2	1.000000e+0	1.000000e+0	3.530595e+1	2.832384e-2	1	2.832384e-2	1.000000e+0	86	2.730472e-2	1.000000e+0	1.000000e+0	3.637298e+1	2.749293e-2	1	248	5.000000e-1	4.032258e-3	unnamed	MSH2
GO Biological Process	GO:0008406	gonad development	87	2.959912e-2	1.000000e+0	1.000000e+0	3.378479e+1	2.959912e-2	1	2.959912e-2	1.000000e+0	76	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	MSH2
GO Biological Process	GO:0002521	leukocyte differentiation	88	2.987590e-2	1.000000e+0	1.000000e+0	3.347179e+1	2.987590e-2	1	2.987590e-2	1.000000e+0	85	2.653920e-2	1.000000e+0	1.000000e+0	3.742946e+1	2.671692e-2	1	241	5.000000e-1	4.149378e-3	unnamed	MSH2
GO Biological Process	GO:0006281	DNA repair	89	3.018395e-2	1.000000e+0	1.000000e+0	3.313019e+1	3.018395e-2	1	3.018395e-2	1.000000e+0	104	4.363624e-2	1.000000e+0	1.000000e+0	2.266457e+1	4.412172e-2	1	398	5.000000e-1	2.512563e-3	unnamed	MSH2
GO Biological Process	GO:0009207	purine ribonucleoside triphosphate catabolic process	90	3.033200e-2	1.000000e+0	1.000000e+0	3.296848e+1	3.033200e-2	1	3.033200e-2	1.000000e+0	99	4.233480e-2	1.000000e+0	1.000000e+0	2.336917e+1	4.279142e-2	1	386	5.000000e-1	2.590674e-3	unnamed	MSH2
GO Biological Process	GO:0009146	purine nucleoside triphosphate catabolic process	91	3.055815e-2	1.000000e+0	1.000000e+0	3.272449e+1	3.055815e-2	1	3.055815e-2	1.000000e+0	100	4.255177e-2	1.000000e+0	1.000000e+0	2.324871e+1	4.301314e-2	1	388	5.000000e-1	2.577320e-3	unnamed	MSH2
GO Biological Process	GO:0009143	nucleoside triphosphate catabolic process	92	3.072920e-2	1.000000e+0	1.000000e+0	3.254234e+1	3.072920e-2	1	3.072920e-2	1.000000e+0	102	4.298563e-2	1.000000e+0	1.000000e+0	2.301148e+1	4.345657e-2	1	392	5.000000e-1	2.551020e-3	unnamed	MSH2
GO Biological Process	GO:0046130	purine ribonucleoside catabolic process	93	3.121346e-2	1.000000e+0	1.000000e+0	3.203746e+1	3.121346e-2	1	3.121346e-2	1.000000e+0	103	4.341939e-2	1.000000e+0	1.000000e+0	2.277904e+1	4.390001e-2	1	396	5.000000e-1	2.525253e-3	unnamed	MSH2
GO Biological Process	GO:0042454	ribonucleoside catabolic process	94	3.149923e-2	1.000000e+0	1.000000e+0	3.174681e+1	3.149923e-2	1	3.149923e-2	1.000000e+0	107	4.450337e-2	1.000000e+0	1.000000e+0	2.221798e+1	4.500859e-2	1	406	5.000000e-1	2.463054e-3	unnamed	MSH2
GO Biological Process	GO:0006091	generation of precursor metabolites and energy	95	3.205061e-2	1.000000e+0	1.000000e+0	3.120066e+1	3.205061e-2	1	3.205061e-2	1.000000e+0	98	4.157523e-2	1.000000e+0	1.000000e+0	2.380079e+1	4.201541e-2	1	379	5.000000e-1	2.638522e-3	unnamed	MSH2
GO Biological Process	GO:0046649	lymphocyte activation	96	3.238380e-2	1.000000e+0	1.000000e+0	3.087964e+1	3.238380e-2	1	3.238380e-2	1.000000e+0	93	3.167331e-2	1.000000e+0	1.000000e+0	3.132118e+1	3.192728e-2	1	288	5.000000e-1	3.472222e-3	unnamed	MSH2
GO Biological Process	GO:0009164	nucleoside catabolic process	97	3.286610e-2	1.000000e+0	1.000000e+0	3.042648e+1	3.286610e-2	1	3.286610e-2	1.000000e+0	111	4.580333e-2	1.000000e+0	1.000000e+0	2.158014e+1	4.633889e-2	1	418	5.000000e-1	2.392344e-3	unnamed	MSH2
GO Biological Process	GO:1901658	glycosyl compound catabolic process	98	3.298459e-2	1.000000e+0	1.000000e+0	3.031719e+1	3.298459e-2	1	3.298459e-2	1.000000e+0	112	4.634471e-2	1.000000e+0	1.000000e+0	2.132506e+1	4.689319e-2	1	423	5.000000e-1	2.364066e-3	unnamed	MSH2
GO Biological Process	GO:0009205	purine ribonucleoside triphosphate metabolic process	99	3.313572e-2	1.000000e+0	1.000000e+0	3.017892e+1	3.313572e-2	1	3.313572e-2	1.000000e+0	118	4.785978e-2	1.000000e+0	1.000000e+0	2.064188e+1	4.844521e-2	1	437	5.000000e-1	2.288330e-3	unnamed	MSH2
GO Biological Process	GO:0009144	purine nucleoside triphosphate metabolic process	100	3.366832e-2	1.000000e+0	1.000000e+0	2.970151e+1	3.366832e-2	1	3.366832e-2	1.000000e+0	120	4.840059e-2	1.000000e+0	1.000000e+0	2.040837e+1	4.899950e-2	1	442	5.000000e-1	2.262443e-3	unnamed	MSH2
GO Biological Process	GO:0009199	ribonucleoside triphosphate metabolic process	101	3.369805e-2	1.000000e+0	1.000000e+0	2.967530e+1	3.369805e-2	1	3.369805e-2	1.000000e+0	121	4.850873e-2	1.000000e+0	1.000000e+0	2.036230e+1	4.911036e-2	1	443	5.000000e-1	2.257336e-3	unnamed	MSH2
GO Biological Process	GO:0015672	monovalent inorganic cation transport	102	3.396906e-2	1.000000e+0	1.000000e+0	2.943856e+1	3.396906e-2	1	3.396906e-2	1.000000e+0	95	3.505220e-2	1.000000e+0	1.000000e+0	2.827743e+1	3.536389e-2	1	319	5.000000e-1	3.134796e-3	unnamed	KCNK12
GO Biological Process	GO:0009154	purine ribonucleotide catabolic process	103	3.482519e-2	1.000000e+0	1.000000e+0	2.871484e+1	3.482519e-2	1	3.482519e-2	1.000000e+0	109	4.493679e-2	1.000000e+0	1.000000e+0	2.200122e+1	4.545203e-2	1	410	5.000000e-1	2.439024e-3	unnamed	MSH2
GO Biological Process	GO:0009261	ribonucleotide catabolic process	104	3.486523e-2	1.000000e+0	1.000000e+0	2.868187e+1	3.486523e-2	1	3.486523e-2	1.000000e+0	110	4.504512e-2	1.000000e+0	1.000000e+0	2.194769e+1	4.556288e-2	1	411	5.000000e-1	2.433090e-3	unnamed	MSH2
GO Biological Process	GO:0009141	nucleoside triphosphate metabolic process	105	3.527014e-2	1.000000e+0	1.000000e+0	2.835259e+1	3.527014e-2	1	3.527014e-2	1.000000e+0	124	5.045424e-2	1.000000e+0	1.000000e+0	1.956725e+1	5.110581e-2	1	461	5.000000e-1	2.169197e-3	unnamed	MSH2
GO Biological Process	GO:0045137	development of primary sexual characteristics	106	3.551401e-2	1.000000e+0	1.000000e+0	2.815790e+1	3.551401e-2	1	3.551401e-2	1.000000e+0	81	2.500727e-2	1.000000e+0	1.000000e+0	3.973789e+1	2.516490e-2	1	227	5.000000e-1	4.405286e-3	unnamed	MSH2
GO Biological Process	GO:0006195	purine nucleotide catabolic process	107	3.553241e-2	1.000000e+0	1.000000e+0	2.814332e+1	3.553241e-2	1	3.553241e-2	1.000000e+0	112	4.634471e-2	1.000000e+0	1.000000e+0	2.132506e+1	4.689319e-2	1	423	5.000000e-1	2.364066e-3	unnamed	MSH2
GO Biological Process	GO:0072523	purine-containing compound catabolic process	108	3.630339e-2	1.000000e+0	1.000000e+0	2.754563e+1	3.630339e-2	1	3.630339e-2	1.000000e+0	115	4.677771e-2	1.000000e+0	1.000000e+0	2.112529e+1	4.733662e-2	1	427	5.000000e-1	2.341920e-3	unnamed	MSH2
GO Biological Process	GO:0009166	nucleotide catabolic process	109	3.673696e-2	1.000000e+0	1.000000e+0	2.722054e+1	3.673696e-2	1	3.673696e-2	1.000000e+0	119	4.818428e-2	1.000000e+0	1.000000e+0	2.050114e+1	4.877778e-2	1	440	5.000000e-1	2.272727e-3	unnamed	MSH2
GO Biological Process	GO:1901292	nucleoside phosphate catabolic process	110	3.698603e-2	1.000000e+0	1.000000e+0	2.703723e+1	3.698603e-2	1	3.698603e-2	1.000000e+0	122	4.894124e-2	1.000000e+0	1.000000e+0	2.018009e+1	4.955379e-2	1	447	5.000000e-1	2.237136e-3	unnamed	MSH2
GO Biological Process	GO:0009314	response to radiation	111	3.804926e-2	1.000000e+0	1.000000e+0	2.628172e+1	3.804926e-2	1	3.804926e-2	1.000000e+0	108	4.482844e-2	1.000000e+0	1.000000e+0	2.205501e+1	4.534117e-2	1	409	5.000000e-1	2.444988e-3	unnamed	MSH2
GO Biological Process	GO:0007548	sex differentiation	112	3.860403e-2	1.000000e+0	1.000000e+0	2.590403e+1	3.860403e-2	1	3.860403e-2	1.000000e+0	87	2.828851e-2	1.000000e+0	1.000000e+0	3.509922e+1	2.849066e-2	1	257	5.000000e-1	3.891051e-3	unnamed	MSH2
GO Biological Process	GO:0046128	purine ribonucleoside metabolic process	113	3.860801e-2	1.000000e+0	1.000000e+0	2.590136e+1	3.860801e-2	1	3.860801e-2	1.000000e+0	128	5.509380e-2	1.000000e+0	1.000000e+0	1.789782e+1	5.587273e-2	1	504	5.000000e-1	1.984127e-3	unnamed	MSH2
GO Biological Process	GO:0045321	leukocyte activation	114	3.863898e-2	1.000000e+0	1.000000e+0	2.588060e+1	3.863898e-2	1	3.863898e-2	1.000000e+0	96	3.864260e-2	1.000000e+0	1.000000e+0	2.562642e+1	3.902223e-2	1	352	5.000000e-1	2.840909e-3	unnamed	MSH2
GO Biological Process	GO:0042278	purine nucleoside metabolic process	115	3.876404e-2	1.000000e+0	1.000000e+0	2.579711e+1	3.876404e-2	1	3.876404e-2	1.000000e+0	129	5.541706e-2	1.000000e+0	1.000000e+0	1.779191e+1	5.620531e-2	1	507	5.000000e-1	1.972387e-3	unnamed	MSH2
GO Biological Process	GO:0034765	regulation of ion transmembrane transport	116	3.928698e-2	1.000000e+0	1.000000e+0	2.545372e+1	3.928698e-2	1	3.928698e-2	1.000000e+0	88	2.916257e-2	1.000000e+0	1.000000e+0	3.403962e+1	2.937753e-2	1	265	5.000000e-1	3.773585e-3	unnamed	KCNK12
GO Biological Process	GO:0046434	organophosphate catabolic process	117	3.976893e-2	1.000000e+0	1.000000e+0	2.514526e+1	3.976893e-2	1	3.976893e-2	1.000000e+0	127	5.282939e-2	1.000000e+0	1.000000e+0	1.867598e+1	5.354470e-2	1	483	5.000000e-1	2.070393e-3	unnamed	MSH2
GO Biological Process	GO:0034762	regulation of transmembrane transport	118	3.988279e-2	1.000000e+0	1.000000e+0	2.507347e+1	3.988279e-2	1	3.988279e-2	1.000000e+0	91	3.014542e-2	1.000000e+0	1.000000e+0	3.292153e+1	3.037526e-2	1	274	5.000000e-1	3.649635e-3	unnamed	KCNK12
GO Biological Process	GO:0010564	regulation of cell cycle process	119	3.998440e-2	1.000000e+0	1.000000e+0	2.500975e+1	3.998440e-2	1	3.998440e-2	1.000000e+0	104	4.363624e-2	1.000000e+0	1.000000e+0	2.266457e+1	4.412172e-2	1	398	5.000000e-1	2.512563e-3	unnamed	MSH2
GO Biological Process	GO:0009119	ribonucleoside metabolic process	120	4.090218e-2	1.000000e+0	1.000000e+0	2.444858e+1	4.090218e-2	1	4.090218e-2	1.000000e+0	131	5.789360e-2	1.000000e+0	1.000000e+0	1.701981e+1	5.875506e-2	1	530	5.000000e-1	1.886792e-3	unnamed	MSH2
GO Biological Process	GO:0048608	reproductive structure development	121	4.100915e-2	1.000000e+0	1.000000e+0	2.438480e+1	4.100915e-2	1	4.100915e-2	1.000000e+0	88	2.916257e-2	1.000000e+0	1.000000e+0	3.403962e+1	2.937753e-2	1	265	5.000000e-1	3.773585e-3	unnamed	MSH2
GO Biological Process	GO:0061458	reproductive system development	122	4.105393e-2	1.000000e+0	1.000000e+0	2.435821e+1	4.105393e-2	1	4.105393e-2	1.000000e+0	90	2.938103e-2	1.000000e+0	1.000000e+0	3.378464e+1	2.959925e-2	1	267	5.000000e-1	3.745318e-3	unnamed	MSH2
GO Biological Process	GO:0009116	nucleoside metabolic process	123	4.293017e-2	1.000000e+0	1.000000e+0	2.329364e+1	4.293017e-2	1	4.293017e-2	1.000000e+0	135	6.047434e-2	1.000000e+0	1.000000e+0	1.628249e+1	6.141566e-2	1	554	5.000000e-1	1.805054e-3	unnamed	MSH2
GO Biological Process	GO:1901657	glycosyl compound metabolic process	124	4.374541e-2	1.000000e+0	1.000000e+0	2.285954e+1	4.374541e-2	1	4.374541e-2	1.000000e+0	140	6.208551e-2	1.000000e+0	1.000000e+0	1.585325e+1	6.307854e-2	1	569	5.000000e-1	1.757469e-3	unnamed	MSH2
GO Biological Process	GO:0048610	cellular process involved in reproduction	125	4.383088e-2	1.000000e+0	1.000000e+0	2.281497e+1	4.383088e-2	1	4.383088e-2	1.000000e+0	112	4.634471e-2	1.000000e+0	1.000000e+0	2.132506e+1	4.689319e-2	1	423	5.000000e-1	2.364066e-3	unnamed	MSH2
GO Biological Process	GO:0001701	in utero embryonic development	126	4.511140e-2	1.000000e+0	1.000000e+0	2.216735e+1	4.511140e-2	1	4.511140e-2	1.000000e+0	96	3.864260e-2	1.000000e+0	1.000000e+0	2.562642e+1	3.902223e-2	1	352	5.000000e-1	2.840909e-3	unnamed	MSH2
GO Biological Process	GO:1901136	carbohydrate derivative catabolic process	127	4.540843e-2	1.000000e+0	1.000000e+0	2.202234e+1	4.540843e-2	1	4.540843e-2	1.000000e+0	132	5.875424e-2	1.000000e+0	1.000000e+0	1.676673e+1	5.964193e-2	1	538	5.000000e-1	1.858736e-3	unnamed	MSH2
GO Biological Process	GO:0009150	purine ribonucleotide metabolic process	128	4.562864e-2	1.000000e+0	1.000000e+0	2.191606e+1	4.562864e-2	1	4.562864e-2	1.000000e+0	133	5.950698e-2	1.000000e+0	1.000000e+0	1.655138e+1	6.041794e-2	1	545	5.000000e-1	1.834862e-3	unnamed	MSH2
GO Biological Process	GO:0006163	purine nucleotide metabolic process	129	4.717629e-2	1.000000e+0	1.000000e+0	2.119709e+1	4.717629e-2	1	4.717629e-2	1.000000e+0	139	6.187077e-2	1.000000e+0	1.000000e+0	1.590917e+1	6.285683e-2	1	567	5.000000e-1	1.763668e-3	unnamed	MSH2
GO Biological Process	GO:0009259	ribonucleotide metabolic process	130	4.777098e-2	1.000000e+0	1.000000e+0	2.093321e+1	4.777098e-2	1	4.777098e-2	1.000000e+0	136	6.122639e-2	1.000000e+0	1.000000e+0	1.607932e+1	6.219167e-2	1	561	5.000000e-1	1.782531e-3	unnamed	MSH2
GO Biological Process	GO:0006974	cellular response to DNA damage stimulus	131	4.790195e-2	1.000000e+0	1.000000e+0	2.087598e+1	4.790195e-2	1	4.790195e-2	1.000000e+0	144	6.669653e-2	1.000000e+0	1.000000e+0	1.473938e+1	6.784546e-2	1	612	5.000000e-1	1.633987e-3	unnamed	MSH2
GO Biological Process	GO:0019693	ribose phosphate metabolic process	132	4.844027e-2	1.000000e+0	1.000000e+0	2.064398e+1	4.844027e-2	1	4.844027e-2	1.000000e+0	137	6.176339e-2	1.000000e+0	1.000000e+0	1.593728e+1	6.274597e-2	1	566	5.000000e-1	1.766784e-3	unnamed	MSH2
GO Biological Process	GO:0030097	hemopoiesis	133	4.927889e-2	1.000000e+0	1.000000e+0	2.029267e+1	4.927889e-2	1	4.927889e-2	1.000000e+0	106	4.439500e-2	1.000000e+0	1.000000e+0	2.227284e+1	4.489773e-2	1	405	5.000000e-1	2.469136e-3	unnamed	MSH2
GO Biological Process	GO:0034220	ion transmembrane transport	134	5.009827e-2	1.000000e+0	1.000000e+0	1.996077e+1	5.009827e-2	1	5.009827e-2	1.000000e+0	124	5.045424e-2	1.000000e+0	1.000000e+0	1.956725e+1	5.110581e-2	1	461	5.000000e-1	2.169197e-3	unnamed	KCNK12
GO Biological Process	GO:0072521	purine-containing compound metabolic process	135	5.075963e-2	1.000000e+0	1.000000e+0	1.970070e+1	5.075963e-2	1	5.075963e-2	1.000000e+0	143	6.541088e-2	1.000000e+0	1.000000e+0	1.503417e+1	6.651516e-2	1	600	5.000000e-1	1.666667e-3	unnamed	MSH2
GO Biological Process	GO:0048534	hematopoietic or lymphoid organ development	136	5.503899e-2	1.000000e+0	1.000000e+0	1.816894e+1	5.503899e-2	1	5.503899e-2	1.000000e+0	122	4.894124e-2	1.000000e+0	1.000000e+0	2.018009e+1	4.955379e-2	1	447	5.000000e-1	2.237136e-3	unnamed	MSH2
GO Biological Process	GO:0034655	nucleobase-containing compound catabolic process	137	5.526871e-2	1.000000e+0	1.000000e+0	1.809342e+1	5.526871e-2	1	5.526871e-2	1.000000e+0	158	7.929164e-2	1.000000e+0	1.000000e+0	1.235685e+1	8.092678e-2	1	730	5.000000e-1	1.369863e-3	unnamed	MSH2
GO Biological Process	GO:0043269	regulation of ion transport	138	5.622673e-2	1.000000e+0	1.000000e+0	1.778513e+1	5.622673e-2	1	5.622673e-2	1.000000e+0	117	4.753523e-2	1.000000e+0	1.000000e+0	2.078456e+1	4.811263e-2	1	434	5.000000e-1	2.304147e-3	unnamed	KCNK12
GO Biological Process	GO:0007276	gamete generation	139	5.686474e-2	1.000000e+0	1.000000e+0	1.758559e+1	5.686474e-2	1	5.686474e-2	1.000000e+0	130	5.735550e-2	1.000000e+0	1.000000e+0	1.718190e+1	5.820076e-2	1	525	5.000000e-1	1.904762e-3	unnamed	MSH2
GO Biological Process	GO:0003006	developmental process involved in reproduction	140	5.715290e-2	1.000000e+0	1.000000e+0	1.749692e+1	5.715290e-2	1	5.715290e-2	1.000000e+0	116	4.721062e-2	1.000000e+0	1.000000e+0	2.092923e+1	4.778006e-2	1	431	5.000000e-1	2.320186e-3	unnamed	MSH2
GO Biological Process	GO:0002520	immune system development	141	5.732186e-2	1.000000e+0	1.000000e+0	1.744535e+1	5.732186e-2	1	5.732186e-2	1.000000e+0	126	5.175015e-2	1.000000e+0	1.000000e+0	1.907082e+1	5.243612e-2	1	473	5.000000e-1	2.114165e-3	unnamed	MSH2
GO Biological Process	GO:0044270	cellular nitrogen compound catabolic process	142	5.795872e-2	1.000000e+0	1.000000e+0	1.725366e+1	5.795872e-2	1	5.795872e-2	1.000000e+0	161	8.375400e-2	1.000000e+0	1.000000e+0	1.168459e+1	8.558284e-2	1	772	5.000000e-1	1.295337e-3	unnamed	MSH2
GO Biological Process	GO:0046700	heterocycle catabolic process	143	5.822606e-2	1.000000e+0	1.000000e+0	1.717444e+1	5.822606e-2	1	5.822606e-2	1.000000e+0	161	8.375400e-2	1.000000e+0	1.000000e+0	1.168459e+1	8.558284e-2	1	772	5.000000e-1	1.295337e-3	unnamed	MSH2
GO Biological Process	GO:1901565	organonitrogen compound catabolic process	144	5.824058e-2	1.000000e+0	1.000000e+0	1.717016e+1	5.824058e-2	1	5.824058e-2	1.000000e+0	151	7.481844e-2	1.000000e+0	1.000000e+0	1.311119e+1	7.627072e-2	1	688	5.000000e-1	1.453488e-3	unnamed	MSH2
GO Biological Process	GO:0001775	cell activation	145	5.914753e-2	1.000000e+0	1.000000e+0	1.690688e+1	5.914753e-2	1	5.914753e-2	1.000000e+0	137	6.176339e-2	1.000000e+0	1.000000e+0	1.593728e+1	6.274597e-2	1	566	5.000000e-1	1.766784e-3	unnamed	MSH2
GO Biological Process	GO:0019439	aromatic compound catabolic process	146	5.918614e-2	1.000000e+0	1.000000e+0	1.689585e+1	5.918614e-2	1	5.918614e-2	1.000000e+0	163	8.417843e-2	1.000000e+0	1.000000e+0	1.162436e+1	8.602627e-2	1	776	5.000000e-1	1.288660e-3	unnamed	MSH2
GO Biological Process	GO:0009117	nucleotide metabolic process	147	5.965229e-2	1.000000e+0	1.000000e+0	1.676382e+1	5.965229e-2	1	5.965229e-2	1.000000e+0	154	7.673686e-2	1.000000e+0	1.000000e+0	1.277691e+1	7.826617e-2	1	706	5.000000e-1	1.416431e-3	unnamed	MSH2
GO Biological Process	GO:0006753	nucleoside phosphate metabolic process	148	5.986549e-2	1.000000e+0	1.000000e+0	1.670411e+1	5.986549e-2	1	5.986549e-2	1.000000e+0	156	7.737589e-2	1.000000e+0	1.000000e+0	1.266924e+1	7.893132e-2	1	712	5.000000e-1	1.404494e-3	unnamed	MSH2
GO Biological Process	GO:0030001	metal ion transport	149	6.152617e-2	1.000000e+0	1.000000e+0	1.625325e+1	6.152617e-2	1	6.152617e-2	1.000000e+0	134	5.972199e-2	1.000000e+0	1.000000e+0	1.649086e+1	6.063965e-2	1	547	5.000000e-1	1.828154e-3	unnamed	KCNK12
GO Biological Process	GO:1901361	organic cyclic compound catabolic process	150	6.156179e-2	1.000000e+0	1.000000e+0	1.624384e+1	6.156179e-2	1	6.156179e-2	1.000000e+0	164	8.767615e-2	1.000000e+0	1.000000e+0	1.115019e+1	8.968461e-2	1	809	5.000000e-1	1.236094e-3	unnamed	MSH2
GO Biological Process	GO:0006259	DNA metabolic process	151	6.242337e-2	1.000000e+0	1.000000e+0	1.601964e+1	6.242337e-2	1	6.242337e-2	1.000000e+0	165	9.011000e-2	1.000000e+0	1.000000e+0	1.084195e+1	9.223436e-2	1	832	5.000000e-1	1.201923e-3	unnamed	MSH2
GO Biological Process	GO:0055086	nucleobase-containing small molecule metabolic process	152	6.296632e-2	1.000000e+0	1.000000e+0	1.588151e+1	6.296632e-2	1	6.296632e-2	1.000000e+0	160	8.216155e-2	1.000000e+0	1.000000e+0	1.191612e+1	8.391996e-2	1	757	5.000000e-1	1.321004e-3	unnamed	MSH2
GO Biological Process	GO:0019953	sexual reproduction	153	6.533147e-2	1.000000e+0	1.000000e+0	1.530656e+1	6.533147e-2	1	6.533147e-2	1.000000e+0	145	6.691072e-2	1.000000e+0	1.000000e+0	1.469137e+1	6.806718e-2	1	614	5.000000e-1	1.628664e-3	unnamed	MSH2
GO Biological Process	GO:0051276	chromosome organization	154	6.817619e-2	1.000000e+0	1.000000e+0	1.466788e+1	6.817619e-2	1	6.817619e-2	1.000000e+0	159	8.194912e-2	1.000000e+0	1.000000e+0	1.194768e+1	8.369824e-2	1	755	5.000000e-1	1.324503e-3	unnamed	MSH2
GO Biological Process	GO:0051345	positive regulation of hydrolase activity	155	6.945880e-2	1.000000e+0	1.000000e+0	1.439702e+1	6.945880e-2	1	6.945880e-2	1.000000e+0	146	6.947907e-2	1.000000e+0	1.000000e+0	1.413871e+1	7.072779e-2	1	638	5.000000e-1	1.567398e-3	unnamed	MSH2
GO Biological Process	GO:0043066	negative regulation of apoptotic process	156	7.076490e-2	1.000000e+0	1.000000e+0	1.413130e+1	7.076490e-2	1	7.076490e-2	1.000000e+0	147	7.150984e-2	1.000000e+0	1.000000e+0	1.372983e+1	7.283410e-2	1	657	5.000000e-1	1.522070e-3	unnamed	MSH2
GO Biological Process	GO:0043069	negative regulation of programmed cell death	157	7.183207e-2	1.000000e+0	1.000000e+0	1.392136e+1	7.183207e-2	1	7.183207e-2	1.000000e+0	148	7.225746e-2	1.000000e+0	1.000000e+0	1.358509e+1	7.361011e-2	1	664	5.000000e-1	1.506024e-3	unnamed	MSH2
GO Biological Process	GO:0006812	cation transport	158	7.387615e-2	1.000000e+0	1.000000e+0	1.353617e+1	7.387615e-2	1	7.387615e-2	1.000000e+0	150	7.471181e-2	1.000000e+0	1.000000e+0	1.313028e+1	7.615986e-2	1	687	5.000000e-1	1.455604e-3	unnamed	KCNK12
GO Biological Process	GO:0051726	regulation of cell cycle	159	7.419191e-2	1.000000e+0	1.000000e+0	1.347856e+1	7.419191e-2	1	7.419191e-2	1.000000e+0	155	7.705640e-2	1.000000e+0	1.000000e+0	1.272285e+1	7.859875e-2	1	709	5.000000e-1	1.410437e-3	unnamed	MSH2
GO Biological Process	GO:0048609	multicellular organismal reproductive process	160	7.483828e-2	1.000000e+0	1.000000e+0	1.336215e+1	7.483828e-2	1	7.483828e-2	1.000000e+0	149	7.289804e-2	1.000000e+0	1.000000e+0	1.346343e+1	7.427526e-2	1	670	5.000000e-1	1.492537e-3	unnamed	MSH2
GO Biological Process	GO:0060548	negative regulation of cell death	161	7.699389e-2	1.000000e+0	1.000000e+0	1.298804e+1	7.699389e-2	1	7.699389e-2	1.000000e+0	153	7.535154e-2	1.000000e+0	1.000000e+0	1.301659e+1	7.682501e-2	1	693	5.000000e-1	1.443001e-3	unnamed	MSH2
GO Biological Process	GO:0043009	chordate embryonic development	162	7.717062e-2	1.000000e+0	1.000000e+0	1.295830e+1	7.717062e-2	1	7.717062e-2	1.000000e+0	141	6.230023e-2	1.000000e+0	1.000000e+0	1.579772e+1	6.330026e-2	1	571	5.000000e-1	1.751313e-3	unnamed	MSH2
GO Biological Process	GO:0032504	multicellular organism reproduction	163	7.740256e-2	1.000000e+0	1.000000e+0	1.291947e+1	7.740256e-2	1	7.740256e-2	1.000000e+0	152	7.503170e-2	1.000000e+0	1.000000e+0	1.307319e+1	7.649243e-2	1	690	5.000000e-1	1.449275e-3	unnamed	MSH2
GO Biological Process	GO:0009792	embryo development ending in birth or egg hatching	164	7.766421e-2	1.000000e+0	1.000000e+0	1.287594e+1	7.766421e-2	1	7.766421e-2	1.000000e+0	142	6.305155e-2	1.000000e+0	1.000000e+0	1.560640e+1	6.407627e-2	1	578	5.000000e-1	1.730104e-3	unnamed	MSH2
GO Biological Process	GO:0044702	single organism reproductive process	165	7.805445e-2	1.000000e+0	1.000000e+0	1.281157e+1	7.805445e-2	1	7.805445e-2	1.000000e+0	157	7.812114e-2	1.000000e+0	1.000000e+0	1.254590e+1	7.970733e-2	1	719	5.000000e-1	1.390821e-3	unnamed	MSH2
GO Biological Process	GO:0055085	transmembrane transport	166	8.563981e-2	1.000000e+0	1.000000e+0	1.167681e+1	8.563981e-2	1	8.563981e-2	1.000000e+0	167	9.602230e-2	1.000000e+0	1.000000e+0	1.015822e+1	9.844244e-2	1	888	5.000000e-1	1.126126e-3	unnamed	KCNK12
GO Biological Process	GO:0019637	organophosphate metabolic process	167	8.707730e-2	1.000000e+0	1.000000e+0	1.148405e+1	8.707730e-2	1	8.707730e-2	1.000000e+0	175	1.118684e-1	1.000000e+0	1.000000e+0	8.681906e+0	1.151821e-1	1	1039	5.000000e-1	9.624639e-4	unnamed	MSH2
GO Biological Process	GO:0009628	response to abiotic stimulus	168	8.711487e-2	1.000000e+0	1.000000e+0	1.147910e+1	8.711487e-2	1	8.711487e-2	1.000000e+0	166	9.370191e-2	1.000000e+0	1.000000e+0	1.041628e+1	9.600355e-2	1	866	5.000000e-1	1.154734e-3	unnamed	MSH2
GO Biological Process	GO:0006955	immune response	169	8.762627e-2	1.000000e+0	1.000000e+0	1.141210e+1	8.762627e-2	1	8.762627e-2	1.000000e+0	180	1.192707e-1	1.000000e+0	1.000000e+0	8.126577e+0	1.230530e-1	1	1110	5.000000e-1	9.009009e-4	unnamed	MSH2
GO Biological Process	GO:0022402	cell cycle process	170	8.847677e-2	1.000000e+0	1.000000e+0	1.130240e+1	8.847677e-2	1	8.847677e-2	1.000000e+0	172	1.077891e-1	1.000000e+0	1.000000e+0	9.020500e+0	1.108586e-1	1	1000	5.000000e-1	1.000000e-3	unnamed	MSH2
GO Biological Process	GO:0006915	apoptotic process	171	9.852721e-2	1.000000e+0	1.000000e+0	1.014948e+1	9.852721e-2	1	9.852721e-2	1.000000e+0	176	1.119728e-1	1.000000e+0	1.000000e+0	8.673558e+0	1.152929e-1	1	1040	5.000000e-1	9.615385e-4	unnamed	MSH2
GO Biological Process	GO:0016310	phosphorylation	172	9.897799e-2	1.000000e+0	1.000000e+0	1.010326e+1	9.897799e-2	1	9.897799e-2	1.000000e+0	169	1.044350e-1	1.000000e+0	1.000000e+0	9.318698e+0	1.073111e-1	1	968	5.000000e-1	1.033058e-3	unnamed	MSH2
GO Biological Process	GO:0012501	programmed cell death	173	1.001273e-1	1.000000e+0	1.000000e+0	9.987290e+0	1.001273e-1	1	1.001273e-1	1.000000e+0	177	1.134348e-1	1.000000e+0	1.000000e+0	8.558349e+0	1.168450e-1	1	1054	5.000000e-1	9.487666e-4	unnamed	MSH2
GO Biological Process	GO:0033554	cellular response to stress	174	1.003642e-1	1.000000e+0	1.000000e+0	9.963713e+0	1.003642e-1	1	1.003642e-1	1.000000e+0	182	1.229084e-1	1.000000e+0	1.000000e+0	7.878166e+0	1.269331e-1	1	1145	5.000000e-1	8.733624e-4	unnamed	MSH2
GO Biological Process	GO:0051336	regulation of hydrolase activity	175	1.030572e-1	1.000000e+0	1.000000e+0	9.703349e+0	1.030572e-1	1	1.030572e-1	1.000000e+0	171	1.073702e-1	1.000000e+0	1.000000e+0	9.056727e+0	1.104152e-1	1	996	5.000000e-1	1.004016e-3	unnamed	MSH2
GO Biological Process	GO:0006811	ion transport	176	1.070764e-1	1.000000e+0	1.000000e+0	9.339125e+0	1.070764e-1	1	1.070764e-1	1.000000e+0	178	1.160425e-1	1.000000e+0	1.000000e+0	8.360056e+0	1.196164e-1	1	1079	5.000000e-1	9.267841e-4	unnamed	KCNK12
GO Biological Process	GO:0007049	cell cycle	177	1.078728e-1	1.000000e+0	1.000000e+0	9.270177e+0	1.078728e-1	1	1.078728e-1	1.000000e+0	188	1.322278e-1	1.000000e+0	1.000000e+0	7.304049e+0	1.369104e-1	1	1235	5.000000e-1	8.097166e-4	unnamed	MSH2
GO Biological Process	GO:0022414	reproductive process	178	1.132946e-1	1.000000e+0	1.000000e+0	8.826548e+0	1.132946e-1	1	1.132946e-1	1.000000e+0	170	1.070559e-1	1.000000e+0	1.000000e+0	9.084089e+0	1.100826e-1	1	993	5.000000e-1	1.007049e-3	unnamed	MSH2
GO Biological Process	GO:1901135	carbohydrate derivative metabolic process	179	1.134958e-1	1.000000e+0	1.000000e+0	8.810897e+0	1.134958e-1	1	1.134958e-1	1.000000e+0	185	1.288165e-1	1.000000e+0	1.000000e+0	7.504576e+0	1.332520e-1	1	1202	5.000000e-1	8.319468e-4	unnamed	MSH2
GO Biological Process	GO:0008219	cell death	180	1.161348e-1	1.000000e+0	1.000000e+0	8.610686e+0	1.161348e-1	1	1.161348e-1	1.000000e+0	189	1.323311e-1	1.000000e+0	1.000000e+0	7.298139e+0	1.370212e-1	1	1236	5.000000e-1	8.090615e-4	unnamed	MSH2
GO Biological Process	GO:0016265	death	181	1.165949e-1	1.000000e+0	1.000000e+0	8.576703e+0	1.165949e-1	1	1.165949e-1	1.000000e+0	190	1.326408e-1	1.000000e+0	1.000000e+0	7.280468e+0	1.373538e-1	1	1239	5.000000e-1	8.071025e-4	unnamed	MSH2
GO Biological Process	GO:0043085	positive regulation of catalytic activity	182	1.192177e-1	1.000000e+0	1.000000e+0	8.388019e+0	1.192177e-1	1	1.192177e-1	1.000000e+0	181	1.198949e-1	1.000000e+0	1.000000e+0	8.082885e+0	1.237182e-1	1	1116	5.000000e-1	8.960573e-4	unnamed	MSH2
GO Biological Process	GO:0042981	regulation of apoptotic process	183	1.200175e-1	1.000000e+0	1.000000e+0	8.332116e+0	1.200175e-1	1	1.200175e-1	1.000000e+0	183	1.243613e-1	1.000000e+0	1.000000e+0	7.783003e+0	1.284851e-1	1	1159	5.000000e-1	8.628128e-4	unnamed	MSH2
GO Biological Process	GO:0000003	reproduction	184	1.207341e-1	1.000000e+0	1.000000e+0	8.282661e+0	1.207341e-1	1	1.207341e-1	1.000000e+0	179	1.175012e-1	1.000000e+0	1.000000e+0	8.252973e+0	1.211684e-1	1	1093	5.000000e-1	9.149131e-4	unnamed	MSH2
GO Biological Process	GO:0043067	regulation of programmed cell death	185	1.213630e-1	1.000000e+0	1.000000e+0	8.239741e+0	1.213630e-1	1	1.213630e-1	1.000000e+0	184	1.256058e-1	1.000000e+0	1.000000e+0	7.703245e+0	1.298154e-1	1	1171	5.000000e-1	8.539710e-4	unnamed	MSH2
GO Biological Process	GO:0045934	negative regulation of nucleobase-containing compound metabolic process	186	1.236988e-1	1.000000e+0	1.000000e+0	8.084155e+0	1.236988e-1	1	1.236988e-1	1.000000e+0	173	1.087313e-1	1.000000e+0	1.000000e+0	8.940040e+0	1.118563e-1	1	1009	5.000000e-1	9.910803e-4	unnamed	MSH2
GO Biological Process	GO:0044248	cellular catabolic process	187	1.236997e-1	1.000000e+0	1.000000e+0	8.084094e+0	1.236997e-1	1	1.236997e-1	1.000000e+0	198	1.690077e-1	1.000000e+0	1.000000e+0	5.655486e+0	1.768195e-1	1	1595	5.000000e-1	6.269592e-4	unnamed	MSH2
GO Biological Process	GO:0051172	negative regulation of nitrogen compound metabolic process	188	1.247094e-1	1.000000e+0	1.000000e+0	8.018640e+0	1.247094e-1	1	1.247094e-1	1.000000e+0	174	1.101959e-1	1.000000e+0	1.000000e+0	8.817693e+0	1.134083e-1	1	1023	5.000000e-1	9.775171e-4	unnamed	MSH2
GO Biological Process	GO:0009790	embryo development	189	1.260409e-1	1.000000e+0	1.000000e+0	7.933935e+0	1.260409e-1	1	1.260409e-1	1.000000e+0	168	1.021254e-1	1.000000e+0	1.000000e+0	9.535412e+0	1.048722e-1	1	946	5.000000e-1	1.057082e-3	unnamed	MSH2
GO Biological Process	GO:0010941	regulation of cell death	190	1.261875e-1	1.000000e+0	1.000000e+0	7.924714e+0	1.261875e-1	1	1.261875e-1	1.000000e+0	186	1.296441e-1	1.000000e+0	1.000000e+0	7.454959e+0	1.341389e-1	1	1210	5.000000e-1	8.264463e-4	unnamed	MSH2
GO Biological Process	GO:1901575	organic substance catabolic process	191	1.333602e-1	1.000000e+0	1.000000e+0	7.498488e+0	1.333602e-1	1	1.333602e-1	1.000000e+0	200	1.828954e-1	1.000000e+0	1.000000e+0	5.205136e+0	1.921180e-1	1	1733	5.000000e-1	5.770340e-4	unnamed	MSH2
GO Biological Process	GO:1901564	organonitrogen compound metabolic process	192	1.379740e-1	1.000000e+0	1.000000e+0	7.247740e+0	1.379740e-1	1	1.379740e-1	1.000000e+0	196	1.637442e-1	1.000000e+0	1.000000e+0	5.846079e+0	1.710548e-1	1	1543	5.000000e-1	6.480881e-4	unnamed	MSH2
GO Biological Process	GO:0051049	regulation of transport	193	1.390239e-1	1.000000e+0	1.000000e+0	7.193009e+0	1.390239e-1	1	1.390239e-1	1.000000e+0	187	1.304713e-1	1.000000e+0	1.000000e+0	7.405993e+0	1.350258e-1	1	1218	5.000000e-1	8.210181e-4	unnamed	KCNK12
GO Biological Process	GO:0044093	positive regulation of molecular function	194	1.422599e-1	1.000000e+0	1.000000e+0	7.029386e+0	1.422599e-1	1	1.422599e-1	1.000000e+0	191	1.401616e-1	1.000000e+0	1.000000e+0	6.875381e+0	1.454465e-1	1	1312	5.000000e-1	7.621951e-4	unnamed	MSH2
GO Biological Process	GO:0009056	catabolic process	195	1.498546e-1	1.000000e+0	1.000000e+0	6.673137e+0	1.498546e-1	1	1.498546e-1	1.000000e+0	203	2.035077e-1	1.000000e+0	1.000000e+0	4.649742e+0	2.150657e-1	1	1940	5.000000e-1	5.154639e-4	unnamed	MSH2
GO Biological Process	GO:0035556	intracellular signal transduction	196	1.533855e-1	1.000000e+0	1.000000e+0	6.519521e+0	1.533855e-1	1	1.533855e-1	1.000000e+0	193	1.538815e-1	1.000000e+0	1.000000e+0	6.238243e+0	1.603015e-1	1	1446	5.000000e-1	6.915629e-4	unnamed	MSH2
GO Biological Process	GO:0002376	immune system process	197	1.536349e-1	1.000000e+0	1.000000e+0	6.508938e+0	1.536349e-1	1	1.536349e-1	1.000000e+0	202	1.884977e-1	1.000000e+0	1.000000e+0	5.042202e+0	1.983260e-1	1	1789	5.000000e-1	5.589715e-4	unnamed	MSH2
GO Biological Process	GO:0010605	negative regulation of macromolecule metabolic process	198	1.635114e-1	1.000000e+0	1.000000e+0	6.115780e+0	1.635114e-1	1	1.635114e-1	1.000000e+0	195	1.573451e-1	1.000000e+0	1.000000e+0	6.094932e+0	1.640707e-1	1	1480	5.000000e-1	6.756757e-4	unnamed	MSH2
GO Biological Process	GO:0031324	negative regulation of cellular metabolic process	199	1.637788e-1	1.000000e+0	1.000000e+0	6.105797e+0	1.637788e-1	1	1.637788e-1	1.000000e+0	194	1.567344e-1	1.000000e+0	1.000000e+0	6.119742e+0	1.634056e-1	1	1474	5.000000e-1	6.784261e-4	unnamed	MSH2
GO Biological Process	GO:0009892	negative regulation of metabolic process	200	1.743568e-1	1.000000e+0	1.000000e+0	5.735367e+0	1.743568e-1	1	1.743568e-1	1.000000e+0	197	1.686034e-1	1.000000e+0	1.000000e+0	5.669705e+0	1.763760e-1	1	1591	5.000000e-1	6.285355e-4	unnamed	MSH2
GO Biological Process	GO:0050790	regulation of catalytic activity	201	1.756788e-1	1.000000e+0	1.000000e+0	5.692208e+0	1.756788e-1	1	1.756788e-1	1.000000e+0	201	1.830959e-1	1.000000e+0	1.000000e+0	5.199135e+0	1.923397e-1	1	1735	5.000000e-1	5.763689e-4	unnamed	MSH2
GO Biological Process	GO:0048468	cell development	202	1.837839e-1	1.000000e+0	1.000000e+0	5.441172e+0	1.837839e-1	1	1.837839e-1	1.000000e+0	192	1.403671e-1	1.000000e+0	1.000000e+0	6.864916e+0	1.456682e-1	1	1314	5.000000e-1	7.610350e-4	unnamed	MSH2
GO Biological Process	GO:0006796	phosphate-containing compound metabolic process	203	1.861159e-1	1.000000e+0	1.000000e+0	5.372996e+0	1.861159e-1	1	1.861159e-1	1.000000e+0	204	2.116001e-1	1.000000e+0	1.000000e+0	4.461177e+0	2.241561e-1	1	2022	5.000000e-1	4.945598e-4	unnamed	MSH2
GO Biological Process	GO:0032879	regulation of localization	204	1.871404e-1	1.000000e+0	1.000000e+0	5.343583e+0	1.871404e-1	1	1.871404e-1	1.000000e+0	199	1.713304e-1	1.000000e+0	1.000000e+0	5.575093e+0	1.793692e-1	1	1618	5.000000e-1	6.180470e-4	unnamed	KCNK12
GO Biological Process	GO:0006793	phosphorus metabolic process	205	1.905359e-1	1.000000e+0	1.000000e+0	5.248354e+0	1.905359e-1	1	1.905359e-1	1.000000e+0	205	2.159254e-1	1.000000e+0	1.000000e+0	4.366167e+0	2.290339e-1	1	2066	5.000000e-1	4.840271e-4	unnamed	MSH2
GO Biological Process	GO:0006996	organelle organization	206	1.979117e-1	1.000000e+0	1.000000e+0	5.052758e+0	1.979117e-1	1	1.979117e-1	1.000000e+0	207	2.321362e-1	1.000000e+0	1.000000e+0	4.041443e+0	2.474364e-1	1	2232	5.000000e-1	4.480287e-4	unnamed	MSH2
GO Biological Process	GO:0044281	small molecule metabolic process	207	2.001784e-1	1.000000e+0	1.000000e+0	4.995545e+0	2.001784e-1	1	2.001784e-1	1.000000e+0	210	2.509628e-1	1.000000e+0	1.000000e+0	3.716728e+0	2.690538e-1	1	2427	5.000000e-1	4.120313e-4	unnamed	MSH2
GO Biological Process	GO:0065009	regulation of molecular function	208	2.156945e-1	1.000000e+0	1.000000e+0	4.636187e+0	2.156945e-1	1	2.156945e-1	1.000000e+0	206	2.197492e-1	1.000000e+0	1.000000e+0	4.285273e+0	2.333574e-1	1	2105	5.000000e-1	4.750594e-4	unnamed	MSH2
GO Biological Process	GO:0044765	single-organism transport	209	2.288177e-1	1.000000e+0	1.000000e+0	4.370291e+0	2.288177e-1	1	2.288177e-1	1.000000e+0	212	2.680389e-1	1.000000e+0	1.000000e+0	3.461435e+0	2.888975e-1	1	2606	5.000000e-1	3.837299e-4	unnamed	KCNK12
GO Biological Process	GO:0006950	response to stress	210	2.428193e-1	1.000000e+0	1.000000e+0	4.118289e+0	2.428193e-1	1	2.428193e-1	1.000000e+0	216	3.014152e-1	1.000000e+0	1.000000e+0	3.045409e+0	3.283632e-1	1	2962	5.000000e-1	3.376097e-4	unnamed	MSH2
GO Biological Process	GO:0044710	single-organism metabolic process	211	2.517961e-1	1.000000e+0	1.000000e+0	3.971468e+0	2.517961e-1	1	2.517961e-1	1.000000e+0	218	3.105584e-1	1.000000e+0	1.000000e+0	2.946913e+0	3.393382e-1	1	3061	5.000000e-1	3.266906e-4	unnamed	MSH2
GO Biological Process	GO:0006810	transport	212	2.770578e-1	1.000000e+0	1.000000e+0	3.609355e+0	2.770578e-1	1	2.770578e-1	1.000000e+0	220	3.291182e-1	1.000000e+0	1.000000e+0	2.763634e+0	3.618425e-1	1	3264	5.000000e-1	3.063725e-4	unnamed	KCNK12
GO Biological Process	GO:0048513	organ development	213	2.824258e-1	1.000000e+0	1.000000e+0	3.540753e+0	2.824258e-1	1	2.824258e-1	1.000000e+0	209	2.446169e-1	1.000000e+0	1.000000e+0	3.820627e+0	2.617372e-1	1	2361	5.000000e-1	4.235493e-4	unnamed	MSH2
GO Biological Process	GO:0051234	establishment of localization	214	2.827781e-1	1.000000e+0	1.000000e+0	3.536342e+0	2.827781e-1	1	2.827781e-1	1.000000e+0	222	3.336507e-1	1.000000e+0	1.000000e+0	2.721937e+0	3.673854e-1	1	3314	5.000000e-1	3.017502e-4	unnamed	KCNK12
GO Biological Process	GO:0090304	nucleic acid metabolic process	215	3.065231e-1	1.000000e+0	1.000000e+0	3.262397e+0	3.065231e-1	1	3.065231e-1	1.000000e+0	225	3.768188e-1	1.000000e+0	1.000000e+0	2.374441e+0	4.211518e-1	1	3799	5.000000e-1	2.632272e-4	unnamed	MSH2
GO Biological Process	GO:0048523	negative regulation of cellular process	216	3.146568e-1	1.000000e+0	1.000000e+0	3.178065e+0	3.146568e-1	1	3.146568e-1	1.000000e+0	217	3.089005e-1	1.000000e+0	1.000000e+0	2.964344e+0	3.373427e-1	1	3043	5.000000e-1	3.286231e-4	unnamed	MSH2
GO Biological Process	GO:0030154	cell differentiation	217	3.160741e-1	1.000000e+0	1.000000e+0	3.163815e+0	3.160741e-1	1	3.160741e-1	1.000000e+0	213	2.690819e-1	1.000000e+0	1.000000e+0	3.446886e+0	2.901170e-1	1	2617	5.000000e-1	3.821169e-4	unnamed	MSH2
GO Biological Process	GO:0048869	cellular developmental process	218	3.225257e-1	1.000000e+0	1.000000e+0	3.100528e+0	3.225257e-1	1	3.225257e-1	1.000000e+0	214	2.802231e-1	1.000000e+0	1.000000e+0	3.298172e+0	3.031983e-1	1	2735	5.000000e-1	3.656307e-4	unnamed	MSH2
GO Biological Process	GO:0048519	negative regulation of biological process	219	3.368683e-1	1.000000e+0	1.000000e+0	2.968519e+0	3.368683e-1	1	3.368683e-1	1.000000e+0	223	3.341936e-1	1.000000e+0	1.000000e+0	2.717018e+0	3.680506e-1	1	3320	5.000000e-1	3.012048e-4	unnamed	MSH2
GO Biological Process	GO:0006139	nucleobase-containing compound metabolic process	220	3.530780e-1	1.000000e+0	1.000000e+0	2.832235e+0	3.530780e-1	1	3.530780e-1	1.000000e+0	236	4.351591e-1	1.000000e+0	1.000000e+0	2.012606e+0	4.968682e-1	1	4482	5.000000e-1	2.231147e-4	unnamed	MSH2
GO Biological Process	GO:0051179	localization	221	3.597525e-1	1.000000e+0	1.000000e+0	2.779689e+0	3.597525e-1	1	3.597525e-1	1.000000e+0	232	3.970433e-1	1.000000e+0	1.000000e+0	2.237227e+0	4.469819e-1	1	4032	5.000000e-1	2.480159e-4	unnamed	KCNK12
GO Biological Process	GO:0019219	regulation of nucleobase-containing compound metabolic process	222	3.657269e-1	1.000000e+0	1.000000e+0	2.734281e+0	3.657269e-1	1	3.657269e-1	1.000000e+0	228	3.879706e-1	1.000000e+0	1.000000e+0	2.297046e+0	4.353417e-1	1	3927	5.000000e-1	2.546473e-4	unnamed	MSH2
GO Biological Process	GO:0046483	heterocycle metabolic process	223	3.657512e-1	1.000000e+0	1.000000e+0	2.734099e+0	3.657512e-1	1	3.657512e-1	1.000000e+0	238	4.495636e-1	1.000000e+0	1.000000e+0	1.937393e+0	5.161576e-1	1	4656	5.000000e-1	2.147766e-4	unnamed	MSH2
GO Biological Process	GO:0006725	cellular aromatic compound metabolic process	224	3.683046e-1	1.000000e+0	1.000000e+0	2.715144e+0	3.683046e-1	1	3.683046e-1	1.000000e+0	239	4.506323e-1	1.000000e+0	1.000000e+0	1.931998e+0	5.175988e-1	1	4669	5.000000e-1	2.141786e-4	unnamed	MSH2
GO Biological Process	GO:0051171	regulation of nitrogen compound metabolic process	225	3.708892e-1	1.000000e+0	1.000000e+0	2.696223e+0	3.708892e-1	1	3.708892e-1	1.000000e+0	230	3.955790e-1	1.000000e+0	1.000000e+0	2.246700e+0	4.450973e-1	1	4015	5.000000e-1	2.490660e-4	unnamed	MSH2
GO Biological Process	GO:0044767	single-organism developmental process	226	3.730678e-1	1.000000e+0	1.000000e+0	2.680478e+0	3.730678e-1	1	3.730678e-1	1.000000e+0	221	3.331076e-1	1.000000e+0	1.000000e+0	2.726874e+0	3.667202e-1	1	3308	5.000000e-1	3.022975e-4	unnamed	MSH2
GO Biological Process	GO:0034641	cellular nitrogen compound metabolic process	227	3.768107e-1	1.000000e+0	1.000000e+0	2.653853e+0	3.768107e-1	1	3.768107e-1	1.000000e+0	241	4.663767e-1	1.000000e+0	1.000000e+0	1.855306e+0	5.389945e-1	1	4862	5.000000e-1	2.056767e-4	unnamed	MSH2
GO Biological Process	GO:1901360	organic cyclic compound metabolic process	228	3.827617e-1	1.000000e+0	1.000000e+0	2.612592e+0	3.827617e-1	1	3.827617e-1	1.000000e+0	243	4.683993e-1	1.000000e+0	1.000000e+0	1.845815e+0	5.417660e-1	1	4887	5.000000e-1	2.046245e-4	unnamed	MSH2
GO Biological Process	GO:0016043	cellular component organization	229	3.831577e-1	1.000000e+0	1.000000e+0	2.609891e+0	3.831577e-1	1	3.831577e-1	1.000000e+0	231	3.965267e-1	1.000000e+0	1.000000e+0	2.240561e+0	4.463167e-1	1	4026	5.000000e-1	2.483855e-4	unnamed	MSH2
GO Biological Process	GO:0071840	cellular component organization or biogenesis	230	3.897194e-1	1.000000e+0	1.000000e+0	2.565949e+0	3.897194e-1	1	3.897194e-1	1.000000e+0	233	4.070731e-1	1.000000e+0	1.000000e+0	2.174138e+0	4.599523e-1	1	4149	5.000000e-1	2.410219e-4	unnamed	MSH2
GO Biological Process	GO:0048731	system development	231	3.900631e-1	1.000000e+0	1.000000e+0	2.563688e+0	3.900631e-1	1	3.900631e-1	1.000000e+0	224	3.405107e-1	1.000000e+0	1.000000e+0	2.660914e+0	3.758107e-1	1	3390	5.000000e-1	2.949853e-4	unnamed	MSH2
GO Biological Process	GO:0007165	signal transduction	232	3.912589e-1	1.000000e+0	1.000000e+0	2.555852e+0	3.912589e-1	1	3.912589e-1	1.000000e+0	234	4.201465e-1	1.000000e+0	1.000000e+0	2.096328e+0	4.770246e-1	1	4303	5.000000e-1	2.323960e-4	unnamed	MSH2
GO Biological Process	GO:0060255	regulation of macromolecule metabolic process	233	4.100897e-1	1.000000e+0	1.000000e+0	2.438491e+0	4.100897e-1	1	4.100897e-1	1.000000e+0	237	4.477526e-1	1.000000e+0	1.000000e+0	1.946590e+0	5.137188e-1	1	4634	5.000000e-1	2.157963e-4	unnamed	MSH2
GO Biological Process	GO:0006807	nitrogen compound metabolic process	234	4.138051e-1	1.000000e+0	1.000000e+0	2.416597e+0	4.138051e-1	1	4.138051e-1	1.000000e+0	246	4.994558e-1	1.000000e+0	1.000000e+0	1.709399e+0	5.850008e-1	1	5277	5.000000e-1	1.895016e-4	unnamed	MSH2
GO Biological Process	GO:0048856	anatomical structure development	235	4.234725e-1	1.000000e+0	1.000000e+0	2.361429e+0	4.234725e-1	1	4.234725e-1	1.000000e+0	227	3.845834e-1	1.000000e+0	1.000000e+0	2.320087e+0	4.310182e-1	1	3888	5.000000e-1	2.572016e-4	unnamed	MSH2
GO Biological Process	GO:0007275	multicellular organismal development	236	4.357034e-1	1.000000e+0	1.000000e+0	2.295139e+0	4.357034e-1	1	4.357034e-1	1.000000e+0	229	3.919536e-1	1.000000e+0	1.000000e+0	2.270451e+0	4.404412e-1	1	3973	5.000000e-1	2.516990e-4	unnamed	MSH2
GO Biological Process	GO:0080090	regulation of primary metabolic process	237	4.363900e-1	1.000000e+0	1.000000e+0	2.291528e+0	4.363900e-1	1	4.363900e-1	1.000000e+0	244	4.714664e-1	1.000000e+0	1.000000e+0	1.831574e+0	5.459786e-1	1	4925	5.000000e-1	2.030457e-4	unnamed	MSH2
GO Biological Process	GO:0044700	single organism signaling	238	4.371810e-1	1.000000e+0	1.000000e+0	2.287382e+0	4.371810e-1	1	4.371810e-1	1.000000e+0	240	4.576762e-1	1.000000e+0	1.000000e+0	1.897056e+0	5.271326e-1	1	4755	5.000000e-1	2.103049e-4	unnamed	MSH2
GO Biological Process	GO:0031323	regulation of cellular metabolic process	239	4.406599e-1	1.000000e+0	1.000000e+0	2.269324e+0	4.406599e-1	1	4.406599e-1	1.000000e+0	245	4.760505e-1	1.000000e+0	1.000000e+0	1.810618e+0	5.522975e-1	1	4982	5.000000e-1	2.007226e-4	unnamed	MSH2
GO Biological Process	GO:0007154	cell communication	240	4.446638e-1	1.000000e+0	1.000000e+0	2.248890e+0	4.446638e-1	1	4.446638e-1	1.000000e+0	242	4.676716e-1	1.000000e+0	1.000000e+0	1.849221e+0	5.407683e-1	1	4878	5.000000e-1	2.050021e-4	unnamed	MSH2
GO Biological Process	GO:0051716	cellular response to stimulus	241	4.562761e-1	1.000000e+0	1.000000e+0	2.191655e+0	4.562761e-1	1	4.562761e-1	1.000000e+0	247	5.039946e-1	1.000000e+0	1.000000e+0	1.690815e+0	5.914306e-1	1	5335	5.000000e-1	1.874414e-4	unnamed	MSH2
GO Biological Process	GO:0032502	developmental process	242	4.657420e-1	1.000000e+0	1.000000e+0	2.147111e+0	4.657420e-1	1	4.657420e-1	1.000000e+0	235	4.306509e-1	1.000000e+0	1.000000e+0	2.037150e+0	4.908819e-1	1	4428	5.000000e-1	2.258356e-4	unnamed	MSH2
GO Biological Process	GO:0019222	regulation of metabolic process	243	4.728179e-1	1.000000e+0	1.000000e+0	2.114979e+0	4.728179e-1	1	4.728179e-1	1.000000e+0	248	5.177180e-1	1.000000e+0	1.000000e+0	1.636520e+0	6.110526e-1	1	5512	5.000000e-1	1.814224e-4	unnamed	MSH2
GO Biological Process	GO:0044260	cellular macromolecule metabolic process	244	4.901841e-1	1.000000e+0	1.000000e+0	2.040050e+0	4.901841e-1	1	4.901841e-1	1.000000e+0	252	5.672657e-1	1.000000e+0	1.000000e+0	1.461283e+0	6.843301e-1	1	6173	5.000000e-1	1.619958e-4	unnamed	MSH2
GO Biological Process	GO:0043170	macromolecule metabolic process	245	5.266956e-1	1.000000e+0	1.000000e+0	1.898630e+0	5.266956e-1	1	5.266956e-1	1.000000e+0	253	6.104699e-1	1.000000e+0	1.000000e+0	1.330261e+0	7.517322e-1	1	6781	5.000000e-1	1.474709e-4	unnamed	MSH2
GO Biological Process	GO:0044707	single-multicellular organism process	246	5.372858e-1	1.000000e+0	1.000000e+0	1.861207e+0	5.372858e-1	1	5.372858e-1	1.000000e+0	249	5.291973e-1	1.000000e+0	1.000000e+0	1.593165e+0	6.276814e-1	1	5662	5.000000e-1	1.766160e-4	unnamed	MSH2
GO Biological Process	GO:0050896	response to stimulus	247	5.533212e-1	1.000000e+0	1.000000e+0	1.807268e+0	5.533212e-1	1	5.533212e-1	1.000000e+0	254	6.177696e-1	1.000000e+0	1.000000e+0	1.309787e+0	7.634832e-1	1	6887	5.000000e-1	1.452011e-4	unnamed	MSH2
GO Biological Process	GO:0032501	multicellular organismal process	248	5.539872e-1	1.000000e+0	1.000000e+0	1.805096e+0	5.539872e-1	1	5.539872e-1	1.000000e+0	250	5.461571e-1	1.000000e+0	1.000000e+0	1.532275e+0	6.526246e-1	1	5887	5.000000e-1	1.698658e-4	unnamed	MSH2
GO Biological Process	GO:0044237	cellular metabolic process	249	6.001923e-1	1.000000e+0	1.000000e+0	1.666133e+0	6.001923e-1	1	6.001923e-1	1.000000e+0	255	7.045181e-1	1.000000e+0	1.000000e+0	1.095519e+0	9.128097e-1	1	8234	5.000000e-1	1.214477e-4	unnamed	MSH2
GO Biological Process	GO:0044238	primary metabolic process	250	6.053666e-1	1.000000e+0	1.000000e+0	1.651892e+0	6.053666e-1	1	6.053666e-1	1.000000e+0	256	7.093792e-1	1.000000e+0	1.000000e+0	1.084847e+0	9.217893e-1	1	8315	5.000000e-1	1.202646e-4	unnamed	MSH2
GO Biological Process	GO:0071704	organic substance metabolic process	251	6.199145e-1	1.000000e+0	1.000000e+0	1.613126e+0	6.199145e-1	1	6.199145e-1	1.000000e+0	257	7.239536e-1	1.000000e+0	1.000000e+0	1.053551e+0	9.491713e-1	1	8562	5.000000e-1	1.167951e-4	unnamed	MSH2
GO Biological Process	GO:0008152	metabolic process	252	6.507895e-1	1.000000e+0	1.000000e+0	1.536595e+0	6.507895e-1	1	6.507895e-1	1.000000e+0	258	7.596471e-1	1.000000e+0	1.000000e+0	9.809156e-1	1.019456e+0	1	9196	5.000000e-1	1.087429e-4	unnamed	MSH2
GO Biological Process	GO:0050794	regulation of cellular process	253	6.759845e-1	1.000000e+0	1.000000e+0	1.479324e+0	6.759845e-1	1	6.759845e-1	1.000000e+0	208	2.408423e-1	1.000000e+0	1.000000e+0	2.037610e+0	9.815420e-1	2	8854	1.000000e+0	2.258866e-4	unnamed	KCNK12,MSH2
GO Biological Process	GO:0050789	regulation of biological process	254	6.921477e-1	1.000000e+0	1.000000e+0	1.444778e+0	6.921477e-1	1	6.921477e-1	1.000000e+0	211	2.673785e-1	1.000000e+0	1.000000e+0	1.933862e+0	1.034200e+0	2	9329	1.000000e+0	2.143853e-4	unnamed	KCNK12,MSH2
GO Biological Process	GO:0065007	biological regulation	255	7.151977e-1	1.000000e+0	1.000000e+0	1.398215e+0	7.151977e-1	1	7.151977e-1	1.000000e+0	215	2.982605e-1	1.000000e+0	1.000000e+0	1.831016e+0	1.092290e+0	2	9853	1.000000e+0	2.029839e-4	unnamed	KCNK12,MSH2
GO Biological Process	GO:0044763	single-organism cellular process	256	7.497126e-1	1.000000e+0	1.000000e+0	1.333844e+0	7.497126e-1	1	7.497126e-1	1.000000e+0	219	3.141478e-1	1.000000e+0	1.000000e+0	1.784118e+0	1.121002e+0	2	10112	1.000000e+0	1.977848e-4	unnamed	KCNK12,MSH2
GO Biological Process	GO:0044699	single-organism process	257	7.935590e-1	1.000000e+0	1.000000e+0	1.260146e+0	7.935590e-1	1	7.935590e-1	1.000000e+0	226	3.800402e-1	1.000000e+0	1.000000e+0	1.622100e+0	1.232969e+0	2	11122	1.000000e+0	1.798238e-4	unnamed	KCNK12,MSH2
GO Biological Process	GO:0009987	cellular process	258	8.656787e-1	1.000000e+0	1.000000e+0	1.155163e+0	8.656787e-1	1	8.656787e-1	1.000000e+0	251	5.606826e-1	1.000000e+0	1.000000e+0	1.335480e+0	1.497589e+0	2	13509	1.000000e+0	1.480494e-4	unnamed	KCNK12,MSH2
GO Cellular Component	GO:0032302	MutSbeta complex	1	7.192132e-5	9.098047e-2	9.098047e-2	1.390408e+4	7.192132e-5	1	7.192132e-5	1.000000e+0	1	2.217111e-4	2.804645e-1	2.804645e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	MSH2
GO Cellular Component	GO:0032301	MutSalpha complex	2	1.847541e-4	2.337139e-1	1.168570e-1	5.412600e+3	1.847541e-4	1	1.847541e-4	1.000000e+0	1	2.217111e-4	2.804645e-1	2.804645e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	MSH2
GO Cellular Component	GO:0032300	mismatch repair complex	3	7.627713e-4	9.649057e-1	3.216352e-1	1.311009e+3	7.627713e-4	1	7.627713e-4	1.000000e+0	3	8.866967e-4	1.000000e+0	3.738904e-1	1.127562e+3	8.868688e-4	1	8	5.000000e-1	1.250000e-1	unnamed	MSH2
GO Cellular Component	GO:0000228	nuclear chromosome	4	2.961235e-2	1.000000e+0	1.000000e+0	3.376969e+1	2.961235e-2	1	2.961235e-2	1.000000e+0	4	3.374495e-2	1.000000e+0	1.000000e+0	2.938274e+1	3.403359e-2	1	307	5.000000e-1	3.257329e-3	unnamed	MSH2
GO Cellular Component	GO:0005694	chromosome	5	5.644203e-2	1.000000e+0	1.000000e+0	1.771729e+1	5.644203e-2	1	5.644203e-2	1.000000e+0	5	7.535154e-2	1.000000e+0	1.000000e+0	1.301659e+1	7.682501e-2	1	693	5.000000e-1	1.443001e-3	unnamed	MSH2
GO Cellular Component	GO:0031981	nuclear lumen	6	1.748307e-1	1.000000e+0	1.000000e+0	5.719819e+0	1.748307e-1	1	1.748307e-1	1.000000e+0	6	2.174952e-1	1.000000e+0	1.000000e+0	4.332613e+0	2.308076e-1	1	2082	5.000000e-1	4.803074e-4	unnamed	MSH2
GO Cellular Component	GO:0044428	nuclear part	7	2.070089e-1	1.000000e+0	1.000000e+0	4.830709e+0	2.070089e-1	1	2.070089e-1	1.000000e+0	7	2.552742e-1	1.000000e+0	1.000000e+0	3.649070e+0	2.740425e-1	1	2472	5.000000e-1	4.045307e-4	unnamed	MSH2
GO Cellular Component	GO:0070013	intracellular organelle lumen	8	2.178720e-1	1.000000e+0	1.000000e+0	4.589852e+0	2.178720e-1	1	2.178720e-1	1.000000e+0	8	2.759844e-1	1.000000e+0	1.000000e+0	3.353346e+0	2.982096e-1	1	2690	5.000000e-1	3.717472e-4	unnamed	MSH2
GO Cellular Component	GO:0043233	organelle lumen	9	2.231770e-1	1.000000e+0	1.000000e+0	4.480748e+0	2.231770e-1	1	2.231770e-1	1.000000e+0	9	2.816332e-1	1.000000e+0	1.000000e+0	3.280182e+0	3.048611e-1	1	2750	5.000000e-1	3.636364e-4	unnamed	MSH2
GO Cellular Component	GO:0031974	membrane-enclosed lumen	10	2.255118e-1	1.000000e+0	1.000000e+0	4.434357e+0	2.255118e-1	1	2.255118e-1	1.000000e+0	10	2.863237e-1	1.000000e+0	1.000000e+0	3.221607e+0	3.104041e-1	1	2800	5.000000e-1	3.571429e-4	unnamed	MSH2
GO Cellular Component	GO:0043232	intracellular non-membrane-bounded organelle	11	2.709879e-1	1.000000e+0	1.000000e+0	3.690202e+0	2.709879e-1	1	2.709879e-1	1.000000e+0	11	3.348266e-1	1.000000e+0	1.000000e+0	2.711301e+0	3.688266e-1	1	3327	5.000000e-1	3.005711e-4	unnamed	MSH2
GO Cellular Component	GO:0043234	protein complex	12	3.027166e-1	1.000000e+0	1.000000e+0	3.303419e+0	3.027166e-1	1	3.027166e-1	1.000000e+0	12	3.630030e-1	1.000000e+0	1.000000e+0	2.476798e+0	4.037470e-1	1	3642	5.000000e-1	2.745744e-4	unnamed	MSH2
GO Cellular Component	GO:0032991	macromolecular complex	13	3.347910e-1	1.000000e+0	1.000000e+0	2.986938e+0	3.347910e-1	1	3.347910e-1	1.000000e+0	13	4.132884e-1	1.000000e+0	1.000000e+0	2.136547e+0	4.680450e-1	1	4222	5.000000e-1	2.368546e-4	unnamed	MSH2
GO Cellular Component	GO:0016021	integral to membrane	14	4.578656e-1	1.000000e+0	1.000000e+0	2.184047e+0	4.578656e-1	1	4.578656e-1	1.000000e+0	14	4.982001e-1	1.000000e+0	1.000000e+0	1.714598e+0	5.832271e-1	1	5261	5.000000e-1	1.900779e-4	unnamed	KCNK12
GO Cellular Component	GO:0031224	intrinsic to membrane	15	4.694206e-1	1.000000e+0	1.000000e+0	2.130286e+0	4.694206e-1	1	4.694206e-1	1.000000e+0	15	5.070350e-1	1.000000e+0	1.000000e+0	1.678545e+0	5.957541e-1	1	5374	5.000000e-1	1.860811e-4	unnamed	KCNK12
GO Cellular Component	GO:0044446	intracellular organelle part	16	4.732075e-1	1.000000e+0	1.000000e+0	2.113238e+0	4.732075e-1	1	4.732075e-1	1.000000e+0	18	5.897910e-1	1.000000e+0	1.000000e+0	1.390765e+0	7.190289e-1	1	6486	5.000000e-1	1.541782e-4	unnamed	MSH2
GO Cellular Component	GO:0005634	nucleus	17	4.766312e-1	1.000000e+0	1.000000e+0	2.098058e+0	4.766312e-1	1	4.766312e-1	1.000000e+0	16	5.600157e-1	1.000000e+0	1.000000e+0	1.485100e+0	6.733551e-1	1	6074	5.000000e-1	1.646362e-4	unnamed	MSH2
GO Cellular Component	GO:0044422	organelle part	18	4.814989e-1	1.000000e+0	1.000000e+0	2.076848e+0	4.814989e-1	1	4.814989e-1	1.000000e+0	19	5.977049e-1	1.000000e+0	1.000000e+0	1.367157e+0	7.314450e-1	1	6598	5.000000e-1	1.515611e-4	unnamed	MSH2
GO Cellular Component	GO:0044425	membrane part	19	5.293034e-1	1.000000e+0	1.000000e+0	1.889276e+0	5.293034e-1	1	5.293034e-1	1.000000e+0	17	5.687230e-1	1.000000e+0	1.000000e+0	1.456564e+0	6.865473e-1	1	6193	5.000000e-1	1.614726e-4	unnamed	KCNK12
GO Cellular Component	GO:0016020	membrane	20	6.308744e-1	1.000000e+0	1.000000e+0	1.585102e+0	6.308744e-1	1	6.308744e-1	1.000000e+0	20	6.811747e-1	1.000000e+0	1.000000e+0	1.148523e+0	8.706834e-1	1	7854	5.000000e-1	1.273237e-4	unnamed	KCNK12
GO Cellular Component	GO:0043231	intracellular membrane-bounded organelle	21	6.973299e-1	1.000000e+0	1.000000e+0	1.434041e+0	6.973299e-1	1	6.973299e-1	1.000000e+0	21	8.019514e-1	1.000000e+0	1.000000e+0	9.009688e-1	1.109916e+0	1	10012	5.000000e-1	9.988014e-5	unnamed	MSH2
GO Cellular Component	GO:0043227	membrane-bounded organelle	22	6.992039e-1	1.000000e+0	1.000000e+0	1.430198e+0	6.992039e-1	1	6.992039e-1	1.000000e+0	22	8.036253e-1	1.000000e+0	1.000000e+0	8.979196e-1	1.113685e+0	1	10046	5.000000e-1	9.954211e-5	unnamed	MSH2
GO Cellular Component	GO:0043229	intracellular organelle	23	7.399473e-1	1.000000e+0	1.000000e+0	1.351448e+0	7.399473e-1	1	7.399473e-1	1.000000e+0	23	8.473502e-1	1.000000e+0	1.000000e+0	8.206423e-1	1.218558e+0	1	10992	5.000000e-1	9.097525e-5	unnamed	MSH2
GO Cellular Component	GO:0043226	organelle	24	7.415866e-1	1.000000e+0	1.000000e+0	1.348460e+0	7.415866e-1	1	7.415866e-1	1.000000e+0	24	8.487331e-1	1.000000e+0	1.000000e+0	8.182602e-1	1.222105e+0	1	11024	5.000000e-1	9.071118e-5	unnamed	MSH2
GO Cellular Component	GO:0044424	intracellular part	25	8.017695e-1	1.000000e+0	1.000000e+0	1.247241e+0	8.017695e-1	1	8.017695e-1	1.000000e+0	25	9.083176e-1	1.000000e+0	1.000000e+0	7.171649e-1	1.394379e+0	1	12578	5.000000e-1	7.950390e-5	unnamed	MSH2
GO Cellular Component	GO:0005622	intracellular	26	8.064789e-1	1.000000e+0	1.000000e+0	1.239958e+0	8.064789e-1	1	8.064789e-1	1.000000e+0	26	9.139354e-1	1.000000e+0	1.000000e+0	7.076012e-1	1.413225e+0	1	12748	5.000000e-1	7.844368e-5	unnamed	MSH2
GO Cellular Component	GO:0044464	cell part	27	8.908971e-1	1.000000e+0	1.000000e+0	1.122464e+0	8.908971e-1	1	8.908971e-1	1.000000e+0	27	9.677154e-1	1.000000e+0	1.000000e+0	6.095344e-1	1.640596e+0	1	14799	5.000000e-1	6.757213e-5	unnamed	MSH2
GO Cellular Component	GO:0005623	cell	28	8.910977e-1	1.000000e+0	1.000000e+0	1.122211e+0	8.910977e-1	1	8.910977e-1	1.000000e+0	28	9.677354e-1	1.000000e+0	1.000000e+0	6.094932e-1	1.640707e+0	1	14800	5.000000e-1	6.756757e-5	unnamed	MSH2
Mouse Phenotype	MP:0010345	increased thyroid C-cell carcinoma incidence	1	1.554047e-4	1.000000e+0	1.000000e+0	6.434813e+3	1.554047e-4	1	1.554047e-4	1.000000e+0	1	3.325574e-4	1.000000e+0	1.000000e+0	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	MSH2
Mouse Phenotype	MP:0010351	increased pituitary melanotroph tumor incidence	2	1.601797e-4	1.000000e+0	6.341514e-1	6.242989e+3	1.601797e-4	1	1.601797e-4	1.000000e+0	3	4.433975e-4	1.000000e+0	1.000000e+0	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	MSH2
Mouse Phenotype	MP:0009320	lymphoblastic lymphoma	3	2.733260e-4	1.000000e+0	7.213984e-1	3.658635e+3	2.733260e-4	1	2.733260e-4	1.000000e+0	1	3.325574e-4	1.000000e+0	1.000000e+0	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	MSH2
Mouse Phenotype	MP:0010350	increased pituitary adenohypophysis tumor incidence	4	4.435191e-4	1.000000e+0	8.779461e-1	2.254694e+3	4.435191e-4	1	4.435191e-4	1.000000e+0	4	5.542315e-4	1.000000e+0	1.000000e+0	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	MSH2
Mouse Phenotype	MP:0009797	abnormal mismatch repair	5	4.648098e-4	1.000000e+0	7.360728e-1	2.151418e+3	4.648098e-4	1	4.648098e-4	1.000000e+0	5	8.866967e-4	1.000000e+0	1.000000e+0	1.127562e+3	8.868688e-4	1	8	5.000000e-1	1.250000e-1	unnamed	MSH2
Mouse Phenotype	MP:0004501	increased incidence of tumors by UV-induction	6	4.805611e-4	1.000000e+0	6.341805e-1	2.080901e+3	4.805611e-4	1	4.805611e-4	1.000000e+0	7	1.108309e-3	1.000000e+0	1.000000e+0	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	MSH2
Mouse Phenotype	MP:0002050	pheochromocytoma	7	6.022774e-4	1.000000e+0	6.812618e-1	1.660364e+3	6.022774e-4	1	6.022774e-4	1.000000e+0	7	1.108309e-3	1.000000e+0	1.000000e+0	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	MSH2
Mouse Phenotype	MP:0003269	colon polyps	8	8.835779e-4	1.000000e+0	8.745212e-1	1.131762e+3	8.835779e-4	1	8.835779e-4	1.000000e+0	10	1.551461e-3	1.000000e+0	1.000000e+0	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	MSH2
Mouse Phenotype	MP:0009704	skin squamous cell carcinoma	9	9.643653e-4	1.000000e+0	8.484272e-1	1.036951e+3	9.643653e-4	1	9.643653e-4	1.000000e+0	14	1.883760e-3	1.000000e+0	1.000000e+0	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	MSH2
Mouse Phenotype	MP:0002031	increased adrenal gland tumor incidence	10	1.044589e-3	1.000000e+0	8.271056e-1	9.573146e+2	1.044589e-3	1	1.044589e-3	1.000000e+0	12	1.773000e-3	1.000000e+0	1.000000e+0	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	MSH2
Mouse Phenotype	MP:0010346	increased thyroid carcinoma incidence	11	1.057458e-3	1.000000e+0	7.611775e-1	9.456636e+2	1.057458e-3	1	1.057458e-3	1.000000e+0	6	9.975062e-4	1.000000e+0	1.000000e+0	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	MSH2
Mouse Phenotype	MP:0004815	abnormal somatic hypermutation frequency	12	1.337091e-3	1.000000e+0	8.822572e-1	7.478925e+2	1.337091e-3	1	1.337091e-3	1.000000e+0	12	1.773000e-3	1.000000e+0	1.000000e+0	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	MSH2
Mouse Phenotype	MP:0009309	small intestine adenocarcinoma	13	1.388853e-3	1.000000e+0	8.459183e-1	7.200187e+2	1.388853e-3	1	1.388853e-3	1.000000e+0	9	1.219107e-3	1.000000e+0	1.000000e+0	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	MSH2
Mouse Phenotype	MP:0003324	increased liver adenoma incidence	14	1.542576e-3	1.000000e+0	8.724369e-1	6.482664e+2	1.542576e-3	1	1.542576e-3	1.000000e+0	16	2.216004e-3	1.000000e+0	1.000000e+0	4.510250e+2	2.217172e-3	1	20	5.000000e-1	5.000000e-2	unnamed	MSH2
Mouse Phenotype	MP:0010316	increased thyroid tumor incidence	15	1.574984e-3	1.000000e+0	8.313816e-1	6.349273e+2	1.574984e-3	1	1.574984e-3	1.000000e+0	15	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	MSH2
Mouse Phenotype	MP:0008410	increased cellular sensitivity to ultraviolet irradiation	16	1.784512e-3	1.000000e+0	8.831104e-1	5.603772e+2	1.784512e-3	1	1.784512e-3	1.000000e+0	24	3.212404e-3	1.000000e+0	1.000000e+0	3.110517e+2	3.214899e-3	1	29	5.000000e-1	3.448276e-2	unnamed	MSH2
Mouse Phenotype	MP:0009222	uterus tumor	17	2.090356e-3	1.000000e+0	9.736140e-1	4.783874e+2	2.090356e-3	1	2.090356e-3	1.000000e+0	16	2.216004e-3	1.000000e+0	1.000000e+0	4.510250e+2	2.217172e-3	1	20	5.000000e-1	5.000000e-2	unnamed	MSH2
Mouse Phenotype	MP:0004191	neuronal intranuclear inclusions	18	2.203622e-3	1.000000e+0	9.693488e-1	4.537983e+2	2.203622e-3	1	2.203622e-3	1.000000e+0	11	1.662234e-3	1.000000e+0	1.000000e+0	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	MSH2
Mouse Phenotype	MP:0008884	abnormal enterocyte apoptosis	19	2.395246e-3	1.000000e+0	9.981873e-1	4.174937e+2	2.395246e-3	1	2.395246e-3	1.000000e+0	20	2.769621e-3	1.000000e+0	1.000000e+0	3.608200e+2	2.771465e-3	1	25	5.000000e-1	4.000000e-2	unnamed	MSH2
Mouse Phenotype	MP:0009828	increased tumor latency	20	2.504078e-3	1.000000e+0	9.913645e-1	3.993486e+2	2.504078e-3	1	2.504078e-3	1.000000e+0	18	2.326740e-3	1.000000e+0	1.000000e+0	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	MSH2
Mouse Phenotype	MP:0009277	brain tumor	21	2.574915e-3	1.000000e+0	9.708656e-1	3.883623e+2	2.574915e-3	1	2.574915e-3	1.000000e+0	22	3.101718e-3	1.000000e+0	1.000000e+0	3.221607e+2	3.104041e-3	1	28	5.000000e-1	3.571429e-2	unnamed	MSH2
Mouse Phenotype	MP:0003789	osteosarcoma	22	2.766283e-3	1.000000e+0	9.956104e-1	3.614958e+2	2.766283e-3	1	2.766283e-3	1.000000e+0	19	2.437470e-3	1.000000e+0	1.000000e+0	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	MSH2
Mouse Phenotype	MP:0008011	intestine polyps	23	3.308763e-3	1.000000e+0	1.000000e+0	3.022277e+2	3.308763e-3	1	3.308763e-3	1.000000e+0	22	3.101718e-3	1.000000e+0	1.000000e+0	3.221607e+2	3.104041e-3	1	28	5.000000e-1	3.571429e-2	unnamed	MSH2
Mouse Phenotype	MP:0002051	skin papilloma	24	3.627202e-3	1.000000e+0	1.000000e+0	2.756946e+2	3.627202e-3	1	3.627202e-3	1.000000e+0	28	4.429551e-3	1.000000e+0	1.000000e+0	2.255125e+2	4.434344e-3	1	40	5.000000e-1	2.500000e-2	unnamed	MSH2
Mouse Phenotype	MP:0003667	hemangiosarcoma	25	3.677923e-3	1.000000e+0	1.000000e+0	2.718926e+2	3.677923e-3	1	3.677923e-3	1.000000e+0	26	3.655089e-3	1.000000e+0	1.000000e+0	2.733485e+2	3.658334e-3	1	33	5.000000e-1	3.030303e-2	unnamed	MSH2
Mouse Phenotype	MP:0010280	increased skeletal tumor incidence	26	3.963581e-3	1.000000e+0	1.000000e+0	2.522971e+2	3.963581e-3	1	3.963581e-3	1.000000e+0	21	2.880326e-3	1.000000e+0	1.000000e+0	3.469423e+2	2.882324e-3	1	26	5.000000e-1	3.846154e-2	unnamed	MSH2
Mouse Phenotype	MP:0003992	increased mortality induced by ionizing radiation	27	3.999546e-3	1.000000e+0	1.000000e+0	2.500283e+2	3.999546e-3	1	3.999546e-3	1.000000e+0	31	4.982553e-3	1.000000e+0	1.000000e+0	2.004556e+2	4.988637e-3	1	45	5.000000e-1	2.222222e-2	unnamed	MSH2
Mouse Phenotype	MP:0010352	gastrointestinal tract polyps	28	4.161266e-3	1.000000e+0	1.000000e+0	2.403115e+2	4.161266e-3	1	4.161266e-3	1.000000e+0	25	3.433759e-3	1.000000e+0	1.000000e+0	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	MSH2
Mouse Phenotype	MP:0002957	intestinal adenocarcinoma	29	4.323254e-3	1.000000e+0	1.000000e+0	2.313073e+2	4.323254e-3	1	4.323254e-3	1.000000e+0	30	4.761371e-3	1.000000e+0	1.000000e+0	2.097791e+2	4.766920e-3	1	43	5.000000e-1	2.325581e-2	unnamed	MSH2
Mouse Phenotype	MP:0008000	increased ovary tumor incidence	30	4.330277e-3	1.000000e+0	1.000000e+0	2.309321e+2	4.330277e-3	1	4.330277e-3	1.000000e+0	28	4.429551e-3	1.000000e+0	1.000000e+0	2.255125e+2	4.434344e-3	1	40	5.000000e-1	2.500000e-2	unnamed	MSH2
Mouse Phenotype	MP:0002048	increased lung adenoma incidence	31	4.364080e-3	1.000000e+0	1.000000e+0	2.291433e+2	4.364080e-3	1	4.364080e-3	1.000000e+0	34	5.645954e-3	1.000000e+0	1.000000e+0	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	MSH2
Mouse Phenotype	MP:0004207	squamous cell carcinoma	32	4.467479e-3	1.000000e+0	1.000000e+0	2.238399e+2	4.467479e-3	1	4.467479e-3	1.000000e+0	33	5.535402e-3	1.000000e+0	1.000000e+0	1.804100e+2	5.542930e-3	1	50	5.000000e-1	2.000000e-2	unnamed	MSH2
Mouse Phenotype	MP:0010320	increased pituitary gland tumor incidence	33	4.560929e-3	1.000000e+0	1.000000e+0	2.192536e+2	4.560929e-3	1	4.560929e-3	1.000000e+0	27	3.765745e-3	1.000000e+0	1.000000e+0	2.653088e+2	3.769192e-3	1	34	5.000000e-1	2.941176e-2	unnamed	MSH2
Mouse Phenotype	MP:0008058	abnormal DNA repair	34	5.036031e-3	1.000000e+0	1.000000e+0	1.985691e+2	5.036031e-3	1	5.036031e-3	1.000000e+0	49	9.952663e-3	1.000000e+0	1.000000e+0	1.002278e+2	9.977274e-3	1	90	5.000000e-1	1.111111e-2	unnamed	MSH2
Mouse Phenotype	MP:0008882	abnormal enterocyte physiology	35	5.183444e-3	1.000000e+0	1.000000e+0	1.929219e+2	5.183444e-3	1	5.183444e-3	1.000000e+0	38	6.198618e-3	1.000000e+0	1.000000e+0	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	MSH2
Mouse Phenotype	MP:0002404	increased intestinal adenoma incidence	36	5.229360e-3	1.000000e+0	1.000000e+0	1.912280e+2	5.229360e-3	1	5.229360e-3	1.000000e+0	32	5.314281e-3	1.000000e+0	1.000000e+0	1.879271e+2	5.321213e-3	1	48	5.000000e-1	2.083333e-2	unnamed	MSH2
Mouse Phenotype	MP:0010291	increased cardiovascular system tumor incidence	37	5.232946e-3	1.000000e+0	1.000000e+0	1.910969e+2	5.232946e-3	1	5.232946e-3	1.000000e+0	36	5.867038e-3	1.000000e+0	1.000000e+0	1.701981e+2	5.875506e-3	1	53	5.000000e-1	1.886792e-2	unnamed	MSH2
Mouse Phenotype	MP:0010307	abnormal tumor latency	38	6.284847e-3	1.000000e+0	1.000000e+0	1.591129e+2	6.284847e-3	1	6.284847e-3	1.000000e+0	34	5.645954e-3	1.000000e+0	1.000000e+0	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	MSH2
Mouse Phenotype	MP:0010300	increased skin tumor incidence	39	6.449714e-3	1.000000e+0	1.000000e+0	1.550456e+2	6.449714e-3	1	6.449714e-3	1.000000e+0	43	8.959636e-3	1.000000e+0	1.000000e+0	1.113642e+2	8.979547e-3	1	81	5.000000e-1	1.234568e-2	unnamed	MSH2
Mouse Phenotype	MP:0002014	increased papilloma incidence	40	6.453089e-3	1.000000e+0	1.000000e+0	1.549646e+2	6.453089e-3	1	6.453089e-3	1.000000e+0	38	6.198618e-3	1.000000e+0	1.000000e+0	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	MSH2
Mouse Phenotype	MP:0002027	lung adenocarcinoma	41	6.674635e-3	1.000000e+0	1.000000e+0	1.498209e+2	6.674635e-3	1	6.674635e-3	1.000000e+0	41	7.524386e-3	1.000000e+0	1.000000e+0	1.326544e+2	7.538385e-3	1	68	5.000000e-1	1.470588e-2	unnamed	MSH2
Mouse Phenotype	MP:0009590	gonad tumor	42	6.682982e-3	1.000000e+0	1.000000e+0	1.496338e+2	6.682982e-3	1	6.682982e-3	1.000000e+0	37	6.088097e-3	1.000000e+0	1.000000e+0	1.640091e+2	6.097223e-3	1	55	5.000000e-1	1.818182e-2	unnamed	MSH2
Mouse Phenotype	MP:0010281	increased nervous system tumor incidence	43	7.002789e-3	1.000000e+0	1.000000e+0	1.428003e+2	7.002789e-3	1	7.002789e-3	1.000000e+0	40	6.861613e-3	1.000000e+0	1.000000e+0	1.454919e+2	6.873233e-3	1	62	5.000000e-1	1.612903e-2	unnamed	MSH2
Mouse Phenotype	MP:0008716	lung non-small cell carcinoma	44	7.123287e-3	1.000000e+0	1.000000e+0	1.403846e+2	7.123287e-3	1	7.123287e-3	1.000000e+0	42	8.297342e-3	1.000000e+0	1.000000e+0	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	MSH2
Mouse Phenotype	MP:0004816	abnormal class switch recombination	45	7.358171e-3	1.000000e+0	1.000000e+0	1.359033e+2	7.358171e-3	1	7.358171e-3	1.000000e+0	45	9.621709e-3	1.000000e+0	1.000000e+0	1.036839e+2	9.644698e-3	1	87	5.000000e-1	1.149425e-2	unnamed	MSH2
Mouse Phenotype	MP:0008714	lung carcinoma	46	8.130735e-3	1.000000e+0	1.000000e+0	1.229901e+2	8.130735e-3	1	8.130735e-3	1.000000e+0	48	9.842351e-3	1.000000e+0	1.000000e+0	1.013539e+2	9.866415e-3	1	89	5.000000e-1	1.123596e-2	unnamed	MSH2
Mouse Phenotype	MP:0008498	decreased IgG3 level	47	9.220685e-3	1.000000e+0	1.000000e+0	1.084518e+2	9.220685e-3	1	9.220685e-3	1.000000e+0	46	9.732033e-3	1.000000e+0	1.000000e+0	1.025057e+2	9.755557e-3	1	88	5.000000e-1	1.136364e-2	unnamed	MSH2
Mouse Phenotype	MP:0010299	increased mammary gland tumor incidence	48	9.402370e-3	1.000000e+0	1.000000e+0	1.063562e+2	9.402370e-3	1	9.402370e-3	1.000000e+0	46	9.732033e-3	1.000000e+0	1.000000e+0	1.025057e+2	9.755557e-3	1	88	5.000000e-1	1.136364e-2	unnamed	MSH2
Mouse Phenotype	MP:0010279	increased gastrointestinal tumor incidence	49	9.719407e-3	1.000000e+0	1.000000e+0	1.028869e+2	9.719407e-3	1	9.719407e-3	1.000000e+0	53	1.116569e-2	1.000000e+0	1.000000e+0	8.931188e+1	1.119672e-2	1	101	5.000000e-1	9.900990e-3	unnamed	MSH2
Mouse Phenotype	MP:0010292	increased alimentary system tumor incidence	50	1.051172e-2	1.000000e+0	1.000000e+0	9.513187e+1	1.051172e-2	1	1.051172e-2	1.000000e+0	56	1.259830e-2	1.000000e+0	1.000000e+0	7.912719e+1	1.263788e-2	1	114	5.000000e-1	8.771930e-3	unnamed	MSH2
Mouse Phenotype	MP:0008943	increased sensitivity to induced cell death	51	1.087050e-2	1.000000e+0	1.000000e+0	9.199209e+1	1.087050e-2	1	1.087050e-2	1.000000e+0	62	1.667005e-2	1.000000e+0	1.000000e+0	5.973841e+1	1.673965e-2	1	151	5.000000e-1	6.622517e-3	unnamed	MSH2
Mouse Phenotype	MP:0010287	increased reproductive system tumor incidence	52	1.089120e-2	1.000000e+0	1.000000e+0	9.181723e+1	1.089120e-2	1	1.089120e-2	1.000000e+0	44	9.511379e-3	1.000000e+0	1.000000e+0	1.048895e+2	9.533840e-3	1	86	5.000000e-1	1.162791e-2	unnamed	MSH2
Mouse Phenotype	MP:0002024	T cell derived lymphoma	53	1.137483e-2	1.000000e+0	1.000000e+0	8.791344e+1	1.137483e-2	1	1.137483e-2	1.000000e+0	51	1.072467e-2	1.000000e+0	1.000000e+0	9.299485e+1	1.075328e-2	1	97	5.000000e-1	1.030928e-2	unnamed	MSH2
Mouse Phenotype	MP:0010365	increased thymus tumor incidence	54	1.140170e-2	1.000000e+0	1.000000e+0	8.770624e+1	1.140170e-2	1	1.140170e-2	1.000000e+0	52	1.083493e-2	1.000000e+0	1.000000e+0	9.204592e+1	1.086414e-2	1	98	5.000000e-1	1.020408e-2	unnamed	MSH2
Mouse Phenotype	MP:0008019	increased liver tumor incidence	55	1.160410e-2	1.000000e+0	1.000000e+0	8.617647e+1	1.160410e-2	1	1.160410e-2	1.000000e+0	55	1.237796e-2	1.000000e+0	1.000000e+0	8.054018e+1	1.241616e-2	1	112	5.000000e-1	8.928571e-3	unnamed	MSH2
Mouse Phenotype	MP:0010297	increased hepatobiliary system tumor incidence	56	1.173767e-2	1.000000e+0	1.000000e+0	8.519581e+1	1.173767e-2	1	1.173767e-2	1.000000e+0	56	1.259830e-2	1.000000e+0	1.000000e+0	7.912719e+1	1.263788e-2	1	114	5.000000e-1	8.771930e-3	unnamed	MSH2
Mouse Phenotype	MP:0002032	sarcoma	57	1.184575e-2	1.000000e+0	1.000000e+0	8.441844e+1	1.184575e-2	1	1.184575e-2	1.000000e+0	58	1.303889e-2	1.000000e+0	1.000000e+0	7.644492e+1	1.308131e-2	1	118	5.000000e-1	8.474576e-3	unnamed	MSH2
Mouse Phenotype	MP:0008014	increased lung tumor incidence	58	1.298326e-2	1.000000e+0	1.000000e+0	7.702228e+1	1.298326e-2	1	1.298326e-2	1.000000e+0	59	1.391979e-2	1.000000e+0	1.000000e+0	7.159127e+1	1.396818e-2	1	126	5.000000e-1	7.936508e-3	unnamed	MSH2
Mouse Phenotype	MP:0000495	abnormal colon morphology	59	1.299585e-2	1.000000e+0	1.000000e+0	7.694764e+1	1.299585e-2	1	1.299585e-2	1.000000e+0	50	1.061440e-2	1.000000e+0	1.000000e+0	9.396354e+1	1.064243e-2	1	96	5.000000e-1	1.041667e-2	unnamed	MSH2
Mouse Phenotype	MP:0008495	decreased IgG1 level	60	1.309759e-2	1.000000e+0	1.000000e+0	7.634992e+1	1.309759e-2	1	1.309759e-2	1.000000e+0	61	1.524040e-2	1.000000e+0	1.000000e+0	6.536594e+1	1.529849e-2	1	138	5.000000e-1	7.246377e-3	unnamed	MSH2
Mouse Phenotype	MP:0004499	increased incidence of tumors by chemical induction	61	1.311595e-2	1.000000e+0	1.000000e+0	7.624306e+1	1.311595e-2	1	1.311595e-2	1.000000e+0	54	1.171681e-2	1.000000e+0	1.000000e+0	8.509906e+1	1.175101e-2	1	106	5.000000e-1	9.433962e-3	unnamed	MSH2
Mouse Phenotype	MP:0009308	adenocarcinoma	62	1.492238e-2	1.000000e+0	1.000000e+0	6.701344e+1	1.492238e-2	1	1.492238e-2	1.000000e+0	64	1.677999e-2	1.000000e+0	1.000000e+0	5.934539e+1	1.685051e-2	1	152	5.000000e-1	6.578947e-3	unnamed	MSH2
Mouse Phenotype	MP:0010293	increased integument system tumor incidence	63	1.498579e-2	1.000000e+0	1.000000e+0	6.672990e+1	1.498579e-2	1	1.498579e-2	1.000000e+0	62	1.667005e-2	1.000000e+0	1.000000e+0	5.973841e+1	1.673965e-2	1	151	5.000000e-1	6.622517e-3	unnamed	MSH2
Mouse Phenotype	MP:0002021	increased incidence of induced tumors	64	1.567887e-2	1.000000e+0	1.000000e+0	6.378010e+1	1.567887e-2	1	1.567887e-2	1.000000e+0	60	1.513038e-2	1.000000e+0	1.000000e+0	6.584307e+1	1.518763e-2	1	137	5.000000e-1	7.299270e-3	unnamed	MSH2
Mouse Phenotype	MP:0010383	increased adenoma incidence	65	1.689252e-2	1.000000e+0	1.000000e+0	5.919779e+1	1.689252e-2	1	1.689252e-2	1.000000e+0	65	1.699983e-2	1.000000e+0	1.000000e+0	5.857468e+1	1.707222e-2	1	154	5.000000e-1	6.493506e-3	unnamed	MSH2
Mouse Phenotype	MP:0008942	abnormal induced cell death	66	1.726637e-2	1.000000e+0	1.000000e+0	5.791607e+1	1.726637e-2	1	1.726637e-2	1.000000e+0	69	2.314545e-2	1.000000e+0	1.000000e+0	4.295476e+1	2.328031e-2	1	210	5.000000e-1	4.761905e-3	unnamed	MSH2
Mouse Phenotype	MP:0003448	altered tumor morphology	67	1.851112e-2	1.000000e+0	1.000000e+0	5.402157e+1	1.851112e-2	1	1.851112e-2	1.000000e+0	68	1.864787e-2	1.000000e+0	1.000000e+0	5.337574e+1	1.873510e-2	1	169	5.000000e-1	5.917160e-3	unnamed	MSH2
Mouse Phenotype	MP:0011110	partial preweaning lethality	68	2.208760e-2	1.000000e+0	1.000000e+0	4.527427e+1	2.208760e-2	1	2.208760e-2	1.000000e+0	66	1.721965e-2	1.000000e+0	1.000000e+0	5.782372e+1	1.729394e-2	1	156	5.000000e-1	6.410256e-3	unnamed	MSH2
Mouse Phenotype	MP:0000489	abnormal large intestine morphology	69	2.211060e-2	1.000000e+0	1.000000e+0	4.522718e+1	2.211060e-2	1	2.211060e-2	1.000000e+0	67	1.798882e-2	1.000000e+0	1.000000e+0	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	MSH2
Mouse Phenotype	MP:0002022	increased lymphoma incidence	70	2.227473e-2	1.000000e+0	1.000000e+0	4.489392e+1	2.227473e-2	1	2.227473e-2	1.000000e+0	71	2.413134e-2	1.000000e+0	1.000000e+0	4.118950e+1	2.427803e-2	1	219	5.000000e-1	4.566210e-3	unnamed	MSH2
Mouse Phenotype	MP:0010155	abnormal intestine physiology	71	2.326312e-2	1.000000e+0	1.000000e+0	4.298649e+1	2.326312e-2	1	2.326312e-2	1.000000e+0	80	2.894409e-2	1.000000e+0	1.000000e+0	3.429848e+1	2.915581e-2	1	263	5.000000e-1	3.802281e-3	unnamed	MSH2
Mouse Phenotype	MP:0001805	decreased IgG level	72	2.347358e-2	1.000000e+0	1.000000e+0	4.260109e+1	2.347358e-2	1	2.347358e-2	1.000000e+0	76	2.697668e-2	1.000000e+0	1.000000e+0	3.681837e+1	2.716036e-2	1	245	5.000000e-1	4.081633e-3	unnamed	MSH2
Mouse Phenotype	MP:0003077	abnormal cell cycle	73	2.376361e-2	1.000000e+0	1.000000e+0	4.208115e+1	2.376361e-2	1	2.376361e-2	1.000000e+0	78	2.850706e-2	1.000000e+0	1.000000e+0	3.482819e+1	2.871238e-2	1	259	5.000000e-1	3.861004e-3	unnamed	MSH2
Mouse Phenotype	MP:0008211	decreased mature B cell number	74	2.473708e-2	1.000000e+0	1.000000e+0	4.042514e+1	2.473708e-2	1	2.473708e-2	1.000000e+0	72	2.555453e-2	1.000000e+0	1.000000e+0	3.888147e+1	2.571920e-2	1	232	5.000000e-1	4.310345e-3	unnamed	MSH2
Mouse Phenotype	MP:0010639	altered tumor pathology	75	2.612052e-2	1.000000e+0	1.000000e+0	3.828408e+1	2.612052e-2	1	2.612052e-2	1.000000e+0	73	2.664858e-2	1.000000e+0	1.000000e+0	3.727479e+1	2.682778e-2	1	242	5.000000e-1	4.132231e-3	unnamed	MSH2
Mouse Phenotype	MP:0010296	increased hemolymphoid system tumor incidence	76	2.613114e-2	1.000000e+0	1.000000e+0	3.826852e+1	2.613114e-2	1	2.613114e-2	1.000000e+0	78	2.850706e-2	1.000000e+0	1.000000e+0	3.482819e+1	2.871238e-2	1	259	5.000000e-1	3.861004e-3	unnamed	MSH2
Mouse Phenotype	MP:0002038	carcinoma	77	2.714825e-2	1.000000e+0	1.000000e+0	3.683478e+1	2.714825e-2	1	2.714825e-2	1.000000e+0	81	2.970866e-2	1.000000e+0	1.000000e+0	3.340926e+1	2.993182e-2	1	270	5.000000e-1	3.703704e-3	unnamed	MSH2
Mouse Phenotype	MP:0008873	increased physiological sensitivity to xenobiotic	78	2.832153e-2	1.000000e+0	1.000000e+0	3.530883e+1	2.832153e-2	1	2.832153e-2	1.000000e+0	73	2.664858e-2	1.000000e+0	1.000000e+0	3.727479e+1	2.682778e-2	1	242	5.000000e-1	4.132231e-3	unnamed	MSH2
Mouse Phenotype	MP:0002460	decreased immunoglobulin level	79	2.899527e-2	1.000000e+0	1.000000e+0	3.448838e+1	2.899527e-2	1	2.899527e-2	1.000000e+0	84	3.363597e-2	1.000000e+0	1.000000e+0	2.947876e+1	3.392273e-2	1	306	5.000000e-1	3.267974e-3	unnamed	MSH2
Mouse Phenotype	MP:0001191	abnormal skin condition	80	3.067339e-2	1.000000e+0	1.000000e+0	3.260155e+1	3.067339e-2	1	3.067339e-2	1.000000e+0	82	3.200056e-2	1.000000e+0	1.000000e+0	3.099828e+1	3.225985e-2	1	291	5.000000e-1	3.436426e-3	unnamed	MSH2
Mouse Phenotype	MP:0010288	increased gland tumor incidence	81	3.105825e-2	1.000000e+0	1.000000e+0	3.219757e+1	3.105825e-2	1	3.105825e-2	1.000000e+0	75	2.675795e-2	1.000000e+0	1.000000e+0	3.712140e+1	2.693864e-2	1	243	5.000000e-1	4.115226e-3	unnamed	MSH2
Mouse Phenotype	MP:0008770	decreased survivor rate	82	3.107263e-2	1.000000e+0	1.000000e+0	3.218266e+1	3.107263e-2	1	3.107263e-2	1.000000e+0	70	2.358369e-2	1.000000e+0	1.000000e+0	4.215187e+1	2.372374e-2	1	214	5.000000e-1	4.672897e-3	unnamed	MSH2
Mouse Phenotype	MP:0008171	abnormal mature B cell morphology	83	3.123786e-2	1.000000e+0	1.000000e+0	3.201244e+1	3.123786e-2	1	3.123786e-2	1.000000e+0	83	3.352698e-2	1.000000e+0	1.000000e+0	2.957541e+1	3.381187e-2	1	305	5.000000e-1	3.278689e-3	unnamed	MSH2
Mouse Phenotype	MP:0002018	malignant tumors	84	3.474739e-2	1.000000e+0	1.000000e+0	2.877914e+1	3.474739e-2	1	3.474739e-2	1.000000e+0	85	3.646740e-2	1.000000e+0	1.000000e+0	2.717018e+1	3.680506e-2	1	332	5.000000e-1	3.012048e-3	unnamed	MSH2
Mouse Phenotype	MP:0010831	partial lethality	85	3.509983e-2	1.000000e+0	1.000000e+0	2.849017e+1	3.509983e-2	1	3.509983e-2	1.000000e+0	77	2.763270e-2	1.000000e+0	1.000000e+0	3.593825e+1	2.782551e-2	1	251	5.000000e-1	3.984064e-3	unnamed	MSH2
Mouse Phenotype	MP:0009763	increased sensitivity to induced morbidity/mortality	86	3.731243e-2	1.000000e+0	1.000000e+0	2.680072e+1	3.731243e-2	1	3.731243e-2	1.000000e+0	86	4.114105e-2	1.000000e+0	1.000000e+0	2.405467e+1	4.157197e-2	1	375	5.000000e-1	2.666667e-3	unnamed	MSH2
Mouse Phenotype	MP:0002144	abnormal B cell differentiation	87	4.316951e-2	1.000000e+0	1.000000e+0	2.316450e+1	4.316951e-2	1	4.316951e-2	1.000000e+0	89	4.461173e-2	1.000000e+0	1.000000e+0	2.216339e+1	4.511945e-2	1	407	5.000000e-1	2.457002e-3	unnamed	MSH2
Mouse Phenotype	MP:0005017	decreased B cell number	88	4.371459e-2	1.000000e+0	1.000000e+0	2.287566e+1	4.371459e-2	1	4.371459e-2	1.000000e+0	87	4.320252e-2	1.000000e+0	1.000000e+0	2.289467e+1	4.367829e-2	1	394	5.000000e-1	2.538071e-3	unnamed	MSH2
Mouse Phenotype	MP:0002490	abnormal immunoglobulin level	89	4.625320e-2	1.000000e+0	1.000000e+0	2.162013e+1	4.625320e-2	1	4.625320e-2	1.000000e+0	90	5.218192e-2	1.000000e+0	1.000000e+0	1.891090e+1	5.287955e-2	1	477	5.000000e-1	2.096436e-3	unnamed	MSH2
Mouse Phenotype	MP:0000477	abnormal intestine morphology	90	4.889648e-2	1.000000e+0	1.000000e+0	2.045137e+1	4.889648e-2	1	4.889648e-2	1.000000e+0	88	4.417824e-2	1.000000e+0	1.000000e+0	2.238337e+1	4.467602e-2	1	403	5.000000e-1	2.481390e-3	unnamed	MSH2
Mouse Phenotype	MP:0001800	abnormal humoral immune response	91	5.047245e-2	1.000000e+0	1.000000e+0	1.981279e+1	5.047245e-2	1	5.047245e-2	1.000000e+0	93	5.692491e-2	1.000000e+0	1.000000e+0	1.731382e+1	5.775733e-2	1	521	5.000000e-1	1.919386e-3	unnamed	MSH2
Mouse Phenotype	MP:0001657	abnormal induced morbidity/mortality	92	5.088453e-2	1.000000e+0	1.000000e+0	1.965234e+1	5.088453e-2	1	5.088453e-2	1.000000e+0	95	6.036688e-2	1.000000e+0	1.000000e+0	1.631193e+1	6.130481e-2	1	553	5.000000e-1	1.808318e-3	unnamed	MSH2
Mouse Phenotype	MP:0002458	abnormal B cell number	93	5.356917e-2	1.000000e+0	1.000000e+0	1.866745e+1	5.356917e-2	1	5.356917e-2	1.000000e+0	92	5.649422e-2	1.000000e+0	1.000000e+0	1.744778e+1	5.731390e-2	1	517	5.000000e-1	1.934236e-3	unnamed	MSH2
Mouse Phenotype	MP:0005266	abnormal metabolism	94	5.387393e-2	1.000000e+0	1.000000e+0	1.856186e+1	5.387393e-2	1	5.387393e-2	1.000000e+0	95	6.036688e-2	1.000000e+0	1.000000e+0	1.631193e+1	6.130481e-2	1	553	5.000000e-1	1.808318e-3	unnamed	MSH2
Mouse Phenotype	MP:0010273	increased classified tumor incidence	95	5.452900e-2	1.000000e+0	1.000000e+0	1.833887e+1	5.452900e-2	1	5.452900e-2	1.000000e+0	91	5.563254e-2	1.000000e+0	1.000000e+0	1.772200e+1	5.642703e-2	1	509	5.000000e-1	1.964637e-3	unnamed	MSH2
Mouse Phenotype	MP:0002459	abnormal B cell physiology	96	5.585276e-2	1.000000e+0	1.000000e+0	1.790422e+1	5.585276e-2	1	5.585276e-2	1.000000e+0	99	6.337345e-2	1.000000e+0	1.000000e+0	1.552582e+1	6.440885e-2	1	581	5.000000e-1	1.721170e-3	unnamed	MSH2
Mouse Phenotype	MP:0001663	abnormal digestive system physiology	97	5.827484e-2	1.000000e+0	1.000000e+0	1.716006e+1	5.827484e-2	1	5.827484e-2	1.000000e+0	98	6.240758e-2	1.000000e+0	1.000000e+0	1.577010e+1	6.341112e-2	1	572	5.000000e-1	1.748252e-3	unnamed	MSH2
Mouse Phenotype	MP:0010274	increased organ/body region tumor incidence	98	5.980108e-2	1.000000e+0	1.000000e+0	1.672211e+1	5.980108e-2	1	5.980108e-2	1.000000e+0	94	5.907688e-2	1.000000e+0	1.000000e+0	1.667375e+1	5.997450e-2	1	541	5.000000e-1	1.848429e-3	unnamed	MSH2
Mouse Phenotype	MP:0004939	abnormal B cell morphology	99	6.254515e-2	1.000000e+0	1.000000e+0	1.598845e+1	6.254515e-2	1	6.254515e-2	1.000000e+0	101	6.744608e-2	1.000000e+0	1.000000e+0	1.457270e+1	6.862147e-2	1	619	5.000000e-1	1.615509e-3	unnamed	MSH2
Mouse Phenotype	MP:0008872	abnormal physiological response to xenobiotic	100	6.542380e-2	1.000000e+0	1.000000e+0	1.528496e+1	6.542380e-2	1	6.542380e-2	1.000000e+0	97	6.187077e-2	1.000000e+0	1.000000e+0	1.590917e+1	6.285683e-2	1	567	5.000000e-1	1.763668e-3	unnamed	MSH2
Mouse Phenotype	MP:0008195	abnormal professional antigen presenting cell morphology	101	6.835128e-2	1.000000e+0	1.000000e+0	1.463030e+1	6.835128e-2	1	6.835128e-2	1.000000e+0	103	7.332497e-2	1.000000e+0	1.000000e+0	1.338353e+1	7.471870e-2	1	674	5.000000e-1	1.483680e-3	unnamed	MSH2
Mouse Phenotype	MP:0002020	increased tumor incidence	102	7.037685e-2	1.000000e+0	1.000000e+0	1.420922e+1	7.037685e-2	1	7.037685e-2	1.000000e+0	102	6.873033e-2	1.000000e+0	1.000000e+0	1.429556e+1	6.995178e-2	1	631	5.000000e-1	1.584786e-3	unnamed	MSH2
Mouse Phenotype	MP:0002019	abnormal tumor incidence	103	7.769090e-2	1.000000e+0	1.000000e+0	1.287152e+1	7.769090e-2	1	7.769090e-2	1.000000e+0	104	7.705640e-2	1.000000e+0	1.000000e+0	1.272285e+1	7.859875e-2	1	709	5.000000e-1	1.410437e-3	unnamed	MSH2
Mouse Phenotype	MP:0002166	altered tumor susceptibility	104	7.903444e-2	1.000000e+0	1.000000e+0	1.265271e+1	7.903444e-2	1	7.903444e-2	1.000000e+0	105	7.854686e-2	1.000000e+0	1.000000e+0	1.247649e+1	8.015077e-2	1	723	5.000000e-1	1.383126e-3	unnamed	MSH2
Mouse Phenotype	MP:0002401	abnormal lymphopoiesis	105	7.968565e-2	1.000000e+0	1.000000e+0	1.254931e+1	7.968565e-2	1	7.968565e-2	1.000000e+0	107	8.523905e-2	1.000000e+0	1.000000e+0	1.147646e+1	8.713486e-2	1	786	5.000000e-1	1.272265e-3	unnamed	MSH2
Mouse Phenotype	MP:0005016	decreased lymphocyte cell number	106	8.004882e-2	1.000000e+0	1.000000e+0	1.249238e+1	8.004882e-2	1	8.004882e-2	1.000000e+0	110	8.809966e-2	1.000000e+0	1.000000e+0	1.109533e+1	9.012804e-2	1	813	5.000000e-1	1.230012e-3	unnamed	MSH2
Mouse Phenotype	MP:0002445	abnormal mononuclear cell differentiation	107	8.007402e-2	1.000000e+0	1.000000e+0	1.248844e+1	8.007402e-2	1	8.007402e-2	1.000000e+0	109	8.587513e-2	1.000000e+0	1.000000e+0	1.138952e+1	8.780001e-2	1	792	5.000000e-1	1.262626e-3	unnamed	MSH2
Mouse Phenotype	MP:0002452	abnormal professional antigen presenting cell physiology	108	8.156256e-2	1.000000e+0	1.000000e+0	1.226053e+1	8.156256e-2	1	8.156256e-2	1.000000e+0	113	9.433504e-2	1.000000e+0	1.000000e+0	1.034461e+1	9.666870e-2	1	872	5.000000e-1	1.146789e-3	unnamed	MSH2
Mouse Phenotype	MP:0011085	complete postnatal lethality	109	8.232293e-2	1.000000e+0	1.000000e+0	1.214728e+1	8.232293e-2	1	8.232293e-2	1.000000e+0	100	6.455328e-2	1.000000e+0	1.000000e+0	1.523733e+1	6.562829e-2	1	592	5.000000e-1	1.689189e-3	unnamed	MSH2
Mouse Phenotype	MP:0002060	abnormal skin morphology	110	8.538698e-2	1.000000e+0	1.000000e+0	1.171139e+1	8.538698e-2	1	8.538698e-2	1.000000e+0	106	8.428452e-2	1.000000e+0	1.000000e+0	1.160940e+1	8.613713e-2	1	777	5.000000e-1	1.287001e-3	unnamed	MSH2
Mouse Phenotype	MP:0002414	abnormal myeloblast morphology/development	111	8.539083e-2	1.000000e+0	1.000000e+0	1.171086e+1	8.539083e-2	1	8.539083e-2	1.000000e+0	111	9.264620e-2	1.000000e+0	1.000000e+0	1.053797e+1	9.489496e-2	1	856	5.000000e-1	1.168224e-3	unnamed	MSH2
Mouse Phenotype	MP:0002006	tumorigenesis	112	8.579997e-2	1.000000e+0	1.000000e+0	1.165502e+1	8.579997e-2	1	8.579997e-2	1.000000e+0	108	8.576913e-2	1.000000e+0	1.000000e+0	1.140392e+1	8.768915e-2	1	791	5.000000e-1	1.264223e-3	unnamed	MSH2
Mouse Phenotype	MP:0005460	abnormal leukopoiesis	113	8.694600e-2	1.000000e+0	1.000000e+0	1.150139e+1	8.694600e-2	1	8.694600e-2	1.000000e+0	112	9.306856e-2	1.000000e+0	1.000000e+0	1.048895e+1	9.533840e-2	1	860	5.000000e-1	1.162791e-3	unnamed	MSH2
Mouse Phenotype	MP:0003945	abnormal lymphocyte physiology	114	9.054147e-2	1.000000e+0	1.000000e+0	1.104466e+1	9.054147e-2	1	9.054147e-2	1.000000e+0	115	1.016001e-1	1.000000e+0	1.000000e+0	9.586079e+0	1.043179e-1	1	941	5.000000e-1	1.062699e-3	unnamed	MSH2
Mouse Phenotype	MP:0002723	abnormal immune serum protein physiology	115	9.094959e-2	1.000000e+0	1.000000e+0	1.099510e+1	9.094959e-2	1	9.094959e-2	1.000000e+0	116	1.059032e-1	1.000000e+0	1.000000e+0	9.185845e+0	1.088631e-1	1	982	5.000000e-1	1.018330e-3	unnamed	MSH2
Mouse Phenotype	MP:0000221	decreased leukocyte cell number	116	9.549676e-2	1.000000e+0	1.000000e+0	1.047156e+1	9.549676e-2	1	9.549676e-2	1.000000e+0	117	1.060080e-1	1.000000e+0	1.000000e+0	9.176501e+0	1.089740e-1	1	983	5.000000e-1	1.017294e-3	unnamed	MSH2
Mouse Phenotype	MP:0000717	abnormal lymphocyte cell number	117	9.986740e-2	1.000000e+0	1.000000e+0	1.001328e+1	9.986740e-2	1	9.986740e-2	1.000000e+0	118	1.109278e-1	1.000000e+0	1.000000e+0	8.757767e+0	1.141844e-1	1	1030	5.000000e-1	9.708738e-4	unnamed	MSH2
Mouse Phenotype	MP:0001845	abnormal inflammatory response	118	1.012612e-1	1.000000e+0	1.000000e+0	9.875447e+0	1.012612e-1	1	1.012612e-1	1.000000e+0	119	1.166678e-1	1.000000e+0	1.000000e+0	8.313825e+0	1.202816e-1	1	1085	5.000000e-1	9.216590e-4	unnamed	MSH2
Mouse Phenotype	MP:0002398	abnormal bone marrow cell morphology/development	119	1.085064e-1	1.000000e+0	1.000000e+0	9.216047e+0	1.085064e-1	1	1.085064e-1	1.000000e+0	121	1.211425e-1	1.000000e+0	1.000000e+0	7.996897e+0	1.250485e-1	1	1128	5.000000e-1	8.865248e-4	unnamed	MSH2
Mouse Phenotype	MP:0011182	decreased hematopoietic cell number	120	1.093948e-1	1.000000e+0	1.000000e+0	9.141200e+0	1.093948e-1	1	1.093948e-1	1.000000e+0	123	1.236350e-1	1.000000e+0	1.000000e+0	7.830295e+0	1.277091e-1	1	1152	5.000000e-1	8.680556e-4	unnamed	MSH2
Mouse Phenotype	MP:0002619	abnormal lymphocyte morphology	121	1.142540e-1	1.000000e+0	1.000000e+0	8.752430e+0	1.142540e-1	1	1.142540e-1	1.000000e+0	124	1.290234e-1	1.000000e+0	1.000000e+0	7.492110e+0	1.334738e-1	1	1204	5.000000e-1	8.305648e-4	unnamed	MSH2
Mouse Phenotype	MP:0000462	abnormal digestive system morphology	122	1.165265e-1	1.000000e+0	1.000000e+0	8.581738e+0	1.165265e-1	1	1.165265e-1	1.000000e+0	114	9.454603e-2	1.000000e+0	1.000000e+0	1.032094e+1	9.689042e-2	1	874	5.000000e-1	1.144165e-3	unnamed	MSH2
Mouse Phenotype	MP:0002442	abnormal leukocyte physiology	123	1.192967e-1	1.000000e+0	1.000000e+0	8.382459e+0	1.192967e-1	1	1.192967e-1	1.000000e+0	126	1.356324e-1	1.000000e+0	1.000000e+0	7.113959e+0	1.405687e-1	1	1268	5.000000e-1	7.886435e-4	unnamed	MSH2
Mouse Phenotype	MP:0001819	abnormal immune cell physiology	124	1.203217e-1	1.000000e+0	1.000000e+0	8.311053e+0	1.203217e-1	1	1.203217e-1	1.000000e+0	130	1.380014e-1	1.000000e+0	1.000000e+0	6.987219e+0	1.431185e-1	1	1291	5.000000e-1	7.745933e-4	unnamed	MSH2
Mouse Phenotype	MP:0002421	abnormal cell-mediated immunity	125	1.209554e-1	1.000000e+0	1.000000e+0	8.267508e+0	1.209554e-1	1	1.209554e-1	1.000000e+0	131	1.391333e-1	1.000000e+0	1.000000e+0	6.928187e+0	1.443379e-1	1	1302	5.000000e-1	7.680492e-4	unnamed	MSH2
Mouse Phenotype	MP:0001648	abnormal apoptosis	126	1.225891e-1	1.000000e+0	1.000000e+0	8.157331e+0	1.225891e-1	1	1.225891e-1	1.000000e+0	120	1.205188e-1	1.000000e+0	1.000000e+0	8.039661e+0	1.243833e-1	1	1122	5.000000e-1	8.912656e-4	unnamed	MSH2
Mouse Phenotype	MP:0002420	abnormal adaptive immunity	127	1.226687e-1	1.000000e+0	1.000000e+0	8.152037e+0	1.226687e-1	1	1.226687e-1	1.000000e+0	133	1.408810e-1	1.000000e+0	1.000000e+0	6.838893e+0	1.462225e-1	1	1319	5.000000e-1	7.581501e-4	unnamed	MSH2
Mouse Phenotype	MP:0000217	abnormal leukocyte cell number	128	1.272684e-1	1.000000e+0	1.000000e+0	7.857411e+0	1.272684e-1	1	1.272684e-1	1.000000e+0	132	1.403671e-1	1.000000e+0	1.000000e+0	6.864916e+0	1.456682e-1	1	1314	5.000000e-1	7.610350e-4	unnamed	MSH2
Mouse Phenotype	MP:0008247	abnormal mononuclear cell morphology	129	1.350005e-1	1.000000e+0	1.000000e+0	7.407378e+0	1.350005e-1	1	1.350005e-1	1.000000e+0	135	1.540854e-1	1.000000e+0	1.000000e+0	6.229627e+0	1.605233e-1	1	1448	5.000000e-1	6.906077e-4	unnamed	MSH2
Mouse Phenotype	MP:0000313	abnormal cell death	130	1.373532e-1	1.000000e+0	1.000000e+0	7.280503e+0	1.373532e-1	1	1.373532e-1	1.000000e+0	129	1.377955e-1	1.000000e+0	1.000000e+0	6.998061e+0	1.428967e-1	1	1289	5.000000e-1	7.757952e-4	unnamed	MSH2
Mouse Phenotype	MP:0005381	digestive/alimentary phenotype	131	1.385091e-1	1.000000e+0	1.000000e+0	7.219740e+0	1.385091e-1	1	1.385091e-1	1.000000e+0	122	1.223892e-1	1.000000e+0	1.000000e+0	7.912719e+0	1.263788e-1	1	1140	5.000000e-1	8.771930e-4	unnamed	MSH2
Mouse Phenotype	MP:0011180	abnormal hematopoietic cell number	132	1.429801e-1	1.000000e+0	1.000000e+0	6.993980e+0	1.429801e-1	1	1.429801e-1	1.000000e+0	137	1.595825e-1	1.000000e+0	1.000000e+0	6.005659e+0	1.665096e-1	1	1502	5.000000e-1	6.657790e-4	unnamed	MSH2
Mouse Phenotype	MP:0002083	premature death	133	1.449089e-1	1.000000e+0	1.000000e+0	6.900889e+0	1.449089e-1	1	1.449089e-1	1.000000e+0	127	1.369718e-1	1.000000e+0	1.000000e+0	7.041764e+0	1.420099e-1	1	1281	5.000000e-1	7.806401e-4	unnamed	MSH2
Mouse Phenotype	MP:0008246	abnormal leukocyte morphology	134	1.497188e-1	1.000000e+0	1.000000e+0	6.679189e+0	1.497188e-1	1	1.497188e-1	1.000000e+0	138	1.698159e-1	1.000000e+0	1.000000e+0	5.627261e+0	1.777063e-1	1	1603	5.000000e-1	6.238303e-4	unnamed	MSH2
Mouse Phenotype	MP:0000716	abnormal immune system cell morphology	135	1.505458e-1	1.000000e+0	1.000000e+0	6.642496e+0	1.505458e-1	1	1.505458e-1	1.000000e+0	139	1.710276e-1	1.000000e+0	1.000000e+0	5.585449e+0	1.790366e-1	1	1615	5.000000e-1	6.191950e-4	unnamed	MSH2
Mouse Phenotype	MP:0005076	abnormal cell differentiation	136	1.541850e-1	1.000000e+0	1.000000e+0	6.485715e+0	1.541850e-1	1	1.541850e-1	1.000000e+0	128	1.371778e-1	1.000000e+0	1.000000e+0	7.030787e+0	1.422316e-1	1	1283	5.000000e-1	7.794232e-4	unnamed	MSH2
Mouse Phenotype	MP:0002082	postnatal lethality	137	1.637535e-1	1.000000e+0	1.000000e+0	6.106739e+0	1.637535e-1	1	1.637535e-1	1.000000e+0	125	1.329505e-1	1.000000e+0	1.000000e+0	7.262882e+0	1.376864e-1	1	1242	5.000000e-1	8.051530e-4	unnamed	MSH2
Mouse Phenotype	MP:0010771	integument phenotype	138	1.731215e-1	1.000000e+0	1.000000e+0	5.776291e+0	1.731215e-1	1	1.731215e-1	1.000000e+0	136	1.570398e-1	1.000000e+0	1.000000e+0	6.107312e+0	1.637382e-1	1	1477	5.000000e-1	6.770481e-4	unnamed	MSH2
Mouse Phenotype	MP:0002123	abnormal hematopoiesis	139	1.777183e-1	1.000000e+0	1.000000e+0	5.626882e+0	1.777183e-1	1	1.777183e-1	1.000000e+0	141	2.055841e-1	1.000000e+0	1.000000e+0	4.599949e+0	2.173937e-1	1	1961	5.000000e-1	5.099439e-4	unnamed	MSH2
Mouse Phenotype	MP:0002429	abnormal blood cell morphology/development	140	1.793335e-1	1.000000e+0	1.000000e+0	5.576203e+0	1.793335e-1	1	1.793335e-1	1.000000e+0	142	2.074604e-1	1.000000e+0	1.000000e+0	4.555808e+0	2.195000e-1	1	1980	5.000000e-1	5.050505e-4	unnamed	MSH2
Mouse Phenotype	MP:0000685	abnormal immune system morphology	141	1.819041e-1	1.000000e+0	1.000000e+0	5.497404e+0	1.819041e-1	1	1.819041e-1	1.000000e+0	140	2.020229e-1	1.000000e+0	1.000000e+0	4.685974e+0	2.134028e-1	1	1925	5.000000e-1	5.194805e-4	unnamed	MSH2
Mouse Phenotype	MP:0002882	abnormal neuron morphology	142	1.824896e-1	1.000000e+0	1.000000e+0	5.479764e+0	1.824896e-1	1	1.824896e-1	1.000000e+0	134	1.439609e-1	1.000000e+0	1.000000e+0	6.686805e+0	1.495483e-1	1	1349	5.000000e-1	7.412898e-4	unnamed	MSH2
Mouse Phenotype	MP:0001790	abnormal immune system physiology	143	1.911135e-1	1.000000e+0	1.000000e+0	5.232494e+0	1.911135e-1	1	1.911135e-1	1.000000e+0	143	2.153363e-1	1.000000e+0	1.000000e+0	4.378883e+0	2.283687e-1	1	2060	5.000000e-1	4.854369e-4	unnamed	MSH2
Mouse Phenotype	MP:0002396	abnormal hematopoietic system morphology/development	144	2.022701e-1	1.000000e+0	1.000000e+0	4.943885e+0	2.022701e-1	1	2.022701e-1	1.000000e+0	145	2.274661e-1	1.000000e+0	1.000000e+0	4.130266e+0	2.421152e-1	1	2184	5.000000e-1	4.578755e-4	unnamed	MSH2
Mouse Phenotype	MP:0005397	hematopoietic system phenotype	145	2.068614e-1	1.000000e+0	1.000000e+0	4.834154e+0	2.068614e-1	1	2.068614e-1	1.000000e+0	146	2.333986e-1	1.000000e+0	1.000000e+0	4.018040e+0	2.488776e-1	1	2245	5.000000e-1	4.454343e-4	unnamed	MSH2
Mouse Phenotype	MP:0005387	immune system phenotype	146	2.446842e-1	1.000000e+0	1.000000e+0	4.086901e+0	2.446842e-1	1	2.446842e-1	1.000000e+0	148	2.754183e-1	1.000000e+0	1.000000e+0	3.360842e+0	2.975445e-1	1	2684	5.000000e-1	3.725782e-4	unnamed	MSH2
Mouse Phenotype	MP:0010832	lethality during fetal growth through weaning	147	2.758093e-1	1.000000e+0	1.000000e+0	3.625694e+0	2.758093e-1	1	2.758093e-1	1.000000e+0	144	2.188676e-1	1.000000e+0	1.000000e+0	4.303674e+0	2.323596e-1	1	2096	5.000000e-1	4.770992e-4	unnamed	MSH2
Mouse Phenotype	MP:0003632	abnormal nervous system morphology	148	2.827167e-1	1.000000e+0	1.000000e+0	3.537110e+0	2.827167e-1	1	2.827167e-1	1.000000e+0	147	2.350478e-1	1.000000e+0	1.000000e+0	3.987843e+0	2.507622e-1	1	2262	5.000000e-1	4.420866e-4	unnamed	MSH2
Mouse Phenotype	MP:0005621	abnormal cell physiology	149	3.078333e-1	1.000000e+0	1.000000e+0	3.248512e+0	3.078333e-1	1	3.078333e-1	1.000000e+0	150	3.046545e-1	1.000000e+0	1.000000e+0	3.009843e+0	3.322432e-1	1	2997	5.000000e-1	3.336670e-4	unnamed	MSH2
Mouse Phenotype	MP:0005384	cellular phenotype	150	3.121556e-1	1.000000e+0	1.000000e+0	3.203530e+0	3.121556e-1	1	3.121556e-1	1.000000e+0	151	3.123982e-1	1.000000e+0	1.000000e+0	2.927783e+0	3.415553e-1	1	3081	5.000000e-1	3.245699e-4	unnamed	MSH2
Mouse Phenotype	MP:0005376	homeostasis/metabolism phenotype	151	3.389663e-1	1.000000e+0	1.000000e+0	2.950146e+0	3.389663e-1	1	3.389663e-1	1.000000e+0	153	3.467977e-1	1.000000e+0	1.000000e+0	2.607081e+0	3.835708e-1	1	3460	5.000000e-1	2.890173e-4	unnamed	MSH2
Mouse Phenotype	MP:0003631	nervous system phenotype	152	3.410385e-1	1.000000e+0	1.000000e+0	2.932220e+0	3.410385e-1	1	3.410385e-1	1.000000e+0	149	2.844493e-1	1.000000e+0	1.000000e+0	3.244784e+0	3.081869e-1	1	2780	5.000000e-1	3.597122e-4	unnamed	MSH2
Mouse Phenotype	MP:0010770	preweaning lethality	153	3.585301e-1	1.000000e+0	1.000000e+0	2.789166e+0	3.585301e-1	1	3.585301e-1	1.000000e+0	152	3.286641e-1	1.000000e+0	1.000000e+0	2.767874e+0	3.612882e-1	1	3259	5.000000e-1	3.068426e-4	unnamed	MSH2
Mouse Phenotype	MP:0010769	abnormal survival	154	3.982821e-1	1.000000e+0	1.000000e+0	2.510783e+0	3.982821e-1	1	3.982821e-1	1.000000e+0	154	3.748920e-1	1.000000e+0	1.000000e+0	2.388271e+0	4.187129e-1	1	3777	5.000000e-1	2.647604e-4	unnamed	MSH2
Mouse Phenotype	MP:0010768	mortality/aging	155	4.155501e-1	1.000000e+0	1.000000e+0	2.406449e+0	4.155501e-1	1	4.155501e-1	1.000000e+0	155	3.982479e-1	1.000000e+0	1.000000e+0	2.229486e+0	4.485339e-1	1	4046	5.000000e-1	2.471577e-4	unnamed	MSH2
Mouse Phenotype	MP:0000001	mammalian phenotype	156	6.422596e-1	1.000000e+0	1.000000e+0	1.557003e+0	6.422596e-1	1	6.422596e-1	1.000000e+0	156	6.601828e-1	1.000000e+0	1.000000e+0	1.198897e+0	8.341001e-1	1	7524	5.000000e-1	1.329080e-4	unnamed	MSH2
Human Phenotype	HP:0006758	Malignant genitourinary tract tumor	1	1.351883e-4	8.308673e-1	8.308673e-1	7.397089e+3	1.351883e-4	1	1.351883e-4	1.000000e+0	1	2.217111e-4	1.000000e+0	1.000000e+0	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	MSH2
Human Phenotype	HP:0012118	Laryngeal carcinoma	1	1.351883e-4	8.308673e-1	8.308673e-1	7.397089e+3	1.351883e-4	1	1.351883e-4	1.000000e+0	1	2.217111e-4	1.000000e+0	1.000000e+0	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	MSH2
Human Phenotype	HP:0006778	Benign genitourinary tract neoplasm	1	1.351883e-4	8.308673e-1	8.308673e-1	7.397089e+3	1.351883e-4	1	1.351883e-4	1.000000e+0	1	2.217111e-4	1.000000e+0	1.000000e+0	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	MSH2
Human Phenotype	HP:0006719	Benign gastrointestinal tract tumors	1	1.351883e-4	8.308673e-1	8.308673e-1	7.397089e+3	1.351883e-4	1	1.351883e-4	1.000000e+0	1	2.217111e-4	1.000000e+0	1.000000e+0	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	MSH2
Human Phenotype	HP:0100684	Salivary gland neoplasm	5	1.920080e-4	1.000000e+0	2.360162e-1	5.208116e+3	1.920080e-4	1	1.920080e-4	1.000000e+0	5	4.433975e-4	1.000000e+0	5.450242e-1	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	MSH2
Human Phenotype	HP:0100843	Glioblastoma	6	3.029155e-4	1.000000e+0	3.102864e-1	3.301251e+3	3.029155e-4	1	3.029155e-4	1.000000e+0	6	5.542315e-4	1.000000e+0	5.677178e-1	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	MSH2
Human Phenotype	HP:0010524	Agnosia	7	3.735612e-4	1.000000e+0	3.279867e-1	2.676938e+3	3.735612e-4	1	3.735612e-4	1.000000e+0	9	7.758812e-4	1.000000e+0	5.298407e-1	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	MSH2
Human Phenotype	HP:0002888	Ependymoma	8	3.781202e-4	1.000000e+0	2.904908e-1	2.644661e+3	3.781202e-4	1	3.781202e-4	1.000000e+0	11	8.866967e-4	1.000000e+0	4.954216e-1	1.127562e+3	8.868688e-4	1	8	5.000000e-1	1.250000e-1	unnamed	MSH2
Human Phenotype	HP:0002253	Colonic diverticulosis	9	4.377250e-4	1.000000e+0	2.989175e-1	2.284540e+3	4.377250e-4	1	4.377250e-4	1.000000e+0	9	7.758812e-4	1.000000e+0	5.298407e-1	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	MSH2
Human Phenotype	HP:0006771	Duodenal carcinoma	10	4.648978e-4	1.000000e+0	2.857262e-1	2.151010e+3	4.648978e-4	1	4.648978e-4	1.000000e+0	6	5.542315e-4	1.000000e+0	5.677178e-1	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	MSH2
Human Phenotype	HP:0003003	Colon cancer	11	5.302146e-4	1.000000e+0	2.962454e-1	1.886029e+3	5.302146e-4	1	5.302146e-4	1.000000e+0	11	8.866967e-4	1.000000e+0	4.954216e-1	1.127562e+3	8.868688e-4	1	8	5.000000e-1	1.250000e-1	unnamed	MSH2
Human Phenotype	HP:0000997	Axillary freckling	12	5.829935e-4	1.000000e+0	2.985898e-1	1.715285e+3	5.829935e-4	1	5.829935e-4	1.000000e+0	8	6.650594e-4	1.000000e+0	5.109319e-1	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	MSH2
Human Phenotype	HP:0009592	Astrocytoma	13	7.142707e-4	1.000000e+0	3.376852e-1	1.400029e+3	7.142707e-4	1	7.142707e-4	1.000000e+0	16	1.219107e-3	1.000000e+0	4.682895e-1	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	MSH2
Human Phenotype	HP:0100743	Neoplasm of the rectum	14	7.501573e-4	1.000000e+0	3.293191e-1	1.333054e+3	7.501573e-4	1	7.501573e-4	1.000000e+0	11	8.866967e-4	1.000000e+0	4.954216e-1	1.127562e+3	8.868688e-4	1	8	5.000000e-1	1.250000e-1	unnamed	MSH2
Human Phenotype	HP:0009733	Glioma	15	7.683865e-4	1.000000e+0	3.148336e-1	1.301428e+3	7.683865e-4	1	7.683865e-4	1.000000e+0	19	1.440682e-3	1.000000e+0	4.660227e-1	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	MSH2
Human Phenotype	HP:0009720	Adenoma sebaceum	16	8.217284e-4	1.000000e+0	3.156464e-1	1.216947e+3	8.217284e-4	1	8.217284e-4	1.000000e+0	23	1.773000e-3	1.000000e+0	4.737764e-1	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	MSH2
Human Phenotype	HP:0100576	Amaurosis fugax	17	9.136417e-4	1.000000e+0	3.303083e-1	1.094521e+3	9.136417e-4	1	9.136417e-4	1.000000e+0	14	1.108309e-3	1.000000e+0	4.865477e-1	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	MSH2
Human Phenotype	HP:0005222	Bowel diverticulosis	18	9.638921e-4	1.000000e+0	3.291156e-1	1.037460e+3	9.638921e-4	1	9.638921e-4	1.000000e+0	19	1.440682e-3	1.000000e+0	4.660227e-1	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	MSH2
Human Phenotype	HP:0002885	Medulloblastoma	19	1.002871e-3	1.000000e+0	3.244024e-1	9.971376e+2	1.002871e-3	1	1.002871e-3	1.000000e+0	18	1.329898e-3	1.000000e+0	4.540863e-1	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	MSH2
Human Phenotype	HP:0100833	Neoplasm of the small intestine	20	1.276192e-3	1.000000e+0	3.921738e-1	7.835814e+2	1.276192e-3	1	1.276192e-3	1.000000e+0	14	1.108309e-3	1.000000e+0	4.865477e-1	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	MSH2
Human Phenotype	HP:0100649	Neoplasm of the oral cavity	21	1.330340e-3	1.000000e+0	3.893462e-1	7.516878e+2	1.330340e-3	1	1.330340e-3	1.000000e+0	16	1.219107e-3	1.000000e+0	4.682895e-1	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	MSH2
Human Phenotype	HP:0002671	Basal cell carcinoma	22	1.379836e-3	1.000000e+0	3.854760e-1	7.247239e+2	1.379836e-3	1	1.379836e-3	1.000000e+0	25	1.994515e-3	1.000000e+0	4.903316e-1	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	MSH2
Human Phenotype	HP:0002859	Rhabdomyosarcoma	23	1.501022e-3	1.000000e+0	4.010992e-1	6.662129e+2	1.501022e-3	1	1.501022e-3	1.000000e+0	19	1.440682e-3	1.000000e+0	4.660227e-1	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	MSH2
Human Phenotype	HP:0010286	Abnormality of the salivary glands	24	1.591235e-3	1.000000e+0	4.074888e-1	6.284425e+2	1.591235e-3	1	1.591235e-3	1.000000e+0	19	1.440682e-3	1.000000e+0	4.660227e-1	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	MSH2
Human Phenotype	HP:0002894	Neoplasm of the pancreas	25	1.664764e-3	1.000000e+0	4.092656e-1	6.006859e+2	1.664764e-3	1	1.664764e-3	1.000000e+0	42	3.544427e-3	1.000000e+0	5.186678e-1	2.818906e+2	3.547475e-3	1	32	5.000000e-1	3.125000e-2	unnamed	MSH2
Human Phenotype	HP:0009728	Neoplasm of striated muscle	26	1.722749e-3	1.000000e+0	4.072314e-1	5.804677e+2	1.722749e-3	1	1.722749e-3	1.000000e+0	23	1.773000e-3	1.000000e+0	4.737764e-1	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	MSH2
Human Phenotype	HP:0100273	Neoplasm of the colon	27	2.057616e-3	1.000000e+0	4.683744e-1	4.859994e+2	2.057616e-3	1	2.057616e-3	1.000000e+0	27	2.326740e-3	1.000000e+0	5.296350e-1	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	MSH2
Human Phenotype	HP:0003002	Breast carcinoma	28	2.270887e-3	1.000000e+0	4.984597e-1	4.403565e+2	2.270887e-3	1	2.270887e-3	1.000000e+0	29	2.437470e-3	1.000000e+0	5.165755e-1	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	MSH2
Human Phenotype	HP:0010614	Fibroma	29	2.334917e-3	1.000000e+0	4.948414e-1	4.282807e+2	2.334917e-3	1	2.334917e-3	1.000000e+0	33	3.101718e-3	1.000000e+0	5.776715e-1	3.221607e+2	3.104041e-3	1	28	5.000000e-1	3.571429e-2	unnamed	MSH2
Human Phenotype	HP:0002516	Increased intracranial pressure	30	2.391495e-3	1.000000e+0	4.899376e-1	4.181486e+2	2.391495e-3	1	2.391495e-3	1.000000e+0	37	3.323085e-3	1.000000e+0	5.519914e-1	3.006833e+2	3.325758e-3	1	30	5.000000e-1	3.333333e-2	unnamed	MSH2
Human Phenotype	HP:0012316	Fibrous tissue neoplasm	31	2.493340e-3	1.000000e+0	4.943248e-1	4.010684e+2	2.493340e-3	1	2.493340e-3	1.000000e+0	34	3.212404e-3	1.000000e+0	5.806893e-1	3.110517e+2	3.214899e-3	1	29	5.000000e-1	3.448276e-2	unnamed	MSH2
Human Phenotype	HP:0100606	Neoplasm of the respiratory system	32	2.762823e-3	1.000000e+0	5.306347e-1	3.619487e+2	2.762823e-3	1	2.762823e-3	1.000000e+0	34	3.212404e-3	1.000000e+0	5.806893e-1	3.110517e+2	3.214899e-3	1	29	5.000000e-1	3.448276e-2	unnamed	MSH2
Human Phenotype	HP:0200008	Intestinal polyposis	33	2.824620e-3	1.000000e+0	5.260641e-1	3.540300e+2	2.824620e-3	1	2.824620e-3	1.000000e+0	34	3.212404e-3	1.000000e+0	5.806893e-1	3.110517e+2	3.214899e-3	1	29	5.000000e-1	3.448276e-2	unnamed	MSH2
Human Phenotype	HP:0003006	Neuroblastoma	34	2.913958e-3	1.000000e+0	5.267408e-1	3.431758e+2	2.913958e-3	1	2.913958e-3	1.000000e+0	26	2.216004e-3	1.000000e+0	5.238293e-1	4.510250e+2	2.217172e-3	1	20	5.000000e-1	5.000000e-2	unnamed	MSH2
Human Phenotype	HP:0004376	Neuroblastic tumors	35	2.928270e-3	1.000000e+0	5.142042e-1	3.414985e+2	2.928270e-3	1	2.928270e-3	1.000000e+0	27	2.326740e-3	1.000000e+0	5.296350e-1	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	MSH2
Human Phenotype	HP:0010622	Neoplasm of the skeletal system	36	3.018936e-3	1.000000e+0	5.153995e-1	3.312425e+2	3.018936e-3	1	3.018936e-3	1.000000e+0	43	3.765745e-3	1.000000e+0	5.382388e-1	2.653088e+2	3.769192e-3	1	34	5.000000e-1	2.941176e-2	unnamed	MSH2
Human Phenotype	HP:0005266	Intestinal polyps	37	3.036220e-3	1.000000e+0	5.043408e-1	3.293568e+2	3.036220e-3	1	3.036220e-3	1.000000e+0	39	3.433759e-3	1.000000e+0	5.411252e-1	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	MSH2
Human Phenotype	HP:0002354	Memory impairment	38	3.088943e-3	1.000000e+0	4.995959e-1	3.237353e+2	3.088943e-3	1	3.088943e-3	1.000000e+0	51	4.540164e-3	1.000000e+0	5.471343e-1	2.200122e+2	4.545203e-3	1	41	5.000000e-1	2.439024e-2	unnamed	MSH2
Human Phenotype	HP:0002034	Abnormality of the rectum	39	3.236423e-3	1.000000e+0	5.100271e-1	3.089831e+2	3.236423e-3	1	3.236423e-3	1.000000e+0	37	3.323085e-3	1.000000e+0	5.519914e-1	3.006833e+2	3.325758e-3	1	30	5.000000e-1	3.333333e-2	unnamed	MSH2
Human Phenotype	HP:0100835	Benign neoplasm of the central nervous system	40	3.247238e-3	1.000000e+0	4.989381e-1	3.079540e+2	3.247238e-3	1	3.247238e-3	1.000000e+0	39	3.433759e-3	1.000000e+0	5.411252e-1	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	MSH2
Human Phenotype	HP:0002672	Gastrointestinal carcinoma	41	3.256809e-3	1.000000e+0	4.882036e-1	3.070490e+2	3.256809e-3	1	3.256809e-3	1.000000e+0	30	2.658910e-3	1.000000e+0	5.447220e-1	3.758542e+2	2.660606e-3	1	24	5.000000e-1	4.166667e-2	unnamed	MSH2
Human Phenotype	HP:0010784	Uterine neoplasm	42	3.367151e-3	1.000000e+0	4.927264e-1	2.969870e+2	3.367151e-3	1	3.367151e-3	1.000000e+0	32	2.991025e-3	1.000000e+0	5.744637e-1	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	MSH2
Human Phenotype	HP:0001480	Freckling	43	3.374996e-3	1.000000e+0	4.823890e-1	2.962966e+2	3.374996e-3	1	3.374996e-3	1.000000e+0	39	3.433759e-3	1.000000e+0	5.411252e-1	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	MSH2
Human Phenotype	HP:0100013	Neoplasm of the breast	44	3.912223e-3	1.000000e+0	5.464664e-1	2.556091e+2	3.912223e-3	1	3.912223e-3	1.000000e+0	47	4.097676e-3	1.000000e+0	5.358365e-1	2.437973e+2	4.101768e-3	1	37	5.000000e-1	2.702703e-2	unnamed	MSH2
Human Phenotype	HP:0100836	Malignant neoplasm of the central nervous system	45	3.920200e-3	1.000000e+0	5.354122e-1	2.550890e+2	3.920200e-3	1	3.920200e-3	1.000000e+0	46	3.876395e-3	1.000000e+0	5.179201e-1	2.577286e+2	3.880051e-3	1	35	5.000000e-1	2.857143e-2	unnamed	MSH2
Human Phenotype	HP:0100615	Ovarian neoplasm	46	4.221632e-3	1.000000e+0	5.640467e-1	2.368752e+2	4.221632e-3	1	4.221632e-3	1.000000e+0	31	2.880326e-3	1.000000e+0	5.710479e-1	3.469423e+2	2.882324e-3	1	26	5.000000e-1	3.846154e-2	unnamed	MSH2
Human Phenotype	HP:0100031	Neoplasm of the thyroid gland	47	4.257060e-3	1.000000e+0	5.566785e-1	2.349039e+2	4.257060e-3	1	4.257060e-3	1.000000e+0	47	4.097676e-3	1.000000e+0	5.358365e-1	2.437973e+2	4.101768e-3	1	37	5.000000e-1	2.702703e-2	unnamed	MSH2
Human Phenotype	HP:0100834	Neoplasm of the large intestine	48	4.259835e-3	1.000000e+0	5.454364e-1	2.347509e+2	4.259835e-3	1	4.259835e-3	1.000000e+0	43	3.765745e-3	1.000000e+0	5.382388e-1	2.653088e+2	3.769192e-3	1	34	5.000000e-1	2.941176e-2	unnamed	MSH2
Human Phenotype	HP:0002896	Neoplasm of the liver	49	4.543233e-3	1.000000e+0	5.698512e-1	2.201076e+2	4.543233e-3	1	4.543233e-3	1.000000e+0	43	3.765745e-3	1.000000e+0	5.382388e-1	2.653088e+2	3.769192e-3	1	34	5.000000e-1	2.941176e-2	unnamed	MSH2
Human Phenotype	HP:0002239	Gastrointestinal hemorrhage	50	4.659658e-3	1.000000e+0	5.727652e-1	2.146080e+2	4.659658e-3	1	4.659658e-3	1.000000e+0	66	7.303486e-3	1.000000e+0	6.801095e-1	1.366742e+2	7.316668e-3	1	66	5.000000e-1	1.515152e-2	unnamed	MSH2
Human Phenotype	HP:0003401	Paresthesia	51	4.820666e-3	1.000000e+0	5.809375e-1	2.074402e+2	4.820666e-3	1	4.820666e-3	1.000000e+0	50	4.429551e-3	1.000000e+0	5.444804e-1	2.255125e+2	4.434344e-3	1	40	5.000000e-1	2.500000e-2	unnamed	MSH2
Human Phenotype	HP:0000957	Cafe-au-lait spot	52	5.182813e-3	1.000000e+0	6.125686e-1	1.929454e+2	5.182813e-3	1	5.182813e-3	1.000000e+0	63	6.972090e-3	1.000000e+0	6.801661e-1	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	MSH2
Human Phenotype	HP:0000738	Hallucinations	53	5.217956e-3	1.000000e+0	6.050860e-1	1.916459e+2	5.217956e-3	1	5.217956e-3	1.000000e+0	58	6.530143e-3	1.000000e+0	6.919700e-1	1.528898e+2	6.540657e-3	1	59	5.000000e-1	1.694915e-2	unnamed	MSH2
Human Phenotype	HP:0100568	Neoplasm of the endocrine system	54	5.285851e-3	1.000000e+0	6.016082e-1	1.891843e+2	5.285851e-3	1	5.285851e-3	1.000000e+0	52	5.645954e-3	1.000000e+0	6.673083e-1	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	MSH2
Human Phenotype	HP:0006753	Neoplasm of the stomach	55	5.467798e-3	1.000000e+0	6.110016e-1	1.828890e+2	5.467798e-3	1	5.467798e-3	1.000000e+0	52	5.645954e-3	1.000000e+0	6.673083e-1	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	MSH2
Human Phenotype	HP:0002665	Lymphoma	56	5.521516e-3	1.000000e+0	6.059864e-1	1.811097e+2	5.521516e-3	1	5.521516e-3	1.000000e+0	63	6.972090e-3	1.000000e+0	6.801661e-1	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	MSH2
Human Phenotype	HP:0100705	Abnormality of the glial cells	57	5.741252e-3	1.000000e+0	6.190480e-1	1.741780e+2	5.741252e-3	1	5.741252e-3	1.000000e+0	68	7.524386e-3	1.000000e+0	6.800717e-1	1.326544e+2	7.538385e-3	1	68	5.000000e-1	1.470588e-2	unnamed	MSH2
Human Phenotype	HP:0001123	Visual field defect	58	5.930192e-3	1.000000e+0	6.283959e-1	1.686286e+2	5.930192e-3	1	5.930192e-3	1.000000e+0	70	7.966112e-3	1.000000e+0	6.994246e-1	1.252847e+2	7.981819e-3	1	72	5.000000e-1	1.388889e-2	unnamed	MSH2
Human Phenotype	HP:0002027	Abdominal pain	59	6.319062e-3	1.000000e+0	6.582535e-1	1.582513e+2	6.319062e-3	1	6.319062e-3	1.000000e+0	72	8.518131e-3	1.000000e+0	7.271171e-1	1.171494e+2	8.536112e-3	1	77	5.000000e-1	1.298701e-2	unnamed	MSH2
Human Phenotype	HP:0002076	Migraine	60	6.522538e-3	1.000000e+0	6.681253e-1	1.533146e+2	6.522538e-3	1	6.522538e-3	1.000000e+0	67	7.413939e-3	1.000000e+0	6.800906e-1	1.346343e+2	7.427526e-3	1	67	5.000000e-1	1.492537e-2	unnamed	MSH2
Human Phenotype	HP:0010785	Gonadal neoplasm	61	6.590097e-3	1.000000e+0	6.639793e-1	1.517428e+2	6.590097e-3	1	6.590097e-3	1.000000e+0	49	4.208307e-3	1.000000e+0	5.278419e-1	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	MSH2
Human Phenotype	HP:0009726	Renal neoplasm	62	6.642061e-3	1.000000e+0	6.584211e-1	1.505557e+2	6.642061e-3	1	6.642061e-3	1.000000e+0	54	5.756499e-3	1.000000e+0	6.551749e-1	1.734712e+2	5.764647e-3	1	52	5.000000e-1	1.923077e-2	unnamed	MSH2
Human Phenotype	HP:0100006	Neoplasm of the central nervous system	63	6.795571e-3	1.000000e+0	6.629457e-1	1.471547e+2	6.795571e-3	1	6.795571e-3	1.000000e+0	57	6.309133e-3	1.000000e+0	6.802795e-1	1.582544e+2	6.318940e-3	1	57	5.000000e-1	1.754386e-2	unnamed	MSH2
Human Phenotype	HP:0007018	Attention deficit hyperactivity disorder	64	7.014625e-3	1.000000e+0	6.736232e-1	1.425593e+2	7.014625e-3	1	7.014625e-3	1.000000e+0	55	5.977571e-3	1.000000e+0	6.679664e-1	1.670463e+2	5.986364e-3	1	54	5.000000e-1	1.851852e-2	unnamed	MSH2
Human Phenotype	HP:0100242	Sarcoma	65	7.244055e-3	1.000000e+0	6.849533e-1	1.380442e+2	7.244055e-3	1	7.244055e-3	1.000000e+0	62	6.861613e-3	1.000000e+0	6.801851e-1	1.454919e+2	6.873233e-3	1	62	5.000000e-1	1.612903e-2	unnamed	MSH2
Human Phenotype	HP:0010786	Urinary tract neoplasm	66	7.320958e-3	1.000000e+0	6.817365e-1	1.365941e+2	7.320958e-3	1	7.320958e-3	1.000000e+0	60	6.640639e-3	1.000000e+0	6.802228e-1	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	MSH2
Human Phenotype	HP:0011772	Abnormality of thyroid morphology	67	7.490933e-3	1.000000e+0	6.871533e-1	1.334947e+2	7.490933e-3	1	7.490933e-3	1.000000e+0	58	6.530143e-3	1.000000e+0	6.919700e-1	1.528898e+2	6.540657e-3	1	59	5.000000e-1	1.694915e-2	unnamed	MSH2
Human Phenotype	HP:0000763	Sensory neuropathy	68	7.521179e-3	1.000000e+0	6.797819e-1	1.329579e+2	7.521179e-3	1	7.521179e-3	1.000000e+0	60	6.640639e-3	1.000000e+0	6.802228e-1	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	MSH2
Human Phenotype	HP:0002315	Headache	69	7.837242e-3	1.000000e+0	6.980825e-1	1.275959e+2	7.837242e-3	1	7.837242e-3	1.000000e+0	77	9.952663e-3	1.000000e+0	7.944035e-1	1.002278e+2	9.977274e-3	1	90	5.000000e-1	1.111111e-2	unnamed	MSH2
Human Phenotype	HP:0011029	Internal hemorrhage	70	8.015556e-3	1.000000e+0	7.037658e-1	1.247574e+2	8.015556e-3	1	8.015556e-3	1.000000e+0	83	1.160660e-2	1.000000e+0	8.594478e-1	8.590952e+1	1.164015e-2	1	105	5.000000e-1	9.523810e-3	unnamed	MSH2
Human Phenotype	HP:0001034	Hypermelanotic macule	71	8.294523e-3	1.000000e+0	7.180019e-1	1.205615e+2	8.294523e-3	1	8.294523e-3	1.000000e+0	82	1.116569e-2	1.000000e+0	8.368821e-1	8.931188e+1	1.119672e-2	1	101	5.000000e-1	9.900990e-3	unnamed	MSH2
Human Phenotype	HP:0000736	Short attention span	72	8.714628e-3	1.000000e+0	7.438903e-1	1.147496e+2	8.714628e-3	1	8.714628e-3	1.000000e+0	63	6.972090e-3	1.000000e+0	6.801661e-1	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	MSH2
Human Phenotype	HP:0010787	Genital neoplasm	73	8.920269e-3	1.000000e+0	7.510133e-1	1.121042e+2	8.920269e-3	1	8.920269e-3	1.000000e+0	55	5.977571e-3	1.000000e+0	6.679664e-1	1.670463e+2	5.986364e-3	1	54	5.000000e-1	1.851852e-2	unnamed	MSH2
Human Phenotype	HP:0004375	Neoplasm of the nervous system	74	9.050370e-3	1.000000e+0	7.516699e-1	1.104927e+2	9.050370e-3	1	9.050370e-3	1.000000e+0	71	8.186938e-3	1.000000e+0	7.086890e-1	1.218986e+2	8.203536e-3	1	74	5.000000e-1	1.351351e-2	unnamed	MSH2
Human Phenotype	HP:0001909	Leukemia	75	9.306101e-3	1.000000e+0	7.626040e-1	1.074564e+2	9.306101e-3	1	9.306101e-3	1.000000e+0	79	1.039385e-2	1.000000e+0	8.086152e-1	9.596277e+1	1.042071e-2	1	94	5.000000e-1	1.063830e-2	unnamed	MSH2
Human Phenotype	HP:0002376	Developmental regression	76	9.522267e-3	1.000000e+0	7.700507e-1	1.050170e+2	9.522267e-3	1	9.522267e-3	1.000000e+0	86	1.292876e-2	1.000000e+0	9.239553e-1	7.709829e+1	1.297046e-2	1	117	5.000000e-1	8.547009e-3	unnamed	MSH2
Human Phenotype	HP:0001274	Agenesis of corpus callosum	77	9.567259e-3	1.000000e+0	7.636412e-1	1.045231e+2	9.567259e-3	1	9.567259e-3	1.000000e+0	73	8.959636e-3	1.000000e+0	7.543277e-1	1.113642e+2	8.979547e-3	1	81	5.000000e-1	1.234568e-2	unnamed	MSH2
Human Phenotype	HP:0006989	Dysplastic corpus callosum	78	9.599562e-3	1.000000e+0	7.563963e-1	1.041714e+2	9.599562e-3	1	9.599562e-3	1.000000e+0	74	9.180352e-3	1.000000e+0	7.624655e-1	1.086807e+2	9.201264e-3	1	83	5.000000e-1	1.204819e-2	unnamed	MSH2
Human Phenotype	HP:0002250	Abnormality of the large intestine	79	9.660118e-3	1.000000e+0	7.515327e-1	1.035184e+2	9.660118e-3	1	9.660118e-3	1.000000e+0	78	1.006297e-2	1.000000e+0	7.929104e-1	9.912637e+1	1.008813e-2	1	91	5.000000e-1	1.098901e-2	unnamed	MSH2
Human Phenotype	HP:0000130	Abnormality of the uterus	80	9.892803e-3	1.000000e+0	7.600146e-1	1.010836e+2	9.892803e-3	1	9.892803e-3	1.000000e+0	68	7.524386e-3	1.000000e+0	6.800717e-1	1.326544e+2	7.538385e-3	1	68	5.000000e-1	1.470588e-2	unnamed	MSH2
Human Phenotype	HP:0001824	Weight loss	81	1.028226e-2	1.000000e+0	7.801823e-1	9.725486e+1	1.028226e-2	1	1.028226e-2	1.000000e+0	76	9.401043e-3	1.000000e+0	7.602475e-1	1.061235e+2	9.422981e-3	1	85	5.000000e-1	1.176471e-2	unnamed	MSH2
Human Phenotype	HP:0007400	Irregular hyperpigmentation	82	1.068274e-2	1.000000e+0	8.006844e-1	9.360890e+1	1.068274e-2	1	1.068274e-2	1.000000e+0	90	1.436009e-2	1.000000e+0	9.806346e-1	6.938846e+1	1.441162e-2	1	130	5.000000e-1	7.692308e-3	unnamed	MSH2
Human Phenotype	HP:0001732	Abnormality of the pancreas	83	1.082484e-2	1.000000e+0	8.015598e-1	9.238008e+1	1.082484e-2	1	1.082484e-2	1.000000e+0	87	1.314903e-2	1.000000e+0	9.288958e-1	7.580252e+1	1.319217e-2	1	119	5.000000e-1	8.403361e-3	unnamed	MSH2
Human Phenotype	HP:0002024	Malabsorption	84	1.118208e-2	1.000000e+0	8.181555e-1	8.942881e+1	1.118208e-2	1	1.118208e-2	1.000000e+0	90	1.436009e-2	1.000000e+0	9.806346e-1	6.938846e+1	1.441162e-2	1	130	5.000000e-1	7.692308e-3	unnamed	MSH2
Human Phenotype	HP:0000137	Abnormality of the ovary	85	1.185914e-2	1.000000e+0	8.574856e-1	8.432312e+1	1.185914e-2	1	1.185914e-2	1.000000e+0	79	1.039385e-2	1.000000e+0	8.086152e-1	9.596277e+1	1.042071e-2	1	94	5.000000e-1	1.063830e-2	unnamed	MSH2
Human Phenotype	HP:0007379	Neoplasm of the genitourinary tract	86	1.245121e-2	1.000000e+0	8.898272e-1	8.031346e+1	1.245121e-2	1	1.245121e-2	1.000000e+0	75	9.290700e-3	1.000000e+0	7.613419e-1	1.073869e+2	9.312122e-3	1	84	5.000000e-1	1.190476e-2	unnamed	MSH2
Human Phenotype	HP:0008069	Neoplasm of the skin	87	1.249858e-2	1.000000e+0	8.829457e-1	8.000907e+1	1.249858e-2	1	1.249858e-2	1.000000e+0	87	1.314903e-2	1.000000e+0	9.288958e-1	7.580252e+1	1.319217e-2	1	119	5.000000e-1	8.403361e-3	unnamed	MSH2
Human Phenotype	HP:0000953	Hyperpigmentation of the skin	88	1.310828e-2	1.000000e+0	9.154942e-1	7.628765e+1	1.310828e-2	1	1.310828e-2	1.000000e+0	94	1.699983e-2	1.000000e+0	1.000000e+0	5.857468e+1	1.707222e-2	1	154	5.000000e-1	6.493506e-3	unnamed	MSH2
Human Phenotype	HP:0000752	Hyperactivity	89	1.367399e-2	1.000000e+0	9.442735e-1	7.313156e+1	1.367399e-2	1	1.367399e-2	1.000000e+0	81	1.061440e-2	1.000000e+0	8.053840e-1	9.396354e+1	1.064243e-2	1	96	5.000000e-1	1.041667e-2	unnamed	MSH2
Human Phenotype	HP:0002019	Constipation	90	1.380603e-2	1.000000e+0	9.427984e-1	7.243213e+1	1.380603e-2	1	1.380603e-2	1.000000e+0	89	1.358950e-2	1.000000e+0	9.384390e-1	7.333740e+1	1.363561e-2	1	123	5.000000e-1	8.130081e-3	unnamed	MSH2
Human Phenotype	HP:0007378	Neoplasm of the gastrointestinal tract	91	1.388019e-2	1.000000e+0	9.374467e-1	7.204511e+1	1.388019e-2	1	1.388019e-2	1.000000e+0	84	1.237796e-2	1.000000e+0	9.056541e-1	8.054018e+1	1.241616e-2	1	112	5.000000e-1	8.928571e-3	unnamed	MSH2
Human Phenotype	HP:0011792	Neoplasm by histology	92	1.405119e-2	1.000000e+0	9.386806e-1	7.116836e+1	1.405119e-2	1	1.405119e-2	1.000000e+0	85	1.248814e-2	1.000000e+0	9.029660e-1	7.982743e+1	1.252702e-2	1	113	5.000000e-1	8.849558e-3	unnamed	MSH2
Human Phenotype	HP:0004377	Hematological neoplasm	93	1.500982e-2	1.000000e+0	9.919393e-1	6.662306e+1	1.500982e-2	1	1.500982e-2	1.000000e+0	95	1.765921e-2	1.000000e+0	1.000000e+0	5.637812e+1	1.773738e-2	1	160	5.000000e-1	6.250000e-3	unnamed	MSH2
Human Phenotype	HP:0011799	Abnormality of facial soft tissue	94	1.583064e-2	1.000000e+0	1.000000e+0	6.316864e+1	1.583064e-2	1	1.583064e-2	1.000000e+0	97	1.787895e-2	1.000000e+0	1.000000e+0	5.568210e+1	1.795909e-2	1	162	5.000000e-1	6.172840e-3	unnamed	MSH2
Human Phenotype	HP:0002017	Nausea and vomiting	95	1.584584e-2	1.000000e+0	1.000000e+0	6.310803e+1	1.584584e-2	1	1.584584e-2	1.000000e+0	99	1.809867e-2	1.000000e+0	1.000000e+0	5.500305e+1	1.818081e-2	1	164	5.000000e-1	6.097561e-3	unnamed	MSH2
Human Phenotype	HP:0000820	Abnormality of the thyroid gland	96	1.638059e-2	1.000000e+0	1.000000e+0	6.104788e+1	1.638059e-2	1	1.638059e-2	1.000000e+0	92	1.458020e-2	1.000000e+0	9.740208e-1	6.833712e+1	1.463334e-2	1	132	5.000000e-1	7.575758e-3	unnamed	MSH2
Human Phenotype	HP:0001892	Abnormal bleeding	97	1.685969e-2	1.000000e+0	1.000000e+0	5.931306e+1	1.685969e-2	1	1.685969e-2	1.000000e+0	101	2.270712e-2	1.000000e+0	1.000000e+0	4.378883e+1	2.283687e-2	1	206	5.000000e-1	4.854369e-3	unnamed	MSH2
Human Phenotype	HP:0004374	Hemiplegia/hemiparesis	98	1.698524e-2	1.000000e+0	1.000000e+0	5.887465e+1	1.698524e-2	1	1.698524e-2	1.000000e+0	93	1.568040e-2	1.000000e+0	1.000000e+0	6.352465e+1	1.574192e-2	1	142	5.000000e-1	7.042254e-3	unnamed	MSH2
Human Phenotype	HP:0002577	Abnormality of the stomach	99	1.809177e-2	1.000000e+0	1.000000e+0	5.527375e+1	1.809177e-2	1	1.809177e-2	1.000000e+0	96	1.776908e-2	1.000000e+0	1.000000e+0	5.602795e+1	1.784823e-2	1	161	5.000000e-1	6.211180e-3	unnamed	MSH2
Human Phenotype	HP:0000769	Abnormality of the breast	100	2.042074e-2	1.000000e+0	1.000000e+0	4.896981e+1	2.042074e-2	1	2.042074e-2	1.000000e+0	97	1.787895e-2	1.000000e+0	1.000000e+0	5.568210e+1	1.795909e-2	1	162	5.000000e-1	6.172840e-3	unnamed	MSH2
Human Phenotype	HP:0010549	Paralysis due to lesions of the principle motor tracts	101	2.184856e-2	1.000000e+0	1.000000e+0	4.576962e+1	2.184856e-2	1	2.184856e-2	1.000000e+0	100	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	MSH2
Human Phenotype	HP:0009830	Peripheral neuropathy	102	2.399642e-2	1.000000e+0	1.000000e+0	4.167288e+1	2.399642e-2	1	2.399642e-2	1.000000e+0	106	2.752338e-2	1.000000e+0	1.000000e+0	3.608200e+1	2.771465e-2	1	250	5.000000e-1	4.000000e-3	unnamed	MSH2
Human Phenotype	HP:0007370	Aplasia/Hypoplasia of the corpus callosum	103	2.446174e-2	1.000000e+0	1.000000e+0	4.088017e+1	2.446174e-2	1	2.446174e-2	1.000000e+0	102	2.347414e-2	1.000000e+0	1.000000e+0	4.234977e+1	2.361288e-2	1	213	5.000000e-1	4.694836e-3	unnamed	MSH2
Human Phenotype	HP:0001000	Abnormality of skin pigmentation	104	2.462739e-2	1.000000e+0	1.000000e+0	4.060519e+1	2.462739e-2	1	2.462739e-2	1.000000e+0	107	2.872559e-2	1.000000e+0	1.000000e+0	3.456130e+1	2.893409e-2	1	261	5.000000e-1	3.831418e-3	unnamed	MSH2
Human Phenotype	HP:0001273	Abnormality of the corpus callosum	105	2.536115e-2	1.000000e+0	1.000000e+0	3.943039e+1	2.536115e-2	1	2.536115e-2	1.000000e+0	104	2.424086e-2	1.000000e+0	1.000000e+0	4.100227e+1	2.438889e-2	1	220	5.000000e-1	4.545455e-3	unnamed	MSH2
Human Phenotype	HP:0002500	Abnormality of the cerebral white matter	106	2.765141e-2	1.000000e+0	1.000000e+0	3.616452e+1	2.765141e-2	1	2.765141e-2	1.000000e+0	105	2.686732e-2	1.000000e+0	1.000000e+0	3.696926e+1	2.704950e-2	1	244	5.000000e-1	4.098361e-3	unnamed	MSH2
Human Phenotype	HP:0001881	Abnormality of leukocytes	107	2.780174e-2	1.000000e+0	1.000000e+0	3.596897e+1	2.780174e-2	1	2.780174e-2	1.000000e+0	114	3.516110e-2	1.000000e+0	1.000000e+0	2.818906e+1	3.547475e-2	1	320	5.000000e-1	3.125000e-3	unnamed	MSH2
Human Phenotype	HP:0001600	Abnormality of the larynx	108	2.804911e-2	1.000000e+0	1.000000e+0	3.565176e+1	2.804911e-2	1	2.804911e-2	1.000000e+0	103	2.402182e-2	1.000000e+0	1.000000e+0	4.137844e+1	2.416717e-2	1	218	5.000000e-1	4.587156e-3	unnamed	MSH2
Human Phenotype	HP:0010993	Abnormality of the cerebral subcortex	109	3.078375e-2	1.000000e+0	1.000000e+0	3.248468e+1	3.078375e-2	1	3.078375e-2	1.000000e+0	108	2.959946e-2	1.000000e+0	1.000000e+0	3.353346e+1	2.982096e-2	1	269	5.000000e-1	3.717472e-3	unnamed	MSH2
Human Phenotype	HP:0001371	Flexion contracture	110	3.355127e-2	1.000000e+0	1.000000e+0	2.980513e+1	3.355127e-2	1	3.355127e-2	1.000000e+0	110	3.276392e-2	1.000000e+0	1.000000e+0	3.027013e+1	3.303586e-2	1	298	5.000000e-1	3.355705e-3	unnamed	MSH2
Human Phenotype	HP:0000008	Abnormality of female internal genitalia	111	3.365925e-2	1.000000e+0	1.000000e+0	2.970951e+1	3.365925e-2	1	3.365925e-2	1.000000e+0	109	2.981786e-2	1.000000e+0	1.000000e+0	3.328598e+1	3.004268e-2	1	271	5.000000e-1	3.690037e-3	unnamed	MSH2
Human Phenotype	HP:0002118	Abnormality of the cerebral ventricles	112	3.540846e-2	1.000000e+0	1.000000e+0	2.824184e+1	3.540846e-2	1	3.540846e-2	1.000000e+0	111	3.385392e-2	1.000000e+0	1.000000e+0	2.928734e+1	3.414445e-2	1	308	5.000000e-1	3.246753e-3	unnamed	MSH2
Human Phenotype	HP:0002087	Abnormality of the upper respiratory tract	113	3.607184e-2	1.000000e+0	1.000000e+0	2.772246e+1	3.607184e-2	1	3.607184e-2	1.000000e+0	113	3.450762e-2	1.000000e+0	1.000000e+0	2.872771e+1	3.480960e-2	1	314	5.000000e-1	3.184713e-3	unnamed	MSH2
Human Phenotype	HP:0011355	Localized skin lesion	114	3.611249e-2	1.000000e+0	1.000000e+0	2.769125e+1	3.611249e-2	1	3.611249e-2	1.000000e+0	116	3.766407e-2	1.000000e+0	1.000000e+0	2.629883e+1	3.802450e-2	1	343	5.000000e-1	2.915452e-3	unnamed	MSH2
Human Phenotype	HP:0001276	Hypertonia	115	3.644032e-2	1.000000e+0	1.000000e+0	2.744213e+1	3.644032e-2	1	3.644032e-2	1.000000e+0	118	4.135815e-2	1.000000e+0	1.000000e+0	2.392706e+1	4.179369e-2	1	377	5.000000e-1	2.652520e-3	unnamed	MSH2
Human Phenotype	HP:0001288	Gait disturbance	116	3.682158e-2	1.000000e+0	1.000000e+0	2.715798e+1	3.682158e-2	1	3.682158e-2	1.000000e+0	115	3.603207e-2	1.000000e+0	1.000000e+0	2.750152e+1	3.636162e-2	1	328	5.000000e-1	3.048780e-3	unnamed	MSH2
Human Phenotype	HP:0010460	Abnormality of the female genitalia	117	3.799718e-2	1.000000e+0	1.000000e+0	2.631774e+1	3.799718e-2	1	3.799718e-2	1.000000e+0	112	3.418080e-2	1.000000e+0	1.000000e+0	2.900482e+1	3.447702e-2	1	311	5.000000e-1	3.215434e-3	unnamed	MSH2
Human Phenotype	HP:0002242	Abnormality of the intestine	118	3.988204e-2	1.000000e+0	1.000000e+0	2.507394e+1	3.988204e-2	1	3.988204e-2	1.000000e+0	117	4.027239e-2	1.000000e+0	1.000000e+0	2.457902e+1	4.068511e-2	1	367	5.000000e-1	2.724796e-3	unnamed	MSH2
Human Phenotype	HP:0002167	Neurological speech impairment	119	4.456011e-2	1.000000e+0	1.000000e+0	2.244160e+1	4.456011e-2	1	4.456011e-2	1.000000e+0	119	4.276871e-2	1.000000e+0	1.000000e+0	2.312949e+1	4.323485e-2	1	390	5.000000e-1	2.564103e-3	unnamed	MSH2
Human Phenotype	HP:0001392	Abnormality of the liver	120	4.545608e-2	1.000000e+0	1.000000e+0	2.199926e+1	4.545608e-2	1	4.545608e-2	1.000000e+0	133	6.154861e-2	1.000000e+0	1.000000e+0	1.599379e+1	6.252425e-2	1	564	5.000000e-1	1.773050e-3	unnamed	MSH2
Human Phenotype	HP:0000505	Visual impairment	121	4.619257e-2	1.000000e+0	1.000000e+0	2.164850e+1	4.619257e-2	1	4.619257e-2	1.000000e+0	121	4.872500e-2	1.000000e+0	1.000000e+0	2.027079e+1	4.933208e-2	1	445	5.000000e-1	2.247191e-3	unnamed	MSH2
Human Phenotype	HP:0011025	Abnormality of cardiovascular system physiology	122	4.649297e-2	1.000000e+0	1.000000e+0	2.150863e+1	4.649297e-2	1	4.649297e-2	1.000000e+0	123	4.958982e-2	1.000000e+0	1.000000e+0	1.991280e+1	5.021895e-2	1	453	5.000000e-1	2.207506e-3	unnamed	MSH2
Human Phenotype	HP:0004325	Decreased body weight	123	4.649404e-2	1.000000e+0	1.000000e+0	2.150813e+1	4.649404e-2	1	4.649404e-2	1.000000e+0	121	4.872500e-2	1.000000e+0	1.000000e+0	2.027079e+1	4.933208e-2	1	445	5.000000e-1	2.247191e-3	unnamed	MSH2
Human Phenotype	HP:0011793	Neoplasm by anatomical site	124	4.811988e-2	1.000000e+0	1.000000e+0	2.078143e+1	4.811988e-2	1	4.811988e-2	1.000000e+0	120	4.656123e-2	1.000000e+0	1.000000e+0	2.122471e+1	4.711490e-2	1	425	5.000000e-1	2.352941e-3	unnamed	MSH2
Human Phenotype	HP:0000759	Abnormality of the peripheral nervous system	125	4.946470e-2	1.000000e+0	1.000000e+0	2.021644e+1	4.946470e-2	1	4.946470e-2	1.000000e+0	125	5.196604e-2	1.000000e+0	1.000000e+0	1.899053e+1	5.265783e-2	1	475	5.000000e-1	2.105263e-3	unnamed	MSH2
Human Phenotype	HP:0000504	Abnormality of vision	126	4.984025e-2	1.000000e+0	1.000000e+0	2.006411e+1	4.984025e-2	1	4.984025e-2	1.000000e+0	126	5.412367e-2	1.000000e+0	1.000000e+0	1.822323e+1	5.487501e-2	1	495	5.000000e-1	2.020202e-3	unnamed	MSH2
Human Phenotype	HP:0002664	Neoplasm	127	5.084040e-2	1.000000e+0	1.000000e+0	1.966940e+1	5.084040e-2	1	5.084040e-2	1.000000e+0	124	4.991402e-2	1.000000e+0	1.000000e+0	1.978180e+1	5.055152e-2	1	456	5.000000e-1	2.192982e-3	unnamed	MSH2
Human Phenotype	HP:0011121	Abnormality of skin morphology	128	5.311577e-2	1.000000e+0	1.000000e+0	1.882680e+1	5.311577e-2	1	5.311577e-2	1.000000e+0	134	6.187077e-2	1.000000e+0	1.000000e+0	1.590917e+1	6.285683e-2	1	567	5.000000e-1	1.763668e-3	unnamed	MSH2
Human Phenotype	HP:0007364	Aplasia/Hypoplasia of the cerebrum	129	5.539730e-2	1.000000e+0	1.000000e+0	1.805142e+1	5.539730e-2	1	5.539730e-2	1.000000e+0	129	5.681724e-2	1.000000e+0	1.000000e+0	1.734712e+1	5.764647e-2	1	520	5.000000e-1	1.923077e-3	unnamed	MSH2
Human Phenotype	HP:0011458	Abdominal symptom	130	5.682180e-2	1.000000e+0	1.000000e+0	1.759888e+1	5.682180e-2	1	5.682180e-2	1.000000e+0	131	6.004447e-2	1.000000e+0	1.000000e+0	1.640091e+1	6.097223e-2	1	550	5.000000e-1	1.818182e-3	unnamed	MSH2
Human Phenotype	HP:0000818	Abnormality of the endocrine system	131	5.830630e-2	1.000000e+0	1.000000e+0	1.715081e+1	5.830630e-2	1	5.830630e-2	1.000000e+0	136	6.294423e-2	1.000000e+0	1.000000e+0	1.563345e+1	6.396541e-2	1	577	5.000000e-1	1.733102e-3	unnamed	MSH2
Human Phenotype	HP:0001871	Abnormality of  blood and blood-forming tissues	132	5.831227e-2	1.000000e+0	1.000000e+0	1.714905e+1	5.831227e-2	1	5.831227e-2	1.000000e+0	150	7.577790e-2	1.000000e+0	1.000000e+0	1.294189e+1	7.726844e-2	1	697	5.000000e-1	1.434720e-3	unnamed	MSH2
Human Phenotype	HP:0007256	Abnormality of pyramidal motor function	133	5.852599e-2	1.000000e+0	1.000000e+0	1.708643e+1	5.852599e-2	1	5.852599e-2	1.000000e+0	137	6.466050e-2	1.000000e+0	1.000000e+0	1.521164e+1	6.573915e-2	1	593	5.000000e-1	1.686341e-3	unnamed	MSH2
Human Phenotype	HP:0002062	Abnormality of the pyramidal tracts	134	5.873395e-2	1.000000e+0	1.000000e+0	1.702593e+1	5.873395e-2	1	5.873395e-2	1.000000e+0	138	6.498213e-2	1.000000e+0	1.000000e+0	1.513507e+1	6.607173e-2	1	596	5.000000e-1	1.677852e-3	unnamed	MSH2
Human Phenotype	HP:0000077	Abnormality of the kidney	135	5.877112e-2	1.000000e+0	1.000000e+0	1.701516e+1	5.877112e-2	1	5.877112e-2	1.000000e+0	127	5.541706e-2	1.000000e+0	1.000000e+0	1.779191e+1	5.620531e-2	1	507	5.000000e-1	1.972387e-3	unnamed	MSH2
Human Phenotype	HP:0011729	Abnormality of joint mobility	136	6.014038e-2	1.000000e+0	1.000000e+0	1.662776e+1	6.014038e-2	1	6.014038e-2	1.000000e+0	128	5.670958e-2	1.000000e+0	1.000000e+0	1.738054e+1	5.753561e-2	1	519	5.000000e-1	1.926782e-3	unnamed	MSH2
Human Phenotype	HP:0000708	Behavioural/Psychiatric Abnormality	137	6.042589e-2	1.000000e+0	1.000000e+0	1.654920e+1	6.042589e-2	1	6.042589e-2	1.000000e+0	134	6.187077e-2	1.000000e+0	1.000000e+0	1.590917e+1	6.285683e-2	1	567	5.000000e-1	1.763668e-3	unnamed	MSH2
Human Phenotype	HP:0010935	Abnormality of the upper urinary tract	138	6.180045e-2	1.000000e+0	1.000000e+0	1.618111e+1	6.180045e-2	1	6.180045e-2	1.000000e+0	130	5.961449e-2	1.000000e+0	1.000000e+0	1.652106e+1	6.052880e-2	1	546	5.000000e-1	1.831502e-3	unnamed	MSH2
Human Phenotype	HP:0011805	Abnormality of muscle morphology	139	6.379056e-2	1.000000e+0	1.000000e+0	1.567630e+1	6.379056e-2	1	6.379056e-2	1.000000e+0	145	6.937213e-2	1.000000e+0	1.000000e+0	1.416091e+1	7.061693e-2	1	637	5.000000e-1	1.569859e-3	unnamed	MSH2
Human Phenotype	HP:0004323	Abnormality of body weight	140	6.465988e-2	1.000000e+0	1.000000e+0	1.546554e+1	6.465988e-2	1	6.465988e-2	1.000000e+0	139	6.541088e-2	1.000000e+0	1.000000e+0	1.503417e+1	6.651516e-2	1	600	5.000000e-1	1.666667e-3	unnamed	MSH2
Human Phenotype	HP:0000812	Abnormal internal genitalia	141	6.482038e-2	1.000000e+0	1.000000e+0	1.542725e+1	6.482038e-2	1	6.482038e-2	1.000000e+0	132	6.068925e-2	1.000000e+0	1.000000e+0	1.622392e+1	6.163738e-2	1	556	5.000000e-1	1.798561e-3	unnamed	MSH2
Human Phenotype	HP:0001252	Muscular hypotonia	142	6.484906e-2	1.000000e+0	1.000000e+0	1.542042e+1	6.484906e-2	1	6.484906e-2	1.000000e+0	140	6.626808e-2	1.000000e+0	1.000000e+0	1.483635e+1	6.740203e-2	1	608	5.000000e-1	1.644737e-3	unnamed	MSH2
Human Phenotype	HP:0003808	Abnormal muscle tone	143	6.512600e-2	1.000000e+0	1.000000e+0	1.535485e+1	6.512600e-2	1	6.512600e-2	1.000000e+0	142	6.637520e-2	1.000000e+0	1.000000e+0	1.481199e+1	6.751289e-2	1	609	5.000000e-1	1.642036e-3	unnamed	MSH2
Human Phenotype	HP:0011024	Abnormality of the gastrointestinal tract	144	6.745114e-2	1.000000e+0	1.000000e+0	1.482555e+1	6.745114e-2	1	6.745114e-2	1.000000e+0	140	6.626808e-2	1.000000e+0	1.000000e+0	1.483635e+1	6.740203e-2	1	608	5.000000e-1	1.644737e-3	unnamed	MSH2
Human Phenotype	HP:0002977	Aplasia/Hypoplasia involving the central nervous system	145	6.843249e-2	1.000000e+0	1.000000e+0	1.461294e+1	6.843249e-2	1	6.843249e-2	1.000000e+0	146	7.150984e-2	1.000000e+0	1.000000e+0	1.372983e+1	7.283410e-2	1	657	5.000000e-1	1.522070e-3	unnamed	MSH2
Human Phenotype	HP:0003549	Abnormality of connective tissue	146	6.968666e-2	1.000000e+0	1.000000e+0	1.434995e+1	6.968666e-2	1	6.968666e-2	1.000000e+0	144	6.798130e-2	1.000000e+0	1.000000e+0	1.445593e+1	6.917577e-2	1	624	5.000000e-1	1.602564e-3	unnamed	MSH2
Human Phenotype	HP:0100022	Abnormality of movement	147	7.002976e-2	1.000000e+0	1.000000e+0	1.427964e+1	7.002976e-2	1	7.002976e-2	1.000000e+0	147	7.172348e-2	1.000000e+0	1.000000e+0	1.368816e+1	7.305582e-2	1	659	5.000000e-1	1.517451e-3	unnamed	MSH2
Human Phenotype	HP:0002715	Abnormality of the immune system	148	7.036261e-2	1.000000e+0	1.000000e+0	1.421209e+1	7.036261e-2	1	7.036261e-2	1.000000e+0	154	8.555712e-2	1.000000e+0	1.000000e+0	1.143283e+1	8.746744e-2	1	789	5.000000e-1	1.267427e-3	unnamed	MSH2
Human Phenotype	HP:0012243	Abnormal genital system morphology	149	7.339808e-2	1.000000e+0	1.000000e+0	1.362434e+1	7.339808e-2	1	7.339808e-2	1.000000e+0	143	6.712488e-2	1.000000e+0	1.000000e+0	1.464367e+1	6.828890e-2	1	616	5.000000e-1	1.623377e-3	unnamed	MSH2
Human Phenotype	HP:0002060	Abnormality of the cerebrum	150	7.579775e-2	1.000000e+0	1.000000e+0	1.319300e+1	7.579775e-2	1	7.579775e-2	1.000000e+0	151	7.875969e-2	1.000000e+0	1.000000e+0	1.244207e+1	8.037248e-2	1	725	5.000000e-1	1.379310e-3	unnamed	MSH2
Human Phenotype	HP:0100547	Abnormality of the forebrain	151	7.625082e-2	1.000000e+0	1.000000e+0	1.311461e+1	7.625082e-2	1	7.625082e-2	1.000000e+0	152	7.918527e-2	1.000000e+0	1.000000e+0	1.237380e+1	8.081592e-2	1	729	5.000000e-1	1.371742e-3	unnamed	MSH2
Human Phenotype	HP:0001367	Abnormal joint morphology	152	7.644753e-2	1.000000e+0	1.000000e+0	1.308087e+1	7.644753e-2	1	7.644753e-2	1.000000e+0	149	7.545814e-2	1.000000e+0	1.000000e+0	1.299784e+1	7.693587e-2	1	694	5.000000e-1	1.440922e-3	unnamed	MSH2
Human Phenotype	HP:0000078	Abnormality of the genital system	153	7.832480e-2	1.000000e+0	1.000000e+0	1.276735e+1	7.832480e-2	1	7.832480e-2	1.000000e+0	148	7.513832e-2	1.000000e+0	1.000000e+0	1.305427e+1	7.660329e-2	1	691	5.000000e-1	1.447178e-3	unnamed	MSH2
Human Phenotype	HP:0011354	Generalized abnormality of skin	154	7.852036e-2	1.000000e+0	1.000000e+0	1.273555e+1	7.852036e-2	1	7.852036e-2	1.000000e+0	159	9.349082e-2	1.000000e+0	1.000000e+0	1.044039e+1	9.578183e-2	1	864	5.000000e-1	1.157407e-3	unnamed	MSH2
Human Phenotype	HP:0001250	Seizures	155	7.857598e-2	1.000000e+0	1.000000e+0	1.272654e+1	7.857598e-2	1	7.857598e-2	1.000000e+0	153	8.216155e-2	1.000000e+0	1.000000e+0	1.191612e+1	8.391996e-2	1	757	5.000000e-1	1.321004e-3	unnamed	MSH2
Human Phenotype	HP:0011442	Abnormality of central motor function	156	7.946206e-2	1.000000e+0	1.000000e+0	1.258462e+1	7.946206e-2	1	7.946206e-2	1.000000e+0	157	8.767615e-2	1.000000e+0	1.000000e+0	1.115019e+1	8.968461e-2	1	809	5.000000e-1	1.236094e-3	unnamed	MSH2
Human Phenotype	HP:0012252	Abnormal respiratory system morphology	157	8.040224e-2	1.000000e+0	1.000000e+0	1.243746e+1	8.040224e-2	1	8.040224e-2	1.000000e+0	156	8.661694e-2	1.000000e+0	1.000000e+0	1.128974e+1	8.857602e-2	1	799	5.000000e-1	1.251564e-3	unnamed	MSH2
Human Phenotype	HP:0002086	Abnormality of the respiratory system	158	8.717457e-2	1.000000e+0	1.000000e+0	1.147124e+1	8.717457e-2	1	8.717457e-2	1.000000e+0	160	9.359637e-2	1.000000e+0	1.000000e+0	1.042832e+1	9.589269e-2	1	865	5.000000e-1	1.156069e-3	unnamed	MSH2
Human Phenotype	HP:0000079	Abnormality of the urinary system	159	8.807497e-2	1.000000e+0	1.000000e+0	1.135396e+1	8.807497e-2	1	8.807497e-2	1.000000e+0	158	9.053295e-2	1.000000e+0	1.000000e+0	1.079007e+1	9.267779e-2	1	836	5.000000e-1	1.196172e-3	unnamed	MSH2
Human Phenotype	HP:0000163	Abnormality of the oral cavity	160	8.862539e-2	1.000000e+0	1.000000e+0	1.128345e+1	8.862539e-2	1	8.862539e-2	1.000000e+0	155	8.576913e-2	1.000000e+0	1.000000e+0	1.140392e+1	8.768915e-2	1	791	5.000000e-1	1.264223e-3	unnamed	MSH2
Human Phenotype	HP:0012443	Abnormality of the brain	161	9.259756e-2	1.000000e+0	1.000000e+0	1.079942e+1	9.259756e-2	1	9.259756e-2	1.000000e+0	162	9.833972e-2	1.000000e+0	1.000000e+0	9.912637e+0	1.008813e-1	1	910	5.000000e-1	1.098901e-3	unnamed	MSH2
Human Phenotype	HP:0002012	Abnormality of the abdominal organs	162	9.395144e-2	1.000000e+0	1.000000e+0	1.064380e+1	9.395144e-2	1	9.395144e-2	1.000000e+0	164	1.060080e-1	1.000000e+0	1.000000e+0	9.176501e+0	1.089740e-1	1	983	5.000000e-1	1.017294e-3	unnamed	MSH2
Human Phenotype	HP:0011804	Abnormality of muscle physiology	163	9.636400e-2	1.000000e+0	1.000000e+0	1.037732e+1	9.636400e-2	1	9.636400e-2	1.000000e+0	163	1.050644e-1	1.000000e+0	1.000000e+0	9.261294e+0	1.079763e-1	1	974	5.000000e-1	1.026694e-3	unnamed	MSH2
Human Phenotype	HP:0000951	Abnormality of the skin	164	9.900756e-2	1.000000e+0	1.000000e+0	1.010024e+1	9.900756e-2	1	9.900756e-2	1.000000e+0	165	1.100914e-1	1.000000e+0	1.000000e+0	8.826321e+0	1.132975e-1	1	1022	5.000000e-1	9.784736e-4	unnamed	MSH2
Human Phenotype	HP:0000153	Abnormality of the mouth	165	1.037371e-1	1.000000e+0	1.000000e+0	9.639755e+0	1.037371e-1	1	1.037371e-1	1.000000e+0	161	9.823445e-2	1.000000e+0	1.000000e+0	9.923542e+0	1.007705e-1	1	909	5.000000e-1	1.100110e-3	unnamed	MSH2
Human Phenotype	HP:0012373	Abnormal eye physiology	166	1.069560e-1	1.000000e+0	1.000000e+0	9.349641e+0	1.069560e-1	1	1.069560e-1	1.000000e+0	167	1.137480e-1	1.000000e+0	1.000000e+0	8.534059e+0	1.171775e-1	1	1057	5.000000e-1	9.460738e-4	unnamed	MSH2
Human Phenotype	HP:0001626	Abnormality of the cardiovascular system	167	1.079230e-1	1.000000e+0	1.000000e+0	9.265867e+0	1.079230e-1	1	1.079230e-1	1.000000e+0	166	1.132260e-1	1.000000e+0	1.000000e+0	8.574620e+0	1.166232e-1	1	1052	5.000000e-1	9.505703e-4	unnamed	MSH2
Human Phenotype	HP:0001507	Growth abnormality	168	1.155115e-1	1.000000e+0	1.000000e+0	8.657146e+0	1.155115e-1	1	1.155115e-1	1.000000e+0	168	1.160425e-1	1.000000e+0	1.000000e+0	8.360056e+0	1.196164e-1	1	1079	5.000000e-1	9.267841e-4	unnamed	MSH2
Human Phenotype	HP:0000119	Abnormality of the genitourinary system	169	1.156102e-1	1.000000e+0	1.000000e+0	8.649757e+0	1.156102e-1	1	1.156102e-1	1.000000e+0	170	1.209346e-1	1.000000e+0	1.000000e+0	8.011101e+0	1.248268e-1	1	1126	5.000000e-1	8.880995e-4	unnamed	MSH2
Human Phenotype	HP:0003011	Abnormality of the musculature	170	1.167900e-1	1.000000e+0	1.000000e+0	8.562375e+0	1.167900e-1	1	1.167900e-1	1.000000e+0	171	1.247763e-1	1.000000e+0	1.000000e+0	7.756234e+0	1.289286e-1	1	1163	5.000000e-1	8.598452e-4	unnamed	MSH2
Human Phenotype	HP:0001438	Abnormality of the abdomen	171	1.198484e-1	1.000000e+0	1.000000e+0	8.343876e+0	1.198484e-1	1	1.198484e-1	1.000000e+0	173	1.315047e-1	1.000000e+0	1.000000e+0	7.345684e+0	1.361344e-1	1	1228	5.000000e-1	8.143322e-4	unnamed	MSH2
Human Phenotype	HP:0000006	Autosomal dominant inheritance	172	1.208130e-1	1.000000e+0	1.000000e+0	8.277255e+0	1.208130e-1	1	1.208130e-1	1.000000e+0	169	1.191667e-1	1.000000e+0	1.000000e+0	8.133904e+0	1.229422e-1	1	1109	5.000000e-1	9.017133e-4	unnamed	MSH2
Human Phenotype	HP:0001574	Abnormality of the integument	173	1.221743e-1	1.000000e+0	1.000000e+0	8.185030e+0	1.221743e-1	1	1.221743e-1	1.000000e+0	172	1.310914e-1	1.000000e+0	1.000000e+0	7.369690e+0	1.356909e-1	1	1224	5.000000e-1	8.169935e-4	unnamed	MSH2
Human Phenotype	HP:0007319	Morphological abnormality of the central nervous system	174	1.231213e-1	1.000000e+0	1.000000e+0	8.122074e+0	1.231213e-1	1	1.231213e-1	1.000000e+0	174	1.321245e-1	1.000000e+0	1.000000e+0	7.309968e+0	1.367995e-1	1	1234	5.000000e-1	8.103728e-4	unnamed	MSH2
Human Phenotype	HP:0100543	Cognitive impairment	175	1.275944e-1	1.000000e+0	1.000000e+0	7.837337e+0	1.275944e-1	1	1.275944e-1	1.000000e+0	175	1.328473e-1	1.000000e+0	1.000000e+0	7.268735e+0	1.375755e-1	1	1241	5.000000e-1	8.058018e-4	unnamed	MSH2
Human Phenotype	HP:0000271	Abnormality of the face	176	1.330333e-1	1.000000e+0	1.000000e+0	7.516916e+0	1.330333e-1	1	1.330333e-1	1.000000e+0	176	1.358386e-1	1.000000e+0	1.000000e+0	7.102756e+0	1.407904e-1	1	1270	5.000000e-1	7.874016e-4	unnamed	MSH2
Human Phenotype	HP:0000007	Autosomal recessive inheritance	177	1.382544e-1	1.000000e+0	1.000000e+0	7.233043e+0	1.382544e-1	1	1.382544e-1	1.000000e+0	183	1.705229e-1	1.000000e+0	1.000000e+0	5.602795e+0	1.784823e-1	1	1610	5.000000e-1	6.211180e-4	unnamed	MSH2
Human Phenotype	HP:0000478	Abnormality of the eye	178	1.387497e-1	1.000000e+0	1.000000e+0	7.207222e+0	1.387497e-1	1	1.387497e-1	1.000000e+0	177	1.483658e-1	1.000000e+0	1.000000e+0	6.480244e+0	1.543152e-1	1	1392	5.000000e-1	7.183908e-4	unnamed	MSH2
Human Phenotype	HP:0011446	Abnormality of higher mental function	179	1.446140e-1	1.000000e+0	1.000000e+0	6.914961e+0	1.446140e-1	1	1.446140e-1	1.000000e+0	178	1.507173e-1	1.000000e+0	1.000000e+0	6.374912e+0	1.568649e-1	1	1415	5.000000e-1	7.067138e-4	unnamed	MSH2
Human Phenotype	HP:0000234	Abnormality of the head	180	1.454011e-1	1.000000e+0	1.000000e+0	6.877527e+0	1.454011e-1	1	1.454011e-1	1.000000e+0	180	1.516365e-1	1.000000e+0	1.000000e+0	6.334621e+0	1.578626e-1	1	1424	5.000000e-1	7.022472e-4	unnamed	MSH2
Human Phenotype	HP:0000152	Abnormality of head and neck	181	1.484435e-1	1.000000e+0	1.000000e+0	6.736568e+0	1.484435e-1	1	1.484435e-1	1.000000e+0	181	1.541874e-1	1.000000e+0	1.000000e+0	6.225328e+0	1.606341e-1	1	1449	5.000000e-1	6.901311e-4	unnamed	MSH2
Human Phenotype	HP:0011842	Abnormality of skeletal morphology	182	1.489554e-1	1.000000e+0	1.000000e+0	6.713421e+0	1.489554e-1	1	1.489554e-1	1.000000e+0	179	1.514323e-1	1.000000e+0	1.000000e+0	6.343530e+0	1.576409e-1	1	1422	5.000000e-1	7.032349e-4	unnamed	MSH2
Human Phenotype	HP:0000924	Abnormality of the skeletal system	183	1.521487e-1	1.000000e+0	1.000000e+0	6.572520e+0	1.521487e-1	1	1.521487e-1	1.000000e+0	182	1.555123e-1	1.000000e+0	1.000000e+0	6.169973e+0	1.620753e-1	1	1462	5.000000e-1	6.839945e-4	unnamed	MSH2
Human Phenotype	HP:0002011	Abnormality of the central nervous system	184	1.748665e-1	1.000000e+0	1.000000e+0	5.718647e+0	1.748665e-1	1	1.748665e-1	1.000000e+0	184	1.821938e-1	1.000000e+0	1.000000e+0	5.226246e+0	1.913419e-1	1	1726	5.000000e-1	5.793743e-4	unnamed	MSH2
Human Phenotype	HP:0000707	Abnormality of the nervous system	185	1.846645e-1	1.000000e+0	1.000000e+0	5.415226e+0	1.846645e-1	1	1.846645e-1	1.000000e+0	185	1.902943e-1	1.000000e+0	1.000000e+0	4.991976e+0	2.003215e-1	1	1807	5.000000e-1	5.534034e-4	unnamed	MSH2
Human Phenotype	HP:0000005	Mode of inheritance	186	2.495240e-1	1.000000e+0	1.000000e+0	4.007630e+0	2.495240e-1	1	2.495240e-1	1.000000e+0	186	2.693662e-1	1.000000e+0	1.000000e+0	3.442939e+0	2.904495e-1	1	2620	5.000000e-1	3.816794e-4	unnamed	MSH2
Human Phenotype	HP:0000118	Phenotypic abnormality	187	2.682332e-1	1.000000e+0	1.000000e+0	3.728099e+0	2.682332e-1	1	2.682332e-1	1.000000e+0	187	2.856679e-1	1.000000e+0	1.000000e+0	3.229681e+0	3.096281e-1	1	2793	5.000000e-1	3.580380e-4	unnamed	MSH2
Human Phenotype	HP:0000001	All	188	2.696410e-1	1.000000e+0	1.000000e+0	3.708635e+0	2.696410e-1	1	2.696410e-1	1.000000e+0	188	2.883826e-1	1.000000e+0	1.000000e+0	3.196492e+0	3.128430e-1	1	2822	5.000000e-1	3.543586e-4	unnamed	MSH2
Disease Ontology	DOID:7398	cerebral primitive neuroectodermal tumor	1	6.982440e-5	1.560575e-1	1.560575e-1	1.432164e+4	6.982440e-5	1	6.982440e-5	1.000000e+0	1	1.108586e-4	2.477690e-1	2.477690e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	MSH2
Disease Ontology	DOID:0050465	Muir-Torre syndrome	2	1.351883e-4	3.021459e-1	1.510729e-1	7.397089e+3	1.351883e-4	1	1.351883e-4	1.000000e+0	2	2.217111e-4	4.955243e-1	2.477622e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	MSH2
Disease Ontology	DOID:4102	secondary carcinoma	2	1.351883e-4	3.021459e-1	1.510729e-1	7.397089e+3	1.351883e-4	1	1.351883e-4	1.000000e+0	2	2.217111e-4	4.955243e-1	2.477622e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	MSH2
Disease Ontology	DOID:4239	alveolar soft part sarcoma	4	2.927193e-4	6.542276e-1	1.635569e-1	3.416243e+3	2.927193e-4	1	2.927193e-4	1.000000e+0	6	5.542315e-4	1.000000e+0	2.064512e-1	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	MSH2
Disease Ontology	DOID:4791	supratentorial primitive neuroectodermal tumor	5	3.189233e-4	7.127936e-1	1.425587e-1	3.135550e+3	3.189233e-4	1	3.189233e-4	1.000000e+0	4	4.433975e-4	9.909934e-1	2.477484e-1	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	MSH2
Disease Ontology	DOID:4840	malignant sebaceous neoplasm	6	3.900090e-4	8.716701e-1	1.452784e-1	2.564043e+3	3.900090e-4	1	3.900090e-4	1.000000e+0	6	5.542315e-4	1.000000e+0	2.064512e-1	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	MSH2
Disease Ontology	DOID:1294	vulva carcinoma	7	4.709107e-4	1.000000e+0	1.503551e-1	2.123545e+3	4.709107e-4	1	4.709107e-4	1.000000e+0	4	4.433975e-4	9.909934e-1	2.477484e-1	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	MSH2
Disease Ontology	DOID:4240	malignant miscellaneous mesenchymal tumor	8	5.324450e-4	1.000000e+0	1.487518e-1	1.878128e+3	5.324450e-4	1	5.324450e-4	1.000000e+0	11	7.758812e-4	1.000000e+0	1.576450e-1	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	MSH2
Disease Ontology	DOID:1282	vulvar neoplasm	9	5.959671e-4	1.000000e+0	1.479985e-1	1.677945e+3	5.959671e-4	1	5.959671e-4	1.000000e+0	6	5.542315e-4	1.000000e+0	2.064512e-1	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	MSH2
Disease Ontology	DOID:2059	vulvar disease	10	6.663531e-4	1.000000e+0	1.489299e-1	1.500706e+3	6.663531e-4	1	6.663531e-4	1.000000e+0	10	6.650594e-4	1.000000e+0	1.486408e-1	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	MSH2
Disease Ontology	DOID:4036	Helicobacter pylori gastritis	11	6.936270e-4	1.000000e+0	1.409324e-1	1.441697e+3	6.936270e-4	1	6.936270e-4	1.000000e+0	6	5.542315e-4	1.000000e+0	2.064512e-1	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	MSH2
Disease Ontology	DOID:9297	lip disease	12	1.046509e-3	1.000000e+0	1.949123e-1	9.555582e+2	1.046509e-3	1	1.046509e-3	1.000000e+0	12	8.866967e-4	1.000000e+0	1.651473e-1	1.127562e+3	8.868688e-4	1	8	5.000000e-1	1.250000e-1	unnamed	MSH2
Disease Ontology	DOID:2433	tumor of epidermal appendage	13	1.204109e-3	1.000000e+0	2.070141e-1	8.304897e+2	1.204109e-3	1	1.204109e-3	1.000000e+0	13	9.975062e-4	1.000000e+0	1.714943e-1	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	MSH2
Disease Ontology	DOID:8711	neurofibromatosis type 1	14	2.261135e-3	1.000000e+0	3.609741e-1	4.422557e+2	2.261135e-3	1	2.261135e-3	1.000000e+0	14	1.662234e-3	1.000000e+0	2.653638e-1	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	MSH2
Disease Ontology	DOID:9098	sebaceous gland disease	15	2.678860e-3	1.000000e+0	3.991501e-1	3.732932e+2	2.678860e-3	1	2.678860e-3	1.000000e+0	17	3.101718e-3	1.000000e+0	4.077847e-1	3.221607e+2	3.104041e-3	1	28	5.000000e-1	3.571429e-2	unnamed	MSH2
Disease Ontology	DOID:8712	neurofibromatosis	16	3.113317e-3	1.000000e+0	4.348915e-1	3.212008e+2	3.113317e-3	1	3.113317e-3	1.000000e+0	15	2.326740e-3	1.000000e+0	3.466843e-1	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	MSH2
Disease Ontology	DOID:4928	intrahepatic cholangiocarcinoma	17	3.825003e-3	1.000000e+0	5.028754e-1	2.614377e+2	3.825003e-3	1	3.825003e-3	1.000000e+0	19	3.876395e-3	1.000000e+0	4.559865e-1	2.577286e+2	3.880051e-3	1	35	5.000000e-1	2.857143e-2	unnamed	MSH2
Disease Ontology	DOID:3463	breast disease	18	4.191570e-3	1.000000e+0	5.204533e-1	2.385741e+2	4.191570e-3	1	4.191570e-3	1.000000e+0	16	2.658910e-3	1.000000e+0	3.714165e-1	3.758542e+2	2.660606e-3	1	24	5.000000e-1	4.166667e-2	unnamed	MSH2
Disease Ontology	DOID:2870	endometrial adenocarcinoma	19	4.506054e-3	1.000000e+0	5.300542e-1	2.219237e+2	4.506054e-3	1	4.506054e-3	1.000000e+0	18	3.433759e-3	1.000000e+0	4.263584e-1	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	MSH2
Disease Ontology	DOID:4029	gastritis	20	5.221363e-3	1.000000e+0	5.834873e-1	1.915209e+2	5.221363e-3	1	5.221363e-3	1.000000e+0	22	7.524386e-3	1.000000e+0	7.644092e-1	1.326544e+2	7.538385e-3	1	68	5.000000e-1	1.470588e-2	unnamed	MSH2
Disease Ontology	DOID:4948	gallbladder carcinoma	21	5.973413e-3	1.000000e+0	6.357418e-1	1.674085e+2	5.973413e-3	1	5.973413e-3	1.000000e+0	20	5.424845e-3	1.000000e+0	6.062264e-1	1.840918e+2	5.432071e-3	1	49	5.000000e-1	2.040816e-2	unnamed	MSH2
Disease Ontology	DOID:2876	laryngeal squamous cell carcinoma	22	6.126726e-3	1.000000e+0	6.224197e-1	1.632193e+2	6.126726e-3	1	6.126726e-3	1.000000e+0	23	8.518131e-3	1.000000e+0	8.277401e-1	1.171494e+2	8.536112e-3	1	77	5.000000e-1	1.298701e-2	unnamed	MSH2
Disease Ontology	DOID:76	stomach disease	23	6.326538e-3	1.000000e+0	6.147745e-1	1.580643e+2	6.326538e-3	1	6.326538e-3	1.000000e+0	25	8.959636e-3	1.000000e+0	8.009915e-1	1.113642e+2	8.979547e-3	1	81	5.000000e-1	1.234568e-2	unnamed	MSH2
Disease Ontology	DOID:2600	carcinoma of larynx	24	6.580420e-3	1.000000e+0	6.128016e-1	1.519660e+2	6.580420e-3	1	6.580420e-3	1.000000e+0	24	8.738896e-3	1.000000e+0	8.138097e-1	1.141835e+2	8.757829e-3	1	79	5.000000e-1	1.265823e-2	unnamed	MSH2
Disease Ontology	DOID:2598	laryngeal neoplasm	25	6.707173e-3	1.000000e+0	5.996213e-1	1.490941e+2	6.707173e-3	1	6.707173e-3	1.000000e+0	26	9.180352e-3	1.000000e+0	7.891572e-1	1.086807e+2	9.201264e-3	1	83	5.000000e-1	1.204819e-2	unnamed	MSH2
Disease Ontology	DOID:786	laryngeal disease	26	7.022191e-3	1.000000e+0	6.036383e-1	1.424057e+2	7.022191e-3	1	7.022191e-3	1.000000e+0	27	1.028356e-2	1.000000e+0	8.512502e-1	9.699462e+1	1.030985e-2	1	93	5.000000e-1	1.075269e-2	unnamed	MSH2
Disease Ontology	DOID:0050339	commensal bacterial infectious disease	27	8.669785e-3	1.000000e+0	7.176655e-1	1.153431e+2	8.669785e-3	1	8.669785e-3	1.000000e+0	29	1.226779e-2	1.000000e+0	9.454659e-1	8.126577e+1	1.230530e-2	1	111	5.000000e-1	9.009009e-3	unnamed	MSH2
Disease Ontology	DOID:2991	stromal neoplasm	28	9.226644e-3	1.000000e+0	7.364839e-1	1.083818e+2	9.226644e-3	1	9.226644e-3	1.000000e+0	21	7.413939e-3	1.000000e+0	7.890549e-1	1.346343e+2	7.427526e-3	1	67	5.000000e-1	1.492537e-2	unnamed	MSH2
Disease Ontology	DOID:10286	prostate carcinoma	29	1.155289e-2	1.000000e+0	8.903693e-1	8.655844e+1	1.155289e-2	1	1.155289e-2	1.000000e+0	28	1.105544e-2	1.000000e+0	8.824610e-1	9.020500e+1	1.108586e-2	1	100	5.000000e-1	1.000000e-2	unnamed	MSH2
Disease Ontology	DOID:4947	cholangiocarcinoma	30	1.226587e-2	1.000000e+0	9.138073e-1	8.152704e+1	1.226587e-2	1	1.226587e-2	1.000000e+0	30	1.325916e-2	1.000000e+0	9.878074e-1	7.517083e+1	1.330303e-2	1	120	5.000000e-1	8.333333e-3	unnamed	MSH2
Disease Ontology	DOID:4897	bile duct carcinoma	31	1.342514e-2	1.000000e+0	9.679093e-1	7.448712e+1	1.342514e-2	1	1.342514e-2	1.000000e+0	31	1.458020e-2	1.000000e+0	1.000000e+0	6.833712e+1	1.463334e-2	1	132	5.000000e-1	7.575758e-3	unnamed	MSH2
Disease Ontology	DOID:4606	bile duct cancer	32	1.345417e-2	1.000000e+0	9.396897e-1	7.432642e+1	1.345417e-2	1	1.345417e-2	1.000000e+0	32	1.469025e-2	1.000000e+0	1.000000e+0	6.782331e+1	1.474419e-2	1	133	5.000000e-1	7.518797e-3	unnamed	MSH2
Disease Ontology	DOID:8778	Crohn's disease	33	1.382583e-2	1.000000e+0	9.363858e-1	7.232841e+1	1.382583e-2	1	1.382583e-2	1.000000e+0	40	1.930669e-2	1.000000e+0	1.000000e+0	5.154571e+1	1.940025e-2	1	175	5.000000e-1	5.714286e-3	unnamed	MSH2
Disease Ontology	DOID:0060031	autoimmune disease of gastrointestinal tract	34	1.484353e-2	1.000000e+0	9.757438e-1	6.736941e+1	1.484353e-2	1	1.484353e-2	1.000000e+0	44	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	MSH2
Disease Ontology	DOID:403	mouth disease	35	1.606891e-2	1.000000e+0	1.000000e+0	6.223199e+1	1.606891e-2	1	1.606891e-2	1.000000e+0	42	1.963603e-2	1.000000e+0	1.000000e+0	5.067697e+1	1.973283e-2	1	178	5.000000e-1	5.617978e-3	unnamed	MSH2
Disease Ontology	DOID:974	upper respiratory tract disease	36	1.623572e-2	1.000000e+0	1.000000e+0	6.159258e+1	1.623572e-2	1	1.623572e-2	1.000000e+0	47	2.325502e-2	1.000000e+0	1.000000e+0	4.275118e+1	2.339116e-2	1	211	5.000000e-1	4.739336e-3	unnamed	MSH2
Disease Ontology	DOID:2871	endometrial carcinoma	37	1.675841e-2	1.000000e+0	1.000000e+0	5.967153e+1	1.675841e-2	1	1.675841e-2	1.000000e+0	32	1.469025e-2	1.000000e+0	1.000000e+0	6.782331e+1	1.474419e-2	1	133	5.000000e-1	7.518797e-3	unnamed	MSH2
Disease Ontology	DOID:5520	head and neck squamous cell carcinoma	38	1.765121e-2	1.000000e+0	1.000000e+0	5.665335e+1	1.765121e-2	1	1.765121e-2	1.000000e+0	37	1.831837e-2	1.000000e+0	1.000000e+0	5.434036e+1	1.840253e-2	1	166	5.000000e-1	6.024096e-3	unnamed	MSH2
Disease Ontology	DOID:4607	biliary tract cancer	39	1.820947e-2	1.000000e+0	1.000000e+0	5.491648e+1	1.820947e-2	1	1.820947e-2	1.000000e+0	39	1.897731e-2	1.000000e+0	1.000000e+0	5.244477e+1	1.906768e-2	1	172	5.000000e-1	5.813953e-3	unnamed	MSH2
Disease Ontology	DOID:2692	muscle tissue neoplasm	40	1.849050e-2	1.000000e+0	1.000000e+0	5.408184e+1	1.849050e-2	1	1.849050e-2	1.000000e+0	38	1.886750e-2	1.000000e+0	1.000000e+0	5.275146e+1	1.895682e-2	1	171	5.000000e-1	5.847953e-3	unnamed	MSH2
Disease Ontology	DOID:4138	bile duct disease	41	1.956557e-2	1.000000e+0	1.000000e+0	5.111019e+1	1.956557e-2	1	1.956557e-2	1.000000e+0	46	2.237830e-2	1.000000e+0	1.000000e+0	4.443596e+1	2.250430e-2	1	203	5.000000e-1	4.926108e-3	unnamed	MSH2
Disease Ontology	DOID:10283	malignant neoplasm of prostate	42	1.968080e-2	1.000000e+0	1.000000e+0	5.081093e+1	1.968080e-2	1	1.968080e-2	1.000000e+0	34	1.699983e-2	1.000000e+0	1.000000e+0	5.857468e+1	1.707222e-2	1	154	5.000000e-1	6.493506e-3	unnamed	MSH2
Disease Ontology	DOID:10284	malignant neoplasm of male genital organ or tract	43	1.969552e-2	1.000000e+0	1.000000e+0	5.077298e+1	1.969552e-2	1	1.969552e-2	1.000000e+0	35	1.710974e-2	1.000000e+0	1.000000e+0	5.819677e+1	1.718308e-2	1	155	5.000000e-1	6.451613e-3	unnamed	MSH2
Disease Ontology	DOID:514	prostatic neoplasm	44	2.097895e-2	1.000000e+0	1.000000e+0	4.766682e+1	2.097895e-2	1	2.097895e-2	1.000000e+0	36	1.820853e-2	1.000000e+0	1.000000e+0	5.466970e+1	1.829167e-2	1	165	5.000000e-1	6.060606e-3	unnamed	MSH2
Disease Ontology	DOID:47	prostate disease	45	2.176279e-2	1.000000e+0	1.000000e+0	4.595000e+1	2.176279e-2	1	2.176279e-2	1.000000e+0	41	1.941648e-2	1.000000e+0	1.000000e+0	5.125284e+1	1.951111e-2	1	176	5.000000e-1	5.681818e-3	unnamed	MSH2
Disease Ontology	DOID:3856	male genital cancer	46	2.324048e-2	1.000000e+0	1.000000e+0	4.302837e+1	2.324048e-2	1	2.324048e-2	1.000000e+0	42	1.963603e-2	1.000000e+0	1.000000e+0	5.067697e+1	1.973283e-2	1	178	5.000000e-1	5.617978e-3	unnamed	MSH2
Disease Ontology	DOID:9741	biliary tract disease	47	2.393130e-2	1.000000e+0	1.000000e+0	4.178628e+1	2.393130e-2	1	2.393130e-2	1.000000e+0	50	2.642982e-2	1.000000e+0	1.000000e+0	3.758542e+1	2.660606e-2	1	240	5.000000e-1	4.166667e-3	unnamed	MSH2
Disease Ontology	DOID:3117	hepatobiliary neoplasm	48	2.482426e-2	1.000000e+0	1.000000e+0	4.028318e+1	2.482426e-2	1	2.482426e-2	1.000000e+0	49	2.424086e-2	1.000000e+0	1.000000e+0	4.100227e+1	2.438889e-2	1	220	5.000000e-1	4.545455e-3	unnamed	MSH2
Disease Ontology	DOID:3007	ductal carcinoma	49	2.482786e-2	1.000000e+0	1.000000e+0	4.027733e+1	2.482786e-2	1	2.482786e-2	1.000000e+0	45	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	MSH2
Disease Ontology	DOID:104	bacterial infectious disease	50	2.577429e-2	1.000000e+0	1.000000e+0	3.879835e+1	2.577429e-2	1	2.577429e-2	1.000000e+0	58	3.559663e-2	1.000000e+0	1.000000e+0	2.784105e+1	3.591819e-2	1	324	5.000000e-1	3.086420e-3	unnamed	MSH2
Disease Ontology	DOID:3996	cancer of urinary tract	51	2.754903e-2	1.000000e+0	1.000000e+0	3.629892e+1	2.754903e-2	1	2.754903e-2	1.000000e+0	48	2.402182e-2	1.000000e+0	1.000000e+0	4.137844e+1	2.416717e-2	1	218	5.000000e-1	4.587156e-3	unnamed	MSH2
Disease Ontology	DOID:2620	ductal, lobular, and medullary neoplasm	52	2.916543e-2	1.000000e+0	1.000000e+0	3.428716e+1	2.916543e-2	1	2.916543e-2	1.000000e+0	50	2.642982e-2	1.000000e+0	1.000000e+0	3.758542e+1	2.660606e-2	1	240	5.000000e-1	4.166667e-3	unnamed	MSH2
Disease Ontology	DOID:5428	bladder cancer	53	2.930843e-2	1.000000e+0	1.000000e+0	3.411987e+1	2.930843e-2	1	2.930843e-2	1.000000e+0	52	2.992705e-2	1.000000e+0	1.000000e+0	3.316360e+1	3.015354e-2	1	272	5.000000e-1	3.676471e-3	unnamed	MSH2
Disease Ontology	DOID:365	bladder disease	54	3.085662e-2	1.000000e+0	1.000000e+0	3.240796e+1	3.085662e-2	1	3.085662e-2	1.000000e+0	53	3.123689e-2	1.000000e+0	1.000000e+0	3.176232e+1	3.148384e-2	1	284	5.000000e-1	3.521127e-3	unnamed	MSH2
Disease Ontology	DOID:1542	neck carcinoma	55	3.222879e-2	1.000000e+0	1.000000e+0	3.102816e+1	3.222879e-2	1	3.222879e-2	1.000000e+0	56	3.287295e-2	1.000000e+0	1.000000e+0	3.016890e+1	3.314672e-2	1	299	5.000000e-1	3.344482e-3	unnamed	MSH2
Disease Ontology	DOID:4450	renal cell carcinoma	56	3.398104e-2	1.000000e+0	1.000000e+0	2.942817e+1	3.398104e-2	1	3.398104e-2	1.000000e+0	57	3.505220e-2	1.000000e+0	1.000000e+0	2.827743e+1	3.536389e-2	1	319	5.000000e-1	3.134796e-3	unnamed	MSH2
Disease Ontology	DOID:5295	intestinal disease	57	3.418180e-2	1.000000e+0	1.000000e+0	2.925534e+1	3.418180e-2	1	3.418180e-2	1.000000e+0	67	4.233480e-2	1.000000e+0	1.000000e+0	2.336917e+1	4.279142e-2	1	386	5.000000e-1	2.590674e-3	unnamed	MSH2
Disease Ontology	DOID:48	male reproductive system disease	58	3.620361e-2	1.000000e+0	1.000000e+0	2.762155e+1	3.620361e-2	1	3.620361e-2	1.000000e+0	54	3.189148e-2	1.000000e+0	1.000000e+0	3.110517e+1	3.214899e-2	1	290	5.000000e-1	3.448276e-3	unnamed	MSH2
Disease Ontology	DOID:3068	glioblastoma	59	3.687427e-2	1.000000e+0	1.000000e+0	2.711918e+1	3.687427e-2	1	3.687427e-2	1.000000e+0	55	3.265489e-2	1.000000e+0	1.000000e+0	3.037205e+1	3.292500e-2	1	297	5.000000e-1	3.367003e-3	unnamed	MSH2
Disease Ontology	DOID:731	urologic neoplasm	60	3.752395e-2	1.000000e+0	1.000000e+0	2.664965e+1	3.752395e-2	1	3.752395e-2	1.000000e+0	59	3.657622e-2	1.000000e+0	1.000000e+0	2.708859e+1	3.691591e-2	1	333	5.000000e-1	3.003003e-3	unnamed	MSH2
Disease Ontology	DOID:4451	renal carcinoma	61	3.907764e-2	1.000000e+0	1.000000e+0	2.559008e+1	3.907764e-2	1	3.907764e-2	1.000000e+0	60	3.940334e-2	1.000000e+0	1.000000e+0	2.512674e+1	3.979824e-2	1	359	5.000000e-1	2.785515e-3	unnamed	MSH2
Disease Ontology	DOID:1112	neck cancer	62	4.017075e-2	1.000000e+0	1.000000e+0	2.489373e+1	4.017075e-2	1	4.017075e-2	1.000000e+0	61	4.124960e-2	1.000000e+0	1.000000e+0	2.399069e+1	4.168283e-2	1	376	5.000000e-1	2.659574e-3	unnamed	MSH2
Disease Ontology	DOID:4725	neck neoplasm	63	4.031124e-2	1.000000e+0	1.000000e+0	2.480698e+1	4.031124e-2	1	4.031124e-2	1.000000e+0	63	4.168376e-2	1.000000e+0	1.000000e+0	2.373816e+1	4.212627e-2	1	380	5.000000e-1	2.631579e-3	unnamed	MSH2
Disease Ontology	DOID:3069	astrocytoma	64	4.313016e-2	1.000000e+0	1.000000e+0	2.318563e+1	4.313016e-2	1	4.313016e-2	1.000000e+0	62	4.157523e-2	1.000000e+0	1.000000e+0	2.380079e+1	4.201541e-2	1	379	5.000000e-1	2.638522e-3	unnamed	MSH2
Disease Ontology	DOID:2126	primary brain tumor	65	4.334785e-2	1.000000e+0	1.000000e+0	2.306920e+1	4.334785e-2	1	4.334785e-2	1.000000e+0	63	4.168376e-2	1.000000e+0	1.000000e+0	2.373816e+1	4.212627e-2	1	380	5.000000e-1	2.631579e-3	unnamed	MSH2
Disease Ontology	DOID:911	malignant neoplasm of brain	66	4.364353e-2	1.000000e+0	1.000000e+0	2.291290e+1	4.364353e-2	1	4.364353e-2	1.000000e+0	66	4.222631e-2	1.000000e+0	1.000000e+0	2.342987e+1	4.268056e-2	1	385	5.000000e-1	2.597403e-3	unnamed	MSH2
Disease Ontology	DOID:3119	gastrointestinal neoplasm	67	4.370194e-2	1.000000e+0	1.000000e+0	2.288228e+1	4.370194e-2	1	4.370194e-2	1.000000e+0	65	4.211781e-2	1.000000e+0	1.000000e+0	2.349089e+1	4.256970e-2	1	384	5.000000e-1	2.604167e-3	unnamed	MSH2
Disease Ontology	DOID:8377	digestive system cancer	68	4.455231e-2	1.000000e+0	1.000000e+0	2.244552e+1	4.455231e-2	1	4.455231e-2	1.000000e+0	68	4.255177e-2	1.000000e+0	1.000000e+0	2.324871e+1	4.301314e-2	1	388	5.000000e-1	2.577320e-3	unnamed	MSH2
Disease Ontology	DOID:3459	breast carcinoma	69	4.496474e-2	1.000000e+0	1.000000e+0	2.223965e+1	4.496474e-2	1	4.496474e-2	1.000000e+0	69	4.287718e-2	1.000000e+0	1.000000e+0	2.307033e+1	4.334571e-2	1	391	5.000000e-1	2.557545e-3	unnamed	MSH2
Disease Ontology	DOID:368	neoplasm of cerebrum	70	4.511970e-2	1.000000e+0	1.000000e+0	2.216327e+1	4.511970e-2	1	4.511970e-2	1.000000e+0	70	4.298563e-2	1.000000e+0	1.000000e+0	2.301148e+1	4.345657e-2	1	392	5.000000e-1	2.551020e-3	unnamed	MSH2
Disease Ontology	DOID:1659	supratentorial neoplasm	71	4.529725e-2	1.000000e+0	1.000000e+0	2.207640e+1	4.529725e-2	1	4.529725e-2	1.000000e+0	71	4.320252e-2	1.000000e+0	1.000000e+0	2.289467e+1	4.367829e-2	1	394	5.000000e-1	2.538071e-3	unnamed	MSH2
Disease Ontology	DOID:3908	non-small cell lung carcinoma	72	4.635042e-2	1.000000e+0	1.000000e+0	2.157478e+1	4.635042e-2	1	4.635042e-2	1.000000e+0	72	4.504512e-2	1.000000e+0	1.000000e+0	2.194769e+1	4.556288e-2	1	411	5.000000e-1	2.433090e-3	unnamed	MSH2
Disease Ontology	DOID:657	adenoma	73	4.777118e-2	1.000000e+0	1.000000e+0	2.093312e+1	4.777118e-2	1	4.777118e-2	1.000000e+0	73	4.656123e-2	1.000000e+0	1.000000e+0	2.122471e+1	4.711490e-2	1	425	5.000000e-1	2.352941e-3	unnamed	MSH2
Disease Ontology	DOID:449	head neoplasm	74	5.090150e-2	1.000000e+0	1.000000e+0	1.964579e+1	5.090150e-2	1	5.090150e-2	1.000000e+0	74	5.045424e-2	1.000000e+0	1.000000e+0	1.956725e+1	5.110581e-2	1	461	5.000000e-1	2.169197e-3	unnamed	MSH2
Disease Ontology	DOID:37	skin disease	75	5.172018e-2	1.000000e+0	1.000000e+0	1.933481e+1	5.172018e-2	1	5.172018e-2	1.000000e+0	80	6.733902e-2	1.000000e+0	1.000000e+0	1.459628e+1	6.851061e-2	1	618	5.000000e-1	1.618123e-3	unnamed	MSH2
Disease Ontology	DOID:229	female reproductive system disease	76	5.249388e-2	1.000000e+0	1.000000e+0	1.904984e+1	5.249388e-2	1	5.249388e-2	1.000000e+0	76	5.185810e-2	1.000000e+0	1.000000e+0	1.903059e+1	5.254698e-2	1	474	5.000000e-1	2.109705e-3	unnamed	MSH2
Disease Ontology	DOID:3905	lung carcinoma	77	5.322895e-2	1.000000e+0	1.000000e+0	1.878677e+1	5.322895e-2	1	5.322895e-2	1.000000e+0	75	5.142625e-2	1.000000e+0	1.000000e+0	1.919255e+1	5.210354e-2	1	470	5.000000e-1	2.127660e-3	unnamed	MSH2
Disease Ontology	DOID:16	integumentary system disease	78	5.565040e-2	1.000000e+0	1.000000e+0	1.796932e+1	5.565040e-2	1	5.565040e-2	1.000000e+0	82	6.979987e-2	1.000000e+0	1.000000e+0	1.407254e+1	7.106036e-2	1	641	5.000000e-1	1.560062e-3	unnamed	MSH2
Disease Ontology	DOID:0050177	simple genetic disease	79	5.697693e-2	1.000000e+0	1.000000e+0	1.755096e+1	5.697693e-2	1	5.697693e-2	1.000000e+0	79	6.337345e-2	1.000000e+0	1.000000e+0	1.552582e+1	6.440885e-2	1	581	5.000000e-1	1.721170e-3	unnamed	MSH2
Disease Ontology	DOID:630	genetic disease	80	6.499915e-2	1.000000e+0	1.000000e+0	1.538482e+1	6.499915e-2	1	6.499915e-2	1.000000e+0	81	6.926518e-2	1.000000e+0	1.000000e+0	1.418318e+1	7.050607e-2	1	636	5.000000e-1	1.572327e-3	unnamed	MSH2
Disease Ontology	DOID:3118	hepatobiliary disease	81	6.824507e-2	1.000000e+0	1.000000e+0	1.465307e+1	6.824507e-2	1	6.824507e-2	1.000000e+0	93	8.109914e-2	1.000000e+0	1.000000e+0	1.207564e+1	8.281137e-2	1	747	5.000000e-1	1.338688e-3	unnamed	MSH2
Disease Ontology	DOID:168	primitive neuroectodermal tumor	82	6.935969e-2	1.000000e+0	1.000000e+0	1.441760e+1	6.935969e-2	1	6.935969e-2	1.000000e+0	77	5.789360e-2	1.000000e+0	1.000000e+0	1.701981e+1	5.875506e-2	1	530	5.000000e-1	1.886792e-3	unnamed	MSH2
Disease Ontology	DOID:688	embryonal cancer	83	7.040036e-2	1.000000e+0	1.000000e+0	1.420447e+1	7.040036e-2	1	7.040036e-2	1.000000e+0	78	5.961449e-2	1.000000e+0	1.000000e+0	1.652106e+1	6.052880e-2	1	546	5.000000e-1	1.831502e-3	unnamed	MSH2
Disease Ontology	DOID:1749	squamous cell carcinoma	84	7.192071e-2	1.000000e+0	1.000000e+0	1.390420e+1	7.192071e-2	1	7.192071e-2	1.000000e+0	85	7.652380e-2	1.000000e+0	1.000000e+0	1.281321e+1	7.804445e-2	1	704	5.000000e-1	1.420455e-3	unnamed	MSH2
Disease Ontology	DOID:2428	epithelioma	85	7.206581e-2	1.000000e+0	1.000000e+0	1.387621e+1	7.206581e-2	1	7.206581e-2	1.000000e+0	86	7.673686e-2	1.000000e+0	1.000000e+0	1.277691e+1	7.826617e-2	1	706	5.000000e-1	1.416431e-3	unnamed	MSH2
Disease Ontology	DOID:353	lymphoma	86	7.370780e-2	1.000000e+0	1.000000e+0	1.356708e+1	7.370780e-2	1	7.370780e-2	1.000000e+0	87	7.694989e-2	1.000000e+0	1.000000e+0	1.274082e+1	7.848789e-2	1	708	5.000000e-1	1.412429e-3	unnamed	MSH2
Disease Ontology	DOID:2144	malignant neoplasm of ovary	87	7.395274e-2	1.000000e+0	1.000000e+0	1.352215e+1	7.395274e-2	1	7.395274e-2	1.000000e+0	88	7.737589e-2	1.000000e+0	1.000000e+0	1.266924e+1	7.893132e-2	1	712	5.000000e-1	1.404494e-3	unnamed	MSH2
Disease Ontology	DOID:417	autoimmune disease	88	7.426329e-2	1.000000e+0	1.000000e+0	1.346560e+1	7.426329e-2	1	7.426329e-2	1.000000e+0	101	8.820552e-2	1.000000e+0	1.000000e+0	1.108170e+1	9.023890e-2	1	814	5.000000e-1	1.228501e-3	unnamed	MSH2
Disease Ontology	DOID:1244	malignant neoplasm of female genital organ	89	7.450734e-2	1.000000e+0	1.000000e+0	1.342150e+1	7.450734e-2	1	7.450734e-2	1.000000e+0	89	7.812114e-2	1.000000e+0	1.000000e+0	1.254590e+1	7.970733e-2	1	719	5.000000e-1	1.390821e-3	unnamed	MSH2
Disease Ontology	DOID:1281	female reproductive cancer	90	7.531950e-2	1.000000e+0	1.000000e+0	1.327677e+1	7.531950e-2	1	7.531950e-2	1.000000e+0	92	7.886609e-2	1.000000e+0	1.000000e+0	1.242493e+1	8.048334e-2	1	726	5.000000e-1	1.377410e-3	unnamed	MSH2
Disease Ontology	DOID:2394	ovarian neoplasm	91	7.564403e-2	1.000000e+0	1.000000e+0	1.321981e+1	7.564403e-2	1	7.564403e-2	1.000000e+0	91	7.875969e-2	1.000000e+0	1.000000e+0	1.244207e+1	8.037248e-2	1	725	5.000000e-1	1.379310e-3	unnamed	MSH2
Disease Ontology	DOID:1909	melanoma	92	8.029886e-2	1.000000e+0	1.000000e+0	1.245348e+1	8.029886e-2	1	8.029886e-2	1.000000e+0	83	7.599104e-2	1.000000e+0	1.000000e+0	1.290486e+1	7.749016e-2	1	699	5.000000e-1	1.430615e-3	unnamed	MSH2
Disease Ontology	DOID:191	melanocytic neoplasm	93	8.062511e-2	1.000000e+0	1.000000e+0	1.240308e+1	8.062511e-2	1	8.062511e-2	1.000000e+0	84	7.631072e-2	1.000000e+0	1.000000e+0	1.284972e+1	7.782274e-2	1	702	5.000000e-1	1.424501e-3	unnamed	MSH2
Disease Ontology	DOID:9256	colorectal cancer	94	8.071500e-2	1.000000e+0	1.000000e+0	1.238927e+1	8.071500e-2	1	8.071500e-2	1.000000e+0	90	7.833401e-2	1.000000e+0	1.000000e+0	1.251110e+1	7.992905e-2	1	721	5.000000e-1	1.386963e-3	unnamed	MSH2
Disease Ontology	DOID:3168	squamous cell neoplasm	95	8.073938e-2	1.000000e+0	1.000000e+0	1.238553e+1	8.073938e-2	1	8.073938e-2	1.000000e+0	97	8.492093e-2	1.000000e+0	1.000000e+0	1.152043e+1	8.680228e-2	1	783	5.000000e-1	1.277139e-3	unnamed	MSH2
Disease Ontology	DOID:120	female genital cancer	96	8.268050e-2	1.000000e+0	1.000000e+0	1.209475e+1	8.268050e-2	1	8.268050e-2	1.000000e+0	98	8.545110e-2	1.000000e+0	1.000000e+0	1.144734e+1	8.735658e-2	1	788	5.000000e-1	1.269036e-3	unnamed	MSH2
Disease Ontology	DOID:1579	respiratory system disease	97	8.437815e-2	1.000000e+0	1.000000e+0	1.185141e+1	8.437815e-2	1	8.437815e-2	1.000000e+0	107	9.707604e-2	1.000000e+0	1.000000e+0	1.004510e+1	9.955102e-2	1	898	5.000000e-1	1.113586e-3	unnamed	MSH2
Disease Ontology	DOID:1994	large Intestine carcinoma	98	8.851868e-2	1.000000e+0	1.000000e+0	1.129705e+1	8.851868e-2	1	8.851868e-2	1.000000e+0	99	8.587513e-2	1.000000e+0	1.000000e+0	1.138952e+1	8.780001e-2	1	792	5.000000e-1	1.262626e-3	unnamed	MSH2
Disease Ontology	DOID:15	reproductive system disease	99	8.872162e-2	1.000000e+0	1.000000e+0	1.127121e+1	8.872162e-2	1	8.872162e-2	1.000000e+0	94	8.290487e-2	1.000000e+0	1.000000e+0	1.180694e+1	8.469597e-2	1	764	5.000000e-1	1.308901e-3	unnamed	MSH2
Disease Ontology	DOID:684	hepatocellular carcinoma	100	9.124792e-2	1.000000e+0	1.000000e+0	1.095915e+1	9.124792e-2	1	9.124792e-2	1.000000e+0	104	9.211812e-2	1.000000e+0	1.000000e+0	1.059988e+1	9.434067e-2	1	851	5.000000e-1	1.175088e-3	unnamed	MSH2
Disease Ontology	DOID:284	malignant neoplasm of abdomen	101	9.133327e-2	1.000000e+0	1.000000e+0	1.094891e+1	9.133327e-2	1	9.133327e-2	1.000000e+0	103	9.063867e-2	1.000000e+0	1.000000e+0	1.077718e+1	9.278865e-2	1	837	5.000000e-1	1.194743e-3	unnamed	MSH2
Disease Ontology	DOID:686	liver and intrahepatic biliary tract carcinoma	102	9.251093e-2	1.000000e+0	1.000000e+0	1.080953e+1	9.251093e-2	1	9.251093e-2	1.000000e+0	105	9.338526e-2	1.000000e+0	1.000000e+0	1.045249e+1	9.567097e-2	1	863	5.000000e-1	1.158749e-3	unnamed	MSH2
Disease Ontology	DOID:1318	malignant neoplasm of central nervous system	103	9.457325e-2	1.000000e+0	1.000000e+0	1.057381e+1	9.457325e-2	1	9.457325e-2	1.000000e+0	95	8.396623e-2	1.000000e+0	1.000000e+0	1.165439e+1	8.580456e-2	1	774	5.000000e-1	1.291990e-3	unnamed	MSH2
Disease Ontology	DOID:4695	malignant neoplasm of nervous system	104	9.564362e-2	1.000000e+0	1.000000e+0	1.045548e+1	9.564362e-2	1	9.564362e-2	1.000000e+0	96	8.439060e-2	1.000000e+0	1.000000e+0	1.159447e+1	8.624799e-2	1	778	5.000000e-1	1.285347e-3	unnamed	MSH2
Disease Ontology	DOID:1033	lymphoid cancer	105	9.576498e-2	1.000000e+0	1.000000e+0	1.044223e+1	9.576498e-2	1	9.576498e-2	1.000000e+0	106	9.602230e-2	1.000000e+0	1.000000e+0	1.015822e+1	9.844244e-2	1	888	5.000000e-1	1.126126e-3	unnamed	MSH2
Disease Ontology	DOID:169	neuroendocrine tumor	106	9.840882e-2	1.000000e+0	1.000000e+0	1.016169e+1	9.840882e-2	1	9.840882e-2	1.000000e+0	102	8.926381e-2	1.000000e+0	1.000000e+0	1.094721e+1	9.134749e-2	1	824	5.000000e-1	1.213592e-3	unnamed	MSH2
Disease Ontology	DOID:3070	malignant glioma	107	9.870456e-2	1.000000e+0	1.000000e+0	1.013124e+1	9.870456e-2	1	9.870456e-2	1.000000e+0	100	8.714662e-2	1.000000e+0	1.000000e+0	1.121953e+1	8.913031e-2	1	804	5.000000e-1	1.243781e-3	unnamed	MSH2
Disease Ontology	DOID:619	lymphoproliferative disease	108	9.974272e-2	1.000000e+0	1.000000e+0	1.002579e+1	9.974272e-2	1	9.974272e-2	1.000000e+0	108	1.010747e-1	1.000000e+0	1.000000e+0	9.637286e+0	1.037636e-1	1	936	5.000000e-1	1.068376e-3	unnamed	MSH2
Disease Ontology	DOID:2916	immunoproliferative disease	109	9.975771e-2	1.000000e+0	1.000000e+0	1.002429e+1	9.975771e-2	1	9.975771e-2	1.000000e+0	109	1.011798e-1	1.000000e+0	1.000000e+0	9.627001e+0	1.038745e-1	1	937	5.000000e-1	1.067236e-3	unnamed	MSH2
Disease Ontology	DOID:75	lymphatic system disease	110	1.035697e-1	1.000000e+0	1.000000e+0	9.655335e+0	1.035697e-1	1	1.035697e-1	1.000000e+0	110	1.052741e-1	1.000000e+0	1.000000e+0	9.242316e+0	1.081980e-1	1	976	5.000000e-1	1.024590e-3	unnamed	MSH2
Disease Ontology	DOID:1265	genitourinary cancer	111	1.098597e-1	1.000000e+0	1.000000e+0	9.102521e+0	1.098597e-1	1	1.098597e-1	1.000000e+0	115	1.099868e-1	1.000000e+0	1.000000e+0	8.834966e+0	1.131866e-1	1	1021	5.000000e-1	9.794319e-4	unnamed	MSH2
Disease Ontology	DOID:1240	leukemia	112	1.114394e-1	1.000000e+0	1.000000e+0	8.973483e+0	1.114394e-1	1	1.114394e-1	1.000000e+0	117	1.125996e-1	1.000000e+0	1.000000e+0	8.623805e+0	1.159581e-1	1	1046	5.000000e-1	9.560229e-4	unnamed	MSH2
Disease Ontology	DOID:122	abdominal cancer	113	1.132547e-1	1.000000e+0	1.000000e+0	8.829653e+0	1.132547e-1	1	1.132547e-1	1.000000e+0	118	1.128084e-1	1.000000e+0	1.000000e+0	8.607347e+0	1.161798e-1	1	1048	5.000000e-1	9.541985e-4	unnamed	MSH2
Disease Ontology	DOID:170	endocrine gland cancer	114	1.163017e-1	1.000000e+0	1.000000e+0	8.598327e+0	1.163017e-1	1	1.163017e-1	1.000000e+0	111	1.061128e-1	1.000000e+0	1.000000e+0	9.167175e+0	1.090849e-1	1	984	5.000000e-1	1.016260e-3	unnamed	MSH2
Disease Ontology	DOID:3165	skin neoplasm	115	1.200813e-1	1.000000e+0	1.000000e+0	8.327690e+0	1.200813e-1	1	1.200813e-1	1.000000e+0	113	1.090453e-1	1.000000e+0	1.000000e+0	8.913538e+0	1.121889e-1	1	1012	5.000000e-1	9.881423e-4	unnamed	MSH2
Disease Ontology	DOID:0050117	disease by infectious agent	116	1.209421e-1	1.000000e+0	1.000000e+0	8.268418e+0	1.209421e-1	1	1.209421e-1	1.000000e+0	126	1.508194e-1	1.000000e+0	1.000000e+0	6.370410e+0	1.569758e-1	1	1416	5.000000e-1	7.062147e-4	unnamed	MSH2
Disease Ontology	DOID:2627	glioma	117	1.253026e-1	1.000000e+0	1.000000e+0	7.980682e+0	1.253026e-1	1	1.253026e-1	1.000000e+0	112	1.084173e-1	1.000000e+0	1.000000e+0	8.966700e+0	1.115238e-1	1	1006	5.000000e-1	9.940358e-4	unnamed	MSH2
Disease Ontology	DOID:1319	brain neoplasm	118	1.265868e-1	1.000000e+0	1.000000e+0	7.899721e+0	1.265868e-1	1	1.265868e-1	1.000000e+0	114	1.094638e-1	1.000000e+0	1.000000e+0	8.878445e+0	1.126323e-1	1	1016	5.000000e-1	9.842520e-4	unnamed	MSH2
Disease Ontology	DOID:3620	central nervous system neoplasm	119	1.271973e-1	1.000000e+0	1.000000e+0	7.861801e+0	1.271973e-1	1	1.271973e-1	1.000000e+0	116	1.101959e-1	1.000000e+0	1.000000e+0	8.817693e+0	1.134083e-1	1	1023	5.000000e-1	9.775171e-4	unnamed	MSH2
Disease Ontology	DOID:2227	malignant neoplasm of lymphatic and hemopoietic tissue	120	1.308045e-1	1.000000e+0	1.000000e+0	7.644994e+0	1.308045e-1	1	1.308045e-1	1.000000e+0	122	1.334666e-1	1.000000e+0	1.000000e+0	7.233761e+0	1.382407e-1	1	1247	5.000000e-1	8.019246e-4	unnamed	MSH2
Disease Ontology	DOID:171	neuroectodermal tumor	121	1.311969e-1	1.000000e+0	1.000000e+0	7.622132e+0	1.311969e-1	1	1.311969e-1	1.000000e+0	119	1.187505e-1	1.000000e+0	1.000000e+0	8.163348e+0	1.224988e-1	1	1105	5.000000e-1	9.049774e-4	unnamed	MSH2
Disease Ontology	DOID:3095	germ cell and embryonal cancer	122	1.321992e-1	1.000000e+0	1.000000e+0	7.564342e+0	1.321992e-1	1	1.321992e-1	1.000000e+0	120	1.204148e-1	1.000000e+0	1.000000e+0	8.046833e+0	1.242725e-1	1	1121	5.000000e-1	8.920607e-4	unnamed	MSH2
Disease Ontology	DOID:2994	germ cell cancer	123	1.346344e-1	1.000000e+0	1.000000e+0	7.427520e+0	1.346344e-1	1	1.346344e-1	1.000000e+0	121	1.229084e-1	1.000000e+0	1.000000e+0	7.878166e+0	1.269331e-1	1	1145	5.000000e-1	8.733624e-4	unnamed	MSH2
Disease Ontology	DOID:177	soft tissue neoplasm	124	1.450676e-1	1.000000e+0	1.000000e+0	6.893336e+0	1.450676e-1	1	1.450676e-1	1.000000e+0	123	1.364568e-1	1.000000e+0	1.000000e+0	7.069357e+0	1.414556e-1	1	1276	5.000000e-1	7.836991e-4	unnamed	MSH2
Disease Ontology	DOID:3350	mesenchymal cell neoplasm	125	1.453323e-1	1.000000e+0	1.000000e+0	6.880783e+0	1.453323e-1	1	1.453323e-1	1.000000e+0	124	1.369718e-1	1.000000e+0	1.000000e+0	7.041764e+0	1.420099e-1	1	1281	5.000000e-1	7.806401e-4	unnamed	MSH2
Disease Ontology	DOID:2531	hematologic cancer	126	1.484252e-1	1.000000e+0	1.000000e+0	6.737401e+0	1.484252e-1	1	1.484252e-1	1.000000e+0	127	1.514323e-1	1.000000e+0	1.000000e+0	6.343530e+0	1.576409e-1	1	1422	5.000000e-1	7.032349e-4	unnamed	MSH2
Disease Ontology	DOID:1115	sarcoma	127	1.495909e-1	1.000000e+0	1.000000e+0	6.684897e+0	1.495909e-1	1	1.495909e-1	1.000000e+0	125	1.416001e-1	1.000000e+0	1.000000e+0	6.802790e+0	1.469985e-1	1	1326	5.000000e-1	7.541478e-4	unnamed	MSH2
Disease Ontology	DOID:77	gastrointestinal system disease	128	1.566959e-1	1.000000e+0	1.000000e+0	6.381787e+0	1.566959e-1	1	1.566959e-1	1.000000e+0	138	1.749595e-1	1.000000e+0	1.000000e+0	5.453748e+0	1.833601e-1	1	1654	5.000000e-1	6.045949e-4	unnamed	MSH2
Disease Ontology	DOID:74	hematopoietic system disease	129	1.634383e-1	1.000000e+0	1.000000e+0	6.118517e+0	1.634383e-1	1	1.634383e-1	1.000000e+0	136	1.726418e-1	1.000000e+0	1.000000e+0	5.530656e+0	1.808104e-1	1	1631	5.000000e-1	6.131208e-4	unnamed	MSH2
Disease Ontology	DOID:3094	neuroepithelial neoplasm	130	1.687017e-1	1.000000e+0	1.000000e+0	5.927623e+0	1.687017e-1	1	1.687017e-1	1.000000e+0	128	1.534735e-1	1.000000e+0	1.000000e+0	6.255548e+0	1.598581e-1	1	1442	5.000000e-1	6.934813e-4	unnamed	MSH2
Disease Ontology	DOID:4241	malignant neoplasm of breast	131	1.689834e-1	1.000000e+0	1.000000e+0	5.917740e+0	1.689834e-1	1	1.689834e-1	1.000000e+0	131	1.624258e-1	1.000000e+0	1.000000e+0	5.895752e+0	1.696137e-1	1	1530	5.000000e-1	6.535948e-4	unnamed	MSH2
Disease Ontology	DOID:3937	malignant neoplasm of thorax	132	1.691008e-1	1.000000e+0	1.000000e+0	5.913634e+0	1.691008e-1	1	1.691008e-1	1.000000e+0	132	1.626287e-1	1.000000e+0	1.000000e+0	5.888055e+0	1.698354e-1	1	1532	5.000000e-1	6.527415e-4	unnamed	MSH2
Disease Ontology	DOID:3195	neural neoplasm	133	1.692055e-1	1.000000e+0	1.000000e+0	5.909975e+0	1.692055e-1	1	1.692055e-1	1.000000e+0	129	1.541874e-1	1.000000e+0	1.000000e+0	6.225328e+0	1.606341e-1	1	1449	5.000000e-1	6.901311e-4	unnamed	MSH2
Disease Ontology	DOID:5093	thoracic cancer	134	1.702657e-1	1.000000e+0	1.000000e+0	5.873173e+0	1.702657e-1	1	1.702657e-1	1.000000e+0	133	1.639470e-1	1.000000e+0	1.000000e+0	5.838511e+0	1.712765e-1	1	1545	5.000000e-1	6.472492e-4	unnamed	MSH2
Disease Ontology	DOID:299	adenocarcinoma	135	1.706462e-1	1.000000e+0	1.000000e+0	5.860077e+0	1.706462e-1	1	1.706462e-1	1.000000e+0	135	1.699169e-1	1.000000e+0	1.000000e+0	5.623753e+0	1.778172e-1	1	1604	5.000000e-1	6.234414e-4	unnamed	MSH2
Disease Ontology	DOID:3093	nervous system cancer	136	1.722624e-1	1.000000e+0	1.000000e+0	5.805099e+0	1.722624e-1	1	1.722624e-1	1.000000e+0	130	1.573451e-1	1.000000e+0	1.000000e+0	6.094932e+0	1.640707e-1	1	1480	5.000000e-1	6.756757e-4	unnamed	MSH2
Disease Ontology	DOID:1612	mammary cancer	137	1.772500e-1	1.000000e+0	1.000000e+0	5.641748e+0	1.772500e-1	1	1.772500e-1	1.000000e+0	134	1.677945e-1	1.000000e+0	1.000000e+0	5.698358e+0	1.754892e-1	1	1583	5.000000e-1	6.317119e-4	unnamed	MSH2
Disease Ontology	DOID:197	glandular cell epithelial neoplasm	138	1.860840e-1	1.000000e+0	1.000000e+0	5.373918e+0	1.860840e-1	1	1.860840e-1	1.000000e+0	139	1.850986e-1	1.000000e+0	1.000000e+0	5.139886e+0	1.945568e-1	1	1755	5.000000e-1	5.698006e-4	unnamed	MSH2
Disease Ontology	DOID:936	brain disease	139	1.872681e-1	1.000000e+0	1.000000e+0	5.339937e+0	1.872681e-1	1	1.872681e-1	1.000000e+0	137	1.748588e-1	1.000000e+0	1.000000e+0	5.457048e+0	1.832493e-1	1	1653	5.000000e-1	6.049607e-4	unnamed	MSH2
Disease Ontology	DOID:225	syndrome	140	2.011593e-1	1.000000e+0	1.000000e+0	4.971185e+0	2.011593e-1	1	2.011593e-1	1.000000e+0	140	1.993468e-1	1.000000e+0	1.000000e+0	4.752634e+0	2.104096e-1	1	1898	5.000000e-1	5.268704e-4	unnamed	MSH2
Disease Ontology	DOID:193	reproductive system cancer	141	2.095200e-1	1.000000e+0	1.000000e+0	4.772814e+0	2.095200e-1	1	2.095200e-1	1.000000e+0	141	2.033098e-1	1.000000e+0	1.000000e+0	4.654541e+0	2.148440e-1	1	1938	5.000000e-1	5.159959e-4	unnamed	MSH2
Disease Ontology	DOID:157	epithelial carcinoma	142	2.158701e-1	1.000000e+0	1.000000e+0	4.632416e+0	2.158701e-1	1	2.158701e-1	1.000000e+0	143	2.169067e-1	1.000000e+0	1.000000e+0	4.345135e+0	2.301425e-1	1	2076	5.000000e-1	4.816956e-4	unnamed	MSH2
Disease Ontology	DOID:155	glandular and epithelial neoplasm	143	2.196335e-1	1.000000e+0	1.000000e+0	4.553039e+0	2.196335e-1	1	2.196335e-1	1.000000e+0	142	2.107139e-1	1.000000e+0	1.000000e+0	4.481123e+0	2.231584e-1	1	2013	5.000000e-1	4.967710e-4	unnamed	MSH2
Disease Ontology	DOID:331	central nervous system disease	144	2.247960e-1	1.000000e+0	1.000000e+0	4.448477e+0	2.247960e-1	1	2.247960e-1	1.000000e+0	144	2.201408e-1	1.000000e+0	1.000000e+0	4.277146e+0	2.338008e-1	1	2109	5.000000e-1	4.741584e-4	unnamed	MSH2
Disease Ontology	DOID:1287	cardiovascular system disease	145	2.464292e-1	1.000000e+0	1.000000e+0	4.057961e+0	2.464292e-1	1	2.464292e-1	1.000000e+0	145	2.586189e-1	1.000000e+0	1.000000e+0	3.598125e+0	2.779225e-1	1	2507	5.000000e-1	3.988831e-4	unnamed	MSH2
Disease Ontology	DOID:863	nervous system disease	146	2.662634e-1	1.000000e+0	1.000000e+0	3.755680e+0	2.662634e-1	1	2.662634e-1	1.000000e+0	146	2.652858e-1	1.000000e+0	1.000000e+0	3.500388e+0	2.856826e-1	1	2577	5.000000e-1	3.880481e-4	unnamed	MSH2
Disease Ontology	DOID:2985	chronic rejection of renal transplant	147	2.674662e-1	1.000000e+0	1.000000e+0	3.738791e+0	2.674662e-1	1	2.674662e-1	1.000000e+0	147	2.866046e-1	1.000000e+0	1.000000e+0	3.218159e+0	3.107367e-1	1	2803	5.000000e-1	3.567606e-4	unnamed	MSH2
Disease Ontology	DOID:2108	transplant-related disease	148	2.674780e-1	1.000000e+0	1.000000e+0	3.738626e+0	2.674780e-1	1	2.674780e-1	1.000000e+0	148	2.866982e-1	1.000000e+0	1.000000e+0	3.217011e+0	3.108475e-1	1	2804	5.000000e-1	3.566334e-4	unnamed	MSH2
Disease Ontology	DOID:557	kidney disease	149	2.854845e-1	1.000000e+0	1.000000e+0	3.502817e+0	2.854845e-1	1	2.854845e-1	1.000000e+0	149	3.062252e-1	1.000000e+0	1.000000e+0	2.992867e+0	3.341278e-1	1	3014	5.000000e-1	3.317850e-4	unnamed	MSH2
Disease Ontology	DOID:18	urinary system disease	150	2.923209e-1	1.000000e+0	1.000000e+0	3.420898e+0	2.923209e-1	1	2.923209e-1	1.000000e+0	150	3.122143e-1	1.000000e+0	1.000000e+0	2.929685e+0	3.413336e-1	1	3079	5.000000e-1	3.247808e-4	unnamed	MSH2
Disease Ontology	DOID:2914	immune system disease	151	3.205063e-1	1.000000e+0	1.000000e+0	3.120063e+0	3.205063e-1	1	3.205063e-1	1.000000e+0	152	3.434783e-1	1.000000e+0	1.000000e+0	2.635261e+0	3.794690e-1	1	3423	5.000000e-1	2.921414e-4	unnamed	MSH2
Disease Ontology	DOID:305	carcinoma	152	3.218892e-1	1.000000e+0	1.000000e+0	3.106659e+0	3.218892e-1	1	3.218892e-1	1.000000e+0	151	3.253901e-1	1.000000e+0	1.000000e+0	2.798790e+0	3.572973e-1	1	3223	5.000000e-1	3.102699e-4	unnamed	MSH2
Disease Ontology	DOID:462	cancer by anatomical entity	153	3.485076e-1	1.000000e+0	1.000000e+0	2.869378e+0	3.485076e-1	1	3.485076e-1	1.000000e+0	153	3.467081e-1	1.000000e+0	1.000000e+0	2.607835e+0	3.834599e-1	1	3459	5.000000e-1	2.891009e-4	unnamed	MSH2
Disease Ontology	DOID:162	cancer	154	4.681931e-1	1.000000e+0	1.000000e+0	2.135871e+0	4.681931e-1	1	4.681931e-1	1.000000e+0	154	4.854768e-1	1.000000e+0	1.000000e+0	1.768725e+0	5.653789e-1	1	5100	5.000000e-1	1.960784e-4	unnamed	MSH2
Disease Ontology	DOID:7	disease of anatomical entity	155	5.144599e-1	1.000000e+0	1.000000e+0	1.943786e+0	5.144599e-1	1	5.144599e-1	1.000000e+0	155	5.469036e-1	1.000000e+0	1.000000e+0	1.529676e+0	6.537332e-1	1	5897	5.000000e-1	1.695778e-4	unnamed	MSH2
Disease Ontology	DOID:4	disease	156	6.581397e-1	1.000000e+0	1.000000e+0	1.519434e+0	6.581397e-1	1	6.581397e-1	1.000000e+0	156	6.831746e-1	1.000000e+0	1.000000e+0	1.143863e+0	8.742309e-1	1	7886	5.000000e-1	1.268070e-4	unnamed	MSH2
MSigDB Cancer Neighborhood	GNF2_MSH2	Neighborhood of MSH2	1	1.492318e-3	6.372198e-1	6.372198e-1	6.700983e+2	1.492318e-3	1	1.492318e-3	1.000000e+0	1	3.101718e-3	1.000000e+0	1.000000e+0	3.221607e+2	3.104041e-3	1	28	5.000000e-1	3.571429e-2	unnamed	MSH2
MSigDB Cancer Neighborhood	GNF2_MLH1	Neighborhood of MLH1	2	2.398387e-3	1.000000e+0	5.120556e-1	4.169469e+2	2.398387e-3	1	2.398387e-3	1.000000e+0	3	4.650770e-3	1.000000e+0	6.619596e-1	2.147738e+2	4.656061e-3	1	42	5.000000e-1	2.380952e-2	unnamed	MSH2
MSigDB Cancer Neighborhood	GNF2_MSH6	Neighborhood of MSH6	3	2.513529e-3	1.000000e+0	3.577590e-1	3.978471e+2	2.513529e-3	1	2.513529e-3	1.000000e+0	2	3.433759e-3	1.000000e+0	7.331075e-1	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	MSH2
MSigDB Cancer Neighborhood	MORF_MSH2	Neighborhood of MSH2	4	3.253665e-3	1.000000e+0	3.473287e-1	3.073457e+2	3.253665e-3	1	3.253665e-3	1.000000e+0	5	6.640639e-3	1.000000e+0	5.671106e-1	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	MSH2
MSigDB Cancer Neighborhood	MORF_RPA1	Neighborhood of RPA1	5	3.824413e-3	1.000000e+0	3.266049e-1	2.614781e+2	3.824413e-3	1	3.824413e-3	1.000000e+0	5	6.640639e-3	1.000000e+0	5.671106e-1	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	MSH2
MSigDB Cancer Neighborhood	MORF_SMC1L1	Neighborhood of SMC1L1	6	3.973058e-3	1.000000e+0	2.827493e-1	2.516953e+2	3.973058e-3	1	3.973058e-3	1.000000e+0	7	6.751129e-3	1.000000e+0	4.118189e-1	1.478770e+2	6.762375e-3	1	61	5.000000e-1	1.639344e-2	unnamed	MSH2
MSigDB Cancer Neighborhood	GNF2_FEN1	Neighborhood of FEN1	7	4.065299e-3	1.000000e+0	2.479832e-1	2.459844e+2	4.065299e-3	1	4.065299e-3	1.000000e+0	4	6.198618e-3	1.000000e+0	6.617025e-1	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	MSH2
MSigDB Cancer Neighborhood	MORF_PCNA	Neighborhood of PCNA	8	4.142711e-3	1.000000e+0	2.211172e-1	2.413878e+2	4.142711e-3	1	4.142711e-3	1.000000e+0	11	9.180352e-3	1.000000e+0	3.563646e-1	1.086807e+2	9.201264e-3	1	83	5.000000e-1	1.204819e-2	unnamed	MSH2
MSigDB Cancer Neighborhood	GNF2_RFC4	Neighborhood of RFC4	9	4.321763e-3	1.000000e+0	2.050436e-1	2.313871e+2	4.321763e-3	1	4.321763e-3	1.000000e+0	7	6.751129e-3	1.000000e+0	4.118189e-1	1.478770e+2	6.762375e-3	1	61	5.000000e-1	1.639344e-2	unnamed	MSH2
MSigDB Cancer Neighborhood	MORF_UNG	Neighborhood of UNG	10	5.151025e-3	1.000000e+0	2.199488e-1	1.941361e+2	5.151025e-3	1	5.151025e-3	1.000000e+0	10	8.297342e-3	1.000000e+0	3.542965e-1	1.202733e+2	8.314395e-3	1	75	5.000000e-1	1.333333e-2	unnamed	MSH2
MSigDB Cancer Neighborhood	GNF2_PCNA	Neighborhood of PCNA	11	5.712645e-3	1.000000e+0	2.217545e-1	1.750503e+2	5.712645e-3	1	5.712645e-3	1.000000e+0	9	7.413939e-3	1.000000e+0	3.517502e-1	1.346343e+2	7.427526e-3	1	67	5.000000e-1	1.492537e-2	unnamed	MSH2
MSigDB Cancer Neighborhood	GNF2_SMC4L1	Neighborhood of SMC4L1	12	6.877679e-3	1.000000e+0	2.447307e-1	1.453979e+2	6.877679e-3	1	6.877679e-3	1.000000e+0	12	9.290700e-3	1.000000e+0	3.305941e-1	1.073869e+2	9.312122e-3	1	84	5.000000e-1	1.190476e-2	unnamed	MSH2
MSigDB Cancer Neighborhood	GNF2_RRM1	Neighborhood of RRM1	13	7.344077e-3	1.000000e+0	2.412247e-1	1.361641e+2	7.344077e-3	1	7.344077e-3	1.000000e+0	13	9.621709e-3	1.000000e+0	3.160361e-1	1.036839e+2	9.644698e-3	1	87	5.000000e-1	1.149425e-2	unnamed	MSH2
MSigDB Cancer Neighborhood	MORF_RRM1	Neighborhood of RRM1	14	8.080274e-3	1.000000e+0	2.464484e-1	1.237582e+2	8.080274e-3	1	8.080274e-3	1.000000e+0	14	1.127592e-2	1.000000e+0	3.439156e-1	8.843627e+1	1.130758e-2	1	102	5.000000e-1	9.803922e-3	unnamed	MSH2
MSigDB Cancer Neighborhood	MORF_RFC4	Neighborhood of RFC4	15	1.096595e-2	1.000000e+0	3.121640e-1	9.119140e+1	1.096595e-2	1	1.096595e-2	1.000000e+0	15	1.645017e-2	1.000000e+0	4.682815e-1	6.054027e+1	1.651793e-2	1	149	5.000000e-1	6.711409e-3	unnamed	MSH2
MSigDB Cancer Neighborhood	MORF_HAT1	Neighborhood of HAT1	16	1.209821e-2	1.000000e+0	3.228710e-1	8.265689e+1	1.209821e-2	1	1.209821e-2	1.000000e+0	16	1.930669e-2	1.000000e+0	5.152473e-1	5.154571e+1	1.940025e-2	1	175	5.000000e-1	5.714286e-3	unnamed	MSH2
MSigDB Cancer Neighborhood	MORF_RAD21	Neighborhood of RAD21	17	1.228195e-2	1.000000e+0	3.084937e-1	8.142029e+1	1.228195e-2	1	1.228195e-2	1.000000e+0	17	1.996530e-2	1.000000e+0	5.014814e-1	4.983702e+1	2.006541e-2	1	181	5.000000e-1	5.524862e-3	unnamed	MSH2
MSigDB Cancer Neighborhood	MORF_BUB3	Neighborhood of BUB3	18	1.577193e-2	1.000000e+0	3.741452e-1	6.340380e+1	1.577193e-2	1	1.577193e-2	1.000000e+0	19	3.058208e-2	1.000000e+0	6.872920e-1	3.244784e+1	3.081869e-2	1	278	5.000000e-1	3.597122e-3	unnamed	MSH2
MSigDB Cancer Neighborhood	MORF_SOD1	Neighborhood of SOD1	19	1.778344e-2	1.000000e+0	3.996594e-1	5.623208e+1	1.778344e-2	1	1.778344e-2	1.000000e+0	21	3.080038e-2	1.000000e+0	6.262744e-1	3.221607e+1	3.104041e-2	1	280	5.000000e-1	3.571429e-3	unnamed	MSH2
MSigDB Cancer Neighborhood	MORF_DEK	Neighborhood of DEK	20	1.800421e-2	1.000000e+0	3.843899e-1	5.554256e+1	1.800421e-2	1	1.800421e-2	1.000000e+0	18	2.883484e-2	1.000000e+0	6.840265e-1	3.442939e+1	2.904495e-2	1	262	5.000000e-1	3.816794e-3	unnamed	MSH2
MSigDB Cancer Neighborhood	MORF_HDAC2	Neighborhood of HDAC2	21	2.010072e-2	1.000000e+0	4.087146e-1	4.974947e+1	2.010072e-2	1	2.010072e-2	1.000000e+0	19	3.058208e-2	1.000000e+0	6.872920e-1	3.244784e+1	3.081869e-2	1	278	5.000000e-1	3.597122e-3	unnamed	MSH2
MSigDB Pathway	KEGG_MISMATCH_REPAIR	Mismatch repair	1	1.939902e-3	1.000000e+0	1.000000e+0	5.154900e+2	1.939902e-3	1	1.939902e-3	1.000000e+0	1	2.548193e-3	1.000000e+0	1.000000e+0	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	MSH2
MSigDB Pathway	KEGG_COLORECTAL_CANCER	Colorectal cancer	2	8.576116e-3	1.000000e+0	1.000000e+0	1.166029e+2	8.576116e-3	1	8.576116e-3	1.000000e+0	2	6.972090e-3	1.000000e+0	1.000000e+0	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	MSH2
MSigDB Pathway	PID_P53DOWNSTREAMPATHWAY	Direct p53 effectors	3	1.324006e-2	1.000000e+0	1.000000e+0	7.552838e+1	1.324006e-2	1	1.324006e-2	1.000000e+0	3	1.513038e-2	1.000000e+0	1.000000e+0	6.584307e+1	1.518763e-2	1	137	5.000000e-1	7.299270e-3	unnamed	MSH2
MSigDB Pathway	KEGG_PATHWAYS_IN_CANCER	Pathways in cancer	4	4.235254e-2	1.000000e+0	1.000000e+0	2.361133e+1	4.235254e-2	1	4.235254e-2	1.000000e+0	4	3.592322e-2	1.000000e+0	1.000000e+0	2.758563e+1	3.625076e-2	1	327	5.000000e-1	3.058104e-3	unnamed	MSH2
MGI Expression: Detected	9412	TS23_tail dorsal root ganglion	1	6.808155e-3	1.000000e+0	1.000000e+0	1.468827e+2	6.808155e-3	1	6.808155e-3	1.000000e+0	1	7.082562e-3	1.000000e+0	1.000000e+0	1.409453e+2	7.094950e-3	1	64	5.000000e-1	1.562500e-2	unnamed	MSH2
MGI Expression: Detected	7752	TS23_tail peripheral nervous system	2	7.066020e-3	1.000000e+0	1.000000e+0	1.415224e+2	7.066020e-3	1	7.066020e-3	1.000000e+0	2	7.193027e-3	1.000000e+0	1.000000e+0	1.387769e+2	7.205809e-3	1	65	5.000000e-1	1.538462e-2	unnamed	MSH2
MGI Expression: Detected	7509	TS23_tail nervous system	3	7.129084e-3	1.000000e+0	1.000000e+0	1.402705e+2	7.129084e-3	1	7.129084e-3	1.000000e+0	3	7.413939e-3	1.000000e+0	1.000000e+0	1.346343e+2	7.427526e-3	1	67	5.000000e-1	1.492537e-2	unnamed	MSH2
MGI Expression: Detected	7457	TS23_tail	4	7.206411e-2	1.000000e+0	1.000000e+0	1.387653e+1	7.206411e-2	1	7.206411e-2	1.000000e+0	4	5.660190e-2	1.000000e+0	1.000000e+0	1.741409e+1	5.742475e-2	1	518	5.000000e-1	1.930502e-3	unnamed	MSH2
MGI Expression: Detected	6963	TS28_liver	5	2.213497e-1	1.000000e+0	1.000000e+0	4.517739e+0	2.213497e-1	1	2.213497e-1	1.000000e+0	7	2.458689e-1	1.000000e+0	1.000000e+0	3.799705e+0	2.631783e-1	1	2374	5.000000e-1	4.212300e-4	unnamed	MSH2
MGI Expression: Detected	6962	TS28_liver and biliary system	6	2.293478e-1	1.000000e+0	1.000000e+0	4.360190e+0	2.293478e-1	1	2.293478e-1	1.000000e+0	10	2.531680e-1	1.000000e+0	1.000000e+0	3.681837e+0	2.716036e-1	1	2450	5.000000e-1	4.081633e-4	unnamed	MSH2
MGI Expression: Detected	6948	TS28_lung	7	2.297513e-1	1.000000e+0	1.000000e+0	4.352532e+0	2.297513e-1	1	2.297513e-1	1.000000e+0	5	2.341749e-1	1.000000e+0	1.000000e+0	4.003773e+0	2.497644e-1	1	2253	5.000000e-1	4.438526e-4	unnamed	MSH2
MGI Expression: Detected	6946	TS28_respiratory system	8	2.309063e-1	1.000000e+0	1.000000e+0	4.330761e+0	2.309063e-1	1	2.309063e-1	1.000000e+0	6	2.354356e-1	1.000000e+0	1.000000e+0	3.980803e+0	2.512056e-1	1	2266	5.000000e-1	4.413063e-4	unnamed	MSH2
MGI Expression: Detected	7103	TS28_heart	9	2.471289e-1	1.000000e+0	1.000000e+0	4.046471e+0	2.471289e-1	1	2.471289e-1	1.000000e+0	8	2.465427e-1	1.000000e+0	1.000000e+0	3.788534e+0	2.639543e-1	1	2381	5.000000e-1	4.199916e-4	unnamed	MSH2
MGI Expression: Detected	6960	TS28_kidney	10	2.525264e-1	1.000000e+0	1.000000e+0	3.959982e+0	2.525264e-1	1	2.525264e-1	1.000000e+0	11	2.607175e-1	1.000000e+0	1.000000e+0	3.566825e+0	2.803614e-1	1	2529	5.000000e-1	3.954132e-4	unnamed	MSH2
MGI Expression: Detected	7098	TS28_cardiovascular system	11	2.541249e-1	1.000000e+0	1.000000e+0	3.935073e+0	2.541249e-1	1	2.541249e-1	1.000000e+0	9	2.524013e-1	1.000000e+0	1.000000e+0	3.693898e+0	2.707167e-1	1	2442	5.000000e-1	4.095004e-4	unnamed	MSH2
MGI Expression: Detected	6959	TS28_renal-urinary system	12	2.619747e-1	1.000000e+0	1.000000e+0	3.817163e+0	2.619747e-1	1	2.619747e-1	1.000000e+0	12	2.693662e-1	1.000000e+0	1.000000e+0	3.442939e+0	2.904495e-1	1	2620	5.000000e-1	3.816794e-4	unnamed	MSH2
MGI Expression: Detected	6945	TS28_visceral organ	13	4.216843e-1	1.000000e+0	1.000000e+0	2.371443e+0	4.216843e-1	1	4.216843e-1	1.000000e+0	13	4.474230e-1	1.000000e+0	1.000000e+0	1.948272e+0	5.132753e-1	1	4630	5.000000e-1	2.159827e-4	unnamed	MSH2
MGI Expression: Detected	7005	TS28_brain	14	4.776274e-1	1.000000e+0	1.000000e+0	2.093682e+0	4.776274e-1	1	4.776274e-1	1.000000e+0	14	4.562057e-1	1.000000e+0	1.000000e+0	1.904264e+0	5.251372e-1	1	4737	5.000000e-1	2.111041e-4	unnamed	MSH2
MGI Expression: Detected	7003	TS28_central nervous system	15	4.961740e-1	1.000000e+0	1.000000e+0	2.015422e+0	4.961740e-1	1	4.961740e-1	1.000000e+0	15	4.783750e-1	1.000000e+0	1.000000e+0	1.800140e+0	5.555124e-1	1	5011	5.000000e-1	1.995610e-4	unnamed	MSH2
MGI Expression: Detected	7001	TS28_nervous system	16	4.974351e-1	1.000000e+0	1.000000e+0	2.010313e+0	4.974351e-1	1	4.974351e-1	1.000000e+0	16	4.798952e-1	1.000000e+0	1.000000e+0	1.793340e+0	5.576188e-1	1	5030	5.000000e-1	1.988072e-4	unnamed	MSH2
MGI Expression: Detected	6944	TS28_organ system	17	6.191523e-1	1.000000e+0	1.000000e+0	1.615112e+0	6.191523e-1	1	6.191523e-1	1.000000e+0	17	6.326325e-1	1.000000e+0	1.000000e+0	1.269420e+0	7.877612e-1	1	7106	5.000000e-1	1.407261e-4	unnamed	MSH2
MGI Expression: Detected	6937	TS28_postnatal mouse	18	6.225233e-1	1.000000e+0	1.000000e+0	1.606366e+0	6.225233e-1	1	6.225233e-1	1.000000e+0	18	6.373878e-1	1.000000e+0	1.000000e+0	1.256862e+0	7.956322e-1	1	7177	5.000000e-1	1.393340e-4	unnamed	MSH2
MGI Expression: Detected	6925	TS23_embryo	19	7.220129e-1	1.000000e+0	1.000000e+0	1.385017e+0	7.220129e-1	1	7.220129e-1	1.000000e+0	19	7.337668e-1	1.000000e+0	1.000000e+0	1.033039e+0	9.680173e-1	1	8732	5.000000e-1	1.145213e-4	unnamed	MSH2
MGI Expression: Detected	6924	Theiler_stage_23	20	7.220179e-1	1.000000e+0	1.000000e+0	1.385007e+0	7.220179e-1	1	7.220179e-1	1.000000e+0	20	7.339383e-1	1.000000e+0	1.000000e+0	1.032685e+0	9.683499e-1	1	8735	5.000000e-1	1.144820e-4	unnamed	MSH2
MSigDB Perturbation	ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	Top genes up-regulated in MM4 vs MM1 subgroup of multiple myeloma samples.	1	1.851898e-3	1.000000e+0	1.000000e+0	5.399864e+2	1.851898e-3	1	1.851898e-3	1.000000e+0	1	3.433759e-3	1.000000e+0	1.000000e+0	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	MSH2
MSigDB Perturbation	WHITFIELD_CELL_CYCLE_LITERATURE	A list of known cell cycle regulated genes that was compiled from the literature by the authors.	2	2.399525e-3	1.000000e+0	1.000000e+0	4.167492e+2	2.399525e-3	1	2.399525e-3	1.000000e+0	4	4.871965e-3	1.000000e+0	1.000000e+0	2.050114e+2	4.877778e-3	1	44	5.000000e-1	2.272727e-2	unnamed	MSH2
MSigDB Perturbation	MENSSEN_MYC_TARGETS	Genes up-regulated by adenoviral expression of c-MYC [GeneID=4609] in HUVEC cells (umbilical vein endothelium).	3	2.872563e-3	1.000000e+0	1.000000e+0	3.481211e+2	2.872563e-3	1	2.872563e-3	1.000000e+0	7	5.977571e-3	1.000000e+0	1.000000e+0	1.670463e+2	5.986364e-3	1	54	5.000000e-1	1.851852e-2	unnamed	MSH2
MSigDB Perturbation	ABRAMSON_INTERACT_WITH_AIRE	Proteins interacting with AIRE [GeneID=326], based on massspectroscopy analysis of co-immunoprecipitates in 293T cells (embryonic kidney).	4	2.930563e-3	1.000000e+0	1.000000e+0	3.412314e+2	2.930563e-3	1	2.930563e-3	1.000000e+0	5	4.982553e-3	1.000000e+0	1.000000e+0	2.004556e+2	4.988637e-3	1	45	5.000000e-1	2.222222e-2	unnamed	MSH2
MSigDB Perturbation	ZHAN_EARLY_DIFFERENTIATION_GENES_DN	B lymphocyte early differentiation genes (EDG): top genes down-regulated in tonsil B lymphocytes (TBC) compared to the tonsil plasma cells (TPC).	5	2.970181e-3	1.000000e+0	1.000000e+0	3.366798e+2	2.970181e-3	1	2.970181e-3	1.000000e+0	3	4.761371e-3	1.000000e+0	1.000000e+0	2.097791e+2	4.766920e-3	1	43	5.000000e-1	2.325581e-2	unnamed	MSH2
MSigDB Perturbation	WAKASUGI_HAVE_ZNF143_BINDING_SITES	DNA repair genes whose promoters contain putative ZNF143 [GeneID=7702] binding sites.	6	3.967709e-3	1.000000e+0	1.000000e+0	2.520346e+2	3.967709e-3	1	3.967709e-3	1.000000e+0	10	6.419641e-3	1.000000e+0	1.000000e+0	1.555259e+2	6.429799e-3	1	58	5.000000e-1	1.724138e-2	unnamed	MSH2
MSigDB Perturbation	PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	The XPRSS-Int network genes up-regulated in breast tumors from patients with germline mutations in BRCA1 [GeneID=672] compared to those with the wild type allele.	7	4.023358e-3	1.000000e+0	1.000000e+0	2.485486e+2	4.023358e-3	1	4.023358e-3	1.000000e+0	9	6.198618e-3	1.000000e+0	1.000000e+0	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	MSH2
MSigDB Perturbation	WONG_IFNA2_RESISTANCE_DN	Genes down-regulated in hepatocellular carcinoma (HCC) cell lines  resistant to IFNA2 [GeneID=3440].	8	4.329262e-3	1.000000e+0	1.000000e+0	2.309863e+2	4.329262e-3	1	4.329262e-3	1.000000e+0	2	3.987038e-3	1.000000e+0	1.000000e+0	2.505694e+2	3.990910e-3	1	36	5.000000e-1	2.777778e-2	unnamed	MSH2
MSigDB Perturbation	HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP	Genes up-regulated in hematopoietic precursor cells conditionally expressing HOXA9 and MEIS1 [GeneID=3205;4211].	9	4.844030e-3	1.000000e+0	1.000000e+0	2.064397e+2	4.844030e-3	1	4.844030e-3	1.000000e+0	14	7.082562e-3	1.000000e+0	1.000000e+0	1.409453e+2	7.094950e-3	1	64	5.000000e-1	1.562500e-2	unnamed	MSH2
MSigDB Perturbation	ALCALA_APOPTOSIS	Genes able to induce cell death in an expression cDNA library screen.	10	5.081512e-3	1.000000e+0	1.000000e+0	1.967918e+2	5.081512e-3	1	5.081512e-3	1.000000e+0	19	9.511379e-3	1.000000e+0	1.000000e+0	1.048895e+2	9.533840e-3	1	86	5.000000e-1	1.162791e-2	unnamed	MSH2
MSigDB Perturbation	REN_BOUND_BY_E2F	Genes whose promoters were bound by E2F1 and E2F4 [GeneID=1869;1874] in the primary fibroblasts WI-38, by ChIP on chip assay.	11	5.473169e-3	1.000000e+0	1.000000e+0	1.827095e+2	5.473169e-3	1	5.473169e-3	1.000000e+0	16	7.855690e-3	1.000000e+0	1.000000e+0	1.270493e+2	7.870961e-3	1	71	5.000000e-1	1.408451e-2	unnamed	MSH2
MSigDB Perturbation	MAYBURD_RESPONSE_TO_L663536_DN	Genes down-regulated in H720 cells (lung cancer) after treatment with L663536 (MK886) [PubChem=105049], an inhibitor of leukotriene biosynthesis.	12	5.494099e-3	1.000000e+0	1.000000e+0	1.820135e+2	5.494099e-3	1	5.494099e-3	1.000000e+0	7	5.977571e-3	1.000000e+0	1.000000e+0	1.670463e+2	5.986364e-3	1	54	5.000000e-1	1.851852e-2	unnamed	MSH2
MSigDB Perturbation	KAUFFMANN_MELANOMA_RELAPSE_UP	DNA repair and replication genes up-regulated in melanoma patients who will relapse vs patients who will not.	13	5.549016e-3	1.000000e+0	1.000000e+0	1.802121e+2	5.549016e-3	1	5.549016e-3	1.000000e+0	11	6.640639e-3	1.000000e+0	1.000000e+0	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	MSH2
MSigDB Perturbation	SONG_TARGETS_OF_IE86_CMV_PROTEIN	Cellular genes up-regulated in forskin fibroblasts by expression of CMV EI86 protein off an adenovirus vector.	14	5.686757e-3	1.000000e+0	1.000000e+0	1.758472e+2	5.686757e-3	1	5.686757e-3	1.000000e+0	11	6.640639e-3	1.000000e+0	1.000000e+0	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	MSH2
MSigDB Perturbation	FRASOR_TAMOXIFEN_RESPONSE_UP	Genes preferentially up-regulated in MCF-7 cells (breast cancer) by tamoxifen [PubChem=5376] but not by estradiol or fulvestrant (ICI 182780) [PubChem=5757;3478439].	15	7.278030e-3	1.000000e+0	1.000000e+0	1.373998e+2	7.278030e-3	1	7.278030e-3	1.000000e+0	6	5.424845e-3	1.000000e+0	1.000000e+0	1.840918e+2	5.432071e-3	1	49	5.000000e-1	2.040816e-2	unnamed	MSH2
MSigDB Perturbation	GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	Genes down-regulated in quiescent vs dividing CD34+ [GeneID=8842] cells isolated from peripheral blood of normal donors.	16	7.721462e-3	1.000000e+0	1.000000e+0	1.295092e+2	7.721462e-3	1	7.721462e-3	1.000000e+0	20	9.732033e-3	1.000000e+0	1.000000e+0	1.025057e+2	9.755557e-3	1	88	5.000000e-1	1.136364e-2	unnamed	MSH2
MSigDB Perturbation	PUJANA_BREAST_CANCER_LIT_INT_NETWORK	Genes constituting the LIT-Int network of proteins interacting with breast cancer reference proteins BRCA1, BRCA2, ATM, and CHEK2 [GeneID=672;675;472;11200]; the interactions were manually curated from the literature.	17	8.136893e-3	1.000000e+0	1.000000e+0	1.228970e+2	8.136893e-3	1	8.136893e-3	1.000000e+0	21	1.116569e-2	1.000000e+0	1.000000e+0	8.931188e+1	1.119672e-2	1	101	5.000000e-1	9.900990e-3	unnamed	MSH2
MSigDB Perturbation	ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP	Genes up-regulated in CD-1 compared to CD-2 cluster of multiple myeloma samples.	18	8.382603e-3	1.000000e+0	1.000000e+0	1.192947e+2	8.382603e-3	1	8.382603e-3	1.000000e+0	13	6.751129e-3	1.000000e+0	1.000000e+0	1.478770e+2	6.762375e-3	1	61	5.000000e-1	1.639344e-2	unnamed	KCNK12
MSigDB Perturbation	HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP	Genes whose expression correlated with higher risk of late recurrence of hepatocellular carcinoma (HCC).	19	8.419958e-3	1.000000e+0	1.000000e+0	1.187654e+2	8.419958e-3	1	8.419958e-3	1.000000e+0	15	7.303486e-3	1.000000e+0	1.000000e+0	1.366742e+2	7.316668e-3	1	66	5.000000e-1	1.515152e-2	unnamed	MSH2
MSigDB Perturbation	LEE_CALORIE_RESTRICTION_NEOCORTEX_UP	Up-regulated in the neocortex of aged (30-month) mice subjected to caloric restriction since young adulthood.	20	8.665415e-3	1.000000e+0	1.000000e+0	1.154013e+2	8.665415e-3	1	8.665415e-3	1.000000e+0	18	9.401043e-3	1.000000e+0	1.000000e+0	1.061235e+2	9.422981e-3	1	85	5.000000e-1	1.176471e-2	unnamed	MSH2
MSigDB Perturbation	DANG_MYC_TARGETS_UP	Genes up-regulated by MYC [GeneID=4609] and whose promoters are bound by MYC, according to MYC Target Gene Database.	21	9.822124e-3	1.000000e+0	1.000000e+0	1.018110e+2	9.822124e-3	1	9.822124e-3	1.000000e+0	26	1.590037e-2	1.000000e+0	1.000000e+0	6.264236e+1	1.596364e-2	1	144	5.000000e-1	6.944444e-3	unnamed	MSH2
MSigDB Perturbation	PUJANA_BRCA_CENTERED_NETWORK	Genes constituting the BRCA-centered network (BCN).	22	1.065216e-2	1.000000e+0	1.000000e+0	9.387771e+1	1.065216e-2	1	1.065216e-2	1.000000e+0	23	1.292876e-2	1.000000e+0	1.000000e+0	7.709829e+1	1.297046e-2	1	117	5.000000e-1	8.547009e-3	unnamed	MSH2
MSigDB Perturbation	WHITFIELD_CELL_CYCLE_G1_S	Genes periodically expressed in synchronized HeLa cells (cervical carcinoma), with peak during the G1/S phase of cell cycle.	23	1.093297e-2	1.000000e+0	1.000000e+0	9.146648e+1	1.093297e-2	1	1.093297e-2	1.000000e+0	24	1.402987e-2	1.000000e+0	1.000000e+0	7.102756e+1	1.407904e-2	1	127	5.000000e-1	7.874016e-3	unnamed	MSH2
MSigDB Perturbation	BENPORATH_PROLIFERATION	Set 'Proliferation Cluster': genes defined in human breast tumor expression data.	24	1.146571e-2	1.000000e+0	1.000000e+0	8.721655e+1	1.146571e-2	1	1.146571e-2	1.000000e+0	27	1.601034e-2	1.000000e+0	1.000000e+0	6.221034e+1	1.607450e-2	1	145	5.000000e-1	6.896552e-3	unnamed	MSH2
MSigDB Perturbation	KAUFFMANN_DNA_REPLICATION_GENES	Genes involved in DNA replication, compiled manually by the authors.	25	1.201358e-2	1.000000e+0	1.000000e+0	8.323914e+1	1.201358e-2	1	1.201358e-2	1.000000e+0	28	1.612031e-2	1.000000e+0	1.000000e+0	6.178425e+1	1.618536e-2	1	146	5.000000e-1	6.849315e-3	unnamed	MSH2
MSigDB Perturbation	BROWN_MYELOID_CELL_DEVELOPMENT_DN	Genes defining proliferation and self renewal potential of the bipotential myeloid cell line FDB.	26	1.252641e-2	1.000000e+0	1.000000e+0	7.983136e+1	1.252641e-2	1	1.252641e-2	1.000000e+0	24	1.402987e-2	1.000000e+0	1.000000e+0	7.102756e+1	1.407904e-2	1	127	5.000000e-1	7.874016e-3	unnamed	MSH2
MSigDB Perturbation	MARKEY_RB1_CHRONIC_LOF_UP	Genes up-regulated in MEF cells (embryonic fibroblasts) isolated from RB1 [GeneID=5925] knockout mice: chronic loss of function (LOF) of RB1.	27	1.343301e-2	1.000000e+0	1.000000e+0	7.444348e+1	1.343301e-2	1	1.343301e-2	1.000000e+0	22	1.248814e-2	1.000000e+0	1.000000e+0	7.982743e+1	1.252702e-2	1	113	5.000000e-1	8.849558e-3	unnamed	MSH2
MSigDB Perturbation	HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP	Genes up-regulated in hematopoietic progenitor cells (HPC) of T lymphocyte and NK (natural killer) lineage.	28	1.459875e-2	1.000000e+0	1.000000e+0	6.849903e+1	1.459875e-2	1	1.459875e-2	1.000000e+0	17	8.738896e-3	1.000000e+0	1.000000e+0	1.141835e+2	8.757829e-3	1	79	5.000000e-1	1.265823e-2	unnamed	MSH2
MSigDB Perturbation	PENG_GLUCOSE_DEPRIVATION_DN	Genes down-regulated in BJAB cells (B-lymphoma) after glucose [PubChem=206] deprivation.	29	1.502966e-2	1.000000e+0	1.000000e+0	6.653511e+1	1.502966e-2	1	1.502966e-2	1.000000e+0	32	1.842821e-2	1.000000e+0	1.000000e+0	5.401497e+1	1.851339e-2	1	167	5.000000e-1	5.988024e-3	unnamed	MSH2
MSigDB Perturbation	JISON_SICKLE_CELL_DISEASE_DN	Genes down-regulated in peripheral blood mononuclear cells (PBMC) from sickle cell disease patients compared to those from healthy subjects.	30	1.569682e-2	1.000000e+0	1.000000e+0	6.370719e+1	1.569682e-2	1	1.569682e-2	1.000000e+0	35	1.930669e-2	1.000000e+0	1.000000e+0	5.154571e+1	1.940025e-2	1	175	5.000000e-1	5.714286e-3	unnamed	MSH2
MSigDB Perturbation	TSAI_RESPONSE_TO_IONIZING_RADIATION	Genes up-regulated in TK6, WTK1, and NH32 cell lines (lymphoblast) in response to ionizing radiation.	31	1.571399e-2	1.000000e+0	1.000000e+0	6.363755e+1	1.571399e-2	1	1.571399e-2	1.000000e+0	29	1.645017e-2	1.000000e+0	1.000000e+0	6.054027e+1	1.651793e-2	1	149	5.000000e-1	6.711409e-3	unnamed	MSH2
MSigDB Perturbation	LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	Genes down-regulated in Wilm's tumor samples compared to fetal  kidney.	32	1.583386e-2	1.000000e+0	1.000000e+0	6.315578e+1	1.583386e-2	1	1.583386e-2	1.000000e+0	30	1.798882e-2	1.000000e+0	1.000000e+0	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	MSH2
MSigDB Perturbation	PUJANA_XPRSS_INT_NETWORK	Genes constituting the XPRSS-Int network: intersection of genes whose expression correlates with BRCA1, BRCA2, ATM, and CHEK2 [GeneID=672;675;472;11200] in a compendium of normal tissues.	33	1.610988e-2	1.000000e+0	1.000000e+0	6.207372e+1	1.610988e-2	1	1.610988e-2	1.000000e+0	32	1.842821e-2	1.000000e+0	1.000000e+0	5.401497e+1	1.851339e-2	1	167	5.000000e-1	5.988024e-3	unnamed	MSH2
MSigDB Perturbation	CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	Marker genes down-regulated in the 'unannotated' subclass of hepatocellular carcinoma (HCC) samples.	34	1.636872e-2	1.000000e+0	1.000000e+0	6.109215e+1	1.636872e-2	1	1.636872e-2	1.000000e+0	36	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	MSH2
MSigDB Perturbation	HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2	Genes differentially expressed in hereditary breast cancer tumors with mutated BRCA1 [GeneID=672] compared to those with mutated BRCA2 [GeneID=675].	35	1.653298e-2	1.000000e+0	1.000000e+0	6.048516e+1	1.653298e-2	1	1.653298e-2	1.000000e+0	30	1.798882e-2	1.000000e+0	1.000000e+0	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	MSH2
MSigDB Perturbation	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	Genes up-regulated in MCF10A cells (breast cancer) grown at low (mesenchymal phenotype) compared to those grown at high (epithelial, basal-like phenotype) confluency.	36	1.771869e-2	1.000000e+0	1.000000e+0	5.643757e+1	1.771869e-2	1	1.771869e-2	1.000000e+0	37	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	MSH2
MSigDB Perturbation	KAUFFMANN_DNA_REPAIR_GENES	Genes involved in DNA repair, compiled manually by the authors.	37	1.883782e-2	1.000000e+0	1.000000e+0	5.308469e+1	1.883782e-2	1	1.883782e-2	1.000000e+0	40	2.467884e-2	1.000000e+0	1.000000e+0	4.027009e+1	2.483233e-2	1	224	5.000000e-1	4.464286e-3	unnamed	MSH2
MSigDB Perturbation	BROWNE_HCMV_INFECTION_48HR_UP	Genes up-regulated in primary fibroblast cell culture after infection with HCMV (AD169 strain) at 48 h time point that were not up-regulated at the previous time point, 24 h.	38	1.990267e-2	1.000000e+0	1.000000e+0	5.024451e+1	1.990267e-2	1	1.990267e-2	1.000000e+0	34	1.897731e-2	1.000000e+0	1.000000e+0	5.244477e+1	1.906768e-2	1	172	5.000000e-1	5.813953e-3	unnamed	MSH2
MSigDB Perturbation	RAMALHO_STEMNESS_UP	Genes enriched in embryonic, neural and hematopoietic stem cells.	39	2.029016e-2	1.000000e+0	1.000000e+0	4.928497e+1	2.029016e-2	1	2.029016e-2	1.000000e+0	38	2.215906e-2	1.000000e+0	1.000000e+0	4.487811e+1	2.228258e-2	1	201	5.000000e-1	4.975124e-3	unnamed	MSH2
MSigDB Perturbation	KOBAYASHI_EGFR_SIGNALING_24HR_DN	Genes down-regulated in H1975 cells (non-small cell lung cancer, NSCLC) resistant to gefitinib [PubChem=123631] after treatment with EGFR inhibitor CL-387785 [PubChem=2776] for 24h.	40	2.179460e-2	1.000000e+0	1.000000e+0	4.588292e+1	2.179460e-2	1	2.179460e-2	1.000000e+0	44	2.894409e-2	1.000000e+0	1.000000e+0	3.429848e+1	2.915581e-2	1	263	5.000000e-1	3.802281e-3	unnamed	MSH2
MSigDB Perturbation	MUELLER_PLURINET	Genes constituting the PluriNet protein-protein network shared by the pluripotent cells (embryonic stem cells, embryonical carcinomas and induced pluripotent cells).	41	2.247319e-2	1.000000e+0	1.000000e+0	4.449746e+1	2.247319e-2	1	2.247319e-2	1.000000e+0	46	3.341799e-2	1.000000e+0	1.000000e+0	2.967270e+1	3.370101e-2	1	304	5.000000e-1	3.289474e-3	unnamed	MSH2
MSigDB Perturbation	AFFAR_YY1_TARGETS_DN	Genes down-regulated in MEF cells (embryonic fibroblast) expressing ~25% of YY1 [GeneID=7528].	42	2.386809e-2	1.000000e+0	1.000000e+0	4.189694e+1	2.386809e-2	1	2.386809e-2	1.000000e+0	42	2.642982e-2	1.000000e+0	1.000000e+0	3.758542e+1	2.660606e-2	1	240	5.000000e-1	4.166667e-3	unnamed	MSH2
MSigDB Perturbation	WONG_EMBRYONIC_STEM_CELL_CORE	The 'core ESC-like gene module': genes coordinately up-regulated in a compendium of mouse embryonic stem cells (ESC) which are shared with the human ESC-like module.	43	2.401219e-2	1.000000e+0	1.000000e+0	4.164551e+1	2.401219e-2	1	2.401219e-2	1.000000e+0	49	3.701143e-2	1.000000e+0	1.000000e+0	2.676706e+1	3.735935e-2	1	337	5.000000e-1	2.967359e-3	unnamed	MSH2
MSigDB Perturbation	MITSIADES_RESPONSE_TO_APLIDIN_DN	Genes down-regulated in the MM1S cells (multiple myeloma) after treatment with aplidin [PubChem=44152164], a marine-derived compound with potential anti-cancer properties.	44	2.562386e-2	1.000000e+0	1.000000e+0	3.902613e+1	2.562386e-2	1	2.562386e-2	1.000000e+0	43	2.719538e-2	1.000000e+0	1.000000e+0	3.652024e+1	2.738207e-2	1	247	5.000000e-1	4.048583e-3	unnamed	MSH2
MSigDB Perturbation	LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	Genes whose expression profile is specific to Cluster III of urothelial cell carcinoma (UCC) tumors.	45	2.574991e-2	1.000000e+0	1.000000e+0	3.883509e+1	2.574991e-2	1	2.574991e-2	1.000000e+0	47	3.635858e-2	1.000000e+0	1.000000e+0	2.725227e+1	3.669420e-2	1	331	5.000000e-1	3.021148e-3	unnamed	MSH2
MSigDB Perturbation	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	Genes down-regulated in RS4;11 cells (MLL, mixed lineage leukemia) in response to SB216763 [PubChemID=176158], an inhibitor of GSK3B [GeneID=2932].	46	2.928641e-2	1.000000e+0	1.000000e+0	3.414553e+1	2.928641e-2	1	2.928641e-2	1.000000e+0	53	4.157523e-2	1.000000e+0	1.000000e+0	2.380079e+1	4.201541e-2	1	379	5.000000e-1	2.638522e-3	unnamed	MSH2
MSigDB Perturbation	MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	Genes with high-CpG-density promoters (HCP) bearing the bivalent histone H3 trimethylation mark at K4 and K27 (H3K4me3 and H3K27me3) in neural progenitor cells (NPC).	47	3.067164e-2	1.000000e+0	1.000000e+0	3.260341e+1	3.067164e-2	1	3.067164e-2	1.000000e+0	39	2.237830e-2	1.000000e+0	1.000000e+0	4.443596e+1	2.250430e-2	1	203	5.000000e-1	4.926108e-3	unnamed	KCNK12
MSigDB Perturbation	BLUM_RESPONSE_TO_SALIRASIB_DN	Selected genes down-regulated in response to the Ras inhibitor salirasib [PubChem=5469318] in a panel of cancer cell lines with constantly active HRAS [GeneID=3265].	48	3.335018e-2	1.000000e+0	1.000000e+0	2.998484e+1	3.335018e-2	1	3.335018e-2	1.000000e+0	50	3.733778e-2	1.000000e+0	1.000000e+0	2.653088e+1	3.769192e-2	1	340	5.000000e-1	2.941176e-3	unnamed	MSH2
MSigDB Perturbation	CHICAS_RB1_TARGETS_GROWING	Genes up-regulated in growing IMR90 cells (fibroblast) after knockdown of RB1 [GeneID=5925] by RNAi.	49	3.635781e-2	1.000000e+0	1.000000e+0	2.750440e+1	3.635781e-2	1	3.635781e-2	1.000000e+0	41	2.610163e-2	1.000000e+0	1.000000e+0	3.806118e+1	2.627349e-2	1	237	5.000000e-1	4.219409e-3	unnamed	MSH2
MSigDB Perturbation	PUJANA_BRCA2_PCC_NETWORK	Genes constituting the BRCA2-PCC network of transcripts whose expression positively correlated (Pearson correlation coefficient, PCC &gt;= 0.4) with that of BRCA2 [GeneID=675] across a compendium of normal tissues.	50	3.791785e-2	1.000000e+0	1.000000e+0	2.637280e+1	3.791785e-2	1	3.791785e-2	1.000000e+0	54	4.569503e-2	1.000000e+0	1.000000e+0	2.163189e+1	4.622804e-2	1	417	5.000000e-1	2.398082e-3	unnamed	MSH2
MSigDB Perturbation	GRESHOCK_CANCER_COPY_NUMBER_UP	Genes from common genomic gains observed in a meta analyis of copy number alterations across a panel of different cancer cell lines and tumor samples.	51	3.901444e-2	1.000000e+0	1.000000e+0	2.563154e+1	3.901444e-2	1	3.901444e-2	1.000000e+0	48	3.668503e-2	1.000000e+0	1.000000e+0	2.700749e+1	3.702677e-2	1	334	5.000000e-1	2.994012e-3	unnamed	MSH2
MSigDB Perturbation	MOHANKUMAR_TLX1_TARGETS_UP	Up-regulated in MCF7 cells (breast cancer) by TLX1 (HOX11) [GeneID=3195].	52	3.940953e-2	1.000000e+0	1.000000e+0	2.537457e+1	3.940953e-2	1	3.940953e-2	1.000000e+0	55	4.634471e-2	1.000000e+0	1.000000e+0	2.132506e+1	4.689319e-2	1	423	5.000000e-1	2.364066e-3	unnamed	MSH2
MSigDB Perturbation	CAIRO_HEPATOBLASTOMA_CLASSES_UP	Genes up-regulated in robust Cluster 2 (rC2) of hepatoblastoma samples compared to those in the robust Cluster 1 (rC1).	53	3.989950e-2	1.000000e+0	1.000000e+0	2.506297e+1	3.989950e-2	1	3.989950e-2	1.000000e+0	64	6.433882e-2	1.000000e+0	1.000000e+0	1.528898e+1	6.540657e-2	1	590	5.000000e-1	1.694915e-3	unnamed	MSH2
MSigDB Perturbation	GABRIELY_MIR21_TARGETS	Genes significantly de-regulated (p &lt; 0.05) by MIR21 [GeneID=406991] in A172 cells (glioma).	54	4.148238e-2	1.000000e+0	1.000000e+0	2.410662e+1	4.148238e-2	1	4.148238e-2	1.000000e+0	45	3.014542e-2	1.000000e+0	1.000000e+0	3.292153e+1	3.037526e-2	1	274	5.000000e-1	3.649635e-3	unnamed	MSH2
MSigDB Perturbation	MARSON_BOUND_BY_E2F4_UNSTIMULATED	Genes with promoters bound by E2F4 [GeneID=1874] in unstimulated hybridoma cells.	55	4.167922e-2	1.000000e+0	1.000000e+0	2.399277e+1	4.167922e-2	1	4.167922e-2	1.000000e+0	69	7.535154e-2	1.000000e+0	1.000000e+0	1.301659e+1	7.682501e-2	1	693	5.000000e-1	1.443001e-3	unnamed	MSH2
MSigDB Perturbation	BENPORATH_ES_1	Set 'ES exp1': genes overexpressed in human embryonic stem cells according to 5 or more out of 20 profiling studies.	56	4.210765e-2	1.000000e+0	1.000000e+0	2.374865e+1	4.210765e-2	1	4.210765e-2	1.000000e+0	52	4.114105e-2	1.000000e+0	1.000000e+0	2.405467e+1	4.157197e-2	1	375	5.000000e-1	2.666667e-3	unnamed	MSH2
MSigDB Perturbation	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3	Genes with high-CpG-density promoters (HCP) bearing histone H3 dimethylation mark at K4 (H3K4me2) and trimethylation mark at K27 (H3K27me3) in neural precursor cells (NPC).	57	4.819989e-2	1.000000e+0	1.000000e+0	2.074694e+1	4.819989e-2	1	4.819989e-2	1.000000e+0	50	3.733778e-2	1.000000e+0	1.000000e+0	2.653088e+1	3.769192e-2	1	340	5.000000e-1	2.941176e-3	unnamed	KCNK12
MSigDB Perturbation	IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR	Genes in the expression cluster 'Early Progenitors Shared': up-regulated in hematopoietic progenitors from adult bone marrow and from fetal liver.	58	4.893719e-2	1.000000e+0	1.000000e+0	2.043436e+1	4.893719e-2	1	4.893719e-2	1.000000e+0	59	5.563254e-2	1.000000e+0	1.000000e+0	1.772200e+1	5.642703e-2	1	509	5.000000e-1	1.964637e-3	unnamed	KCNK12
MSigDB Perturbation	BERENJENO_TRANSFORMED_BY_RHOA_UP	Genes up-regulated in NIH3T3 cells (fibroblasts) transformed by  expression of contitutively active (Q63L) form of RHOA [GeneID=387] off plasmid vector.	59	5.123973e-2	1.000000e+0	1.000000e+0	1.951611e+1	5.123973e-2	1	5.123973e-2	1.000000e+0	60	5.800120e-2	1.000000e+0	1.000000e+0	1.698776e+1	5.886592e-2	1	531	5.000000e-1	1.883239e-3	unnamed	MSH2
MSigDB Perturbation	BENPORATH_MYC_MAX_TARGETS	Set 'Myc targets2': targets of c-Myc [GeneID=4609] and Max [GeneID=4149] identified by ChIP on chip in a Burkitt's lymphoma cell line; overlap set.	60	5.249114e-2	1.000000e+0	1.000000e+0	1.905083e+1	5.249114e-2	1	5.249114e-2	1.000000e+0	71	8.576913e-2	1.000000e+0	1.000000e+0	1.140392e+1	8.768915e-2	1	791	5.000000e-1	1.264223e-3	unnamed	MSH2
MSigDB Perturbation	FEVR_CTNNB1_TARGETS_DN	Genes down-regulated in intestinal crypt cells upon deletion of CTNNB1 [GeneID=1499].	61	5.544406e-2	1.000000e+0	1.000000e+0	1.803620e+1	5.544406e-2	1	5.544406e-2	1.000000e+0	62	5.950698e-2	1.000000e+0	1.000000e+0	1.655138e+1	6.041794e-2	1	545	5.000000e-1	1.834862e-3	unnamed	MSH2
MSigDB Perturbation	BENPORATH_CYCLING_GENES	Genes showing cell-cycle stage-specific expression [PMID=12058064].	62	5.607900e-2	1.000000e+0	1.000000e+0	1.783199e+1	5.607900e-2	1	5.607900e-2	1.000000e+0	66	7.022751e-2	1.000000e+0	1.000000e+0	1.398527e+1	7.150380e-2	1	645	5.000000e-1	1.550388e-3	unnamed	MSH2
MSigDB Perturbation	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING	Genes whose expression in suboptimally debulked ovarian tumors is associated with survival prognosis.	63	5.680281e-2	1.000000e+0	1.000000e+0	1.760476e+1	5.680281e-2	1	5.680281e-2	1.000000e+0	58	5.444710e-2	1.000000e+0	1.000000e+0	1.811345e+1	5.520758e-2	1	498	5.000000e-1	2.008032e-3	unnamed	KCNK12
MSigDB Perturbation	CHICAS_RB1_TARGETS_SENESCENT	Genes up-regulated in senescent IMR90 cells (fibroblast) after knockdown of RB1 [GeneID=5925] by RNAi.	64	5.829074e-2	1.000000e+0	1.000000e+0	1.715538e+1	5.829074e-2	1	5.829074e-2	1.000000e+0	61	5.907688e-2	1.000000e+0	1.000000e+0	1.667375e+1	5.997450e-2	1	541	5.000000e-1	1.848429e-3	unnamed	MSH2
MSigDB Perturbation	BAELDE_DIABETIC_NEPHROPATHY_DN	Genes down-regulated in glomeruli of kidneys from patients with diabetic nephropathy (type 2 diabetes mellitus).	65	5.861782e-2	1.000000e+0	1.000000e+0	1.705966e+1	5.861782e-2	1	5.861782e-2	1.000000e+0	56	4.666947e-2	1.000000e+0	1.000000e+0	2.117488e+1	4.722576e-2	1	426	5.000000e-1	2.347418e-3	unnamed	MSH2
MSigDB Perturbation	PUJANA_CHEK2_PCC_NETWORK	Genes constituting the CHEK2-PCC network of transcripts whose expression positively correlates (Pearson correlation coefficient, PCC &gt;= 0.4) with that of CHEK2 [GeneID=11200].	66	5.889590e-2	1.000000e+0	1.000000e+0	1.697911e+1	5.889590e-2	1	5.889590e-2	1.000000e+0	72	8.608710e-2	1.000000e+0	1.000000e+0	1.136083e+1	8.802173e-2	1	794	5.000000e-1	1.259446e-3	unnamed	MSH2
MSigDB Perturbation	LOPEZ_MBD_TARGETS	Genes up-regulated in HeLa cells (cervical cancer) after simultaneus knockdown of all three MBD (methyl-CpG binding domain) proteins MeCP2, MBD1 and MBD2 [GeneID=4204;4152;8932] by RNAi.	67	6.397820e-2	1.000000e+0	1.000000e+0	1.563032e+1	6.397820e-2	1	6.397820e-2	1.000000e+0	75	1.014950e-1	1.000000e+0	1.000000e+0	9.596277e+0	1.042071e-1	1	940	5.000000e-1	1.063830e-3	unnamed	MSH2
MSigDB Perturbation	WEI_MYCN_TARGETS_WITH_E_BOX	Genes whose promoters contain E-box motifs and whose expression changed in MYCN-3 cells (neuroblastoma) upon induction of MYCN [GeneID=4613].	68	6.806111e-2	1.000000e+0	1.000000e+0	1.469268e+1	6.806111e-2	1	6.806111e-2	1.000000e+0	70	8.343562e-2	1.000000e+0	1.000000e+0	1.173017e+1	8.525026e-2	1	769	5.000000e-1	1.300390e-3	unnamed	MSH2
MSigDB Perturbation	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR	Genes in the expression cluster 'HSC and Progenitors Shared': up-regulated in hematopoietic stem cells (HSC) and progenitors from adult bone marrow and fetal liver.	69	7.135492e-2	1.000000e+0	1.000000e+0	1.401445e+1	7.135492e-2	1	7.135492e-2	1.000000e+0	67	7.054818e-2	1.000000e+0	1.000000e+0	1.392052e+1	7.183637e-2	1	648	5.000000e-1	1.543210e-3	unnamed	MSH2
MSigDB Perturbation	SCHLOSSER_SERUM_RESPONSE_DN	Cluster 4: genes down-regulated in B493-6 cells (B lymphocytes) upon serum stimulation but not affected by MYC [GeneID=4609].	70	7.399847e-2	1.000000e+0	1.000000e+0	1.351379e+1	7.399847e-2	1	7.399847e-2	1.000000e+0	68	7.524493e-2	1.000000e+0	1.000000e+0	1.303540e+1	7.671415e-2	1	692	5.000000e-1	1.445087e-3	unnamed	MSH2
MSigDB Perturbation	HAMAI_APOPTOSIS_VIA_TRAIL_UP	Genes up-regulated in T1 cells (primary melanoma, sensitive to TRAIL [GeneID=8743]) compared to G1 cells (metastatic melanoma, resistant to TRAIL).	71	7.409110e-2	1.000000e+0	1.000000e+0	1.349690e+1	7.409110e-2	1	7.409110e-2	1.000000e+0	63	6.144121e-2	1.000000e+0	1.000000e+0	1.602220e+1	6.241339e-2	1	563	5.000000e-1	1.776199e-3	unnamed	MSH2
MSigDB Perturbation	DANG_BOUND_BY_MYC	Genes whose promoters are bound by MYC [GeneID=4609], according to MYC Target Gene Database.	72	7.799204e-2	1.000000e+0	1.000000e+0	1.282182e+1	7.799204e-2	1	7.799204e-2	1.000000e+0	82	1.188545e-1	1.000000e+0	1.000000e+0	8.155967e+0	1.226096e-1	1	1106	5.000000e-1	9.041591e-4	unnamed	MSH2
MSigDB Perturbation	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	Common down-regulated transcripts in fibroblasts expressing either XP/CS or TDD mutant forms of ERCC3 [GeneID=2071], after UVC irradiation.	73	8.562533e-2	1.000000e+0	1.000000e+0	1.167879e+1	8.562533e-2	1	8.562533e-2	1.000000e+0	57	5.228984e-2	1.000000e+0	1.000000e+0	1.887134e+1	5.299041e-2	1	478	5.000000e-1	2.092050e-3	unnamed	MSH2
MSigDB Perturbation	JOHNSTONE_PARVB_TARGETS_3_DN	Genes down-regulated upon overexpression of PARVB [GeneID=29780] in MDA-MB-231 cells (breast cancer) cultured in 3D Matrigel only.	74	8.753961e-2	1.000000e+0	1.000000e+0	1.142340e+1	8.753961e-2	1	8.753961e-2	1.000000e+0	74	9.317413e-2	1.000000e+0	1.000000e+0	1.047677e+1	9.544925e-2	1	861	5.000000e-1	1.161440e-3	unnamed	MSH2
MSigDB Perturbation	BENPORATH_NANOG_TARGETS	Set 'Nanog targets': genes upregulated and identified by ChIP on chip as Nanog [GeneID=79923] transcription factor targets in human embryonic stem cells.	75	1.005508e-1	1.000000e+0	1.000000e+0	9.945225e+0	1.005508e-1	1	1.005508e-1	1.000000e+0	76	1.050644e-1	1.000000e+0	1.000000e+0	9.261294e+0	1.079763e-1	1	974	5.000000e-1	1.026694e-3	unnamed	MSH2
MSigDB Perturbation	BRUINS_UVC_RESPONSE_LATE	Late response genes: differentially expressed only 12 h after UV-C irradiation of MEF cells (embryonic fibroblast).	76	1.021113e-1	1.000000e+0	1.000000e+0	9.793235e+0	1.021113e-1	1	1.021113e-1	1.000000e+0	81	1.178136e-1	1.000000e+0	1.000000e+0	8.230383e+0	1.215010e-1	1	1096	5.000000e-1	9.124088e-4	unnamed	MSH2
MSigDB Perturbation	BENPORATH_PRC2_TARGETS	Set 'PRC2 targets': Polycomb Repression Complex 2 (PRC) targets; identified by ChIP on chip on human embryonic stem cells as genes that: posess the trimethylated H3K27 mark in their promoters and are bound by SUZ12 [GeneID=23512] and EED [GeneID=8726] Polycomb proteins.	77	1.039276e-1	1.000000e+0	1.000000e+0	9.622088e+0	1.039276e-1	1	1.039276e-1	1.000000e+0	65	6.680363e-2	1.000000e+0	1.000000e+0	1.471533e+1	6.795632e-2	1	613	5.000000e-1	1.631321e-3	unnamed	KCNK12
MSigDB Perturbation	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP	Genes up-regulated in TC71 and EWS502 cells (Ewing's sarcoma) by EWSR1-FLI1  [GeneID=2130;2314] as inferred from RNAi knockdown of this fusion protein.	78	1.219335e-1	1.000000e+0	1.000000e+0	8.201193e+0	1.219335e-1	1	1.219335e-1	1.000000e+0	83	1.314014e-1	1.000000e+0	1.000000e+0	7.351671e+0	1.360235e-1	1	1227	5.000000e-1	8.149959e-4	unnamed	MSH2
MSigDB Perturbation	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP	Genes up-regulated in CD34+ [GeneID=947] cells isolated from bone marrow of CML (chronic myelogenous leukemia) patients, compared to those from normal donors.	79	1.224048e-1	1.000000e+0	1.000000e+0	8.169613e+0	1.224048e-1	1	1.224048e-1	1.000000e+0	86	1.472401e-1	1.000000e+0	1.000000e+0	6.531861e+0	1.530957e-1	1	1381	5.000000e-1	7.241130e-4	unnamed	MSH2
MSigDB Perturbation	PUJANA_ATM_PCC_NETWORK	Genes constituting the ATM-PCC network of transcripts whose expression positively correlated (Pearson correlation coefficient, PCC &gt;= 0.4) with that of ATM [GeneID=472] across a compendium of normal tissues.	80	1.248339e-1	1.000000e+0	1.000000e+0	8.010648e+0	1.248339e-1	1	1.248339e-1	1.000000e+0	87	1.508194e-1	1.000000e+0	1.000000e+0	6.370410e+0	1.569758e-1	1	1416	5.000000e-1	7.062147e-4	unnamed	MSH2
MSigDB Perturbation	DODD_NASOPHARYNGEAL_CARCINOMA_DN	Genes down-regulated in nasopharyngeal carcinoma (NPC) compared to the normal tissue.	81	1.258050e-1	1.000000e+0	1.000000e+0	7.948812e+0	1.258050e-1	1	1.258050e-1	1.000000e+0	85	1.382073e-1	1.000000e+0	1.000000e+0	6.976411e+0	1.433402e-1	1	1293	5.000000e-1	7.733952e-4	unnamed	MSH2
MSigDB Perturbation	PUJANA_BRCA1_PCC_NETWORK	Genes constituting the BRCA1-PCC network of transcripts whose expression positively correlated (Pearson correlation coefficient, PCC &gt;= 0.4) with that of BRCA1 [GeneID=672] across a compendium of normal tissues.	82	1.292550e-1	1.000000e+0	1.000000e+0	7.736644e+0	1.292550e-1	1	1.292550e-1	1.000000e+0	88	1.731460e-1	1.000000e+0	1.000000e+0	5.513753e+0	1.813647e-1	1	1636	5.000000e-1	6.112469e-4	unnamed	MSH2
MSigDB Perturbation	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	Genes down-regulated in fibroblasts expressing mutant forms of ERCC3 [GeneID=2071] after UV irradiation.	83	1.422357e-1	1.000000e+0	1.000000e+0	7.030586e+0	1.422357e-1	1	1.422357e-1	1.000000e+0	73	9.095579e-2	1.000000e+0	1.000000e+0	1.073869e+1	9.312122e-2	1	840	5.000000e-1	1.190476e-3	unnamed	MSH2
MSigDB Perturbation	BLALOCK_ALZHEIMERS_DISEASE_DN	Genes down-regulated in brain from patients with Alzheimer's disease.	84	1.457059e-1	1.000000e+0	1.000000e+0	6.863142e+0	1.457059e-1	1	1.457059e-1	1.000000e+0	84	1.317114e-1	1.000000e+0	1.000000e+0	7.333740e+0	1.363561e-1	1	1230	5.000000e-1	8.130081e-4	unnamed	MSH2
MSigDB Perturbation	BENPORATH_EED_TARGETS	Set 'Eed targets': genes identified by ChIP on chip as targets of the Polycomb protein EED [GeneID=8726] in human embryonic stem cells.	85	1.549577e-1	1.000000e+0	1.000000e+0	6.453376e+0	1.549577e-1	1	1.549577e-1	1.000000e+0	78	1.083126e-1	1.000000e+0	1.000000e+0	8.975622e+0	1.114129e-1	1	1005	5.000000e-1	9.950249e-4	unnamed	KCNK12
MSigDB Perturbation	MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3	Genes with high-CpG-density promoters (HCP) bearing histone H3 dimethylation at K4 (H3K4me2) and trimethylation at K27 (H3K27me3) in brain.	86	1.581088e-1	1.000000e+0	1.000000e+0	6.324759e+0	1.581088e-1	1	1.581088e-1	1.000000e+0	79	1.118684e-1	1.000000e+0	1.000000e+0	8.681906e+0	1.151821e-1	1	1039	5.000000e-1	9.624639e-4	unnamed	KCNK12
MSigDB Perturbation	BENPORATH_SUZ12_TARGETS	Set 'Suz12 targets': genes identified by ChIP on chip as targets of the Polycomb protein SUZ12 [GeneID=23512] in human embryonic stem cells.	87	1.616879e-1	1.000000e+0	1.000000e+0	6.184754e+0	1.616879e-1	1	1.616879e-1	1.000000e+0	77	1.061128e-1	1.000000e+0	1.000000e+0	9.167175e+0	1.090849e-1	1	984	5.000000e-1	1.016260e-3	unnamed	KCNK12
MSigDB Perturbation	BENPORATH_ES_WITH_H3K27ME3	Set 'H3K27 bound': genes posessing the trimethylated H3K27 (H3K27me3) mark in their promoters in human embryonic stem cells, as identified by ChIP on chip.	88	1.619781e-1	1.000000e+0	1.000000e+0	6.173675e+0	1.619781e-1	1	1.619781e-1	1.000000e+0	80	1.139567e-1	1.000000e+0	1.000000e+0	8.517941e+0	1.173993e-1	1	1059	5.000000e-1	9.442871e-4	unnamed	KCNK12
MSigDB Perturbation	PILON_KLF1_TARGETS_DN	Genes down-regulated in erythroid progenitor cells from fetal livers of E13.5 embryos with KLF1 [GeneID=10661] knockout compared to those from the wild type embryos.	89	1.766774e-1	1.000000e+0	1.000000e+0	5.660033e+0	1.766774e-1	1	1.766774e-1	1.000000e+0	89	2.003385e-1	1.000000e+0	1.000000e+0	4.727725e+0	2.115182e-1	1	1908	5.000000e-1	5.241090e-4	unnamed	MSH2
MSigDB Predicted Promoter Motifs	GTTNYYNNGGTNA_UNKNOWN	Motif GTTNYYNNGGTNA (no known TF)	1	8.097048e-3	1.000000e+0	1.000000e+0	1.235018e+2	8.097048e-3	1	8.097048e-3	1.000000e+0	1	8.849269e-3	1.000000e+0	1.000000e+0	1.127562e+2	8.868688e-3	1	80	5.000000e-1	1.250000e-2	unnamed	KCNK12
MSigDB Predicted Promoter Motifs	SGCGSSAAA_V$E2F1DP2_01	Motif SGCGSSAAA matches E2F1: E2F transcription factor 1&lt;br&gt; TFDP1: transcription factor Dp-1&lt;br&gt; RB1: retinoblastoma 1 (including osteosarcoma)	2	1.245324e-2	1.000000e+0	1.000000e+0	8.030041e+1	1.245324e-2	1	1.245324e-2	1.000000e+0	4	2.062369e-2	1.000000e+0	1.000000e+0	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	TTTNNANAGCYR_UNKNOWN	Motif TTTNNANAGCYR (no known TF)	3	1.536941e-2	1.000000e+0	1.000000e+0	6.506430e+1	1.536941e-2	1	1.536941e-2	1.000000e+0	3	1.623027e-2	1.000000e+0	1.000000e+0	6.136395e+1	1.629621e-2	1	147	5.000000e-1	6.802721e-3	unnamed	KCNK12
MSigDB Predicted Promoter Motifs	V$AR_Q2	Motif AGWACATNWTGTTCT matches AR: androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease)	4	1.915176e-2	1.000000e+0	1.000000e+0	5.221452e+1	1.915176e-2	1	1.915176e-2	1.000000e+0	2	1.336928e-2	1.000000e+0	1.000000e+0	7.454959e+1	1.341389e-2	1	121	5.000000e-1	8.264463e-3	unnamed	KCNK12
MSigDB Predicted Promoter Motifs	V$E2F1DP1RB_01	Motif TTTSGCGC matches E2F1: E2F transcription factor 1&lt;br&gt; TFDP1: transcription factor Dp-1&lt;br&gt; RB1: retinoblastoma 1 (including osteosarcoma)	5	2.030172e-2	1.000000e+0	1.000000e+0	4.925690e+1	2.030172e-2	1	2.030172e-2	1.000000e+0	6	2.522619e-2	1.000000e+0	1.000000e+0	3.939083e+1	2.538662e-2	1	229	5.000000e-1	4.366812e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	V$E2F1_Q6_01	Motif NTTTCGCGCS matches E2F1: E2F transcription factor 1	6	2.079478e-2	1.000000e+0	1.000000e+0	4.808899e+1	2.079478e-2	1	2.079478e-2	1.000000e+0	9	2.555453e-2	1.000000e+0	1.000000e+0	3.888147e+1	2.571920e-2	1	232	5.000000e-1	4.310345e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	V$E2F_02	Motif TTTSGCGC (no known TF)	7	2.146128e-2	1.000000e+0	1.000000e+0	4.659555e+1	2.146128e-2	1	2.146128e-2	1.000000e+0	20	2.796063e-2	1.000000e+0	8.597894e-1	3.551378e+1	2.815808e-2	1	254	5.000000e-1	3.937008e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	V$E2F_Q6	Motif TTTSGCGS (no known TF)	8	2.155031e-2	1.000000e+0	1.000000e+0	4.640305e+1	2.155031e-2	1	2.155031e-2	1.000000e+0	19	2.785133e-2	1.000000e+0	9.015036e-1	3.565415e+1	2.804723e-2	1	253	5.000000e-1	3.952569e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	V$E2F_Q4	Motif TTTSGCGS (no known TF)	9	2.157092e-2	1.000000e+0	1.000000e+0	4.635871e+1	2.157092e-2	1	2.157092e-2	1.000000e+0	10	2.566396e-2	1.000000e+0	1.000000e+0	3.871459e+1	2.583005e-2	1	233	5.000000e-1	4.291845e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	V$E2F1DP2_01	Motif TTTSSCGC matches E2F1: E2F transcription factor 1&lt;br&gt; TFDP2: transcription factor Dp-2 (E2F dimerization partner 2)	10	2.172672e-2	1.000000e+0	1.000000e+0	4.602627e+1	2.172672e-2	1	2.172672e-2	1.000000e+0	20	2.796063e-2	1.000000e+0	8.597894e-1	3.551378e+1	2.815808e-2	1	254	5.000000e-1	3.937008e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	V$E2F4DP2_01	Motif TTTCSCGC matches E2F4: E2F transcription factor 4, p107/p130-binding&lt;br&gt; TFDP2: transcription factor Dp-2 (E2F dimerization partner 2)	10	2.172672e-2	1.000000e+0	1.000000e+0	4.602627e+1	2.172672e-2	1	2.172672e-2	1.000000e+0	20	2.796063e-2	1.000000e+0	8.597894e-1	3.551378e+1	2.815808e-2	1	254	5.000000e-1	3.937008e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	V$E2F1DP1_01	Motif TTTCSCGC matches E2F1: E2F transcription factor 1&lt;br&gt; TFDP1: transcription factor Dp-1	10	2.172672e-2	1.000000e+0	1.000000e+0	4.602627e+1	2.172672e-2	1	2.172672e-2	1.000000e+0	20	2.796063e-2	1.000000e+0	8.597894e-1	3.551378e+1	2.815808e-2	1	254	5.000000e-1	3.937008e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	V$E2F1_Q6	Motif TTTSGCGS matches E2F1: E2F transcription factor 1	13	2.206827e-2	1.000000e+0	1.000000e+0	4.531393e+1	2.206827e-2	1	2.206827e-2	1.000000e+0	18	2.763270e-2	1.000000e+0	9.441173e-1	3.593825e+1	2.782551e-2	1	251	5.000000e-1	3.984064e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	V$E2F4DP1_01	Motif TTTSGCGC matches E2F4: E2F transcription factor 4, p107/p130-binding&lt;br&gt; TFDP1: transcription factor Dp-1	14	2.242736e-2	1.000000e+0	9.852019e-1	4.458839e+1	2.242736e-2	1	2.242736e-2	1.000000e+0	24	2.839779e-2	1.000000e+0	7.276934e-1	3.496318e+1	2.860152e-2	1	258	5.000000e-1	3.875969e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	V$E2F1_Q3	Motif NKTSSCGC matches E2F1: E2F transcription factor 1	15	2.249982e-2	1.000000e+0	9.224926e-1	4.444481e+1	2.249982e-2	1	2.249982e-2	1.000000e+0	12	2.653920e-2	1.000000e+0	1.000000e+0	3.742946e+1	2.671692e-2	1	241	5.000000e-1	4.149378e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	V$AP2GAMMA_01	Motif GCCYNNGGS matches TFAP2C: transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma)	16	2.586850e-2	1.000000e+0	9.943205e-1	3.865705e+1	2.586850e-2	1	2.586850e-2	1.000000e+0	14	2.664858e-2	1.000000e+0	1.000000e+0	3.727479e+1	2.682778e-2	1	242	5.000000e-1	4.132231e-3	unnamed	KCNK12
MSigDB Predicted Promoter Motifs	V$AP2ALPHA_01	Motif GCCNNNRGS matches TFAP2A: transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)	17	2.598670e-2	1.000000e+0	9.401071e-1	3.848122e+1	2.598670e-2	1	2.598670e-2	1.000000e+0	8	2.544509e-2	1.000000e+0	1.000000e+0	3.904978e+1	2.560834e-2	1	231	5.000000e-1	4.329004e-3	unnamed	KCNK12
MSigDB Predicted Promoter Motifs	V$MYOD_Q6_01	Motif CNGNRNCAGGTGNNGNAN matches MYOD1: myogenic differentiation 1	18	2.651834e-2	1.000000e+0	9.060433e-1	3.770975e+1	2.651834e-2	1	2.651834e-2	1.000000e+0	12	2.653920e-2	1.000000e+0	1.000000e+0	3.742946e+1	2.671692e-2	1	241	5.000000e-1	4.149378e-3	unnamed	KCNK12
MSigDB Predicted Promoter Motifs	V$NFY_Q6	Motif TRRCCAATSRN (no known TF)	19	2.815657e-2	1.000000e+0	9.113837e-1	3.551569e+1	2.815657e-2	1	2.815657e-2	1.000000e+0	25	2.905334e-2	1.000000e+0	7.147122e-1	3.416856e+1	2.926667e-2	1	264	5.000000e-1	3.787879e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	V$E47_01	Motif VSNGCAGGTGKNCNN matches TCF3: transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47)	20	2.841388e-2	1.000000e+0	8.737268e-1	3.519407e+1	2.841388e-2	1	2.841388e-2	1.000000e+0	16	2.697668e-2	1.000000e+0	1.000000e+0	3.681837e+1	2.716036e-2	1	245	5.000000e-1	4.081633e-3	unnamed	KCNK12
MSigDB Predicted Promoter Motifs	V$E12_Q6	Motif RRCAGGTGNCV matches TCF3: transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47)	21	3.028492e-2	1.000000e+0	8.869155e-1	3.301973e+1	3.028492e-2	1	3.028492e-2	1.000000e+0	17	2.752338e-2	1.000000e+0	9.956987e-1	3.608200e+1	2.771465e-2	1	250	5.000000e-1	4.000000e-3	unnamed	KCNK12
MSigDB Predicted Promoter Motifs	V$GATA1_01	Motif SNNGATNNNN matches GATA1: GATA binding protein 1 (globin transcription factor 1)	22	3.085231e-2	1.000000e+0	8.624623e-1	3.241249e+1	3.085231e-2	1	3.085231e-2	1.000000e+0	5	2.478833e-2	1.000000e+0	1.000000e+0	4.009111e+1	2.494318e-2	1	225	5.000000e-1	4.444444e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	V$HNF1_C	Motif DGTTAATKAWTNACCAM matches TCF1: transcription factor 1, hepatic; LF-B1, hepatic nuclear factor (HNF1), albumin proximal factor	23	3.766180e-2	1.000000e+0	1.000000e+0	2.655211e+1	3.766180e-2	1	3.766180e-2	1.000000e+0	7	2.533565e-2	1.000000e+0	1.000000e+0	3.921957e+1	2.549748e-2	1	230	5.000000e-1	4.347826e-3	unnamed	KCNK12
MSigDB Predicted Promoter Motifs	V$TCF11_01	Motif GTCATNNWNNNNN matches NFE2L1: nuclear factor (erythroid-derived 2)-like 1	24	3.906347e-2	1.000000e+0	1.000000e+0	2.559936e+1	3.906347e-2	1	3.906347e-2	1.000000e+0	11	2.642982e-2	1.000000e+0	1.000000e+0	3.758542e+1	2.660606e-2	1	240	5.000000e-1	4.166667e-3	unnamed	KCNK12
MSigDB Predicted Promoter Motifs	V$TATA_C	Motif NCTATAAAAR matches TAF&lt;br&gt; TATA	25	4.326028e-2	1.000000e+0	1.000000e+0	2.311589e+1	4.326028e-2	1	4.326028e-2	1.000000e+0	26	3.036376e-2	1.000000e+0	7.182197e-1	3.268297e+1	3.059697e-2	1	276	5.000000e-1	3.623188e-3	unnamed	KCNK12
MSigDB Predicted Promoter Motifs	TGCGCANK_UNKNOWN	Motif TGCGCANK (no known TF)	26	4.586364e-2	1.000000e+0	1.000000e+0	2.180377e+1	4.586364e-2	1	4.586364e-2	1.000000e+0	27	5.670958e-2	1.000000e+0	1.000000e+0	1.738054e+1	5.753561e-2	1	519	5.000000e-1	1.926782e-3	unnamed	MSH2
MSigDB Predicted Promoter Motifs	V$CDC5_01	Motif GATTTAACATAA matches CDC5L: CDC5 cell division cycle 5-like (S. pombe)	27	4.686973e-2	1.000000e+0	1.000000e+0	2.133573e+1	4.686973e-2	1	4.686973e-2	1.000000e+0	15	2.675795e-2	1.000000e+0	1.000000e+0	3.712140e+1	2.693864e-2	1	243	5.000000e-1	4.115226e-3	unnamed	KCNK12
MSigDB Predicted Promoter Motifs	TGCTGAY_UNKNOWN	Motif TGCTGAY (no known TF)	28	7.174661e-2	1.000000e+0	1.000000e+0	1.393794e+1	7.174661e-2	1	7.174661e-2	1.000000e+0	28	5.692491e-2	1.000000e+0	1.000000e+0	1.731382e+1	5.775733e-2	1	521	5.000000e-1	1.919386e-3	unnamed	KCNK12
MSigDB Predicted Promoter Motifs	GATTGGY_V$NFY_Q6_01	Motif GATTGGY (no known TF)	29	1.117321e-1	1.000000e+0	1.000000e+0	8.949976e+0	1.117321e-1	1	1.117321e-1	1.000000e+0	30	1.216620e-1	1.000000e+0	1.000000e+0	7.961606e+0	1.256028e-1	1	1133	5.000000e-1	8.826125e-4	unnamed	MSH2
MSigDB Predicted Promoter Motifs	GGGTGGRR_V$PAX4_03	Motif GGGTGGRR matches PAX4: paired box gene 4	30	1.242001e-1	1.000000e+0	1.000000e+0	8.051523e+0	1.242001e-1	1	1.242001e-1	1.000000e+0	31	1.337762e-1	1.000000e+0	1.000000e+0	7.216400e+0	1.385732e-1	1	1250	5.000000e-1	8.000000e-4	unnamed	KCNK12
MSigDB Predicted Promoter Motifs	CTTTAAR_UNKNOWN	Motif CTTTAAR (no known TF)	31	1.299965e-1	1.000000e+0	1.000000e+0	7.692514e+0	1.299965e-1	1	1.299965e-1	1.000000e+0	29	9.960251e-2	1.000000e+0	1.000000e+0	9.783623e+0	1.022116e-1	1	922	5.000000e-1	1.084599e-3	unnamed	KCNK12
MSigDB Predicted Promoter Motifs	TATAAA_V$TATA_01	Motif TATAAA matches TAF&lt;br&gt; TATA	32	1.585244e-1	1.000000e+0	1.000000e+0	6.308178e+0	1.585244e-1	1	1.585244e-1	1.000000e+0	32	1.364568e-1	1.000000e+0	1.000000e+0	7.069357e+0	1.414556e-1	1	1276	5.000000e-1	7.836991e-4	unnamed	KCNK12
MSigDB Predicted Promoter Motifs	GGGCGGR_V$SP1_Q6	Motif GGGCGGR matches SP1: Sp1 transcription factor	33	2.425080e-1	1.000000e+0	1.000000e+0	4.123575e+0	2.425080e-1	1	2.425080e-1	1.000000e+0	35	2.900650e-1	1.000000e+0	1.000000e+0	3.176232e+0	3.148384e-1	1	2840	5.000000e-1	3.521127e-4	unnamed	KCNK12
MSigDB Predicted Promoter Motifs	CAGGTG_V$E12_Q6	Motif CAGGTG matches TCF3: transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47)	34	2.657598e-1	1.000000e+0	1.000000e+0	3.762796e+0	2.657598e-1	1	2.657598e-1	1.000000e+0	34	2.455801e-1	1.000000e+0	1.000000e+0	3.804513e+0	2.628457e-1	1	2371	5.000000e-1	4.217630e-4	unnamed	KCNK12
MSigDB Predicted Promoter Motifs	AACTTT_UNKNOWN	Motif AACTTT (no known TF)	35	2.964325e-1	1.000000e+0	1.000000e+0	3.373449e+0	2.964325e-1	1	2.964325e-1	1.000000e+0	33	1.917900e-1	1.000000e+0	1.000000e+0	4.950878e+0	2.019844e-1	1	1822	5.000000e-1	5.488474e-4	unnamed	KCNK12
MSigDB miRNA Motifs	GCGCTTT,MIR-518B,MIR-518C,MIR-518D	Targets of MicroRNA GCGCTTT,MIR-518B,MIR-518C,MIR-518D	1	4.444995e-3	9.823439e-1	9.823439e-1	2.249721e+2	4.444995e-3	1	4.444995e-3	1.000000e+0	1	2.216004e-3	4.897369e-1	4.897369e-1	4.510250e+2	2.217172e-3	1	20	5.000000e-1	5.000000e-2	unnamed	KCNK12
InterPro	IPR011184	DNA mismatch repair protein, MSH2	1	6.982440e-5	6.578855e-1	6.578855e-1	1.432164e+4	6.982440e-5	1	6.982440e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	MSH2
InterPro	IPR007695	DNA mismatch repair protein MutS-like, N-terminal	2	1.868510e-4	1.000000e+0	8.802551e-1	5.351857e+3	1.868510e-4	1	1.868510e-4	1.000000e+0	3	3.325574e-4	1.000000e+0	1.000000e+0	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	MSH2
InterPro	IPR005410	Two pore domain potassium channel, THIK	3	2.327287e-4	1.000000e+0	7.309233e-1	4.296849e+3	2.327287e-4	1	2.327287e-4	1.000000e+0	2	2.217111e-4	1.000000e+0	1.000000e+0	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	KCNK12
InterPro	IPR007860	DNA mismatch repair protein MutS, connector domain	4	2.372577e-4	1.000000e+0	5.588605e-1	4.214827e+3	2.372577e-4	1	2.372577e-4	1.000000e+0	4	4.433975e-4	1.000000e+0	1.000000e+0	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	MSH2
InterPro	IPR007696	DNA mismatch repair protein MutS, core	5	2.516827e-4	1.000000e+0	4.742709e-1	3.973257e+3	2.516827e-4	1	2.516827e-4	1.000000e+0	5	6.650594e-4	1.000000e+0	1.000000e+0	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	MSH2
InterPro	IPR007861	DNA mismatch repair protein MutS, clamp	5	2.516827e-4	1.000000e+0	4.742709e-1	3.973257e+3	2.516827e-4	1	2.516827e-4	1.000000e+0	5	6.650594e-4	1.000000e+0	1.000000e+0	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	MSH2
InterPro	IPR000432	DNA mismatch repair protein MutS, C-terminal	5	2.516827e-4	1.000000e+0	4.742709e-1	3.973257e+3	2.516827e-4	1	2.516827e-4	1.000000e+0	5	6.650594e-4	1.000000e+0	1.000000e+0	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	MSH2
InterPro	IPR003280	Two pore domain potassium channel	8	1.585917e-3	1.000000e+0	1.000000e+0	6.305501e+2	1.585917e-3	1	1.585917e-3	1.000000e+0	8	1.662234e-3	1.000000e+0	1.000000e+0	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	KCNK12
InterPro	IPR013099	Two pore domain potassium channel domain	9	3.416073e-3	1.000000e+0	1.000000e+0	2.927338e+2	3.416073e-3	1	3.416073e-3	1.000000e+0	9	2.437470e-3	1.000000e+0	1.000000e+0	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	KCNK12
InterPro	IPR027417	P-loop containing nucleoside triphosphate hydrolase	10	7.861815e-2	1.000000e+0	1.000000e+0	1.271971e+1	7.861815e-2	1	7.861815e-2	1.000000e+0	10	9.275180e-2	1.000000e+0	1.000000e+0	1.052567e+1	9.500582e-2	1	857	5.000000e-1	1.166861e-3	unnamed	MSH2
TreeFam	TF351780	MSH2	1	6.982440e-5	5.673931e-1	5.673931e-1	1.432164e+4	6.982440e-5	1	6.982440e-5	1.000000e+0	1	1.108586e-4	9.008370e-1	9.008370e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	MSH2
Ensembl Genes	10933	MSH2	1	6.982440e-5	1.000000e+0	1.000000e+0	1.432164e+4	6.982440e-5	1	6.982440e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	MSH2
Ensembl Genes	10934	KCNK12	2	1.307471e-4	1.000000e+0	1.000000e+0	7.648355e+3	1.307471e-4	1	1.307471e-4	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	KCNK12
MSigDB Oncogenic Signatures	YAP1_UP	Genes up-regulated in MCF10A cells (breast cancer) over-expressing YAP1 [Gene ID=10413] gene.	1	4.659433e-3	8.713140e-1	8.713140e-1	2.146184e+2	4.659433e-3	1	4.659433e-3	1.000000e+0	1	4.650770e-3	8.696940e-1	8.696940e-1	2.147738e+2	4.656061e-3	1	42	5.000000e-1	2.380952e-2	unnamed	KCNK12
MSigDB Oncogenic Signatures	RPS14_DN.V1_DN	Genes down-regulated in CD34+ hematopoietic progenitor cells after knockdown of RPS14 [Gene ID=6208] by RNAi.	2	1.454501e-2	1.000000e+0	1.000000e+0	6.875211e+1	1.454501e-2	1	1.454501e-2	1.000000e+0	3	2.029452e-2	1.000000e+0	1.000000e+0	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	MSH2
MSigDB Oncogenic Signatures	NOTCH_DN.V1_UP	Genes up-regulated in MOLT4 cells (T-ALL) by DAPT [PubChem=16219261], an inhibitor of NOTCH signaling pathway.	3	1.706381e-2	1.000000e+0	1.000000e+0	5.860357e+1	1.706381e-2	1	1.706381e-2	1.000000e+0	2	1.941648e-2	1.000000e+0	1.000000e+0	5.125284e+1	1.951111e-2	1	176	5.000000e-1	5.681818e-3	unnamed	KCNK12
MSigDB Oncogenic Signatures	ERB2_UP.V1_DN	Genes down-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] and engineered to express ligand-activatable ERBB2 [Gene ID=2064].	4	2.349699e-2	1.000000e+0	1.000000e+0	4.255865e+1	2.349699e-2	1	2.349699e-2	1.000000e+0	4	2.117217e-2	1.000000e+0	9.897989e-1	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	MSH2
MSigDB Oncogenic Signatures	TBK1.DF_DN	Genes down-regulated in epithelial lung cancer cell lines upon over-expression of an oncogenic form of KRAS [Gene ID=3845] gene and knockdown of TBK1 [Gene ID=29110] gene by RNAi.	5	3.599592e-2	1.000000e+0	1.000000e+0	2.778093e+1	3.599592e-2	1	3.599592e-2	1.000000e+0	5	3.210963e-2	1.000000e+0	1.000000e+0	3.089212e+1	3.237071e-2	1	292	5.000000e-1	3.424658e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 6 h.	1	1.127530e-2	1.000000e+0	1.000000e+0	8.868940e+1	1.127530e-2	1	1.127530e-2	1.000000e+0	16	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 4 h.	2	1.296595e-2	1.000000e+0	1.000000e+0	7.712510e+1	1.296595e-2	1	1.296595e-2	1.000000e+0	3	2.018479e-2	1.000000e+0	1.000000e+0	4.929235e+1	2.028712e-2	1	183	5.000000e-1	5.464481e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE3982_MAST_CELL_VS_TH2_DN	Genes down-regulated in comparison of mast cells versus Th2 cells.	3	1.345597e-2	1.000000e+0	1.000000e+0	7.431648e+1	1.345597e-2	1	1.345597e-2	1.000000e+0	37	2.215906e-2	1.000000e+0	1.000000e+0	4.487811e+1	2.228258e-2	1	201	5.000000e-1	4.975124e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_UP	Genes up-regulated in comparison of polysome bound (translated) mRNA before and 4 h after LPS (TLR4 agonist) stimulation.	4	1.361816e-2	1.000000e+0	1.000000e+0	7.343134e+1	1.361816e-2	1	1.361816e-2	1.000000e+0	14	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP	Genes up-regulated in comparison of CD4 [GeneID=920] thymocytes versus thymic stromal cells.	5	1.377939e-2	1.000000e+0	1.000000e+0	7.257216e+1	1.377939e-2	1	1.377939e-2	1.000000e+0	5	2.040425e-2	1.000000e+0	1.000000e+0	4.875946e+1	2.050884e-2	1	185	5.000000e-1	5.405405e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 10 h.	6	1.394933e-2	1.000000e+0	1.000000e+0	7.168801e+1	1.394933e-2	1	1.394933e-2	1.000000e+0	6	2.051397e-2	1.000000e+0	1.000000e+0	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 6 h versus cDCs infected with Newcastle disease virus (NDV) at 6 h.	7	1.417033e-2	1.000000e+0	1.000000e+0	7.056996e+1	1.417033e-2	1	1.417033e-2	1.000000e+0	6	2.051397e-2	1.000000e+0	1.000000e+0	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE360_L_MAJOR_VS_T_GONDII_MAC_DN	Genes down-regulated in comparison of macrophages exposed to L. major versus macrophages exposed to M. tuberculosis.	8	1.439255e-2	1.000000e+0	1.000000e+0	6.948041e+1	1.439255e-2	1	1.439255e-2	1.000000e+0	45	2.314545e-2	1.000000e+0	9.823958e-1	4.295476e+1	2.328031e-2	1	210	5.000000e-1	4.761905e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 12 h.	9	1.461935e-2	1.000000e+0	1.000000e+0	6.840248e+1	1.461935e-2	1	1.461935e-2	1.000000e+0	6	2.051397e-2	1.000000e+0	1.000000e+0	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE360_CTRL_VS_L_MAJOR_MAC_UP	Genes up-regulated in comparison of macrophages versus macrophages exposed to L. major.	10	1.474389e-2	1.000000e+0	1.000000e+0	6.782470e+1	1.474389e-2	1	1.474389e-2	1.000000e+0	34	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_DN	Genes down-regulated in comparison of virus specific (gp33) exhausted CD8 T cells versus the virus specific (gp276) cells.	11	1.475137e-2	1.000000e+0	1.000000e+0	6.779029e+1	1.475137e-2	1	1.475137e-2	1.000000e+0	29	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE3982_BASOPHIL_VS_TH2_DN	Genes down-regulated in comparison of basophils versus Th2 cells.	12	1.531831e-2	1.000000e+0	1.000000e+0	6.528134e+1	1.531831e-2	1	1.531831e-2	1.000000e+0	25	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 1 day after stimulation with YF17D vaccine versus PBMC 7 days after the stimulation.	13	1.539378e-2	1.000000e+0	1.000000e+0	6.496130e+1	1.539378e-2	1	1.539378e-2	1.000000e+0	16	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC 7 days after stimulation with YF17D vaccine.	14	1.559108e-2	1.000000e+0	1.000000e+0	6.413926e+1	1.559108e-2	1	1.559108e-2	1.000000e+0	21	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN	Genes down-regulated in comparison of IgD- peripheral blood B cells versus dark zone germinal center B cells.	15	1.582168e-2	1.000000e+0	1.000000e+0	6.320441e+1	1.582168e-2	1	1.582168e-2	1.000000e+0	28	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE3982_BASOPHIL_VS_TH1_DN	Genes down-regulated in comparison of basophils versus Th1 cells.	16	1.586461e-2	1.000000e+0	1.000000e+0	6.303338e+1	1.586461e-2	1	1.586461e-2	1.000000e+0	16	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE3982_MEMORY_CD4_TCELL_VS_TH2_DN	Genes down-regulated in comparison of memory CD4 [GeneID=920] T cells versus Th2 cells.	17	1.608243e-2	1.000000e+0	1.000000e+0	6.217967e+1	1.608243e-2	1	1.608243e-2	1.000000e+0	46	2.347414e-2	1.000000e+0	9.746871e-1	4.234977e+1	2.361288e-2	1	213	5.000000e-1	4.694836e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_UP	Genes up-regulated in comparison of intrathymic T progenitor cells (ITTP) versus thymic stromal cells.	18	1.658251e-2	1.000000e+0	1.000000e+0	6.030451e+1	1.658251e-2	1	1.658251e-2	1.000000e+0	10	2.062369e-2	1.000000e+0	1.000000e+0	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE27786_NKCELL_VS_MONO_MAC_UP	Genes up-regulated in comparison of NK cells versus monocyte macrophages.	19	1.665736e-2	1.000000e+0	1.000000e+0	6.003353e+1	1.665736e-2	1	1.665736e-2	1.000000e+0	29	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE27786_NKTCELL_VS_MONO_MAC_DN	Genes down-regulated in comparison of NKT cells versus monocyte macrophages.	20	1.677996e-2	1.000000e+0	1.000000e+0	5.959490e+1	1.677996e-2	1	1.677996e-2	1.000000e+0	33	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	KCNK12
MSigDB Immunologic Signatures	GSE3982_MEMORY_CD4_TCELL_VS_TH1_DN	Genes down-regulated in comparison of memory CD4 [GeneID=920] T cells versus Th1 cells.	21	1.678214e-2	1.000000e+0	1.000000e+0	5.958715e+1	1.678214e-2	1	1.678214e-2	1.000000e+0	37	2.215906e-2	1.000000e+0	1.000000e+0	4.487811e+1	2.228258e-2	1	201	5.000000e-1	4.975124e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE27786_CD8_TCELL_VS_NKCELL_UP	Genes up-regulated in comparison of CD8 T cells versus NK cells.	22	1.683751e-2	1.000000e+0	1.000000e+0	5.939121e+1	1.683751e-2	1	1.683751e-2	1.000000e+0	16	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_UP	Genes up-regulated in comparison of macrophages exposed to T. gondii versus macrophages exposed to M. tuberculosis.	23	1.695740e-2	1.000000e+0	1.000000e+0	5.897129e+1	1.695740e-2	1	1.695740e-2	1.000000e+0	41	2.259752e-2	1.000000e+0	1.000000e+0	4.400244e+1	2.272601e-2	1	205	5.000000e-1	4.878049e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_UP	Genes up-regulated in comparison of control conventional dendritic cells (cDC) at 0 h versus cDCs infected with Newcastle disease virus (NDV) at 16 h.	24	1.718212e-2	1.000000e+0	1.000000e+0	5.820004e+1	1.718212e-2	1	1.718212e-2	1.000000e+0	21	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE360_CTRL_VS_T_GONDII_MAC_DN	Genes down-regulated in comparison of macrophages versus macrophages exposed to T. gondii.	25	1.718937e-2	1.000000e+0	1.000000e+0	5.817548e+1	1.718937e-2	1	1.718937e-2	1.000000e+0	36	2.204943e-2	1.000000e+0	1.000000e+0	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE3982_NKCELL_VS_TH2_DN	Genes down-regulated in comparison of NK cells versus Th2 cells.	26	1.720574e-2	1.000000e+0	1.000000e+0	5.812015e+1	1.720574e-2	1	1.720574e-2	1.000000e+0	43	2.281671e-2	1.000000e+0	1.000000e+0	4.357729e+1	2.294773e-2	1	207	5.000000e-1	4.830918e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP	Genes up-regulated in comparison of control microglia cells versus those 6 h after stimulation with IFNG [GeneID=3458].	27	1.736983e-2	1.000000e+0	1.000000e+0	5.757108e+1	1.736983e-2	1	1.736983e-2	1.000000e+0	12	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE27786_BCELL_VS_MONO_MAC_DN	Genes down-regulated in comparison of B cells versus monocyte macrophages.	28	1.741414e-2	1.000000e+0	1.000000e+0	5.742461e+1	1.741414e-2	1	1.741414e-2	1.000000e+0	23	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	KCNK12
MSigDB Immunologic Signatures	GSE3982_NKCELL_VS_TH1_DN	Genes down-regulated in comparison of NK cells versus Th1 cells.	29	1.767959e-2	1.000000e+0	1.000000e+0	5.656238e+1	1.767959e-2	1	1.767959e-2	1.000000e+0	29	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_UP	Genes up-regulated in comparison of macrophages exposed to T. gondii versus  macrophages exposed to 50 worms/well B. malayi.	30	1.809191e-2	1.000000e+0	1.000000e+0	5.527332e+1	1.809191e-2	1	1.809191e-2	1.000000e+0	41	2.259752e-2	1.000000e+0	1.000000e+0	4.400244e+1	2.272601e-2	1	205	5.000000e-1	4.878049e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_UP	Genes up-regulated in comparison of TregCD103-Klrg1- versus TregCD103+Klrg1- (see Table 1S in the paper for details).	31	1.836806e-2	1.000000e+0	1.000000e+0	5.444234e+1	1.836806e-2	1	1.836806e-2	1.000000e+0	6	2.051397e-2	1.000000e+0	1.000000e+0	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	KCNK12
MSigDB Immunologic Signatures	GSE27786_NKCELL_VS_NKTCELL_DN	Genes down-regulated in comparison of NK cells versus NKT cells.	32	1.870951e-2	1.000000e+0	1.000000e+0	5.344875e+1	1.870951e-2	1	1.870951e-2	1.000000e+0	4	2.029452e-2	1.000000e+0	1.000000e+0	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE3982_MAST_CELL_VS_TH1_DN	Genes down-regulated in comparison of mast cells versus Th1 cells.	33	1.880871e-2	1.000000e+0	1.000000e+0	5.316686e+1	1.880871e-2	1	1.880871e-2	1.000000e+0	25	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE360_L_DONOVANI_VS_L_MAJOR_MAC_UP	Genes up-regulated in comparison of macrophages exposed to L. donovani versus macrophages exposed to L. major.	34	1.884169e-2	1.000000e+0	1.000000e+0	5.307378e+1	1.884169e-2	1	1.884169e-2	1.000000e+0	35	2.193980e-2	1.000000e+0	1.000000e+0	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE360_L_DONOVANI_VS_T_GONDII_DC_DN	Genes down-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to T. gondii.	35	1.891202e-2	1.000000e+0	1.000000e+0	5.287643e+1	1.891202e-2	1	1.891202e-2	1.000000e+0	29	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN	Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus CD4 [GeneID=920] effector memory T cells.	36	1.920016e-2	1.000000e+0	1.000000e+0	5.208290e+1	1.920016e-2	1	1.920016e-2	1.000000e+0	2	1.963603e-2	1.000000e+0	1.000000e+0	5.067697e+1	1.973283e-2	1	178	5.000000e-1	5.617978e-3	unnamed	KCNK12
MSigDB Immunologic Signatures	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP	Genes up-regulated in comparison of intrathymic T progenitor cells (ITTP) versus naive CD4 [GeneID=920] T cells from cord blood.	37	1.927061e-2	1.000000e+0	9.947801e-1	5.189250e+1	1.927061e-2	1	1.927061e-2	1.000000e+0	44	2.303588e-2	1.000000e+0	9.999666e-1	4.316029e+1	2.316945e-2	1	209	5.000000e-1	4.784689e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE22886_IGA_VS_IGM_MEMORY_BCELL_DN	Genes down-regulated in comparison of memory IgG IgA B cells versus memory IgM B cells.	38	1.993829e-2	1.000000e+0	1.000000e+0	5.015475e+1	1.993829e-2	1	1.993829e-2	1.000000e+0	25	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	KCNK12
MSigDB Immunologic Signatures	GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_DN	Genes down-regulated in comparison of effective memory CD4 [GeneID=920] T cells versus central memory CD4 [GeneID=920] T cells.	39	2.011301e-2	1.000000e+0	9.850218e-1	4.971907e+1	2.011301e-2	1	2.011301e-2	1.000000e+0	16	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with R848 at 8 h versus DCs stimulated with LPS (TLR4 agonist) and R848 for 8 h.	40	2.047346e-2	1.000000e+0	9.776077e-1	4.884371e+1	2.047346e-2	1	2.047346e-2	1.000000e+0	1	1.886750e-2	1.000000e+0	1.000000e+0	5.275146e+1	1.895682e-2	1	171	5.000000e-1	5.847953e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP	Genes up-regulated in comparison of CD4 [GeneID=920] thymocytes versus naive CD4 [GeneID=920] T cells from cord blood.	41	2.191022e-2	1.000000e+0	1.000000e+0	4.564081e+1	2.191022e-2	1	2.191022e-2	1.000000e+0	37	2.215906e-2	1.000000e+0	1.000000e+0	4.487811e+1	2.228258e-2	1	201	5.000000e-1	4.975124e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE22886_NAIVE_TCELL_VS_MONOCYTE_UP	Genes up-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus monocytes cultured for 0 days.	42	2.217254e-2	1.000000e+0	1.000000e+0	4.510083e+1	2.217254e-2	1	2.217254e-2	1.000000e+0	10	2.062369e-2	1.000000e+0	1.000000e+0	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP	Genes up-regulated in comparison of CD4 [GeneID=920] thymocytes versus naive CD4 [GeneID=920] T cells from adult blood.	43	2.231274e-2	1.000000e+0	9.911008e-1	4.481744e+1	2.231274e-2	1	2.231274e-2	1.000000e+0	40	2.237830e-2	1.000000e+0	1.000000e+0	4.443596e+1	2.250430e-2	1	203	5.000000e-1	4.926108e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_UP	Genes up-regulated in comparison of naive CD8 T cells versus day 0 monocytes.	44	2.394608e-2	1.000000e+0	1.000000e+0	4.176049e+1	2.394608e-2	1	2.394608e-2	1.000000e+0	23	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE10325_CD4_TCELL_VS_MYELOID_UP	Genes up-regulated in comparison of healthy CD4 [GeneID=920] T cells versus healthy myeloid cells.	45	2.519278e-2	1.000000e+0	1.000000e+0	3.969391e+1	2.519278e-2	1	2.519278e-2	1.000000e+0	12	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	MSH2
MSigDB Immunologic Signatures	GSE7852_TREG_VS_TCONV_LN_DN	Genes down-regulated in comparison of lymph node regulatory T cells versus lymph node conventional T cells.	46	2.534373e-2	1.000000e+0	1.000000e+0	3.945749e+1	2.534373e-2	1	2.534373e-2	1.000000e+0	14	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	KCNK12
#
# Ontology	TermsTested	MinAnnotCount	MaxAnnotCount
#
# GO Molecular Function	3688	1	Inf
# GO Biological Process	10440	1	Inf
# GO Cellular Component	1265	1	Inf
# Mouse Phenotype	7918	1	Inf
# Human Phenotype	6146	1	Inf
# Disease Ontology	2235	1	Inf
# MSigDB Cancer Neighborhood	427	1	Inf
# Placenta Disorders	3	1	Inf
# PANTHER Pathway	152	1	Inf
# BioCyc Pathway	332	1	Inf
# MSigDB Pathway	1320	1	Inf
# MGI Expression: Detected	9337	1	Inf
# MSigDB Perturbation	3364	1	Inf
# MSigDB Predicted Promoter Motifs	615	1	Inf
# MSigDB miRNA Motifs	221	1	Inf
# InterPro	9422	1	Inf
# TreeFam	8126	1	Inf
# HGNC Gene Families	478	1	Inf
# Ensembl Genes	18041	1	Inf
# MSigDB Oncogenic Signatures	187	1	Inf
# MSigDB Immunologic Signatures	1910	1	Inf
